{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-105","SUBJID":"id-105","SITEID":"BRA-1","AGE":38,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":4.15691,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-12","TRTSDTM":"2020-10-12 15:04:31","TRTEDTM":"2021-09-24 04:26:07","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":347,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-24","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03062,"AVALU":"YEARS","ADTM":"2021-07-07","ADY":268,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-105","SUBJID":"id-105","SITEID":"BRA-1","AGE":38,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":4.15691,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-12","TRTSDTM":"2020-10-12 15:04:31","TRTEDTM":"2021-09-24 04:26:07","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":347,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-24","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.11939,"AVALU":"YEARS","ADTM":"2021-05-28","ADY":228,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-105","SUBJID":"id-105","SITEID":"BRA-1","AGE":38,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":4.15691,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-12","TRTSDTM":"2020-10-12 15:04:31","TRTEDTM":"2021-09-24 04:26:07","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":347,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-24","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.63408,"AVALU":"YEARS","ADTM":"2021-06-14","ADY":245,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-134","SUBJID":"id-134","SITEID":"BRA-1","AGE":47,"SEX":"M","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":6.46299,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-09","TRTSDTM":"2021-06-10 13:26:53","TRTEDTM":"2023-06-11 01:05:17","EOSSTT":"COMPLETED","EOSDT":"2023-06-11","EOSDY":731,"DTHDT":"2023-06-11","LSTALVDT":"2023-06-29","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12154,"AVALU":"YEARS","ADTM":"2022-05-31","ADY":355,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-134","SUBJID":"id-134","SITEID":"BRA-1","AGE":47,"SEX":"M","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":6.46299,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-09","TRTSDTM":"2021-06-10 13:26:53","TRTEDTM":"2023-06-11 01:05:17","EOSSTT":"COMPLETED","EOSDT":"2023-06-11","EOSDY":731,"DTHDT":"2023-06-11","LSTALVDT":"2023-06-29","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.04026,"AVALU":"YEARS","ADTM":"2022-10-27","ADY":504,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-134","SUBJID":"id-134","SITEID":"BRA-1","AGE":47,"SEX":"M","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":6.46299,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-09","TRTSDTM":"2021-06-10 13:26:53","TRTEDTM":"2023-06-11 01:05:17","EOSSTT":"COMPLETED","EOSDT":"2023-06-11","EOSDY":731,"DTHDT":"2023-06-11","LSTALVDT":"2023-06-29","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.30461,"AVALU":"YEARS","ADTM":"2022-02-18","ADY":253,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-141","SUBJID":"id-141","SITEID":"BRA-1","AGE":35,"SEX":"F","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":7.51608,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-02-25","TRTSDTM":"2021-02-28 23:47:16","TRTEDTM":"2023-03-01 11:25:40","EOSSTT":"COMPLETED","EOSDT":"2023-03-01","EOSDY":731,"DTHDT":"2023-03-01","LSTALVDT":"2023-03-30","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.17006,"AVALU":"YEARS","ADTM":"2022-04-05","ADY":401,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-141","SUBJID":"id-141","SITEID":"BRA-1","AGE":35,"SEX":"F","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":7.51608,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-02-25","TRTSDTM":"2021-02-28 23:47:16","TRTEDTM":"2023-03-01 11:25:40","EOSSTT":"COMPLETED","EOSDT":"2023-03-01","EOSDY":731,"DTHDT":"2023-03-01","LSTALVDT":"2023-03-30","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.4109,"AVALU":"YEARS","ADTM":"2021-10-08","ADY":222,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-141","SUBJID":"id-141","SITEID":"BRA-1","AGE":35,"SEX":"F","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":7.51608,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-02-25","TRTSDTM":"2021-02-28 23:47:16","TRTEDTM":"2023-03-01 11:25:40","EOSSTT":"COMPLETED","EOSDT":"2023-03-01","EOSDY":731,"DTHDT":"2023-03-01","LSTALVDT":"2023-03-30","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.10756,"AVALU":"YEARS","ADTM":"2022-01-18","ADY":324,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-236","SUBJID":"id-236","SITEID":"BRA-1","AGE":32,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":7.663,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-17","TRTSDTM":"2021-08-21 18:13:25","TRTEDTM":"2023-08-22 05:51:49","EOSSTT":"COMPLETED","EOSDT":"2023-08-22","EOSDY":731,"DTHDT":"2023-08-22","LSTALVDT":"2023-09-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.08053,"AVALU":"YEARS","ADTM":"2023-03-03","ADY":559,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-236","SUBJID":"id-236","SITEID":"BRA-1","AGE":32,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":7.663,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-17","TRTSDTM":"2021-08-21 18:13:25","TRTEDTM":"2023-08-22 05:51:49","EOSSTT":"COMPLETED","EOSDT":"2023-08-22","EOSDY":731,"DTHDT":"2023-08-22","LSTALVDT":"2023-09-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.23239,"AVALU":"YEARS","ADTM":"2021-11-01","ADY":72,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-236","SUBJID":"id-236","SITEID":"BRA-1","AGE":32,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":7.663,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-17","TRTSDTM":"2021-08-21 18:13:25","TRTEDTM":"2023-08-22 05:51:49","EOSSTT":"COMPLETED","EOSDT":"2023-08-22","EOSDY":731,"DTHDT":"2023-08-22","LSTALVDT":"2023-09-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02904,"AVALU":"YEARS","ADTM":"2023-08-21","ADY":730,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-265","SUBJID":"id-265","SITEID":"BRA-1","AGE":25,"SEX":"M","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":10.32335,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-09","TRTSDTM":"2020-05-13 00:38:12","TRTEDTM":"2021-09-18 15:23:35","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":494,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-18","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.16375,"AVALU":"YEARS","ADTM":"2020-11-13","ADY":184,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-265","SUBJID":"id-265","SITEID":"BRA-1","AGE":25,"SEX":"M","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":10.32335,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-09","TRTSDTM":"2020-05-13 00:38:12","TRTEDTM":"2021-09-18 15:23:35","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":494,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-18","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.31437,"AVALU":"YEARS","ADTM":"2021-07-02","ADY":415,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-265","SUBJID":"id-265","SITEID":"BRA-1","AGE":25,"SEX":"M","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":10.32335,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-09","TRTSDTM":"2020-05-13 00:38:12","TRTEDTM":"2021-09-18 15:23:35","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":494,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-18","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00612,"AVALU":"YEARS","ADTM":"2020-07-18","ADY":66,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-42","SUBJID":"id-42","SITEID":"BRA-1","AGE":36,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":2.26754,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-06","TRTSDTM":"2020-08-07 06:44:59","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.06609,"AVALU":"YEARS","ADTM":"2022-05-05","ADY":636,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-42","SUBJID":"id-42","SITEID":"BRA-1","AGE":36,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":2.26754,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-06","TRTSDTM":"2020-08-07 06:44:59","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.19855,"AVALU":"YEARS","ADTM":"2022-07-03","ADY":695,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-42","SUBJID":"id-42","SITEID":"BRA-1","AGE":36,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":2.26754,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-06","TRTSDTM":"2020-08-07 06:44:59","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.16461,"AVALU":"YEARS","ADTM":"2021-04-23","ADY":259,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-65","SUBJID":"id-65","SITEID":"BRA-1","AGE":25,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":7.34092,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-02-18","TRTSDTM":"2020-02-18 22:33:01","TRTEDTM":"2022-02-18 10:11:25","EOSSTT":"COMPLETED","EOSDT":"2022-02-18","EOSDY":731,"DTHDT":"2022-02-18","LSTALVDT":"2022-03-10","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.07401,"AVALU":"YEARS","ADTM":"2021-01-13","ADY":330,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-65","SUBJID":"id-65","SITEID":"BRA-1","AGE":25,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":7.34092,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-02-18","TRTSDTM":"2020-02-18 22:33:01","TRTEDTM":"2022-02-18 10:11:25","EOSSTT":"COMPLETED","EOSDT":"2022-02-18","EOSDY":731,"DTHDT":"2022-02-18","LSTALVDT":"2022-03-10","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.22778,"AVALU":"YEARS","ADTM":"2022-01-30","ADY":712,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-65","SUBJID":"id-65","SITEID":"BRA-1","AGE":25,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":7.34092,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-02-18","TRTSDTM":"2020-02-18 22:33:01","TRTEDTM":"2022-02-18 10:11:25","EOSSTT":"COMPLETED","EOSDT":"2022-02-18","EOSDY":731,"DTHDT":"2022-02-18","LSTALVDT":"2022-03-10","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08249,"AVALU":"YEARS","ADTM":"2020-08-11","ADY":175,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-93","SUBJID":"id-93","SITEID":"BRA-1","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":3.86835,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-01-21","TRTSDTM":"2021-01-24 16:04:28","TRTEDTM":"2021-09-24 23:59:09","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":244,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-19","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.31258,"AVALU":"YEARS","ADTM":"2021-08-10","ADY":198,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-93","SUBJID":"id-93","SITEID":"BRA-1","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":3.86835,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-01-21","TRTSDTM":"2021-01-24 16:04:28","TRTEDTM":"2021-09-24 23:59:09","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":244,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-19","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.07791,"AVALU":"YEARS","ADTM":"2021-03-09","ADY":44,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-1-id-93","SUBJID":"id-93","SITEID":"BRA-1","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":3.86835,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-01-21","TRTSDTM":"2021-01-24 16:04:28","TRTEDTM":"2021-09-24 23:59:09","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":244,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-19","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11825,"AVALU":"YEARS","ADTM":"2021-05-07","ADY":103,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-171","SUBJID":"id-171","SITEID":"BRA-11","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":7.7018,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-07-06","TRTSDTM":"2020-07-08 12:41:07","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12718,"AVALU":"YEARS","ADTM":"2021-02-08","ADY":215,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-171","SUBJID":"id-171","SITEID":"BRA-11","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":7.7018,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-07-06","TRTSDTM":"2020-07-08 12:41:07","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01964,"AVALU":"YEARS","ADTM":"2020-10-27","ADY":111,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-171","SUBJID":"id-171","SITEID":"BRA-11","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":7.7018,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-07-06","TRTSDTM":"2020-07-08 12:41:07","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.18204,"AVALU":"YEARS","ADTM":"2020-09-17","ADY":71,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-217","SUBJID":"id-217","SITEID":"BRA-11","AGE":43,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":0.4056,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-04-30","TRTSDTM":"2020-05-03 22:33:18","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.09443,"AVALU":"YEARS","ADTM":"2021-05-21","ADY":383,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-217","SUBJID":"id-217","SITEID":"BRA-11","AGE":43,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":0.4056,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-04-30","TRTSDTM":"2020-05-03 22:33:18","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.74754,"AVALU":"YEARS","ADTM":"2022-01-29","ADY":636,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-217","SUBJID":"id-217","SITEID":"BRA-11","AGE":43,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":0.4056,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-04-30","TRTSDTM":"2020-05-03 22:33:18","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.249,"AVALU":"YEARS","ADTM":"2020-07-26","ADY":84,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-237","SUBJID":"id-237","SITEID":"BRA-11","AGE":64,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.29531,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-15","TRTSDTM":"2020-10-15 01:12:04","TRTEDTM":"2021-09-18 16:32:14","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":339,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-18","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.33621,"AVALU":"YEARS","ADTM":"2021-06-05","ADY":233,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-237","SUBJID":"id-237","SITEID":"BRA-11","AGE":64,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.29531,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-15","TRTSDTM":"2020-10-15 01:12:04","TRTEDTM":"2021-09-18 16:32:14","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":339,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-18","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.39091,"AVALU":"YEARS","ADTM":"2021-06-02","ADY":230,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-237","SUBJID":"id-237","SITEID":"BRA-11","AGE":64,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.29531,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-15","TRTSDTM":"2020-10-15 01:12:04","TRTEDTM":"2021-09-18 16:32:14","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":339,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-18","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.37987,"AVALU":"YEARS","ADTM":"2021-02-13","ADY":121,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-321","SUBJID":"id-321","SITEID":"BRA-11","AGE":33,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":1.77524,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-12","TRTSDTM":"2021-05-12 20:46:37","TRTEDTM":"2023-05-13 08:25:01","EOSSTT":"COMPLETED","EOSDT":"2023-05-13","EOSDY":731,"DTHDT":"2023-05-13","LSTALVDT":"2023-06-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0578,"AVALU":"YEARS","ADTM":"2022-05-09","ADY":362,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-321","SUBJID":"id-321","SITEID":"BRA-11","AGE":33,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":1.77524,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-12","TRTSDTM":"2021-05-12 20:46:37","TRTEDTM":"2023-05-13 08:25:01","EOSSTT":"COMPLETED","EOSDT":"2023-05-13","EOSDY":731,"DTHDT":"2023-05-13","LSTALVDT":"2023-06-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.34283,"AVALU":"YEARS","ADTM":"2023-04-29","ADY":717,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-321","SUBJID":"id-321","SITEID":"BRA-11","AGE":33,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":1.77524,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-12","TRTSDTM":"2021-05-12 20:46:37","TRTEDTM":"2023-05-13 08:25:01","EOSSTT":"COMPLETED","EOSDT":"2023-05-13","EOSDY":731,"DTHDT":"2023-05-13","LSTALVDT":"2023-06-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1338,"AVALU":"YEARS","ADTM":"2022-07-10","ADY":424,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-345","SUBJID":"id-345","SITEID":"BRA-11","AGE":37,"SEX":"F","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":3.45154,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-03-21","TRTSDTM":"2021-03-24 14:11:19","TRTEDTM":"2023-03-25 01:49:43","EOSSTT":"COMPLETED","EOSDT":"2023-03-25","EOSDY":731,"DTHDT":"2023-03-25","LSTALVDT":"2023-04-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00019,"AVALU":"YEARS","ADTM":"2022-11-17","ADY":603,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-345","SUBJID":"id-345","SITEID":"BRA-11","AGE":37,"SEX":"F","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":3.45154,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-03-21","TRTSDTM":"2021-03-24 14:11:19","TRTEDTM":"2023-03-25 01:49:43","EOSSTT":"COMPLETED","EOSDT":"2023-03-25","EOSDY":731,"DTHDT":"2023-03-25","LSTALVDT":"2023-04-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.50191,"AVALU":"YEARS","ADTM":"2022-08-15","ADY":509,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-345","SUBJID":"id-345","SITEID":"BRA-11","AGE":37,"SEX":"F","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":3.45154,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-03-21","TRTSDTM":"2021-03-24 14:11:19","TRTEDTM":"2023-03-25 01:49:43","EOSSTT":"COMPLETED","EOSDT":"2023-03-25","EOSDY":731,"DTHDT":"2023-03-25","LSTALVDT":"2023-04-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01298,"AVALU":"YEARS","ADTM":"2022-07-01","ADY":464,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-397","SUBJID":"id-397","SITEID":"BRA-11","AGE":38,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":11.66389,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-01-28","TRTSDTM":"2021-02-01 07:16:21","TRTEDTM":"2023-02-01 18:54:45","EOSSTT":"COMPLETED","EOSDT":"2023-02-01","EOSDY":731,"DTHDT":"2023-02-01","LSTALVDT":"2023-02-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12265,"AVALU":"YEARS","ADTM":"2021-12-25","ADY":327,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-397","SUBJID":"id-397","SITEID":"BRA-11","AGE":38,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":11.66389,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-01-28","TRTSDTM":"2021-02-01 07:16:21","TRTEDTM":"2023-02-01 18:54:45","EOSSTT":"COMPLETED","EOSDT":"2023-02-01","EOSDY":731,"DTHDT":"2023-02-01","LSTALVDT":"2023-02-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01211,"AVALU":"YEARS","ADTM":"2022-12-29","ADY":696,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-397","SUBJID":"id-397","SITEID":"BRA-11","AGE":38,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":11.66389,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-01-28","TRTSDTM":"2021-02-01 07:16:21","TRTEDTM":"2023-02-01 18:54:45","EOSSTT":"COMPLETED","EOSDT":"2023-02-01","EOSDY":731,"DTHDT":"2023-02-01","LSTALVDT":"2023-02-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.22672,"AVALU":"YEARS","ADTM":"2022-03-30","ADY":422,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-50","SUBJID":"id-50","SITEID":"BRA-11","AGE":26,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.60612,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-12-02","TRTSDTM":"2019-12-02 14:23:36","TRTEDTM":"2021-12-02 02:02:00","EOSSTT":"COMPLETED","EOSDT":"2021-12-02","EOSDY":731,"DTHDT":"2021-12-02","LSTALVDT":"2021-12-29","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.26615,"AVALU":"YEARS","ADTM":"2021-05-25","ADY":540,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-50","SUBJID":"id-50","SITEID":"BRA-11","AGE":26,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.60612,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-12-02","TRTSDTM":"2019-12-02 14:23:36","TRTEDTM":"2021-12-02 02:02:00","EOSSTT":"COMPLETED","EOSDT":"2021-12-02","EOSDY":731,"DTHDT":"2021-12-02","LSTALVDT":"2021-12-29","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.12227,"AVALU":"YEARS","ADTM":"2021-06-13","ADY":559,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-50","SUBJID":"id-50","SITEID":"BRA-11","AGE":26,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.60612,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-12-02","TRTSDTM":"2019-12-02 14:23:36","TRTEDTM":"2021-12-02 02:02:00","EOSSTT":"COMPLETED","EOSDT":"2021-12-02","EOSDY":731,"DTHDT":"2021-12-02","LSTALVDT":"2021-12-29","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04613,"AVALU":"YEARS","ADTM":"2020-09-23","ADY":296,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-9","SUBJID":"id-9","SITEID":"BRA-11","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":7.0163,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-10-29","TRTSDTM":"2019-10-30 09:16:19","TRTEDTM":"2021-10-29 20:54:43","EOSSTT":"COMPLETED","EOSDT":"2021-10-29","EOSDY":731,"DTHDT":"2021-10-29","LSTALVDT":"2021-11-13","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.31209,"AVALU":"YEARS","ADTM":"2021-10-07","ADY":708,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-9","SUBJID":"id-9","SITEID":"BRA-11","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":7.0163,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-10-29","TRTSDTM":"2019-10-30 09:16:19","TRTEDTM":"2021-10-29 20:54:43","EOSSTT":"COMPLETED","EOSDT":"2021-10-29","EOSDY":731,"DTHDT":"2021-10-29","LSTALVDT":"2021-11-13","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.11306,"AVALU":"YEARS","ADTM":"2020-11-15","ADY":382,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-11-id-9","SUBJID":"id-9","SITEID":"BRA-11","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":7.0163,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-10-29","TRTSDTM":"2019-10-30 09:16:19","TRTEDTM":"2021-10-29 20:54:43","EOSSTT":"COMPLETED","EOSDT":"2021-10-29","EOSDY":731,"DTHDT":"2021-10-29","LSTALVDT":"2021-11-13","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07376,"AVALU":"YEARS","ADTM":"2019-11-08","ADY":9,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-12-id-59","SUBJID":"id-59","SITEID":"BRA-12","AGE":36,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":11.1938,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-29","TRTSDTM":"2020-07-01 09:10:18","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.22617,"AVALU":"YEARS","ADTM":"2022-04-24","ADY":662,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-12-id-59","SUBJID":"id-59","SITEID":"BRA-12","AGE":36,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":11.1938,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-29","TRTSDTM":"2020-07-01 09:10:18","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.07439,"AVALU":"YEARS","ADTM":"2021-12-21","ADY":538,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-12-id-59","SUBJID":"id-59","SITEID":"BRA-12","AGE":36,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":11.1938,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-29","TRTSDTM":"2020-07-01 09:10:18","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.62966,"AVALU":"YEARS","ADTM":"2021-12-27","ADY":544,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-13-id-177","SUBJID":"id-177","SITEID":"BRA-13","AGE":24,"SEX":"M","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":12.71923,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-04-02","TRTSDTM":"2021-04-05 18:05:38","TRTEDTM":"2023-04-06 05:44:02","EOSSTT":"COMPLETED","EOSDT":"2023-04-06","EOSDY":731,"DTHDT":"2023-04-06","LSTALVDT":"2023-04-29","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00814,"AVALU":"YEARS","ADTM":"2022-12-10","ADY":614,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-13-id-177","SUBJID":"id-177","SITEID":"BRA-13","AGE":24,"SEX":"M","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":12.71923,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-04-02","TRTSDTM":"2021-04-05 18:05:38","TRTEDTM":"2023-04-06 05:44:02","EOSSTT":"COMPLETED","EOSDT":"2023-04-06","EOSDY":731,"DTHDT":"2023-04-06","LSTALVDT":"2023-04-29","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.03438,"AVALU":"YEARS","ADTM":"2022-02-11","ADY":312,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-13-id-177","SUBJID":"id-177","SITEID":"BRA-13","AGE":24,"SEX":"M","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":12.71923,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-04-02","TRTSDTM":"2021-04-05 18:05:38","TRTEDTM":"2023-04-06 05:44:02","EOSSTT":"COMPLETED","EOSDT":"2023-04-06","EOSDY":731,"DTHDT":"2023-04-06","LSTALVDT":"2023-04-29","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.31092,"AVALU":"YEARS","ADTM":"2021-04-27","ADY":22,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-14-id-120","SUBJID":"id-120","SITEID":"BRA-14","AGE":33,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":6.93474,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-23","TRTSDTM":"2021-04-25 18:27:08","TRTEDTM":"2023-04-26 06:05:32","EOSSTT":"COMPLETED","EOSDT":"2023-04-26","EOSDY":731,"DTHDT":"2023-04-26","LSTALVDT":"2023-05-24","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.10468,"AVALU":"YEARS","ADTM":"2021-12-18","ADY":237,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-14-id-120","SUBJID":"id-120","SITEID":"BRA-14","AGE":33,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":6.93474,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-23","TRTSDTM":"2021-04-25 18:27:08","TRTEDTM":"2023-04-26 06:05:32","EOSSTT":"COMPLETED","EOSDT":"2023-04-26","EOSDY":731,"DTHDT":"2023-04-26","LSTALVDT":"2023-05-24","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.20289,"AVALU":"YEARS","ADTM":"2022-08-21","ADY":483,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-14-id-120","SUBJID":"id-120","SITEID":"BRA-14","AGE":33,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":6.93474,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-23","TRTSDTM":"2021-04-25 18:27:08","TRTEDTM":"2023-04-26 06:05:32","EOSSTT":"COMPLETED","EOSDT":"2023-04-26","EOSDY":731,"DTHDT":"2023-04-26","LSTALVDT":"2023-05-24","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04914,"AVALU":"YEARS","ADTM":"2021-09-02","ADY":130,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-14-id-23","SUBJID":"id-23","SITEID":"BRA-14","AGE":37,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":6.20239,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-08","TRTSDTM":"2020-06-11 20:02:23","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00444,"AVALU":"YEARS","ADTM":"2020-08-14","ADY":64,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-14-id-23","SUBJID":"id-23","SITEID":"BRA-14","AGE":37,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":6.20239,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-08","TRTSDTM":"2020-06-11 20:02:23","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.04889,"AVALU":"YEARS","ADTM":"2021-08-21","ADY":436,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-14-id-23","SUBJID":"id-23","SITEID":"BRA-14","AGE":37,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":6.20239,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-08","TRTSDTM":"2020-06-11 20:02:23","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.71389,"AVALU":"YEARS","ADTM":"2020-12-06","ADY":178,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-15-id-36","SUBJID":"id-36","SITEID":"BRA-15","AGE":38,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":4.40685,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-12","TRTSDTM":"2020-08-13 12:12:25","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.27454,"AVALU":"YEARS","ADTM":"2022-06-12","ADY":668,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-15-id-36","SUBJID":"id-36","SITEID":"BRA-15","AGE":38,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":4.40685,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-12","TRTSDTM":"2020-08-13 12:12:25","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.10383,"AVALU":"YEARS","ADTM":"2021-01-07","ADY":147,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-15-id-36","SUBJID":"id-36","SITEID":"BRA-15","AGE":38,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":4.40685,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-12","TRTSDTM":"2020-08-13 12:12:25","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08297,"AVALU":"YEARS","ADTM":"2021-02-15","ADY":186,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-2-id-101","SUBJID":"id-101","SITEID":"BRA-2","AGE":34,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":8.18055,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-01-28","TRTSDTM":"2021-01-30 09:46:16","TRTEDTM":"2023-01-30 21:24:40","EOSSTT":"COMPLETED","EOSDT":"2023-01-30","EOSDY":731,"DTHDT":"2023-01-30","LSTALVDT":"2023-02-22","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.4181,"AVALU":"YEARS","ADTM":"2021-12-11","ADY":315,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-2-id-101","SUBJID":"id-101","SITEID":"BRA-2","AGE":34,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":8.18055,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-01-28","TRTSDTM":"2021-01-30 09:46:16","TRTEDTM":"2023-01-30 21:24:40","EOSSTT":"COMPLETED","EOSDT":"2023-01-30","EOSDY":731,"DTHDT":"2023-01-30","LSTALVDT":"2023-02-22","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.55579,"AVALU":"YEARS","ADTM":"2021-08-20","ADY":202,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-2-id-101","SUBJID":"id-101","SITEID":"BRA-2","AGE":34,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":8.18055,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-01-28","TRTSDTM":"2021-01-30 09:46:16","TRTEDTM":"2023-01-30 21:24:40","EOSSTT":"COMPLETED","EOSDT":"2023-01-30","EOSDY":731,"DTHDT":"2023-01-30","LSTALVDT":"2023-02-22","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.56775,"AVALU":"YEARS","ADTM":"2021-06-15","ADY":136,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-2-id-296","SUBJID":"id-296","SITEID":"BRA-2","AGE":44,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":2.75083,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-25","TRTSDTM":"2021-08-28 11:34:15","TRTEDTM":"2021-09-24 15:24:27","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":28,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.22545,"AVALU":"YEARS","ADTM":"2021-08-30","ADY":2,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-2-id-296","SUBJID":"id-296","SITEID":"BRA-2","AGE":44,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":2.75083,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-25","TRTSDTM":"2021-08-28 11:34:15","TRTEDTM":"2021-09-24 15:24:27","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":28,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.61633,"AVALU":"YEARS","ADTM":"2021-09-16","ADY":19,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-2-id-296","SUBJID":"id-296","SITEID":"BRA-2","AGE":44,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":2.75083,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-25","TRTSDTM":"2021-08-28 11:34:15","TRTEDTM":"2021-09-24 15:24:27","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":28,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.25946,"AVALU":"YEARS","ADTM":"2021-08-28","ADY":0,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-3-id-13","SUBJID":"id-13","SITEID":"BRA-3","AGE":42,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-3","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.88873,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-11-25","TRTSDTM":"2020-11-29 08:13:36","TRTEDTM":"2022-11-29 19:52:00","EOSSTT":"COMPLETED","EOSDT":"2022-11-29","EOSDY":731,"DTHDT":"2022-11-29","LSTALVDT":"2022-12-28","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.46722,"AVALU":"YEARS","ADTM":"2022-10-01","ADY":671,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-3-id-13","SUBJID":"id-13","SITEID":"BRA-3","AGE":42,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-3","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.88873,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-11-25","TRTSDTM":"2020-11-29 08:13:36","TRTEDTM":"2022-11-29 19:52:00","EOSSTT":"COMPLETED","EOSDT":"2022-11-29","EOSDY":731,"DTHDT":"2022-11-29","LSTALVDT":"2022-12-28","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.86684,"AVALU":"YEARS","ADTM":"2021-05-06","ADY":158,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-3-id-13","SUBJID":"id-13","SITEID":"BRA-3","AGE":42,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-3","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.88873,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-11-25","TRTSDTM":"2020-11-29 08:13:36","TRTEDTM":"2022-11-29 19:52:00","EOSSTT":"COMPLETED","EOSDT":"2022-11-29","EOSDY":731,"DTHDT":"2022-11-29","LSTALVDT":"2022-12-28","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.13947,"AVALU":"YEARS","ADTM":"2022-08-27","ADY":636,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-3-id-8","SUBJID":"id-8","SITEID":"BRA-3","AGE":25,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-3","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":0.64837,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-13","TRTSDTM":"2020-10-17 09:05:53","TRTEDTM":"2022-10-17 20:44:17","EOSSTT":"COMPLETED","EOSDT":"2022-10-17","EOSDY":731,"DTHDT":"2022-10-17","LSTALVDT":"2022-11-01","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.24305,"AVALU":"YEARS","ADTM":"2022-04-27","ADY":557,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-3-id-8","SUBJID":"id-8","SITEID":"BRA-3","AGE":25,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-3","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":0.64837,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-13","TRTSDTM":"2020-10-17 09:05:53","TRTEDTM":"2022-10-17 20:44:17","EOSSTT":"COMPLETED","EOSDT":"2022-10-17","EOSDY":731,"DTHDT":"2022-10-17","LSTALVDT":"2022-11-01","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.79013,"AVALU":"YEARS","ADTM":"2021-01-30","ADY":105,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-3-id-8","SUBJID":"id-8","SITEID":"BRA-3","AGE":25,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-3","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":0.64837,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-13","TRTSDTM":"2020-10-17 09:05:53","TRTEDTM":"2022-10-17 20:44:17","EOSSTT":"COMPLETED","EOSDT":"2022-10-17","EOSDY":731,"DTHDT":"2022-10-17","LSTALVDT":"2022-11-01","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.19763,"AVALU":"YEARS","ADTM":"2022-05-06","ADY":566,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-4-id-368","SUBJID":"id-368","SITEID":"BRA-4","AGE":46,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.20454,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-01","TRTSDTM":"2020-10-01 05:11:27","TRTEDTM":"2022-10-01 16:49:51","EOSSTT":"COMPLETED","EOSDT":"2022-10-01","EOSDY":731,"DTHDT":"2022-10-01","LSTALVDT":"2022-10-13","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.19473,"AVALU":"YEARS","ADTM":"2021-05-23","ADY":234,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-4-id-368","SUBJID":"id-368","SITEID":"BRA-4","AGE":46,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.20454,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-01","TRTSDTM":"2020-10-01 05:11:27","TRTEDTM":"2022-10-01 16:49:51","EOSSTT":"COMPLETED","EOSDT":"2022-10-01","EOSDY":731,"DTHDT":"2022-10-01","LSTALVDT":"2022-10-13","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.72439,"AVALU":"YEARS","ADTM":"2021-05-12","ADY":223,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-4-id-368","SUBJID":"id-368","SITEID":"BRA-4","AGE":46,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"BRA","INVID":"BRA-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.20454,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-01","TRTSDTM":"2020-10-01 05:11:27","TRTEDTM":"2022-10-01 16:49:51","EOSSTT":"COMPLETED","EOSDT":"2022-10-01","EOSDY":731,"DTHDT":"2022-10-01","LSTALVDT":"2022-10-13","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.24564,"AVALU":"YEARS","ADTM":"2020-12-12","ADY":72,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-4-id-383","SUBJID":"id-383","SITEID":"BRA-4","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.60353,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-21","TRTSDTM":"2020-08-24 07:10:59","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.06206,"AVALU":"YEARS","ADTM":"2020-12-31","ADY":129,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-4-id-383","SUBJID":"id-383","SITEID":"BRA-4","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.60353,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-21","TRTSDTM":"2020-08-24 07:10:59","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.09493,"AVALU":"YEARS","ADTM":"2021-08-14","ADY":355,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-4-id-383","SUBJID":"id-383","SITEID":"BRA-4","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.60353,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-21","TRTSDTM":"2020-08-24 07:10:59","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.57889,"AVALU":"YEARS","ADTM":"2020-12-05","ADY":103,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-5-id-234","SUBJID":"id-234","SITEID":"BRA-5","AGE":32,"SEX":"M","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.86786,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-01-26","TRTSDTM":"2020-01-27 06:20:11","TRTEDTM":"2022-01-26 17:58:35","EOSSTT":"COMPLETED","EOSDT":"2022-01-26","EOSDY":731,"DTHDT":"2022-01-26","LSTALVDT":"2022-02-22","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.29521,"AVALU":"YEARS","ADTM":"2020-04-28","ADY":92,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-5-id-234","SUBJID":"id-234","SITEID":"BRA-5","AGE":32,"SEX":"M","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.86786,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-01-26","TRTSDTM":"2020-01-27 06:20:11","TRTEDTM":"2022-01-26 17:58:35","EOSSTT":"COMPLETED","EOSDT":"2022-01-26","EOSDY":731,"DTHDT":"2022-01-26","LSTALVDT":"2022-02-22","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.1373,"AVALU":"YEARS","ADTM":"2021-12-17","ADY":690,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-5-id-234","SUBJID":"id-234","SITEID":"BRA-5","AGE":32,"SEX":"M","RACE":"WHITE","COUNTRY":"BRA","INVID":"BRA-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.86786,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-01-26","TRTSDTM":"2020-01-27 06:20:11","TRTEDTM":"2022-01-26 17:58:35","EOSSTT":"COMPLETED","EOSDT":"2022-01-26","EOSDY":731,"DTHDT":"2022-01-26","LSTALVDT":"2022-02-22","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.35722,"AVALU":"YEARS","ADTM":"2021-09-24","ADY":606,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-6-id-369","SUBJID":"id-369","SITEID":"BRA-6","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-6","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":5.41359,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-15","TRTSDTM":"2021-03-19 19:47:24","TRTEDTM":"2023-03-20 07:25:48","EOSSTT":"COMPLETED","EOSDT":"2023-03-20","EOSDY":731,"DTHDT":"2023-03-20","LSTALVDT":"2023-04-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.16444,"AVALU":"YEARS","ADTM":"2022-10-19","ADY":579,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-6-id-369","SUBJID":"id-369","SITEID":"BRA-6","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-6","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":5.41359,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-15","TRTSDTM":"2021-03-19 19:47:24","TRTEDTM":"2023-03-20 07:25:48","EOSSTT":"COMPLETED","EOSDT":"2023-03-20","EOSDY":731,"DTHDT":"2023-03-20","LSTALVDT":"2023-04-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.06829,"AVALU":"YEARS","ADTM":"2022-06-15","ADY":453,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-6-id-369","SUBJID":"id-369","SITEID":"BRA-6","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-6","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":5.41359,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-15","TRTSDTM":"2021-03-19 19:47:24","TRTEDTM":"2023-03-20 07:25:48","EOSSTT":"COMPLETED","EOSDT":"2023-03-20","EOSDY":731,"DTHDT":"2023-03-20","LSTALVDT":"2023-04-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07211,"AVALU":"YEARS","ADTM":"2021-11-07","ADY":233,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-7-id-301","SUBJID":"id-301","SITEID":"BRA-7","AGE":35,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-7","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":10.52061,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-24","TRTSDTM":"2020-02-28 13:03:59","TRTEDTM":"2022-02-28 00:42:23","EOSSTT":"COMPLETED","EOSDT":"2022-02-28","EOSDY":731,"DTHDT":"2022-02-28","LSTALVDT":"2022-03-19","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.09271,"AVALU":"YEARS","ADTM":"2020-12-06","ADY":282,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-7-id-301","SUBJID":"id-301","SITEID":"BRA-7","AGE":35,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-7","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":10.52061,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-24","TRTSDTM":"2020-02-28 13:03:59","TRTEDTM":"2022-02-28 00:42:23","EOSSTT":"COMPLETED","EOSDT":"2022-02-28","EOSDY":731,"DTHDT":"2022-02-28","LSTALVDT":"2022-03-19","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.16748,"AVALU":"YEARS","ADTM":"2022-02-15","ADY":718,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-BRA-7-id-301","SUBJID":"id-301","SITEID":"BRA-7","AGE":35,"SEX":"M","RACE":"ASIAN","COUNTRY":"BRA","INVID":"BRA-7","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":10.52061,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-24","TRTSDTM":"2020-02-28 13:03:59","TRTEDTM":"2022-02-28 00:42:23","EOSSTT":"COMPLETED","EOSDT":"2022-02-28","EOSDY":731,"DTHDT":"2022-02-28","LSTALVDT":"2022-03-19","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08613,"AVALU":"YEARS","ADTM":"2020-10-14","ADY":229,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-1-id-18","SUBJID":"id-18","SITEID":"CAN-1","AGE":41,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CAN","INVID":"CAN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":7.47872,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-05","TRTSDTM":"2021-08-08 11:17:26","TRTEDTM":"2023-08-08 22:55:50","EOSSTT":"COMPLETED","EOSDT":"2023-08-08","EOSDY":731,"DTHDT":"2023-08-08","LSTALVDT":"2023-08-27","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.17561,"AVALU":"YEARS","ADTM":"2022-09-06","ADY":394,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-1-id-18","SUBJID":"id-18","SITEID":"CAN-1","AGE":41,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CAN","INVID":"CAN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":7.47872,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-05","TRTSDTM":"2021-08-08 11:17:26","TRTEDTM":"2023-08-08 22:55:50","EOSSTT":"COMPLETED","EOSDT":"2023-08-08","EOSDY":731,"DTHDT":"2023-08-08","LSTALVDT":"2023-08-27","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.03349,"AVALU":"YEARS","ADTM":"2022-03-11","ADY":215,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-1-id-18","SUBJID":"id-18","SITEID":"CAN-1","AGE":41,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CAN","INVID":"CAN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":7.47872,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-05","TRTSDTM":"2021-08-08 11:17:26","TRTEDTM":"2023-08-08 22:55:50","EOSSTT":"COMPLETED","EOSDT":"2023-08-08","EOSDY":731,"DTHDT":"2023-08-08","LSTALVDT":"2023-08-27","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.26948,"AVALU":"YEARS","ADTM":"2023-01-18","ADY":528,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-1-id-341","SUBJID":"id-341","SITEID":"CAN-1","AGE":43,"SEX":"F","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":4.64258,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-12-24","TRTSDTM":"2019-12-27 17:57:39","TRTEDTM":"2021-09-22 20:18:14","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":636,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.20188,"AVALU":"YEARS","ADTM":"2020-12-13","ADY":352,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-1-id-341","SUBJID":"id-341","SITEID":"CAN-1","AGE":43,"SEX":"F","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":4.64258,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-12-24","TRTSDTM":"2019-12-27 17:57:39","TRTEDTM":"2021-09-22 20:18:14","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":636,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02341,"AVALU":"YEARS","ADTM":"2020-06-07","ADY":163,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-1-id-341","SUBJID":"id-341","SITEID":"CAN-1","AGE":43,"SEX":"F","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":4.64258,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-12-24","TRTSDTM":"2019-12-27 17:57:39","TRTEDTM":"2021-09-22 20:18:14","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":636,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0207,"AVALU":"YEARS","ADTM":"2021-03-14","ADY":443,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-11-id-139","SUBJID":"id-139","SITEID":"CAN-11","AGE":31,"SEX":"M","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":15.07391,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-04-20","TRTSDTM":"2021-04-21 10:36:25","TRTEDTM":"2023-04-21 22:14:49","EOSSTT":"COMPLETED","EOSDT":"2023-04-21","EOSDY":731,"DTHDT":"2023-04-21","LSTALVDT":"2023-05-17","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.08883,"AVALU":"YEARS","ADTM":"2022-03-23","ADY":336,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-11-id-139","SUBJID":"id-139","SITEID":"CAN-11","AGE":31,"SEX":"M","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":15.07391,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-04-20","TRTSDTM":"2021-04-21 10:36:25","TRTEDTM":"2023-04-21 22:14:49","EOSSTT":"COMPLETED","EOSDT":"2023-04-21","EOSDY":731,"DTHDT":"2023-04-21","LSTALVDT":"2023-05-17","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.10887,"AVALU":"YEARS","ADTM":"2021-07-18","ADY":88,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-11-id-139","SUBJID":"id-139","SITEID":"CAN-11","AGE":31,"SEX":"M","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":15.07391,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-04-20","TRTSDTM":"2021-04-21 10:36:25","TRTEDTM":"2023-04-21 22:14:49","EOSSTT":"COMPLETED","EOSDT":"2023-04-21","EOSDY":731,"DTHDT":"2023-04-21","LSTALVDT":"2023-05-17","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.21815,"AVALU":"YEARS","ADTM":"2023-02-08","ADY":658,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-11-id-306","SUBJID":"id-306","SITEID":"CAN-11","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":3.11267,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-01-09","TRTSDTM":"2021-01-13 09:17:48","TRTEDTM":"2023-01-13 20:56:12","EOSSTT":"COMPLETED","EOSDT":"2023-01-13","EOSDY":731,"DTHDT":"2023-01-13","LSTALVDT":"2023-02-05","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.29632,"AVALU":"YEARS","ADTM":"2021-07-13","ADY":181,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-11-id-306","SUBJID":"id-306","SITEID":"CAN-11","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":3.11267,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-01-09","TRTSDTM":"2021-01-13 09:17:48","TRTEDTM":"2023-01-13 20:56:12","EOSSTT":"COMPLETED","EOSDT":"2023-01-13","EOSDY":731,"DTHDT":"2023-01-13","LSTALVDT":"2023-02-05","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.21706,"AVALU":"YEARS","ADTM":"2022-08-09","ADY":573,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-11-id-306","SUBJID":"id-306","SITEID":"CAN-11","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":3.11267,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-01-09","TRTSDTM":"2021-01-13 09:17:48","TRTEDTM":"2023-01-13 20:56:12","EOSSTT":"COMPLETED","EOSDT":"2023-01-13","EOSDY":731,"DTHDT":"2023-01-13","LSTALVDT":"2023-02-05","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02643,"AVALU":"YEARS","ADTM":"2022-04-13","ADY":455,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-14-id-104","SUBJID":"id-104","SITEID":"CAN-14","AGE":39,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CAN","INVID":"CAN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":4.66313,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-30","TRTSDTM":"2020-02-01 12:24:31","TRTEDTM":"2021-09-25 09:15:49","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":602,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00308,"AVALU":"YEARS","ADTM":"2021-03-02","ADY":395,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-14-id-104","SUBJID":"id-104","SITEID":"CAN-14","AGE":39,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CAN","INVID":"CAN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":4.66313,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-30","TRTSDTM":"2020-02-01 12:24:31","TRTEDTM":"2021-09-25 09:15:49","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":602,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.44493,"AVALU":"YEARS","ADTM":"2020-04-06","ADY":65,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-14-id-104","SUBJID":"id-104","SITEID":"CAN-14","AGE":39,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CAN","INVID":"CAN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":4.66313,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-30","TRTSDTM":"2020-02-01 12:24:31","TRTEDTM":"2021-09-25 09:15:49","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":602,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.23794,"AVALU":"YEARS","ADTM":"2020-10-15","ADY":257,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-4-id-324","SUBJID":"id-324","SITEID":"CAN-4","AGE":32,"SEX":"M","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.34637,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-21","TRTSDTM":"2021-06-23 17:22:47","TRTEDTM":"2023-06-24 05:01:11","EOSSTT":"COMPLETED","EOSDT":"2023-06-24","EOSDY":731,"DTHDT":"2023-06-24","LSTALVDT":"2023-07-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.10223,"AVALU":"YEARS","ADTM":"2021-12-30","ADY":190,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-4-id-324","SUBJID":"id-324","SITEID":"CAN-4","AGE":32,"SEX":"M","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.34637,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-21","TRTSDTM":"2021-06-23 17:22:47","TRTEDTM":"2023-06-24 05:01:11","EOSSTT":"COMPLETED","EOSDT":"2023-06-24","EOSDY":731,"DTHDT":"2023-06-24","LSTALVDT":"2023-07-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.09799,"AVALU":"YEARS","ADTM":"2023-04-17","ADY":663,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-4-id-324","SUBJID":"id-324","SITEID":"CAN-4","AGE":32,"SEX":"M","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.34637,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-21","TRTSDTM":"2021-06-23 17:22:47","TRTEDTM":"2023-06-24 05:01:11","EOSSTT":"COMPLETED","EOSDT":"2023-06-24","EOSDY":731,"DTHDT":"2023-06-24","LSTALVDT":"2023-07-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.19295,"AVALU":"YEARS","ADTM":"2023-01-15","ADY":571,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-4-id-331","SUBJID":"id-331","SITEID":"CAN-4","AGE":34,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CAN","INVID":"CAN-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":3.65637,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-12-04","TRTSDTM":"2020-12-07 14:23:11","TRTEDTM":"2022-12-08 02:01:35","EOSSTT":"COMPLETED","EOSDT":"2022-12-08","EOSDY":731,"DTHDT":"2022-12-08","LSTALVDT":"2022-12-29","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.16039,"AVALU":"YEARS","ADTM":"2021-12-12","ADY":370,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-4-id-331","SUBJID":"id-331","SITEID":"CAN-4","AGE":34,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CAN","INVID":"CAN-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":3.65637,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-12-04","TRTSDTM":"2020-12-07 14:23:11","TRTEDTM":"2022-12-08 02:01:35","EOSSTT":"COMPLETED","EOSDT":"2022-12-08","EOSDY":731,"DTHDT":"2022-12-08","LSTALVDT":"2022-12-29","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.16908,"AVALU":"YEARS","ADTM":"2021-12-04","ADY":362,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-4-id-331","SUBJID":"id-331","SITEID":"CAN-4","AGE":34,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CAN","INVID":"CAN-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":3.65637,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-12-04","TRTSDTM":"2020-12-07 14:23:11","TRTEDTM":"2022-12-08 02:01:35","EOSSTT":"COMPLETED","EOSDT":"2022-12-08","EOSDY":731,"DTHDT":"2022-12-08","LSTALVDT":"2022-12-29","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.24823,"AVALU":"YEARS","ADTM":"2022-01-04","ADY":393,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-5-id-121","SUBJID":"id-121","SITEID":"CAN-5","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":8.41726,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-16","TRTSDTM":"2020-05-20 16:35:39","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.17595,"AVALU":"YEARS","ADTM":"2021-10-04","ADY":502,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-5-id-121","SUBJID":"id-121","SITEID":"CAN-5","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":8.41726,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-16","TRTSDTM":"2020-05-20 16:35:39","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.28829,"AVALU":"YEARS","ADTM":"2022-02-22","ADY":643,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CAN-5-id-121","SUBJID":"id-121","SITEID":"CAN-5","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"CAN","INVID":"CAN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":8.41726,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-16","TRTSDTM":"2020-05-20 16:35:39","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.40155,"AVALU":"YEARS","ADTM":"2021-10-13","ADY":511,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-107","SUBJID":"id-107","SITEID":"CHN-1","AGE":41,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":11.02114,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-03","TRTSDTM":"2021-03-06 11:11:52","TRTEDTM":"2023-03-06 22:50:16","EOSSTT":"COMPLETED","EOSDT":"2023-03-06","EOSDY":731,"DTHDT":"2023-03-06","LSTALVDT":"2023-03-19","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02073,"AVALU":"YEARS","ADTM":"2021-03-13","ADY":7,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-107","SUBJID":"id-107","SITEID":"CHN-1","AGE":41,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":11.02114,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-03","TRTSDTM":"2021-03-06 11:11:52","TRTEDTM":"2023-03-06 22:50:16","EOSSTT":"COMPLETED","EOSDT":"2023-03-06","EOSDY":731,"DTHDT":"2023-03-06","LSTALVDT":"2023-03-19","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.13357,"AVALU":"YEARS","ADTM":"2021-08-12","ADY":159,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-107","SUBJID":"id-107","SITEID":"CHN-1","AGE":41,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":11.02114,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-03","TRTSDTM":"2021-03-06 11:11:52","TRTEDTM":"2023-03-06 22:50:16","EOSSTT":"COMPLETED","EOSDT":"2023-03-06","EOSDY":731,"DTHDT":"2023-03-06","LSTALVDT":"2023-03-19","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1652,"AVALU":"YEARS","ADTM":"2022-05-24","ADY":444,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-119","SUBJID":"id-119","SITEID":"CHN-1","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":8.61739,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-18","TRTSDTM":"2020-08-19 10:25:25","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00037,"AVALU":"YEARS","ADTM":"2020-10-29","ADY":71,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-119","SUBJID":"id-119","SITEID":"CHN-1","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":8.61739,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-18","TRTSDTM":"2020-08-19 10:25:25","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.0601,"AVALU":"YEARS","ADTM":"2021-06-23","ADY":308,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-119","SUBJID":"id-119","SITEID":"CHN-1","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":8.61739,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-18","TRTSDTM":"2020-08-19 10:25:25","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1643,"AVALU":"YEARS","ADTM":"2020-10-24","ADY":66,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-12","SUBJID":"id-12","SITEID":"CHN-1","AGE":42,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.24721,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-07-23","TRTSDTM":"2021-07-26 15:01:36","TRTEDTM":"2023-07-27 02:40:00","EOSSTT":"COMPLETED","EOSDT":"2023-07-27","EOSDY":731,"DTHDT":"2023-07-27","LSTALVDT":"2023-08-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.22208,"AVALU":"YEARS","ADTM":"2023-04-12","ADY":625,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-12","SUBJID":"id-12","SITEID":"CHN-1","AGE":42,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.24721,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-07-23","TRTSDTM":"2021-07-26 15:01:36","TRTEDTM":"2023-07-27 02:40:00","EOSSTT":"COMPLETED","EOSDT":"2023-07-27","EOSDY":731,"DTHDT":"2023-07-27","LSTALVDT":"2023-08-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.30322,"AVALU":"YEARS","ADTM":"2022-10-22","ADY":453,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-12","SUBJID":"id-12","SITEID":"CHN-1","AGE":42,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.24721,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-07-23","TRTSDTM":"2021-07-26 15:01:36","TRTEDTM":"2023-07-27 02:40:00","EOSSTT":"COMPLETED","EOSDT":"2023-07-27","EOSDY":731,"DTHDT":"2023-07-27","LSTALVDT":"2023-08-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01233,"AVALU":"YEARS","ADTM":"2023-06-11","ADY":685,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-123","SUBJID":"id-123","SITEID":"CHN-1","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.88609,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-30","TRTSDTM":"2020-09-03 02:52:29","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.37037,"AVALU":"YEARS","ADTM":"2022-01-02","ADY":486,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-123","SUBJID":"id-123","SITEID":"CHN-1","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.88609,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-30","TRTSDTM":"2020-09-03 02:52:29","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.27724,"AVALU":"YEARS","ADTM":"2021-03-06","ADY":184,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-123","SUBJID":"id-123","SITEID":"CHN-1","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.88609,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-30","TRTSDTM":"2020-09-03 02:52:29","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.06029,"AVALU":"YEARS","ADTM":"2020-11-11","ADY":69,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-133","SUBJID":"id-133","SITEID":"CHN-1","AGE":25,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":9.31712,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-12","TRTSDTM":"2021-03-14 12:30:45","TRTEDTM":"2023-03-15 00:09:09","EOSSTT":"COMPLETED","EOSDT":"2023-03-15","EOSDY":731,"DTHDT":"2023-03-15","LSTALVDT":"2023-04-04","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.11403,"AVALU":"YEARS","ADTM":"2021-11-06","ADY":237,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-133","SUBJID":"id-133","SITEID":"CHN-1","AGE":25,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":9.31712,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-12","TRTSDTM":"2021-03-14 12:30:45","TRTEDTM":"2023-03-15 00:09:09","EOSSTT":"COMPLETED","EOSDT":"2023-03-15","EOSDY":731,"DTHDT":"2023-03-15","LSTALVDT":"2023-04-04","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.44613,"AVALU":"YEARS","ADTM":"2021-10-08","ADY":208,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-133","SUBJID":"id-133","SITEID":"CHN-1","AGE":25,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":9.31712,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-12","TRTSDTM":"2021-03-14 12:30:45","TRTEDTM":"2023-03-15 00:09:09","EOSSTT":"COMPLETED","EOSDT":"2023-03-15","EOSDY":731,"DTHDT":"2023-03-15","LSTALVDT":"2023-04-04","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08933,"AVALU":"YEARS","ADTM":"2021-10-03","ADY":203,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-144","SUBJID":"id-144","SITEID":"CHN-1","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":5.10856,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-09-22","TRTSDTM":"2020-09-25 05:55:22","TRTEDTM":"2022-09-25 17:33:46","EOSSTT":"COMPLETED","EOSDT":"2022-09-25","EOSDY":731,"DTHDT":"2022-09-25","LSTALVDT":"2022-10-22","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01871,"AVALU":"YEARS","ADTM":"2021-02-16","ADY":144,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-144","SUBJID":"id-144","SITEID":"CHN-1","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":5.10856,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-09-22","TRTSDTM":"2020-09-25 05:55:22","TRTEDTM":"2022-09-25 17:33:46","EOSSTT":"COMPLETED","EOSDT":"2022-09-25","EOSDY":731,"DTHDT":"2022-09-25","LSTALVDT":"2022-10-22","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.28245,"AVALU":"YEARS","ADTM":"2021-11-13","ADY":414,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-144","SUBJID":"id-144","SITEID":"CHN-1","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":5.10856,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-09-22","TRTSDTM":"2020-09-25 05:55:22","TRTEDTM":"2022-09-25 17:33:46","EOSSTT":"COMPLETED","EOSDT":"2022-09-25","EOSDY":731,"DTHDT":"2022-09-25","LSTALVDT":"2022-10-22","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.16328,"AVALU":"YEARS","ADTM":"2021-08-18","ADY":327,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-156","SUBJID":"id-156","SITEID":"CHN-1","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":5.72875,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-11","TRTSDTM":"2021-04-12 20:30:59","TRTEDTM":"2021-09-24 18:52:54","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":165,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.2661,"AVALU":"YEARS","ADTM":"2021-08-27","ADY":137,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-156","SUBJID":"id-156","SITEID":"CHN-1","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":5.72875,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-11","TRTSDTM":"2021-04-12 20:30:59","TRTEDTM":"2021-09-24 18:52:54","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":165,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.15161,"AVALU":"YEARS","ADTM":"2021-09-09","ADY":150,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-156","SUBJID":"id-156","SITEID":"CHN-1","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":5.72875,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-11","TRTSDTM":"2021-04-12 20:30:59","TRTEDTM":"2021-09-24 18:52:54","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":165,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00154,"AVALU":"YEARS","ADTM":"2021-07-28","ADY":107,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-16","SUBJID":"id-16","SITEID":"CHN-1","AGE":46,"SEX":"UNDIFFERENTIATED","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":9.92419,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-08-09","TRTSDTM":"2021-08-10 00:47:25","TRTEDTM":"2023-08-10 12:25:49","EOSSTT":"COMPLETED","EOSDT":"2023-08-10","EOSDY":731,"DTHDT":"2023-08-10","LSTALVDT":"2023-09-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.04531,"AVALU":"YEARS","ADTM":"2023-04-18","ADY":616,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-16","SUBJID":"id-16","SITEID":"CHN-1","AGE":46,"SEX":"UNDIFFERENTIATED","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":9.92419,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-08-09","TRTSDTM":"2021-08-10 00:47:25","TRTEDTM":"2023-08-10 12:25:49","EOSSTT":"COMPLETED","EOSDT":"2023-08-10","EOSDY":731,"DTHDT":"2023-08-10","LSTALVDT":"2023-09-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.14421,"AVALU":"YEARS","ADTM":"2022-04-10","ADY":243,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-16","SUBJID":"id-16","SITEID":"CHN-1","AGE":46,"SEX":"UNDIFFERENTIATED","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":9.92419,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-08-09","TRTSDTM":"2021-08-10 00:47:25","TRTEDTM":"2023-08-10 12:25:49","EOSSTT":"COMPLETED","EOSDT":"2023-08-10","EOSDY":731,"DTHDT":"2023-08-10","LSTALVDT":"2023-09-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.06866,"AVALU":"YEARS","ADTM":"2021-08-16","ADY":6,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-163","SUBJID":"id-163","SITEID":"CHN-1","AGE":41,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":6.76362,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-12-31","TRTSDTM":"2020-12-31 13:08:55","TRTEDTM":"2021-09-22 12:58:28","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":265,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-22","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.11509,"AVALU":"YEARS","ADTM":"2021-03-18","ADY":77,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-163","SUBJID":"id-163","SITEID":"CHN-1","AGE":41,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":6.76362,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-12-31","TRTSDTM":"2020-12-31 13:08:55","TRTEDTM":"2021-09-22 12:58:28","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":265,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-22","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.50234,"AVALU":"YEARS","ADTM":"2021-05-26","ADY":146,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-163","SUBJID":"id-163","SITEID":"CHN-1","AGE":41,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":6.76362,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-12-31","TRTSDTM":"2020-12-31 13:08:55","TRTEDTM":"2021-09-22 12:58:28","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":265,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-22","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.57752,"AVALU":"YEARS","ADTM":"2021-04-05","ADY":95,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-181","SUBJID":"id-181","SITEID":"CHN-1","AGE":47,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":4.5313,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-07","TRTSDTM":"2020-12-09 13:38:37","TRTEDTM":"2022-12-10 01:17:01","EOSSTT":"COMPLETED","EOSDT":"2022-12-10","EOSDY":731,"DTHDT":"2022-12-10","LSTALVDT":"2023-01-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.16561,"AVALU":"YEARS","ADTM":"2021-12-19","ADY":375,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-181","SUBJID":"id-181","SITEID":"CHN-1","AGE":47,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":4.5313,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-07","TRTSDTM":"2020-12-09 13:38:37","TRTEDTM":"2022-12-10 01:17:01","EOSSTT":"COMPLETED","EOSDT":"2022-12-10","EOSDY":731,"DTHDT":"2022-12-10","LSTALVDT":"2023-01-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.43005,"AVALU":"YEARS","ADTM":"2021-05-26","ADY":168,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-181","SUBJID":"id-181","SITEID":"CHN-1","AGE":47,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":4.5313,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-07","TRTSDTM":"2020-12-09 13:38:37","TRTEDTM":"2022-12-10 01:17:01","EOSSTT":"COMPLETED","EOSDT":"2022-12-10","EOSDY":731,"DTHDT":"2022-12-10","LSTALVDT":"2023-01-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.38478,"AVALU":"YEARS","ADTM":"2022-10-27","ADY":687,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-186","SUBJID":"id-186","SITEID":"CHN-1","AGE":27,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.52118,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-09-06","TRTSDTM":"2021-09-09 04:51:06","TRTEDTM":"2023-09-09 16:29:30","EOSSTT":"COMPLETED","EOSDT":"2023-09-09","EOSDY":731,"DTHDT":"2023-09-09","LSTALVDT":"2023-10-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.1482,"AVALU":"YEARS","ADTM":"2023-03-30","ADY":567,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-186","SUBJID":"id-186","SITEID":"CHN-1","AGE":27,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.52118,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-09-06","TRTSDTM":"2021-09-09 04:51:06","TRTEDTM":"2023-09-09 16:29:30","EOSSTT":"COMPLETED","EOSDT":"2023-09-09","EOSDY":731,"DTHDT":"2023-09-09","LSTALVDT":"2023-10-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.50233,"AVALU":"YEARS","ADTM":"2023-05-24","ADY":622,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-186","SUBJID":"id-186","SITEID":"CHN-1","AGE":27,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.52118,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-09-06","TRTSDTM":"2021-09-09 04:51:06","TRTEDTM":"2023-09-09 16:29:30","EOSSTT":"COMPLETED","EOSDT":"2023-09-09","EOSDY":731,"DTHDT":"2023-09-09","LSTALVDT":"2023-10-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.70751,"AVALU":"YEARS","ADTM":"2023-03-18","ADY":555,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-197","SUBJID":"id-197","SITEID":"CHN-1","AGE":31,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":3.65225,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-01-02","TRTSDTM":"2021-01-05 16:25:29","TRTEDTM":"2023-01-06 04:03:53","EOSSTT":"COMPLETED","EOSDT":"2023-01-06","EOSDY":731,"DTHDT":"2023-01-06","LSTALVDT":"2023-01-28","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12669,"AVALU":"YEARS","ADTM":"2021-11-20","ADY":319,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-197","SUBJID":"id-197","SITEID":"CHN-1","AGE":31,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":3.65225,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-01-02","TRTSDTM":"2021-01-05 16:25:29","TRTEDTM":"2023-01-06 04:03:53","EOSSTT":"COMPLETED","EOSDT":"2023-01-06","EOSDY":731,"DTHDT":"2023-01-06","LSTALVDT":"2023-01-28","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.06877,"AVALU":"YEARS","ADTM":"2022-01-08","ADY":368,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-197","SUBJID":"id-197","SITEID":"CHN-1","AGE":31,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":3.65225,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-01-02","TRTSDTM":"2021-01-05 16:25:29","TRTEDTM":"2023-01-06 04:03:53","EOSSTT":"COMPLETED","EOSDT":"2023-01-06","EOSDY":731,"DTHDT":"2023-01-06","LSTALVDT":"2023-01-28","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07891,"AVALU":"YEARS","ADTM":"2022-12-10","ADY":704,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-199","SUBJID":"id-199","SITEID":"CHN-1","AGE":27,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":8.85826,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-13","TRTSDTM":"2020-08-14 07:14:14","TRTEDTM":"2021-09-22 14:30:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":405,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14356,"AVALU":"YEARS","ADTM":"2021-02-08","ADY":178,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-199","SUBJID":"id-199","SITEID":"CHN-1","AGE":27,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":8.85826,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-13","TRTSDTM":"2020-08-14 07:14:14","TRTEDTM":"2021-09-22 14:30:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":405,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01386,"AVALU":"YEARS","ADTM":"2021-06-11","ADY":301,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-199","SUBJID":"id-199","SITEID":"CHN-1","AGE":27,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":8.85826,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-13","TRTSDTM":"2020-08-14 07:14:14","TRTEDTM":"2021-09-22 14:30:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":405,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07348,"AVALU":"YEARS","ADTM":"2020-10-17","ADY":64,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-208","SUBJID":"id-208","SITEID":"CHN-1","AGE":28,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.5165,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-03","TRTSDTM":"2021-03-07 00:35:48","TRTEDTM":"2021-09-18 16:32:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":196,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-18","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.47663,"AVALU":"YEARS","ADTM":"2021-06-11","ADY":96,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-208","SUBJID":"id-208","SITEID":"CHN-1","AGE":28,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.5165,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-03","TRTSDTM":"2021-03-07 00:35:48","TRTEDTM":"2021-09-18 16:32:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":196,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-18","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.04225,"AVALU":"YEARS","ADTM":"2021-04-28","ADY":52,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-208","SUBJID":"id-208","SITEID":"CHN-1","AGE":28,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.5165,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-03","TRTSDTM":"2021-03-07 00:35:48","TRTEDTM":"2021-09-18 16:32:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":196,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-18","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.22249,"AVALU":"YEARS","ADTM":"2021-06-04","ADY":89,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-212","SUBJID":"id-212","SITEID":"CHN-1","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":5.12569,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-03","TRTSDTM":"2021-08-05 15:56:51","TRTEDTM":"2021-09-19 03:19:47","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":45,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-19","LSTALVDT":"2021-09-29","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.15225,"AVALU":"YEARS","ADTM":"2021-08-17","ADY":12,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-212","SUBJID":"id-212","SITEID":"CHN-1","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":5.12569,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-03","TRTSDTM":"2021-08-05 15:56:51","TRTEDTM":"2021-09-19 03:19:47","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":45,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-19","LSTALVDT":"2021-09-29","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.1248,"AVALU":"YEARS","ADTM":"2021-08-29","ADY":24,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-212","SUBJID":"id-212","SITEID":"CHN-1","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":5.12569,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-03","TRTSDTM":"2021-08-05 15:56:51","TRTEDTM":"2021-09-19 03:19:47","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":45,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-19","LSTALVDT":"2021-09-29","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.18083,"AVALU":"YEARS","ADTM":"2021-09-05","ADY":31,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-216","SUBJID":"id-216","SITEID":"CHN-1","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":7.43058,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-06","TRTSDTM":"2021-05-10 12:10:05","TRTEDTM":"2021-09-19 16:46:37","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":133,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-19","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02239,"AVALU":"YEARS","ADTM":"2021-07-27","ADY":78,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-216","SUBJID":"id-216","SITEID":"CHN-1","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":7.43058,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-06","TRTSDTM":"2021-05-10 12:10:05","TRTEDTM":"2021-09-19 16:46:37","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":133,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-19","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.06654,"AVALU":"YEARS","ADTM":"2021-08-19","ADY":101,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-216","SUBJID":"id-216","SITEID":"CHN-1","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":7.43058,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-06","TRTSDTM":"2021-05-10 12:10:05","TRTEDTM":"2021-09-19 16:46:37","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":133,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-19","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01619,"AVALU":"YEARS","ADTM":"2021-08-25","ADY":107,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-227","SUBJID":"id-227","SITEID":"CHN-1","AGE":26,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":12.1904,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-11-12","TRTSDTM":"2019-11-14 08:44:17","TRTEDTM":"2021-11-13 20:22:41","EOSSTT":"COMPLETED","EOSDT":"2021-11-13","EOSDY":731,"DTHDT":"2021-11-13","LSTALVDT":"2021-12-02","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.28859,"AVALU":"YEARS","ADTM":"2021-10-10","ADY":696,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-227","SUBJID":"id-227","SITEID":"CHN-1","AGE":26,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":12.1904,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-11-12","TRTSDTM":"2019-11-14 08:44:17","TRTEDTM":"2021-11-13 20:22:41","EOSSTT":"COMPLETED","EOSDT":"2021-11-13","EOSDY":731,"DTHDT":"2021-11-13","LSTALVDT":"2021-12-02","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.10403,"AVALU":"YEARS","ADTM":"2021-06-29","ADY":593,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-227","SUBJID":"id-227","SITEID":"CHN-1","AGE":26,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":12.1904,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-11-12","TRTSDTM":"2019-11-14 08:44:17","TRTEDTM":"2021-11-13 20:22:41","EOSSTT":"COMPLETED","EOSDT":"2021-11-13","EOSDY":731,"DTHDT":"2021-11-13","LSTALVDT":"2021-12-02","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.79945,"AVALU":"YEARS","ADTM":"2020-09-26","ADY":317,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-229","SUBJID":"id-229","SITEID":"CHN-1","AGE":37,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":9.50695,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-05-15","TRTSDTM":"2021-05-19 21:22:14","TRTEDTM":"2023-05-20 09:00:38","EOSSTT":"COMPLETED","EOSDT":"2023-05-20","EOSDY":731,"DTHDT":"2023-05-20","LSTALVDT":"2023-06-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.26016,"AVALU":"YEARS","ADTM":"2022-04-04","ADY":320,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-229","SUBJID":"id-229","SITEID":"CHN-1","AGE":37,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":9.50695,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-05-15","TRTSDTM":"2021-05-19 21:22:14","TRTEDTM":"2023-05-20 09:00:38","EOSSTT":"COMPLETED","EOSDT":"2023-05-20","EOSDY":731,"DTHDT":"2023-05-20","LSTALVDT":"2023-06-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.39013,"AVALU":"YEARS","ADTM":"2021-06-06","ADY":18,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-229","SUBJID":"id-229","SITEID":"CHN-1","AGE":37,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":9.50695,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-05-15","TRTSDTM":"2021-05-19 21:22:14","TRTEDTM":"2023-05-20 09:00:38","EOSSTT":"COMPLETED","EOSDT":"2023-05-20","EOSDY":731,"DTHDT":"2023-05-20","LSTALVDT":"2023-06-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1799,"AVALU":"YEARS","ADTM":"2022-12-23","ADY":583,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-232","SUBJID":"id-232","SITEID":"CHN-1","AGE":42,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.17424,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-09-30","TRTSDTM":"2020-09-30 00:00:28","TRTEDTM":"2022-09-30 11:38:52","EOSSTT":"COMPLETED","EOSDT":"2022-09-30","EOSDY":731,"DTHDT":"2022-09-30","LSTALVDT":"2022-10-11","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03435,"AVALU":"YEARS","ADTM":"2020-12-10","ADY":71,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-232","SUBJID":"id-232","SITEID":"CHN-1","AGE":42,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.17424,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-09-30","TRTSDTM":"2020-09-30 00:00:28","TRTEDTM":"2022-09-30 11:38:52","EOSSTT":"COMPLETED","EOSDT":"2022-09-30","EOSDY":731,"DTHDT":"2022-09-30","LSTALVDT":"2022-10-11","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.43853,"AVALU":"YEARS","ADTM":"2020-12-19","ADY":80,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-232","SUBJID":"id-232","SITEID":"CHN-1","AGE":42,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.17424,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-09-30","TRTSDTM":"2020-09-30 00:00:28","TRTEDTM":"2022-09-30 11:38:52","EOSSTT":"COMPLETED","EOSDT":"2022-09-30","EOSDY":731,"DTHDT":"2022-09-30","LSTALVDT":"2022-10-11","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.09606,"AVALU":"YEARS","ADTM":"2020-10-03","ADY":3,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-233","SUBJID":"id-233","SITEID":"CHN-1","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.07682,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-09-16","TRTSDTM":"2021-09-18 07:09:28","TRTEDTM":"2021-09-23 18:48:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":6,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.11273,"AVALU":"YEARS","ADTM":"2021-09-23","ADY":5,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-233","SUBJID":"id-233","SITEID":"CHN-1","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.07682,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-09-16","TRTSDTM":"2021-09-18 07:09:28","TRTEDTM":"2021-09-23 18:48:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":6,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.24985,"AVALU":"YEARS","ADTM":"2021-09-22","ADY":4,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-233","SUBJID":"id-233","SITEID":"CHN-1","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.07682,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-09-16","TRTSDTM":"2021-09-18 07:09:28","TRTEDTM":"2021-09-23 18:48:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":6,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.20741,"AVALU":"YEARS","ADTM":"2021-09-21","ADY":3,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-235","SUBJID":"id-235","SITEID":"CHN-1","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":4.71119,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-02-14","TRTSDTM":"2020-02-16 10:09:27","TRTEDTM":"2021-09-20 14:19:32","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":583,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-20","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.25853,"AVALU":"YEARS","ADTM":"2021-09-08","ADY":570,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-235","SUBJID":"id-235","SITEID":"CHN-1","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":4.71119,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-02-14","TRTSDTM":"2020-02-16 10:09:27","TRTEDTM":"2021-09-20 14:19:32","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":583,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-20","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.16362,"AVALU":"YEARS","ADTM":"2021-03-01","ADY":379,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-235","SUBJID":"id-235","SITEID":"CHN-1","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":4.71119,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-02-14","TRTSDTM":"2020-02-16 10:09:27","TRTEDTM":"2021-09-20 14:19:32","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":583,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-20","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.66142,"AVALU":"YEARS","ADTM":"2021-05-09","ADY":448,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-25","SUBJID":"id-25","SITEID":"CHN-1","AGE":26,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":1.7821,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-06-04","TRTSDTM":"2021-06-08 22:09:06","TRTEDTM":"2023-06-09 09:47:30","EOSSTT":"COMPLETED","EOSDT":"2023-06-09","EOSDY":731,"DTHDT":"2023-06-09","LSTALVDT":"2023-07-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00975,"AVALU":"YEARS","ADTM":"2022-05-07","ADY":333,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-25","SUBJID":"id-25","SITEID":"CHN-1","AGE":26,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":1.7821,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-06-04","TRTSDTM":"2021-06-08 22:09:06","TRTEDTM":"2023-06-09 09:47:30","EOSSTT":"COMPLETED","EOSDT":"2023-06-09","EOSDY":731,"DTHDT":"2023-06-09","LSTALVDT":"2023-07-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.17964,"AVALU":"YEARS","ADTM":"2022-01-01","ADY":207,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-25","SUBJID":"id-25","SITEID":"CHN-1","AGE":26,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":1.7821,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-06-04","TRTSDTM":"2021-06-08 22:09:06","TRTEDTM":"2023-06-09 09:47:30","EOSSTT":"COMPLETED","EOSDT":"2023-06-09","EOSDY":731,"DTHDT":"2023-06-09","LSTALVDT":"2023-07-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01187,"AVALU":"YEARS","ADTM":"2022-02-13","ADY":250,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-253","SUBJID":"id-253","SITEID":"CHN-1","AGE":38,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.93549,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-05-31","TRTSDTM":"2021-05-31 21:24:29","TRTEDTM":"2023-06-01 09:02:53","EOSSTT":"COMPLETED","EOSDT":"2023-06-01","EOSDY":731,"DTHDT":"2023-06-01","LSTALVDT":"2023-06-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14797,"AVALU":"YEARS","ADTM":"2021-09-30","ADY":122,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-253","SUBJID":"id-253","SITEID":"CHN-1","AGE":38,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.93549,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-05-31","TRTSDTM":"2021-05-31 21:24:29","TRTEDTM":"2023-06-01 09:02:53","EOSSTT":"COMPLETED","EOSDT":"2023-06-01","EOSDY":731,"DTHDT":"2023-06-01","LSTALVDT":"2023-06-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.22849,"AVALU":"YEARS","ADTM":"2023-03-22","ADY":660,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-253","SUBJID":"id-253","SITEID":"CHN-1","AGE":38,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.93549,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-05-31","TRTSDTM":"2021-05-31 21:24:29","TRTEDTM":"2023-06-01 09:02:53","EOSSTT":"COMPLETED","EOSDT":"2023-06-01","EOSDY":731,"DTHDT":"2023-06-01","LSTALVDT":"2023-06-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.4207,"AVALU":"YEARS","ADTM":"2022-05-26","ADY":360,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-26","SUBJID":"id-26","SITEID":"CHN-1","AGE":29,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":1.07407,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-02-15","TRTSDTM":"2021-02-19 21:48:35","TRTEDTM":"2023-02-20 09:26:59","EOSSTT":"COMPLETED","EOSDT":"2023-02-20","EOSDY":731,"DTHDT":"2023-02-20","LSTALVDT":"2023-03-20","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01206,"AVALU":"YEARS","ADTM":"2022-02-09","ADY":355,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-26","SUBJID":"id-26","SITEID":"CHN-1","AGE":29,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":1.07407,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-02-15","TRTSDTM":"2021-02-19 21:48:35","TRTEDTM":"2023-02-20 09:26:59","EOSSTT":"COMPLETED","EOSDT":"2023-02-20","EOSDY":731,"DTHDT":"2023-02-20","LSTALVDT":"2023-03-20","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.17532,"AVALU":"YEARS","ADTM":"2022-04-02","ADY":407,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-26","SUBJID":"id-26","SITEID":"CHN-1","AGE":29,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":1.07407,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-02-15","TRTSDTM":"2021-02-19 21:48:35","TRTEDTM":"2023-02-20 09:26:59","EOSSTT":"COMPLETED","EOSDT":"2023-02-20","EOSDY":731,"DTHDT":"2023-02-20","LSTALVDT":"2023-03-20","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0431,"AVALU":"YEARS","ADTM":"2022-03-12","ADY":386,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-275","SUBJID":"id-275","SITEID":"CHN-1","AGE":27,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":7.14151,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-01-06","TRTSDTM":"2021-01-07 08:51:13","TRTEDTM":"2023-01-07 20:29:37","EOSSTT":"COMPLETED","EOSDT":"2023-01-07","EOSDY":731,"DTHDT":"2023-01-07","LSTALVDT":"2023-01-29","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.114,"AVALU":"YEARS","ADTM":"2022-04-26","ADY":474,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-275","SUBJID":"id-275","SITEID":"CHN-1","AGE":27,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":7.14151,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-01-06","TRTSDTM":"2021-01-07 08:51:13","TRTEDTM":"2023-01-07 20:29:37","EOSSTT":"COMPLETED","EOSDT":"2023-01-07","EOSDY":731,"DTHDT":"2023-01-07","LSTALVDT":"2023-01-29","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.09668,"AVALU":"YEARS","ADTM":"2021-01-25","ADY":18,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-275","SUBJID":"id-275","SITEID":"CHN-1","AGE":27,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":7.14151,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-01-06","TRTSDTM":"2021-01-07 08:51:13","TRTEDTM":"2023-01-07 20:29:37","EOSSTT":"COMPLETED","EOSDT":"2023-01-07","EOSDY":731,"DTHDT":"2023-01-07","LSTALVDT":"2023-01-29","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.06484,"AVALU":"YEARS","ADTM":"2021-08-12","ADY":217,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-276","SUBJID":"id-276","SITEID":"CHN-1","AGE":50,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":3.68599,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-27","TRTSDTM":"2021-05-30 14:35:56","TRTEDTM":"2023-05-31 02:14:20","EOSSTT":"COMPLETED","EOSDT":"2023-05-31","EOSDY":731,"DTHDT":"2023-05-31","LSTALVDT":"2023-06-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.2126,"AVALU":"YEARS","ADTM":"2023-03-31","ADY":670,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-276","SUBJID":"id-276","SITEID":"CHN-1","AGE":50,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":3.68599,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-27","TRTSDTM":"2021-05-30 14:35:56","TRTEDTM":"2023-05-31 02:14:20","EOSSTT":"COMPLETED","EOSDT":"2023-05-31","EOSDY":731,"DTHDT":"2023-05-31","LSTALVDT":"2023-06-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.29249,"AVALU":"YEARS","ADTM":"2023-03-19","ADY":658,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-276","SUBJID":"id-276","SITEID":"CHN-1","AGE":50,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":3.68599,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-27","TRTSDTM":"2021-05-30 14:35:56","TRTEDTM":"2023-05-31 02:14:20","EOSSTT":"COMPLETED","EOSDT":"2023-05-31","EOSDY":731,"DTHDT":"2023-05-31","LSTALVDT":"2023-06-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.42677,"AVALU":"YEARS","ADTM":"2022-03-20","ADY":294,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-277","SUBJID":"id-277","SITEID":"CHN-1","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":4.07227,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-20","TRTSDTM":"2021-08-21 02:19:36","TRTEDTM":"2021-09-22 01:40:16","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":32,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.1628,"AVALU":"YEARS","ADTM":"2021-08-23","ADY":2,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-277","SUBJID":"id-277","SITEID":"CHN-1","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":4.07227,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-20","TRTSDTM":"2021-08-21 02:19:36","TRTEDTM":"2021-09-22 01:40:16","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":32,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.06331,"AVALU":"YEARS","ADTM":"2021-09-09","ADY":19,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-277","SUBJID":"id-277","SITEID":"CHN-1","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":4.07227,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-20","TRTSDTM":"2021-08-21 02:19:36","TRTEDTM":"2021-09-22 01:40:16","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":32,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.15965,"AVALU":"YEARS","ADTM":"2021-09-18","ADY":28,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-279","SUBJID":"id-279","SITEID":"CHN-1","AGE":33,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":3.64194,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-21","TRTSDTM":"2020-10-22 03:43:22","TRTEDTM":"2021-09-19 04:59:19","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":333,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-19","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.10838,"AVALU":"YEARS","ADTM":"2021-07-07","ADY":258,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-279","SUBJID":"id-279","SITEID":"CHN-1","AGE":33,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":3.64194,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-21","TRTSDTM":"2020-10-22 03:43:22","TRTEDTM":"2021-09-19 04:59:19","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":333,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-19","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.5392,"AVALU":"YEARS","ADTM":"2021-02-13","ADY":114,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-279","SUBJID":"id-279","SITEID":"CHN-1","AGE":33,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":3.64194,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-21","TRTSDTM":"2020-10-22 03:43:22","TRTEDTM":"2021-09-19 04:59:19","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":333,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-19","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.51542,"AVALU":"YEARS","ADTM":"2020-11-12","ADY":21,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-287","SUBJID":"id-287","SITEID":"CHN-1","AGE":34,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":10.19352,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-24","TRTSDTM":"2020-06-28 22:14:09","TRTEDTM":"2021-09-26 05:46:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":455,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-26","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.17026,"AVALU":"YEARS","ADTM":"2020-09-16","ADY":80,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-287","SUBJID":"id-287","SITEID":"CHN-1","AGE":34,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":10.19352,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-24","TRTSDTM":"2020-06-28 22:14:09","TRTEDTM":"2021-09-26 05:46:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":455,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-26","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.09627,"AVALU":"YEARS","ADTM":"2021-06-29","ADY":366,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-287","SUBJID":"id-287","SITEID":"CHN-1","AGE":34,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":10.19352,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-24","TRTSDTM":"2020-06-28 22:14:09","TRTEDTM":"2021-09-26 05:46:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":455,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-26","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.17134,"AVALU":"YEARS","ADTM":"2021-08-19","ADY":417,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-288","SUBJID":"id-288","SITEID":"CHN-1","AGE":42,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":4.58264,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-14","TRTSDTM":"2020-07-16 18:44:42","TRTEDTM":"2021-09-25 04:12:51","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":436,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-25","LSTALVDT":"2021-10-10","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.15176,"AVALU":"YEARS","ADTM":"2021-07-01","ADY":350,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-288","SUBJID":"id-288","SITEID":"CHN-1","AGE":42,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":4.58264,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-14","TRTSDTM":"2020-07-16 18:44:42","TRTEDTM":"2021-09-25 04:12:51","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":436,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-25","LSTALVDT":"2021-10-10","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.67846,"AVALU":"YEARS","ADTM":"2021-04-10","ADY":268,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-288","SUBJID":"id-288","SITEID":"CHN-1","AGE":42,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":4.58264,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-14","TRTSDTM":"2020-07-16 18:44:42","TRTEDTM":"2021-09-25 04:12:51","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":436,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-25","LSTALVDT":"2021-10-10","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.03377,"AVALU":"YEARS","ADTM":"2021-06-26","ADY":345,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-307","SUBJID":"id-307","SITEID":"CHN-1","AGE":24,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.57499,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-10-12","TRTSDTM":"2019-10-15 17:37:13","TRTEDTM":"2021-10-15 05:15:37","EOSSTT":"COMPLETED","EOSDT":"2021-10-15","EOSDY":731,"DTHDT":"2021-10-15","LSTALVDT":"2021-11-03","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.17538,"AVALU":"YEARS","ADTM":"2021-08-24","ADY":679,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-307","SUBJID":"id-307","SITEID":"CHN-1","AGE":24,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.57499,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-10-12","TRTSDTM":"2019-10-15 17:37:13","TRTEDTM":"2021-10-15 05:15:37","EOSSTT":"COMPLETED","EOSDT":"2021-10-15","EOSDY":731,"DTHDT":"2021-10-15","LSTALVDT":"2021-11-03","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.44925,"AVALU":"YEARS","ADTM":"2019-12-24","ADY":70,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-307","SUBJID":"id-307","SITEID":"CHN-1","AGE":24,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.57499,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-10-12","TRTSDTM":"2019-10-15 17:37:13","TRTEDTM":"2021-10-15 05:15:37","EOSSTT":"COMPLETED","EOSDT":"2021-10-15","EOSDY":731,"DTHDT":"2021-10-15","LSTALVDT":"2021-11-03","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00539,"AVALU":"YEARS","ADTM":"2020-06-24","ADY":253,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-312","SUBJID":"id-312","SITEID":"CHN-1","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":11.48925,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-09-09","TRTSDTM":"2020-09-12 12:30:18","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01883,"AVALU":"YEARS","ADTM":"2020-10-12","ADY":30,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-312","SUBJID":"id-312","SITEID":"CHN-1","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":11.48925,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-09-09","TRTSDTM":"2020-09-12 12:30:18","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.18891,"AVALU":"YEARS","ADTM":"2021-05-25","ADY":255,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-312","SUBJID":"id-312","SITEID":"CHN-1","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":11.48925,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-09-09","TRTSDTM":"2020-09-12 12:30:18","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11906,"AVALU":"YEARS","ADTM":"2021-01-17","ADY":127,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-315","SUBJID":"id-315","SITEID":"CHN-1","AGE":32,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":7.43787,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-26","TRTSDTM":"2020-03-26 17:01:35","TRTEDTM":"2022-03-27 04:39:59","EOSSTT":"COMPLETED","EOSDT":"2022-03-27","EOSDY":731,"DTHDT":"2022-03-27","LSTALVDT":"2022-04-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00706,"AVALU":"YEARS","ADTM":"2021-04-10","ADY":380,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-315","SUBJID":"id-315","SITEID":"CHN-1","AGE":32,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":7.43787,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-26","TRTSDTM":"2020-03-26 17:01:35","TRTEDTM":"2022-03-27 04:39:59","EOSSTT":"COMPLETED","EOSDT":"2022-03-27","EOSDY":731,"DTHDT":"2022-03-27","LSTALVDT":"2022-04-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.16785,"AVALU":"YEARS","ADTM":"2022-01-26","ADY":671,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-315","SUBJID":"id-315","SITEID":"CHN-1","AGE":32,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":7.43787,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-26","TRTSDTM":"2020-03-26 17:01:35","TRTEDTM":"2022-03-27 04:39:59","EOSSTT":"COMPLETED","EOSDT":"2022-03-27","EOSDY":731,"DTHDT":"2022-03-27","LSTALVDT":"2022-04-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.23791,"AVALU":"YEARS","ADTM":"2022-02-05","ADY":681,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-316","SUBJID":"id-316","SITEID":"CHN-1","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":7.57574,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-04-18","TRTSDTM":"2021-04-21 19:25:05","TRTEDTM":"2023-04-22 07:03:29","EOSSTT":"COMPLETED","EOSDT":"2023-04-22","EOSDY":731,"DTHDT":"2023-04-22","LSTALVDT":"2023-05-18","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.23763,"AVALU":"YEARS","ADTM":"2022-01-06","ADY":260,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-316","SUBJID":"id-316","SITEID":"CHN-1","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":7.57574,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-04-18","TRTSDTM":"2021-04-21 19:25:05","TRTEDTM":"2023-04-22 07:03:29","EOSSTT":"COMPLETED","EOSDT":"2023-04-22","EOSDY":731,"DTHDT":"2023-04-22","LSTALVDT":"2023-05-18","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00602,"AVALU":"YEARS","ADTM":"2022-08-22","ADY":488,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-316","SUBJID":"id-316","SITEID":"CHN-1","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":7.57574,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-04-18","TRTSDTM":"2021-04-21 19:25:05","TRTEDTM":"2023-04-22 07:03:29","EOSSTT":"COMPLETED","EOSDT":"2023-04-22","EOSDY":731,"DTHDT":"2023-04-22","LSTALVDT":"2023-05-18","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.24257,"AVALU":"YEARS","ADTM":"2022-11-10","ADY":568,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-329","SUBJID":"id-329","SITEID":"CHN-1","AGE":48,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.07281,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-02-07","TRTSDTM":"2020-02-10 06:27:07","TRTEDTM":"2022-02-09 18:05:31","EOSSTT":"COMPLETED","EOSDT":"2022-02-09","EOSDY":731,"DTHDT":"2022-02-09","LSTALVDT":"2022-02-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03685,"AVALU":"YEARS","ADTM":"2021-01-20","ADY":345,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-329","SUBJID":"id-329","SITEID":"CHN-1","AGE":48,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.07281,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-02-07","TRTSDTM":"2020-02-10 06:27:07","TRTEDTM":"2022-02-09 18:05:31","EOSSTT":"COMPLETED","EOSDT":"2022-02-09","EOSDY":731,"DTHDT":"2022-02-09","LSTALVDT":"2022-02-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.29813,"AVALU":"YEARS","ADTM":"2020-10-26","ADY":259,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-329","SUBJID":"id-329","SITEID":"CHN-1","AGE":48,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.07281,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-02-07","TRTSDTM":"2020-02-10 06:27:07","TRTEDTM":"2022-02-09 18:05:31","EOSSTT":"COMPLETED","EOSDT":"2022-02-09","EOSDY":731,"DTHDT":"2022-02-09","LSTALVDT":"2022-02-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02378,"AVALU":"YEARS","ADTM":"2020-07-03","ADY":144,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-33","SUBJID":"id-33","SITEID":"CHN-1","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.68515,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-07-23","TRTSDTM":"2021-07-25 12:21:06","TRTEDTM":"2023-07-25 23:59:30","EOSSTT":"COMPLETED","EOSDT":"2023-07-25","EOSDY":731,"DTHDT":"2023-07-25","LSTALVDT":"2023-08-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.25077,"AVALU":"YEARS","ADTM":"2023-07-16","ADY":721,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-33","SUBJID":"id-33","SITEID":"CHN-1","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.68515,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-07-23","TRTSDTM":"2021-07-25 12:21:06","TRTEDTM":"2023-07-25 23:59:30","EOSSTT":"COMPLETED","EOSDT":"2023-07-25","EOSDY":731,"DTHDT":"2023-07-25","LSTALVDT":"2023-08-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.18713,"AVALU":"YEARS","ADTM":"2022-10-28","ADY":460,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-33","SUBJID":"id-33","SITEID":"CHN-1","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.68515,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-07-23","TRTSDTM":"2021-07-25 12:21:06","TRTEDTM":"2023-07-25 23:59:30","EOSSTT":"COMPLETED","EOSDT":"2023-07-25","EOSDY":731,"DTHDT":"2023-07-25","LSTALVDT":"2023-08-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.10937,"AVALU":"YEARS","ADTM":"2022-07-23","ADY":363,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-336","SUBJID":"id-336","SITEID":"CHN-1","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":2.82925,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-03-28","TRTSDTM":"2021-03-30 09:28:03","TRTEDTM":"2023-03-30 21:06:27","EOSSTT":"COMPLETED","EOSDT":"2023-03-30","EOSDY":731,"DTHDT":"2023-03-30","LSTALVDT":"2023-04-23","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.05756,"AVALU":"YEARS","ADTM":"2021-10-26","ADY":210,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-336","SUBJID":"id-336","SITEID":"CHN-1","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":2.82925,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-03-28","TRTSDTM":"2021-03-30 09:28:03","TRTEDTM":"2023-03-30 21:06:27","EOSSTT":"COMPLETED","EOSDT":"2023-03-30","EOSDY":731,"DTHDT":"2023-03-30","LSTALVDT":"2023-04-23","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02042,"AVALU":"YEARS","ADTM":"2022-01-21","ADY":297,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-336","SUBJID":"id-336","SITEID":"CHN-1","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":2.82925,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-03-28","TRTSDTM":"2021-03-30 09:28:03","TRTEDTM":"2023-03-30 21:06:27","EOSSTT":"COMPLETED","EOSDT":"2023-03-30","EOSDY":731,"DTHDT":"2023-03-30","LSTALVDT":"2023-04-23","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11833,"AVALU":"YEARS","ADTM":"2021-11-15","ADY":230,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-337","SUBJID":"id-337","SITEID":"CHN-1","AGE":47,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":2.22759,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-01-08","TRTSDTM":"2021-01-10 09:02:19","TRTEDTM":"2023-01-10 20:40:43","EOSSTT":"COMPLETED","EOSDT":"2023-01-10","EOSDY":731,"DTHDT":"2023-01-10","LSTALVDT":"2023-02-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00687,"AVALU":"YEARS","ADTM":"2021-03-17","ADY":66,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-337","SUBJID":"id-337","SITEID":"CHN-1","AGE":47,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":2.22759,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-01-08","TRTSDTM":"2021-01-10 09:02:19","TRTEDTM":"2023-01-10 20:40:43","EOSSTT":"COMPLETED","EOSDT":"2023-01-10","EOSDY":731,"DTHDT":"2023-01-10","LSTALVDT":"2023-02-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.18104,"AVALU":"YEARS","ADTM":"2021-06-09","ADY":150,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-337","SUBJID":"id-337","SITEID":"CHN-1","AGE":47,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":2.22759,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-01-08","TRTSDTM":"2021-01-10 09:02:19","TRTEDTM":"2023-01-10 20:40:43","EOSSTT":"COMPLETED","EOSDT":"2023-01-10","EOSDY":731,"DTHDT":"2023-01-10","LSTALVDT":"2023-02-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.38353,"AVALU":"YEARS","ADTM":"2022-07-01","ADY":537,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-344","SUBJID":"id-344","SITEID":"CHN-1","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":2.58443,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-20","TRTSDTM":"2021-06-23 04:08:58","TRTEDTM":"2021-09-24 14:55:32","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":94,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0734,"AVALU":"YEARS","ADTM":"2021-08-29","ADY":67,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-344","SUBJID":"id-344","SITEID":"CHN-1","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":2.58443,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-20","TRTSDTM":"2021-06-23 04:08:58","TRTEDTM":"2021-09-24 14:55:32","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":94,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.50545,"AVALU":"YEARS","ADTM":"2021-07-02","ADY":9,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-344","SUBJID":"id-344","SITEID":"CHN-1","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":2.58443,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-20","TRTSDTM":"2021-06-23 04:08:58","TRTEDTM":"2021-09-24 14:55:32","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":94,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.22652,"AVALU":"YEARS","ADTM":"2021-07-07","ADY":14,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-346","SUBJID":"id-346","SITEID":"CHN-1","AGE":21,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":3.08004,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-26","TRTSDTM":"2020-06-29 04:02:39","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.33039,"AVALU":"YEARS","ADTM":"2021-01-14","ADY":199,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-346","SUBJID":"id-346","SITEID":"CHN-1","AGE":21,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":3.08004,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-26","TRTSDTM":"2020-06-29 04:02:39","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.4197,"AVALU":"YEARS","ADTM":"2021-02-19","ADY":235,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-346","SUBJID":"id-346","SITEID":"CHN-1","AGE":21,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":3.08004,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-26","TRTSDTM":"2020-06-29 04:02:39","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.17066,"AVALU":"YEARS","ADTM":"2021-08-27","ADY":424,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-347","SUBJID":"id-347","SITEID":"CHN-1","AGE":33,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":1.15631,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-02","TRTSDTM":"2021-05-03 01:01:35","TRTEDTM":"2023-05-03 12:39:59","EOSSTT":"COMPLETED","EOSDT":"2023-05-03","EOSDY":731,"DTHDT":"2023-05-03","LSTALVDT":"2023-05-28","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":1.08165,"AVALU":"YEARS","ADTM":"2021-11-22","ADY":203,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-347","SUBJID":"id-347","SITEID":"CHN-1","AGE":33,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":1.15631,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-02","TRTSDTM":"2021-05-03 01:01:35","TRTEDTM":"2023-05-03 12:39:59","EOSSTT":"COMPLETED","EOSDT":"2023-05-03","EOSDY":731,"DTHDT":"2023-05-03","LSTALVDT":"2023-05-28","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.46703,"AVALU":"YEARS","ADTM":"2023-03-22","ADY":688,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-347","SUBJID":"id-347","SITEID":"CHN-1","AGE":33,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":1.15631,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-02","TRTSDTM":"2021-05-03 01:01:35","TRTEDTM":"2023-05-03 12:39:59","EOSSTT":"COMPLETED","EOSDT":"2023-05-03","EOSDY":731,"DTHDT":"2023-05-03","LSTALVDT":"2023-05-28","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.40323,"AVALU":"YEARS","ADTM":"2023-04-27","ADY":724,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-351","SUBJID":"id-351","SITEID":"CHN-1","AGE":33,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.36685,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-05","TRTSDTM":"2021-03-08 02:24:57","TRTEDTM":"2023-03-08 14:03:21","EOSSTT":"COMPLETED","EOSDT":"2023-03-08","EOSDY":731,"DTHDT":"2023-03-08","LSTALVDT":"2023-03-26","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.4597,"AVALU":"YEARS","ADTM":"2022-01-23","ADY":321,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-351","SUBJID":"id-351","SITEID":"CHN-1","AGE":33,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.36685,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-05","TRTSDTM":"2021-03-08 02:24:57","TRTEDTM":"2023-03-08 14:03:21","EOSSTT":"COMPLETED","EOSDT":"2023-03-08","EOSDY":731,"DTHDT":"2023-03-08","LSTALVDT":"2023-03-26","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.27261,"AVALU":"YEARS","ADTM":"2021-06-02","ADY":86,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-351","SUBJID":"id-351","SITEID":"CHN-1","AGE":33,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.36685,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-05","TRTSDTM":"2021-03-08 02:24:57","TRTEDTM":"2023-03-08 14:03:21","EOSSTT":"COMPLETED","EOSDT":"2023-03-08","EOSDY":731,"DTHDT":"2023-03-08","LSTALVDT":"2023-03-26","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.14612,"AVALU":"YEARS","ADTM":"2022-07-19","ADY":498,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-360","SUBJID":"id-360","SITEID":"CHN-1","AGE":28,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.84995,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-12-15","TRTSDTM":"2020-12-17 06:37:12","TRTEDTM":"2022-12-17 18:15:36","EOSSTT":"COMPLETED","EOSDT":"2022-12-17","EOSDY":731,"DTHDT":"2022-12-17","LSTALVDT":"2023-01-03","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.49221,"AVALU":"YEARS","ADTM":"2021-06-13","ADY":178,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-360","SUBJID":"id-360","SITEID":"CHN-1","AGE":28,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.84995,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-12-15","TRTSDTM":"2020-12-17 06:37:12","TRTEDTM":"2022-12-17 18:15:36","EOSSTT":"COMPLETED","EOSDT":"2022-12-17","EOSDY":731,"DTHDT":"2022-12-17","LSTALVDT":"2023-01-03","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.86104,"AVALU":"YEARS","ADTM":"2022-06-02","ADY":532,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-360","SUBJID":"id-360","SITEID":"CHN-1","AGE":28,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.84995,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-12-15","TRTSDTM":"2020-12-17 06:37:12","TRTEDTM":"2022-12-17 18:15:36","EOSSTT":"COMPLETED","EOSDT":"2022-12-17","EOSDY":731,"DTHDT":"2022-12-17","LSTALVDT":"2023-01-03","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00984,"AVALU":"YEARS","ADTM":"2021-11-06","ADY":324,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-371","SUBJID":"id-371","SITEID":"CHN-1","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":6.32686,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-09-13","TRTSDTM":"2021-09-15 15:05:12","TRTEDTM":"2021-09-26 04:42:21","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":11,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-26","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.09587,"AVALU":"YEARS","ADTM":"2021-09-22","ADY":7,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-371","SUBJID":"id-371","SITEID":"CHN-1","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":6.32686,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-09-13","TRTSDTM":"2021-09-15 15:05:12","TRTEDTM":"2021-09-26 04:42:21","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":11,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-26","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.11167,"AVALU":"YEARS","ADTM":"2021-09-17","ADY":2,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-371","SUBJID":"id-371","SITEID":"CHN-1","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":6.32686,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-09-13","TRTSDTM":"2021-09-15 15:05:12","TRTEDTM":"2021-09-26 04:42:21","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":11,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-26","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04938,"AVALU":"YEARS","ADTM":"2021-09-15","ADY":0,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-376","SUBJID":"id-376","SITEID":"CHN-1","AGE":41,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":21.39337,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-05-02","TRTSDTM":"2020-05-06 09:12:41","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00064,"AVALU":"YEARS","ADTM":"2021-09-05","ADY":487,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-376","SUBJID":"id-376","SITEID":"CHN-1","AGE":41,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":21.39337,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-05-02","TRTSDTM":"2020-05-06 09:12:41","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.24443,"AVALU":"YEARS","ADTM":"2020-09-02","ADY":119,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-376","SUBJID":"id-376","SITEID":"CHN-1","AGE":41,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":21.39337,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-05-02","TRTSDTM":"2020-05-06 09:12:41","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.25869,"AVALU":"YEARS","ADTM":"2020-12-28","ADY":236,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-389","SUBJID":"id-389","SITEID":"CHN-1","AGE":35,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":7.82133,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-02-03","TRTSDTM":"2021-02-05 21:29:26","TRTEDTM":"2023-02-06 09:07:50","EOSSTT":"COMPLETED","EOSDT":"2023-02-06","EOSDY":731,"DTHDT":"2023-02-06","LSTALVDT":"2023-02-22","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.006,"AVALU":"YEARS","ADTM":"2021-10-04","ADY":241,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-389","SUBJID":"id-389","SITEID":"CHN-1","AGE":35,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":7.82133,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-02-03","TRTSDTM":"2021-02-05 21:29:26","TRTEDTM":"2023-02-06 09:07:50","EOSSTT":"COMPLETED","EOSDT":"2023-02-06","EOSDY":731,"DTHDT":"2023-02-06","LSTALVDT":"2023-02-22","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.21495,"AVALU":"YEARS","ADTM":"2022-05-03","ADY":452,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-389","SUBJID":"id-389","SITEID":"CHN-1","AGE":35,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":7.82133,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-02-03","TRTSDTM":"2021-02-05 21:29:26","TRTEDTM":"2023-02-06 09:07:50","EOSSTT":"COMPLETED","EOSDT":"2023-02-06","EOSDY":731,"DTHDT":"2023-02-06","LSTALVDT":"2023-02-22","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0844,"AVALU":"YEARS","ADTM":"2021-05-08","ADY":92,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-400","SUBJID":"id-400","SITEID":"CHN-1","AGE":26,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.77615,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-19","TRTSDTM":"2020-04-22 03:57:34","TRTEDTM":"2021-09-24 23:45:42","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":521,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.05055,"AVALU":"YEARS","ADTM":"2020-06-10","ADY":49,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-400","SUBJID":"id-400","SITEID":"CHN-1","AGE":26,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.77615,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-19","TRTSDTM":"2020-04-22 03:57:34","TRTEDTM":"2021-09-24 23:45:42","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":521,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.30508,"AVALU":"YEARS","ADTM":"2021-09-02","ADY":498,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-400","SUBJID":"id-400","SITEID":"CHN-1","AGE":26,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.77615,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-19","TRTSDTM":"2020-04-22 03:57:34","TRTEDTM":"2021-09-24 23:45:42","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":521,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.03562,"AVALU":"YEARS","ADTM":"2020-08-11","ADY":111,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-47","SUBJID":"id-47","SITEID":"CHN-1","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":6.39866,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-21","TRTSDTM":"2020-08-24 14:25:07","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.35808,"AVALU":"YEARS","ADTM":"2021-10-07","ADY":409,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-47","SUBJID":"id-47","SITEID":"CHN-1","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":6.39866,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-21","TRTSDTM":"2020-08-24 14:25:07","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.10244,"AVALU":"YEARS","ADTM":"2020-10-16","ADY":53,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-47","SUBJID":"id-47","SITEID":"CHN-1","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":6.39866,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-21","TRTSDTM":"2020-08-24 14:25:07","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.17434,"AVALU":"YEARS","ADTM":"2022-06-28","ADY":673,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-53","SUBJID":"id-53","SITEID":"CHN-1","AGE":48,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.90562,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-09","TRTSDTM":"2020-06-12 16:56:42","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.36459,"AVALU":"YEARS","ADTM":"2022-04-05","ADY":662,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-53","SUBJID":"id-53","SITEID":"CHN-1","AGE":48,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.90562,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-09","TRTSDTM":"2020-06-12 16:56:42","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.03566,"AVALU":"YEARS","ADTM":"2021-05-21","ADY":343,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-53","SUBJID":"id-53","SITEID":"CHN-1","AGE":48,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.90562,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-09","TRTSDTM":"2020-06-12 16:56:42","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01938,"AVALU":"YEARS","ADTM":"2021-09-21","ADY":466,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-62","SUBJID":"id-62","SITEID":"CHN-1","AGE":36,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":6.50974,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-27","TRTSDTM":"2021-06-28 11:09:35","TRTEDTM":"2023-06-28 22:47:59","EOSSTT":"COMPLETED","EOSDT":"2023-06-28","EOSDY":731,"DTHDT":"2023-06-28","LSTALVDT":"2023-07-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.44016,"AVALU":"YEARS","ADTM":"2022-01-12","ADY":198,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-62","SUBJID":"id-62","SITEID":"CHN-1","AGE":36,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":6.50974,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-27","TRTSDTM":"2021-06-28 11:09:35","TRTEDTM":"2023-06-28 22:47:59","EOSSTT":"COMPLETED","EOSDT":"2023-06-28","EOSDY":731,"DTHDT":"2023-06-28","LSTALVDT":"2023-07-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.39963,"AVALU":"YEARS","ADTM":"2023-03-10","ADY":620,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-62","SUBJID":"id-62","SITEID":"CHN-1","AGE":36,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":6.50974,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-27","TRTSDTM":"2021-06-28 11:09:35","TRTEDTM":"2023-06-28 22:47:59","EOSSTT":"COMPLETED","EOSDT":"2023-06-28","EOSDY":731,"DTHDT":"2023-06-28","LSTALVDT":"2023-07-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.12127,"AVALU":"YEARS","ADTM":"2021-10-25","ADY":119,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-64","SUBJID":"id-64","SITEID":"CHN-1","AGE":34,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":3.16063,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-29","TRTSDTM":"2019-12-02 12:15:54","TRTEDTM":"2021-12-01 23:54:18","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-18","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.20144,"AVALU":"YEARS","ADTM":"2021-05-25","ADY":540,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-64","SUBJID":"id-64","SITEID":"CHN-1","AGE":34,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":3.16063,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-29","TRTSDTM":"2019-12-02 12:15:54","TRTEDTM":"2021-12-01 23:54:18","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-18","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00594,"AVALU":"YEARS","ADTM":"2021-11-28","ADY":727,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-64","SUBJID":"id-64","SITEID":"CHN-1","AGE":34,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":3.16063,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-29","TRTSDTM":"2019-12-02 12:15:54","TRTEDTM":"2021-12-01 23:54:18","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-18","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00148,"AVALU":"YEARS","ADTM":"2021-02-24","ADY":450,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-69","SUBJID":"id-69","SITEID":"CHN-1","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":8.54,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-06","TRTSDTM":"2020-11-09 04:06:19","TRTEDTM":"2022-11-09 15:44:43","EOSSTT":"COMPLETED","EOSDT":"2022-11-09","EOSDY":731,"DTHDT":"2022-11-09","LSTALVDT":"2022-11-19","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.04501,"AVALU":"YEARS","ADTM":"2021-11-14","ADY":370,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-69","SUBJID":"id-69","SITEID":"CHN-1","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":8.54,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-06","TRTSDTM":"2020-11-09 04:06:19","TRTEDTM":"2022-11-09 15:44:43","EOSSTT":"COMPLETED","EOSDT":"2022-11-09","EOSDY":731,"DTHDT":"2022-11-09","LSTALVDT":"2022-11-19","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.39618,"AVALU":"YEARS","ADTM":"2022-08-08","ADY":637,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-69","SUBJID":"id-69","SITEID":"CHN-1","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":8.54,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-06","TRTSDTM":"2020-11-09 04:06:19","TRTEDTM":"2022-11-09 15:44:43","EOSSTT":"COMPLETED","EOSDT":"2022-11-09","EOSDY":731,"DTHDT":"2022-11-09","LSTALVDT":"2022-11-19","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.16576,"AVALU":"YEARS","ADTM":"2022-08-07","ADY":636,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-71","SUBJID":"id-71","SITEID":"CHN-1","AGE":33,"SEX":"U","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":7.70143,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-07-27","TRTSDTM":"2021-07-30 21:52:06","TRTEDTM":"2023-07-31 09:30:30","EOSSTT":"COMPLETED","EOSDT":"2023-07-31","EOSDY":731,"DTHDT":"2023-07-31","LSTALVDT":"2023-08-23","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0083,"AVALU":"YEARS","ADTM":"2023-07-10","ADY":710,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-71","SUBJID":"id-71","SITEID":"CHN-1","AGE":33,"SEX":"U","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":7.70143,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-07-27","TRTSDTM":"2021-07-30 21:52:06","TRTEDTM":"2023-07-31 09:30:30","EOSSTT":"COMPLETED","EOSDT":"2023-07-31","EOSDY":731,"DTHDT":"2023-07-31","LSTALVDT":"2023-08-23","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.21462,"AVALU":"YEARS","ADTM":"2021-10-30","ADY":92,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-71","SUBJID":"id-71","SITEID":"CHN-1","AGE":33,"SEX":"U","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":7.70143,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-07-27","TRTSDTM":"2021-07-30 21:52:06","TRTEDTM":"2023-07-31 09:30:30","EOSSTT":"COMPLETED","EOSDT":"2023-07-31","EOSDY":731,"DTHDT":"2023-07-31","LSTALVDT":"2023-08-23","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.23348,"AVALU":"YEARS","ADTM":"2022-09-10","ADY":407,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-74","SUBJID":"id-74","SITEID":"CHN-1","AGE":23,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":1.80318,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-23","TRTSDTM":"2020-08-23 13:28:23","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.32143,"AVALU":"YEARS","ADTM":"2021-03-12","ADY":201,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-74","SUBJID":"id-74","SITEID":"CHN-1","AGE":23,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":1.80318,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-23","TRTSDTM":"2020-08-23 13:28:23","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.24572,"AVALU":"YEARS","ADTM":"2022-06-25","ADY":671,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-74","SUBJID":"id-74","SITEID":"CHN-1","AGE":23,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":1.80318,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-23","TRTSDTM":"2020-08-23 13:28:23","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00428,"AVALU":"YEARS","ADTM":"2022-05-26","ADY":641,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-78","SUBJID":"id-78","SITEID":"CHN-1","AGE":44,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.74209,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-09-23","TRTSDTM":"2020-09-27 01:46:44","TRTEDTM":"2022-09-27 13:25:08","EOSSTT":"COMPLETED","EOSDT":"2022-09-27","EOSDY":731,"DTHDT":"2022-09-27","LSTALVDT":"2022-10-26","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.31068,"AVALU":"YEARS","ADTM":"2022-04-27","ADY":577,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-78","SUBJID":"id-78","SITEID":"CHN-1","AGE":44,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.74209,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-09-23","TRTSDTM":"2020-09-27 01:46:44","TRTEDTM":"2022-09-27 13:25:08","EOSSTT":"COMPLETED","EOSDT":"2022-09-27","EOSDY":731,"DTHDT":"2022-09-27","LSTALVDT":"2022-10-26","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.28999,"AVALU":"YEARS","ADTM":"2021-05-21","ADY":236,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-78","SUBJID":"id-78","SITEID":"CHN-1","AGE":44,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.74209,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-09-23","TRTSDTM":"2020-09-27 01:46:44","TRTEDTM":"2022-09-27 13:25:08","EOSSTT":"COMPLETED","EOSDT":"2022-09-27","EOSDY":731,"DTHDT":"2022-09-27","LSTALVDT":"2022-10-26","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02707,"AVALU":"YEARS","ADTM":"2021-07-28","ADY":304,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-86","SUBJID":"id-86","SITEID":"CHN-1","AGE":31,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":3.36363,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-15","TRTSDTM":"2020-12-19 09:41:45","TRTEDTM":"2022-12-19 21:20:09","EOSSTT":"COMPLETED","EOSDT":"2022-12-19","EOSDY":731,"DTHDT":"2022-12-19","LSTALVDT":"2023-01-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03098,"AVALU":"YEARS","ADTM":"2022-11-02","ADY":683,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-86","SUBJID":"id-86","SITEID":"CHN-1","AGE":31,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":3.36363,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-15","TRTSDTM":"2020-12-19 09:41:45","TRTEDTM":"2022-12-19 21:20:09","EOSSTT":"COMPLETED","EOSDT":"2022-12-19","EOSDY":731,"DTHDT":"2022-12-19","LSTALVDT":"2023-01-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.20714,"AVALU":"YEARS","ADTM":"2021-08-12","ADY":236,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-86","SUBJID":"id-86","SITEID":"CHN-1","AGE":31,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":3.36363,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-15","TRTSDTM":"2020-12-19 09:41:45","TRTEDTM":"2022-12-19 21:20:09","EOSSTT":"COMPLETED","EOSDT":"2022-12-19","EOSDY":731,"DTHDT":"2022-12-19","LSTALVDT":"2023-01-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.35732,"AVALU":"YEARS","ADTM":"2022-04-01","ADY":468,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-97","SUBJID":"id-97","SITEID":"CHN-1","AGE":39,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":1.49296,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-25","TRTSDTM":"2020-08-25 17:35:40","TRTEDTM":"2021-09-23 13:46:03","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":394,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01728,"AVALU":"YEARS","ADTM":"2021-03-19","ADY":206,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-97","SUBJID":"id-97","SITEID":"CHN-1","AGE":39,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":1.49296,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-25","TRTSDTM":"2020-08-25 17:35:40","TRTEDTM":"2021-09-23 13:46:03","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":394,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.04577,"AVALU":"YEARS","ADTM":"2020-11-26","ADY":93,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-1-id-97","SUBJID":"id-97","SITEID":"CHN-1","AGE":39,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":1.49296,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-25","TRTSDTM":"2020-08-25 17:35:40","TRTEDTM":"2021-09-23 13:46:03","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":394,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0419,"AVALU":"YEARS","ADTM":"2021-08-07","ADY":347,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-10-id-380","SUBJID":"id-380","SITEID":"CHN-10","AGE":42,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-10","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":5.37548,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-10","TRTSDTM":"2020-12-14 04:08:15","TRTEDTM":"2021-09-24 11:29:14","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":285,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":1.02087,"AVALU":"YEARS","ADTM":"2020-12-17","ADY":3,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-10-id-380","SUBJID":"id-380","SITEID":"CHN-10","AGE":42,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-10","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":5.37548,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-10","TRTSDTM":"2020-12-14 04:08:15","TRTEDTM":"2021-09-24 11:29:14","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":285,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.42892,"AVALU":"YEARS","ADTM":"2020-12-25","ADY":11,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-10-id-380","SUBJID":"id-380","SITEID":"CHN-10","AGE":42,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-10","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":5.37548,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-10","TRTSDTM":"2020-12-14 04:08:15","TRTEDTM":"2021-09-24 11:29:14","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":285,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.31509,"AVALU":"YEARS","ADTM":"2021-01-16","ADY":33,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-113","SUBJID":"id-113","SITEID":"CHN-11","AGE":38,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":10.86591,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-08-13","TRTSDTM":"2021-08-17 01:07:49","TRTEDTM":"2021-09-24 02:33:15","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":39,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.04706,"AVALU":"YEARS","ADTM":"2021-09-15","ADY":29,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-113","SUBJID":"id-113","SITEID":"CHN-11","AGE":38,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":10.86591,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-08-13","TRTSDTM":"2021-08-17 01:07:49","TRTEDTM":"2021-09-24 02:33:15","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":39,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.09362,"AVALU":"YEARS","ADTM":"2021-09-21","ADY":35,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-113","SUBJID":"id-113","SITEID":"CHN-11","AGE":38,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":10.86591,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-08-13","TRTSDTM":"2021-08-17 01:07:49","TRTEDTM":"2021-09-24 02:33:15","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":39,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.26185,"AVALU":"YEARS","ADTM":"2021-08-22","ADY":5,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-116","SUBJID":"id-116","SITEID":"CHN-11","AGE":30,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":13.31633,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-10-16","TRTSDTM":"2020-10-20 04:26:30","TRTEDTM":"2022-10-20 16:04:54","EOSSTT":"COMPLETED","EOSDT":"2022-10-20","EOSDY":731,"DTHDT":"2022-10-20","LSTALVDT":"2022-11-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.29291,"AVALU":"YEARS","ADTM":"2021-04-26","ADY":188,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-116","SUBJID":"id-116","SITEID":"CHN-11","AGE":30,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":13.31633,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-10-16","TRTSDTM":"2020-10-20 04:26:30","TRTEDTM":"2022-10-20 16:04:54","EOSSTT":"COMPLETED","EOSDT":"2022-10-20","EOSDY":731,"DTHDT":"2022-10-20","LSTALVDT":"2022-11-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.59436,"AVALU":"YEARS","ADTM":"2020-12-31","ADY":72,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-116","SUBJID":"id-116","SITEID":"CHN-11","AGE":30,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":13.31633,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-10-16","TRTSDTM":"2020-10-20 04:26:30","TRTEDTM":"2022-10-20 16:04:54","EOSSTT":"COMPLETED","EOSDT":"2022-10-20","EOSDY":731,"DTHDT":"2022-10-20","LSTALVDT":"2022-11-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.30317,"AVALU":"YEARS","ADTM":"2021-08-07","ADY":291,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-124","SUBJID":"id-124","SITEID":"CHN-11","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":4.36798,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-15","TRTSDTM":"2020-02-17 18:23:51","TRTEDTM":"2021-09-19 16:52:56","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":580,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-19","LSTALVDT":"2021-10-01","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12777,"AVALU":"YEARS","ADTM":"2021-06-12","ADY":481,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-124","SUBJID":"id-124","SITEID":"CHN-11","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":4.36798,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-15","TRTSDTM":"2020-02-17 18:23:51","TRTEDTM":"2021-09-19 16:52:56","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":580,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-19","LSTALVDT":"2021-10-01","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.0041,"AVALU":"YEARS","ADTM":"2020-03-14","ADY":26,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-124","SUBJID":"id-124","SITEID":"CHN-11","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":4.36798,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-15","TRTSDTM":"2020-02-17 18:23:51","TRTEDTM":"2021-09-19 16:52:56","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":580,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-19","LSTALVDT":"2021-10-01","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.2027,"AVALU":"YEARS","ADTM":"2020-06-26","ADY":130,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-132","SUBJID":"id-132","SITEID":"CHN-11","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.94925,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-09-30","TRTSDTM":"2020-10-02 22:48:11","TRTEDTM":"2021-09-23 06:50:23","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":356,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14584,"AVALU":"YEARS","ADTM":"2021-06-23","ADY":264,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-132","SUBJID":"id-132","SITEID":"CHN-11","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.94925,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-09-30","TRTSDTM":"2020-10-02 22:48:11","TRTEDTM":"2021-09-23 06:50:23","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":356,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.1415,"AVALU":"YEARS","ADTM":"2021-07-08","ADY":279,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-132","SUBJID":"id-132","SITEID":"CHN-11","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.94925,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-09-30","TRTSDTM":"2020-10-02 22:48:11","TRTEDTM":"2021-09-23 06:50:23","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":356,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04227,"AVALU":"YEARS","ADTM":"2021-06-04","ADY":245,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-146","SUBJID":"id-146","SITEID":"CHN-11","AGE":28,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":9.15901,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-08-12","TRTSDTM":"2021-08-16 05:58:22","TRTEDTM":"2023-08-16 17:36:46","EOSSTT":"COMPLETED","EOSDT":"2023-08-16","EOSDY":731,"DTHDT":"2023-08-16","LSTALVDT":"2023-09-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.13402,"AVALU":"YEARS","ADTM":"2021-09-25","ADY":40,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-146","SUBJID":"id-146","SITEID":"CHN-11","AGE":28,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":9.15901,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-08-12","TRTSDTM":"2021-08-16 05:58:22","TRTEDTM":"2023-08-16 17:36:46","EOSSTT":"COMPLETED","EOSDT":"2023-08-16","EOSDY":731,"DTHDT":"2023-08-16","LSTALVDT":"2023-09-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.06989,"AVALU":"YEARS","ADTM":"2021-09-26","ADY":41,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-146","SUBJID":"id-146","SITEID":"CHN-11","AGE":28,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":9.15901,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-08-12","TRTSDTM":"2021-08-16 05:58:22","TRTEDTM":"2023-08-16 17:36:46","EOSSTT":"COMPLETED","EOSDT":"2023-08-16","EOSDY":731,"DTHDT":"2023-08-16","LSTALVDT":"2023-09-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.10384,"AVALU":"YEARS","ADTM":"2023-01-18","ADY":520,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-153","SUBJID":"id-153","SITEID":"CHN-11","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":6.79286,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-05-16","TRTSDTM":"2021-05-20 06:33:59","TRTEDTM":"2023-05-20 18:12:23","EOSSTT":"COMPLETED","EOSDT":"2023-05-20","EOSDY":731,"DTHDT":"2023-05-20","LSTALVDT":"2023-06-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01061,"AVALU":"YEARS","ADTM":"2022-08-10","ADY":447,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-153","SUBJID":"id-153","SITEID":"CHN-11","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":6.79286,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-05-16","TRTSDTM":"2021-05-20 06:33:59","TRTEDTM":"2023-05-20 18:12:23","EOSSTT":"COMPLETED","EOSDT":"2023-05-20","EOSDY":731,"DTHDT":"2023-05-20","LSTALVDT":"2023-06-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.26647,"AVALU":"YEARS","ADTM":"2023-05-10","ADY":720,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-153","SUBJID":"id-153","SITEID":"CHN-11","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":6.79286,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-05-16","TRTSDTM":"2021-05-20 06:33:59","TRTEDTM":"2023-05-20 18:12:23","EOSSTT":"COMPLETED","EOSDT":"2023-05-20","EOSDY":731,"DTHDT":"2023-05-20","LSTALVDT":"2023-06-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.17388,"AVALU":"YEARS","ADTM":"2021-11-30","ADY":194,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-158","SUBJID":"id-158","SITEID":"CHN-11","AGE":24,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":2.18135,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-20","TRTSDTM":"2021-02-23 10:14:09","TRTEDTM":"2023-02-23 21:52:33","EOSSTT":"COMPLETED","EOSDT":"2023-02-23","EOSDY":731,"DTHDT":"2023-02-23","LSTALVDT":"2023-03-22","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00283,"AVALU":"YEARS","ADTM":"2022-04-12","ADY":413,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-158","SUBJID":"id-158","SITEID":"CHN-11","AGE":24,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":2.18135,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-20","TRTSDTM":"2021-02-23 10:14:09","TRTEDTM":"2023-02-23 21:52:33","EOSSTT":"COMPLETED","EOSDT":"2023-02-23","EOSDY":731,"DTHDT":"2023-02-23","LSTALVDT":"2023-03-22","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.46826,"AVALU":"YEARS","ADTM":"2022-12-24","ADY":669,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-158","SUBJID":"id-158","SITEID":"CHN-11","AGE":24,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":2.18135,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-20","TRTSDTM":"2021-02-23 10:14:09","TRTEDTM":"2023-02-23 21:52:33","EOSSTT":"COMPLETED","EOSDT":"2023-02-23","EOSDY":731,"DTHDT":"2023-02-23","LSTALVDT":"2023-03-22","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02188,"AVALU":"YEARS","ADTM":"2021-06-12","ADY":109,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-167","SUBJID":"id-167","SITEID":"CHN-11","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":11.96265,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-12","TRTSDTM":"2020-06-13 23:47:33","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.32465,"AVALU":"YEARS","ADTM":"2022-03-10","ADY":635,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-167","SUBJID":"id-167","SITEID":"CHN-11","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":11.96265,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-12","TRTSDTM":"2020-06-13 23:47:33","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.16986,"AVALU":"YEARS","ADTM":"2022-01-11","ADY":577,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-167","SUBJID":"id-167","SITEID":"CHN-11","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":11.96265,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-12","TRTSDTM":"2020-06-13 23:47:33","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11504,"AVALU":"YEARS","ADTM":"2022-05-03","ADY":689,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-174","SUBJID":"id-174","SITEID":"CHN-11","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":3.08848,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-22","TRTSDTM":"2020-12-24 06:29:55","TRTEDTM":"2022-12-24 18:08:19","EOSSTT":"COMPLETED","EOSDT":"2022-12-24","EOSDY":731,"DTHDT":"2022-12-24","LSTALVDT":"2023-01-09","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.38732,"AVALU":"YEARS","ADTM":"2022-08-01","ADY":585,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-174","SUBJID":"id-174","SITEID":"CHN-11","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":3.08848,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-22","TRTSDTM":"2020-12-24 06:29:55","TRTEDTM":"2022-12-24 18:08:19","EOSSTT":"COMPLETED","EOSDT":"2022-12-24","EOSDY":731,"DTHDT":"2022-12-24","LSTALVDT":"2023-01-09","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.43923,"AVALU":"YEARS","ADTM":"2021-03-19","ADY":85,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-174","SUBJID":"id-174","SITEID":"CHN-11","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":3.08848,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-22","TRTSDTM":"2020-12-24 06:29:55","TRTEDTM":"2022-12-24 18:08:19","EOSSTT":"COMPLETED","EOSDT":"2022-12-24","EOSDY":731,"DTHDT":"2022-12-24","LSTALVDT":"2023-01-09","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.26318,"AVALU":"YEARS","ADTM":"2021-09-26","ADY":276,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-184","SUBJID":"id-184","SITEID":"CHN-11","AGE":38,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":1.63913,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-12-08","TRTSDTM":"2019-12-08 17:53:58","TRTEDTM":"2021-12-08 05:32:22","EOSSTT":"COMPLETED","EOSDT":"2021-12-08","EOSDY":731,"DTHDT":"2021-12-08","LSTALVDT":"2022-01-02","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02359,"AVALU":"YEARS","ADTM":"2021-11-30","ADY":723,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-184","SUBJID":"id-184","SITEID":"CHN-11","AGE":38,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":1.63913,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-12-08","TRTSDTM":"2019-12-08 17:53:58","TRTEDTM":"2021-12-08 05:32:22","EOSSTT":"COMPLETED","EOSDT":"2021-12-08","EOSDY":731,"DTHDT":"2021-12-08","LSTALVDT":"2022-01-02","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.22312,"AVALU":"YEARS","ADTM":"2020-04-20","ADY":134,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-184","SUBJID":"id-184","SITEID":"CHN-11","AGE":38,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":1.63913,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-12-08","TRTSDTM":"2019-12-08 17:53:58","TRTEDTM":"2021-12-08 05:32:22","EOSSTT":"COMPLETED","EOSDT":"2021-12-08","EOSDY":731,"DTHDT":"2021-12-08","LSTALVDT":"2022-01-02","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08429,"AVALU":"YEARS","ADTM":"2020-08-05","ADY":241,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-192","SUBJID":"id-192","SITEID":"CHN-11","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.76819,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-07-31","TRTSDTM":"2020-07-31 10:11:04","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.06615,"AVALU":"YEARS","ADTM":"2021-02-22","ADY":206,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-192","SUBJID":"id-192","SITEID":"CHN-11","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.76819,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-07-31","TRTSDTM":"2020-07-31 10:11:04","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.10721,"AVALU":"YEARS","ADTM":"2022-07-18","ADY":717,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-192","SUBJID":"id-192","SITEID":"CHN-11","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.76819,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-07-31","TRTSDTM":"2020-07-31 10:11:04","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.12842,"AVALU":"YEARS","ADTM":"2022-06-12","ADY":681,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-2","SUBJID":"id-2","SITEID":"CHN-11","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":6.01534,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-02-12","TRTSDTM":"2021-02-16 14:03:35","TRTEDTM":"2023-02-17 01:41:59","EOSSTT":"COMPLETED","EOSDT":"2023-02-17","EOSDY":731,"DTHDT":"2023-02-17","LSTALVDT":"2023-03-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.49549,"AVALU":"YEARS","ADTM":"2022-07-30","ADY":529,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-2","SUBJID":"id-2","SITEID":"CHN-11","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":6.01534,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-02-12","TRTSDTM":"2021-02-16 14:03:35","TRTEDTM":"2023-02-17 01:41:59","EOSSTT":"COMPLETED","EOSDT":"2023-02-17","EOSDY":731,"DTHDT":"2023-02-17","LSTALVDT":"2023-03-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.03843,"AVALU":"YEARS","ADTM":"2023-01-31","ADY":714,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-2","SUBJID":"id-2","SITEID":"CHN-11","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":6.01534,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-02-12","TRTSDTM":"2021-02-16 14:03:35","TRTEDTM":"2023-02-17 01:41:59","EOSSTT":"COMPLETED","EOSDT":"2023-02-17","EOSDY":731,"DTHDT":"2023-02-17","LSTALVDT":"2023-03-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.5805,"AVALU":"YEARS","ADTM":"2022-02-28","ADY":377,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-220","SUBJID":"id-220","SITEID":"CHN-11","AGE":26,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":10.26273,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-10-03","TRTSDTM":"2019-10-05 23:09:23","TRTEDTM":"2021-10-05 10:47:47","EOSSTT":"COMPLETED","EOSDT":"2021-10-05","EOSDY":731,"DTHDT":"2021-10-05","LSTALVDT":"2021-10-24","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.05963,"AVALU":"YEARS","ADTM":"2020-05-05","ADY":213,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-220","SUBJID":"id-220","SITEID":"CHN-11","AGE":26,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":10.26273,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-10-03","TRTSDTM":"2019-10-05 23:09:23","TRTEDTM":"2021-10-05 10:47:47","EOSSTT":"COMPLETED","EOSDT":"2021-10-05","EOSDY":731,"DTHDT":"2021-10-05","LSTALVDT":"2021-10-24","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.50008,"AVALU":"YEARS","ADTM":"2021-01-22","ADY":475,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-220","SUBJID":"id-220","SITEID":"CHN-11","AGE":26,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":10.26273,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-10-03","TRTSDTM":"2019-10-05 23:09:23","TRTEDTM":"2021-10-05 10:47:47","EOSSTT":"COMPLETED","EOSDT":"2021-10-05","EOSDY":731,"DTHDT":"2021-10-05","LSTALVDT":"2021-10-24","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.80543,"AVALU":"YEARS","ADTM":"2020-02-13","ADY":131,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-222","SUBJID":"id-222","SITEID":"CHN-11","AGE":28,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":1.65329,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-09-27","TRTSDTM":"2020-09-30 15:55:54","TRTEDTM":"2021-09-22 03:41:10","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":357,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00064,"AVALU":"YEARS","ADTM":"2021-03-31","ADY":182,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-222","SUBJID":"id-222","SITEID":"CHN-11","AGE":28,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":1.65329,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-09-27","TRTSDTM":"2020-09-30 15:55:54","TRTEDTM":"2021-09-22 03:41:10","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":357,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.64739,"AVALU":"YEARS","ADTM":"2021-06-19","ADY":262,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-222","SUBJID":"id-222","SITEID":"CHN-11","AGE":28,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":1.65329,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-09-27","TRTSDTM":"2020-09-30 15:55:54","TRTEDTM":"2021-09-22 03:41:10","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":357,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.14539,"AVALU":"YEARS","ADTM":"2021-08-01","ADY":305,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-24","SUBJID":"id-24","SITEID":"CHN-11","AGE":46,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.98174,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-01","TRTSDTM":"2021-06-05 02:03:15","TRTEDTM":"2023-06-05 13:41:39","EOSSTT":"COMPLETED","EOSDT":"2023-06-05","EOSDY":731,"DTHDT":"2023-06-05","LSTALVDT":"2023-06-22","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.40256,"AVALU":"YEARS","ADTM":"2022-04-20","ADY":319,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-24","SUBJID":"id-24","SITEID":"CHN-11","AGE":46,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.98174,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-01","TRTSDTM":"2021-06-05 02:03:15","TRTEDTM":"2023-06-05 13:41:39","EOSSTT":"COMPLETED","EOSDT":"2023-06-05","EOSDY":731,"DTHDT":"2023-06-05","LSTALVDT":"2023-06-22","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.9686,"AVALU":"YEARS","ADTM":"2022-09-11","ADY":463,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-24","SUBJID":"id-24","SITEID":"CHN-11","AGE":46,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.98174,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-01","TRTSDTM":"2021-06-05 02:03:15","TRTEDTM":"2023-06-05 13:41:39","EOSSTT":"COMPLETED","EOSDT":"2023-06-05","EOSDY":731,"DTHDT":"2023-06-05","LSTALVDT":"2023-06-22","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.50563,"AVALU":"YEARS","ADTM":"2021-12-22","ADY":200,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-244","SUBJID":"id-244","SITEID":"CHN-11","AGE":26,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":7.26417,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-17","TRTSDTM":"2021-02-20 12:14:34","TRTEDTM":"2023-02-20 23:52:58","EOSSTT":"COMPLETED","EOSDT":"2023-02-20","EOSDY":731,"DTHDT":"2023-02-20","LSTALVDT":"2023-03-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14974,"AVALU":"YEARS","ADTM":"2022-01-20","ADY":334,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-244","SUBJID":"id-244","SITEID":"CHN-11","AGE":26,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":7.26417,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-17","TRTSDTM":"2021-02-20 12:14:34","TRTEDTM":"2023-02-20 23:52:58","EOSSTT":"COMPLETED","EOSDT":"2023-02-20","EOSDY":731,"DTHDT":"2023-02-20","LSTALVDT":"2023-03-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.09804,"AVALU":"YEARS","ADTM":"2022-12-03","ADY":651,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-244","SUBJID":"id-244","SITEID":"CHN-11","AGE":26,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":7.26417,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-17","TRTSDTM":"2021-02-20 12:14:34","TRTEDTM":"2023-02-20 23:52:58","EOSSTT":"COMPLETED","EOSDT":"2023-02-20","EOSDY":731,"DTHDT":"2023-02-20","LSTALVDT":"2023-03-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.27253,"AVALU":"YEARS","ADTM":"2021-06-08","ADY":108,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-246","SUBJID":"id-246","SITEID":"CHN-11","AGE":31,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":3.11334,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-07-24","TRTSDTM":"2021-07-28 14:56:50","TRTEDTM":"2023-07-29 02:35:14","EOSSTT":"COMPLETED","EOSDT":"2023-07-29","EOSDY":731,"DTHDT":"2023-07-29","LSTALVDT":"2023-08-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12843,"AVALU":"YEARS","ADTM":"2021-08-11","ADY":14,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-246","SUBJID":"id-246","SITEID":"CHN-11","AGE":31,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":3.11334,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-07-24","TRTSDTM":"2021-07-28 14:56:50","TRTEDTM":"2023-07-29 02:35:14","EOSSTT":"COMPLETED","EOSDT":"2023-07-29","EOSDY":731,"DTHDT":"2023-07-29","LSTALVDT":"2023-08-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.70091,"AVALU":"YEARS","ADTM":"2023-07-28","ADY":730,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-246","SUBJID":"id-246","SITEID":"CHN-11","AGE":31,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":3.11334,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-07-24","TRTSDTM":"2021-07-28 14:56:50","TRTEDTM":"2023-07-29 02:35:14","EOSSTT":"COMPLETED","EOSDT":"2023-07-29","EOSDY":731,"DTHDT":"2023-07-29","LSTALVDT":"2023-08-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.16584,"AVALU":"YEARS","ADTM":"2021-10-26","ADY":90,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-247","SUBJID":"id-247","SITEID":"CHN-11","AGE":30,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.01895,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-02","TRTSDTM":"2020-03-03 09:20:03","TRTEDTM":"2022-03-03 20:58:27","EOSSTT":"COMPLETED","EOSDT":"2022-03-03","EOSDY":731,"DTHDT":"2022-03-03","LSTALVDT":"2022-03-31","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14351,"AVALU":"YEARS","ADTM":"2020-06-18","ADY":107,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-247","SUBJID":"id-247","SITEID":"CHN-11","AGE":30,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.01895,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-02","TRTSDTM":"2020-03-03 09:20:03","TRTEDTM":"2022-03-03 20:58:27","EOSSTT":"COMPLETED","EOSDT":"2022-03-03","EOSDY":731,"DTHDT":"2022-03-03","LSTALVDT":"2022-03-31","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.30227,"AVALU":"YEARS","ADTM":"2020-12-15","ADY":287,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-247","SUBJID":"id-247","SITEID":"CHN-11","AGE":30,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.01895,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-02","TRTSDTM":"2020-03-03 09:20:03","TRTEDTM":"2022-03-03 20:58:27","EOSSTT":"COMPLETED","EOSDT":"2022-03-03","EOSDY":731,"DTHDT":"2022-03-03","LSTALVDT":"2022-03-31","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.19518,"AVALU":"YEARS","ADTM":"2021-12-15","ADY":652,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-256","SUBJID":"id-256","SITEID":"CHN-11","AGE":23,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.65204,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-18","TRTSDTM":"2020-10-21 10:00:47","TRTEDTM":"2022-10-21 21:39:11","EOSSTT":"COMPLETED","EOSDT":"2022-10-21","EOSDY":731,"DTHDT":"2022-10-21","LSTALVDT":"2022-10-31","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.1567,"AVALU":"YEARS","ADTM":"2022-10-04","ADY":713,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-256","SUBJID":"id-256","SITEID":"CHN-11","AGE":23,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.65204,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-18","TRTSDTM":"2020-10-21 10:00:47","TRTEDTM":"2022-10-21 21:39:11","EOSSTT":"COMPLETED","EOSDT":"2022-10-21","EOSDY":731,"DTHDT":"2022-10-21","LSTALVDT":"2022-10-31","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.32459,"AVALU":"YEARS","ADTM":"2021-08-23","ADY":306,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-256","SUBJID":"id-256","SITEID":"CHN-11","AGE":23,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.65204,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-18","TRTSDTM":"2020-10-21 10:00:47","TRTEDTM":"2022-10-21 21:39:11","EOSSTT":"COMPLETED","EOSDT":"2022-10-21","EOSDY":731,"DTHDT":"2022-10-21","LSTALVDT":"2022-10-31","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.155,"AVALU":"YEARS","ADTM":"2021-11-11","ADY":386,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-257","SUBJID":"id-257","SITEID":"CHN-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.83771,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-22","TRTSDTM":"2021-06-22 02:56:07","TRTEDTM":"2023-06-22 14:34:31","EOSSTT":"COMPLETED","EOSDT":"2023-06-22","EOSDY":731,"DTHDT":"2023-06-22","LSTALVDT":"2023-07-09","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03295,"AVALU":"YEARS","ADTM":"2022-12-23","ADY":549,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-257","SUBJID":"id-257","SITEID":"CHN-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.83771,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-22","TRTSDTM":"2021-06-22 02:56:07","TRTEDTM":"2023-06-22 14:34:31","EOSSTT":"COMPLETED","EOSDT":"2023-06-22","EOSDY":731,"DTHDT":"2023-06-22","LSTALVDT":"2023-07-09","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.15207,"AVALU":"YEARS","ADTM":"2022-02-09","ADY":232,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-257","SUBJID":"id-257","SITEID":"CHN-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.83771,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-22","TRTSDTM":"2021-06-22 02:56:07","TRTEDTM":"2023-06-22 14:34:31","EOSSTT":"COMPLETED","EOSDT":"2023-06-22","EOSDY":731,"DTHDT":"2023-06-22","LSTALVDT":"2023-07-09","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00032,"AVALU":"YEARS","ADTM":"2022-08-20","ADY":424,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-263","SUBJID":"id-263","SITEID":"CHN-11","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":6.82823,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-11-08","TRTSDTM":"2019-11-08 07:26:12","TRTEDTM":"2021-09-20 09:34:53","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":683,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-20","LSTALVDT":"2021-10-01","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12576,"AVALU":"YEARS","ADTM":"2020-11-01","ADY":359,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-263","SUBJID":"id-263","SITEID":"CHN-11","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":6.82823,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-11-08","TRTSDTM":"2019-11-08 07:26:12","TRTEDTM":"2021-09-20 09:34:53","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":683,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-20","LSTALVDT":"2021-10-01","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.14699,"AVALU":"YEARS","ADTM":"2021-06-04","ADY":574,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-263","SUBJID":"id-263","SITEID":"CHN-11","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":6.82823,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-11-08","TRTSDTM":"2019-11-08 07:26:12","TRTEDTM":"2021-09-20 09:34:53","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":683,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-20","LSTALVDT":"2021-10-01","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.16903,"AVALU":"YEARS","ADTM":"2021-07-21","ADY":621,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-27","SUBJID":"id-27","SITEID":"CHN-11","AGE":35,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":12.81348,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-06-19","TRTSDTM":"2020-06-23 14:52:22","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.32508,"AVALU":"YEARS","ADTM":"2022-02-15","ADY":602,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-27","SUBJID":"id-27","SITEID":"CHN-11","AGE":35,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":12.81348,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-06-19","TRTSDTM":"2020-06-23 14:52:22","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02571,"AVALU":"YEARS","ADTM":"2020-11-16","ADY":146,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-27","SUBJID":"id-27","SITEID":"CHN-11","AGE":35,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":12.81348,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-06-19","TRTSDTM":"2020-06-23 14:52:22","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.13926,"AVALU":"YEARS","ADTM":"2022-03-12","ADY":627,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-278","SUBJID":"id-278","SITEID":"CHN-11","AGE":47,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":2.07981,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-03-29","TRTSDTM":"2021-03-30 16:15:13","TRTEDTM":"2023-03-31 03:53:37","EOSSTT":"COMPLETED","EOSDT":"2023-03-31","EOSDY":731,"DTHDT":"2023-03-31","LSTALVDT":"2023-04-10","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.4877,"AVALU":"YEARS","ADTM":"2022-09-29","ADY":548,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-278","SUBJID":"id-278","SITEID":"CHN-11","AGE":47,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":2.07981,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-03-29","TRTSDTM":"2021-03-30 16:15:13","TRTEDTM":"2023-03-31 03:53:37","EOSSTT":"COMPLETED","EOSDT":"2023-03-31","EOSDY":731,"DTHDT":"2023-03-31","LSTALVDT":"2023-04-10","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.03548,"AVALU":"YEARS","ADTM":"2023-02-08","ADY":680,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-278","SUBJID":"id-278","SITEID":"CHN-11","AGE":47,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":2.07981,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-03-29","TRTSDTM":"2021-03-30 16:15:13","TRTEDTM":"2023-03-31 03:53:37","EOSSTT":"COMPLETED","EOSDT":"2023-03-31","EOSDY":731,"DTHDT":"2023-03-31","LSTALVDT":"2023-04-10","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.46658,"AVALU":"YEARS","ADTM":"2022-12-12","ADY":622,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-289","SUBJID":"id-289","SITEID":"CHN-11","AGE":40,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":13.91181,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-05-03","TRTSDTM":"2021-05-05 04:24:36","TRTEDTM":"2023-05-05 16:03:00","EOSSTT":"COMPLETED","EOSDT":"2023-05-05","EOSDY":731,"DTHDT":"2023-05-05","LSTALVDT":"2023-05-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.42482,"AVALU":"YEARS","ADTM":"2021-09-24","ADY":142,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-289","SUBJID":"id-289","SITEID":"CHN-11","AGE":40,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":13.91181,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-05-03","TRTSDTM":"2021-05-05 04:24:36","TRTEDTM":"2023-05-05 16:03:00","EOSSTT":"COMPLETED","EOSDT":"2023-05-05","EOSDY":731,"DTHDT":"2023-05-05","LSTALVDT":"2023-05-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.51776,"AVALU":"YEARS","ADTM":"2021-12-25","ADY":234,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-289","SUBJID":"id-289","SITEID":"CHN-11","AGE":40,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":13.91181,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-05-03","TRTSDTM":"2021-05-05 04:24:36","TRTEDTM":"2023-05-05 16:03:00","EOSSTT":"COMPLETED","EOSDT":"2023-05-05","EOSDY":731,"DTHDT":"2023-05-05","LSTALVDT":"2023-05-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.48608,"AVALU":"YEARS","ADTM":"2022-09-22","ADY":505,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-291","SUBJID":"id-291","SITEID":"CHN-11","AGE":50,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.30136,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-04","TRTSDTM":"2021-06-06 23:35:02","TRTEDTM":"2023-06-07 11:13:26","EOSSTT":"COMPLETED","EOSDT":"2023-06-07","EOSDY":731,"DTHDT":"2023-06-07","LSTALVDT":"2023-06-18","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.79667,"AVALU":"YEARS","ADTM":"2022-09-12","ADY":463,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-291","SUBJID":"id-291","SITEID":"CHN-11","AGE":50,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.30136,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-04","TRTSDTM":"2021-06-06 23:35:02","TRTEDTM":"2023-06-07 11:13:26","EOSSTT":"COMPLETED","EOSDT":"2023-06-07","EOSDY":731,"DTHDT":"2023-06-07","LSTALVDT":"2023-06-18","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.07043,"AVALU":"YEARS","ADTM":"2022-04-20","ADY":318,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-291","SUBJID":"id-291","SITEID":"CHN-11","AGE":50,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.30136,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-04","TRTSDTM":"2021-06-06 23:35:02","TRTEDTM":"2023-06-07 11:13:26","EOSSTT":"COMPLETED","EOSDT":"2023-06-07","EOSDY":731,"DTHDT":"2023-06-07","LSTALVDT":"2023-06-18","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.26005,"AVALU":"YEARS","ADTM":"2022-07-24","ADY":413,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-298","SUBJID":"id-298","SITEID":"CHN-11","AGE":31,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.78011,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-10-31","TRTSDTM":"2020-11-02 00:49:27","TRTEDTM":"2022-11-02 12:27:51","EOSSTT":"COMPLETED","EOSDT":"2022-11-02","EOSDY":731,"DTHDT":"2022-11-02","LSTALVDT":"2022-11-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.11771,"AVALU":"YEARS","ADTM":"2021-06-07","ADY":217,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-298","SUBJID":"id-298","SITEID":"CHN-11","AGE":31,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.78011,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-10-31","TRTSDTM":"2020-11-02 00:49:27","TRTEDTM":"2022-11-02 12:27:51","EOSSTT":"COMPLETED","EOSDT":"2022-11-02","EOSDY":731,"DTHDT":"2022-11-02","LSTALVDT":"2022-11-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.2424,"AVALU":"YEARS","ADTM":"2022-09-05","ADY":672,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-298","SUBJID":"id-298","SITEID":"CHN-11","AGE":31,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.78011,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-10-31","TRTSDTM":"2020-11-02 00:49:27","TRTEDTM":"2022-11-02 12:27:51","EOSSTT":"COMPLETED","EOSDT":"2022-11-02","EOSDY":731,"DTHDT":"2022-11-02","LSTALVDT":"2022-11-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.10885,"AVALU":"YEARS","ADTM":"2022-09-12","ADY":679,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-317","SUBJID":"id-317","SITEID":"CHN-11","AGE":38,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.05702,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-24","TRTSDTM":"2020-12-25 08:05:39","TRTEDTM":"2021-09-19 05:55:57","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":268,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-19","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.07222,"AVALU":"YEARS","ADTM":"2021-08-09","ADY":227,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-317","SUBJID":"id-317","SITEID":"CHN-11","AGE":38,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.05702,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-24","TRTSDTM":"2020-12-25 08:05:39","TRTEDTM":"2021-09-19 05:55:57","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":268,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-19","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.29166,"AVALU":"YEARS","ADTM":"2021-06-29","ADY":186,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-317","SUBJID":"id-317","SITEID":"CHN-11","AGE":38,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.05702,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-24","TRTSDTM":"2020-12-25 08:05:39","TRTEDTM":"2021-09-19 05:55:57","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":268,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-19","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.27608,"AVALU":"YEARS","ADTM":"2021-06-10","ADY":167,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-318","SUBJID":"id-318","SITEID":"CHN-11","AGE":42,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":3.39501,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-03-29","TRTSDTM":"2020-04-02 19:07:49","TRTEDTM":"2021-09-23 15:00:03","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":539,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":1.46489,"AVALU":"YEARS","ADTM":"2021-06-05","ADY":429,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-318","SUBJID":"id-318","SITEID":"CHN-11","AGE":42,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":3.39501,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-03-29","TRTSDTM":"2020-04-02 19:07:49","TRTEDTM":"2021-09-23 15:00:03","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":539,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.33283,"AVALU":"YEARS","ADTM":"2021-02-10","ADY":314,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-318","SUBJID":"id-318","SITEID":"CHN-11","AGE":42,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":3.39501,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-03-29","TRTSDTM":"2020-04-02 19:07:49","TRTEDTM":"2021-09-23 15:00:03","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":539,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.13349,"AVALU":"YEARS","ADTM":"2020-12-13","ADY":255,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-349","SUBJID":"id-349","SITEID":"CHN-11","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.32398,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-18","TRTSDTM":"2021-06-20 04:55:44","TRTEDTM":"2023-06-20 16:34:08","EOSSTT":"COMPLETED","EOSDT":"2023-06-20","EOSDY":731,"DTHDT":"2023-06-20","LSTALVDT":"2023-07-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.19797,"AVALU":"YEARS","ADTM":"2022-09-09","ADY":446,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-349","SUBJID":"id-349","SITEID":"CHN-11","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.32398,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-18","TRTSDTM":"2021-06-20 04:55:44","TRTEDTM":"2023-06-20 16:34:08","EOSSTT":"COMPLETED","EOSDT":"2023-06-20","EOSDY":731,"DTHDT":"2023-06-20","LSTALVDT":"2023-07-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.22688,"AVALU":"YEARS","ADTM":"2022-03-08","ADY":261,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-349","SUBJID":"id-349","SITEID":"CHN-11","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.32398,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-18","TRTSDTM":"2021-06-20 04:55:44","TRTEDTM":"2023-06-20 16:34:08","EOSSTT":"COMPLETED","EOSDT":"2023-06-20","EOSDY":731,"DTHDT":"2023-06-20","LSTALVDT":"2023-07-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.55564,"AVALU":"YEARS","ADTM":"2021-08-03","ADY":44,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-354","SUBJID":"id-354","SITEID":"CHN-11","AGE":42,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":5.59138,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-09-12","TRTSDTM":"2020-09-15 14:15:05","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.22762,"AVALU":"YEARS","ADTM":"2021-10-02","ADY":382,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-354","SUBJID":"id-354","SITEID":"CHN-11","AGE":42,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":5.59138,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-09-12","TRTSDTM":"2020-09-15 14:15:05","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02225,"AVALU":"YEARS","ADTM":"2022-07-07","ADY":660,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-354","SUBJID":"id-354","SITEID":"CHN-11","AGE":42,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":5.59138,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-09-12","TRTSDTM":"2020-09-15 14:15:05","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.05874,"AVALU":"YEARS","ADTM":"2022-02-23","ADY":526,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-356","SUBJID":"id-356","SITEID":"CHN-11","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":6.24981,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-12","TRTSDTM":"2020-10-16 20:02:08","TRTEDTM":"2022-10-17 07:40:32","EOSSTT":"COMPLETED","EOSDT":"2022-10-17","EOSDY":731,"DTHDT":"2022-10-17","LSTALVDT":"2022-10-27","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.92768,"AVALU":"YEARS","ADTM":"2021-07-29","ADY":286,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-356","SUBJID":"id-356","SITEID":"CHN-11","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":6.24981,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-12","TRTSDTM":"2020-10-16 20:02:08","TRTEDTM":"2022-10-17 07:40:32","EOSSTT":"COMPLETED","EOSDT":"2022-10-17","EOSDY":731,"DTHDT":"2022-10-17","LSTALVDT":"2022-10-27","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.32286,"AVALU":"YEARS","ADTM":"2021-10-31","ADY":380,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-356","SUBJID":"id-356","SITEID":"CHN-11","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":6.24981,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-12","TRTSDTM":"2020-10-16 20:02:08","TRTEDTM":"2022-10-17 07:40:32","EOSSTT":"COMPLETED","EOSDT":"2022-10-17","EOSDY":731,"DTHDT":"2022-10-17","LSTALVDT":"2022-10-27","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.13401,"AVALU":"YEARS","ADTM":"2020-11-02","ADY":17,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-358","SUBJID":"id-358","SITEID":"CHN-11","AGE":32,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":1.39002,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-04","TRTSDTM":"2021-07-08 23:04:22","TRTEDTM":"2023-07-09 10:42:46","EOSSTT":"COMPLETED","EOSDT":"2023-07-09","EOSDY":731,"DTHDT":"2023-07-09","LSTALVDT":"2023-08-02","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02853,"AVALU":"YEARS","ADTM":"2023-02-06","ADY":578,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-358","SUBJID":"id-358","SITEID":"CHN-11","AGE":32,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":1.39002,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-04","TRTSDTM":"2021-07-08 23:04:22","TRTEDTM":"2023-07-09 10:42:46","EOSSTT":"COMPLETED","EOSDT":"2023-07-09","EOSDY":731,"DTHDT":"2023-07-09","LSTALVDT":"2023-08-02","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.07399,"AVALU":"YEARS","ADTM":"2022-03-31","ADY":266,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-358","SUBJID":"id-358","SITEID":"CHN-11","AGE":32,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":1.39002,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-04","TRTSDTM":"2021-07-08 23:04:22","TRTEDTM":"2023-07-09 10:42:46","EOSSTT":"COMPLETED","EOSDT":"2023-07-09","EOSDY":731,"DTHDT":"2023-07-09","LSTALVDT":"2023-08-02","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.10278,"AVALU":"YEARS","ADTM":"2022-01-06","ADY":182,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-362","SUBJID":"id-362","SITEID":"CHN-11","AGE":39,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":7.60836,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-27","TRTSDTM":"2020-11-27 12:24:13","TRTEDTM":"2021-09-22 21:13:53","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":300,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.2679,"AVALU":"YEARS","ADTM":"2021-09-11","ADY":288,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-362","SUBJID":"id-362","SITEID":"CHN-11","AGE":39,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":7.60836,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-27","TRTSDTM":"2020-11-27 12:24:13","TRTEDTM":"2021-09-22 21:13:53","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":300,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.69956,"AVALU":"YEARS","ADTM":"2021-06-25","ADY":210,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-362","SUBJID":"id-362","SITEID":"CHN-11","AGE":39,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":7.60836,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-27","TRTSDTM":"2020-11-27 12:24:13","TRTEDTM":"2021-09-22 21:13:53","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":300,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11758,"AVALU":"YEARS","ADTM":"2020-12-12","ADY":15,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-364","SUBJID":"id-364","SITEID":"CHN-11","AGE":48,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":1.68839,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-07-26","TRTSDTM":"2021-07-26 14:48:42","TRTEDTM":"2023-07-27 02:27:06","EOSSTT":"COMPLETED","EOSDT":"2023-07-27","EOSDY":731,"DTHDT":"2023-07-27","LSTALVDT":"2023-08-18","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.10514,"AVALU":"YEARS","ADTM":"2023-03-25","ADY":607,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-364","SUBJID":"id-364","SITEID":"CHN-11","AGE":48,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":1.68839,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-07-26","TRTSDTM":"2021-07-26 14:48:42","TRTEDTM":"2023-07-27 02:27:06","EOSSTT":"COMPLETED","EOSDT":"2023-07-27","EOSDY":731,"DTHDT":"2023-07-27","LSTALVDT":"2023-08-18","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.58524,"AVALU":"YEARS","ADTM":"2022-11-25","ADY":487,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-364","SUBJID":"id-364","SITEID":"CHN-11","AGE":48,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":1.68839,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-07-26","TRTSDTM":"2021-07-26 14:48:42","TRTEDTM":"2023-07-27 02:27:06","EOSSTT":"COMPLETED","EOSDT":"2023-07-27","EOSDY":731,"DTHDT":"2023-07-27","LSTALVDT":"2023-08-18","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.31175,"AVALU":"YEARS","ADTM":"2023-02-12","ADY":566,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-377","SUBJID":"id-377","SITEID":"CHN-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.66603,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-16","TRTSDTM":"2020-08-16 01:54:45","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.19643,"AVALU":"YEARS","ADTM":"2022-01-30","ADY":532,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-377","SUBJID":"id-377","SITEID":"CHN-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.66603,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-16","TRTSDTM":"2020-08-16 01:54:45","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.46191,"AVALU":"YEARS","ADTM":"2022-05-27","ADY":649,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-377","SUBJID":"id-377","SITEID":"CHN-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.66603,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-16","TRTSDTM":"2020-08-16 01:54:45","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.14871,"AVALU":"YEARS","ADTM":"2022-01-25","ADY":527,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-379","SUBJID":"id-379","SITEID":"CHN-11","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":5.84651,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-03-03","TRTSDTM":"2020-03-04 10:14:58","TRTEDTM":"2022-03-04 21:53:22","EOSSTT":"COMPLETED","EOSDT":"2022-03-04","EOSDY":731,"DTHDT":"2022-03-04","LSTALVDT":"2022-03-31","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.30188,"AVALU":"YEARS","ADTM":"2022-01-26","ADY":693,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-379","SUBJID":"id-379","SITEID":"CHN-11","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":5.84651,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-03-03","TRTSDTM":"2020-03-04 10:14:58","TRTEDTM":"2022-03-04 21:53:22","EOSSTT":"COMPLETED","EOSDT":"2022-03-04","EOSDY":731,"DTHDT":"2022-03-04","LSTALVDT":"2022-03-31","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.26853,"AVALU":"YEARS","ADTM":"2021-11-01","ADY":607,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-379","SUBJID":"id-379","SITEID":"CHN-11","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":5.84651,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-03-03","TRTSDTM":"2020-03-04 10:14:58","TRTEDTM":"2022-03-04 21:53:22","EOSSTT":"COMPLETED","EOSDT":"2022-03-04","EOSDY":731,"DTHDT":"2022-03-04","LSTALVDT":"2022-03-31","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08318,"AVALU":"YEARS","ADTM":"2021-10-15","ADY":590,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-38","SUBJID":"id-38","SITEID":"CHN-11","AGE":25,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":1.48993,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-17","TRTSDTM":"2020-01-21 10:27:24","TRTEDTM":"2021-09-19 17:31:04","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":608,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-19","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.32479,"AVALU":"YEARS","ADTM":"2021-05-11","ADY":476,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-38","SUBJID":"id-38","SITEID":"CHN-11","AGE":25,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":1.48993,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-17","TRTSDTM":"2020-01-21 10:27:24","TRTEDTM":"2021-09-19 17:31:04","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":608,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-19","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.70651,"AVALU":"YEARS","ADTM":"2021-03-16","ADY":420,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-38","SUBJID":"id-38","SITEID":"CHN-11","AGE":25,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":1.48993,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-17","TRTSDTM":"2020-01-21 10:27:24","TRTEDTM":"2021-09-19 17:31:04","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":608,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-19","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01692,"AVALU":"YEARS","ADTM":"2021-01-04","ADY":349,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-386","SUBJID":"id-386","SITEID":"CHN-11","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.56042,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-21","TRTSDTM":"2020-08-23 22:21:52","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01383,"AVALU":"YEARS","ADTM":"2021-04-18","ADY":238,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-386","SUBJID":"id-386","SITEID":"CHN-11","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.56042,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-21","TRTSDTM":"2020-08-23 22:21:52","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.05661,"AVALU":"YEARS","ADTM":"2020-10-28","ADY":66,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-386","SUBJID":"id-386","SITEID":"CHN-11","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.56042,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-21","TRTSDTM":"2020-08-23 22:21:52","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.75796,"AVALU":"YEARS","ADTM":"2021-01-15","ADY":145,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-391","SUBJID":"id-391","SITEID":"CHN-11","AGE":35,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.9676,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-17","TRTSDTM":"2020-12-20 06:31:17","TRTEDTM":"2022-12-20 18:09:41","EOSSTT":"COMPLETED","EOSDT":"2022-12-20","EOSDY":731,"DTHDT":"2022-12-20","LSTALVDT":"2023-01-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.08198,"AVALU":"YEARS","ADTM":"2022-08-24","ADY":612,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-391","SUBJID":"id-391","SITEID":"CHN-11","AGE":35,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.9676,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-17","TRTSDTM":"2020-12-20 06:31:17","TRTEDTM":"2022-12-20 18:09:41","EOSSTT":"COMPLETED","EOSDT":"2022-12-20","EOSDY":731,"DTHDT":"2022-12-20","LSTALVDT":"2023-01-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.11029,"AVALU":"YEARS","ADTM":"2022-11-14","ADY":694,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-391","SUBJID":"id-391","SITEID":"CHN-11","AGE":35,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.9676,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-17","TRTSDTM":"2020-12-20 06:31:17","TRTEDTM":"2022-12-20 18:09:41","EOSSTT":"COMPLETED","EOSDT":"2022-12-20","EOSDY":731,"DTHDT":"2022-12-20","LSTALVDT":"2023-01-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.16048,"AVALU":"YEARS","ADTM":"2022-06-24","ADY":551,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-392","SUBJID":"id-392","SITEID":"CHN-11","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.77395,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-04-29","TRTSDTM":"2020-05-03 19:30:17","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01519,"AVALU":"YEARS","ADTM":"2020-07-11","ADY":69,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-392","SUBJID":"id-392","SITEID":"CHN-11","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.77395,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-04-29","TRTSDTM":"2020-05-03 19:30:17","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.10812,"AVALU":"YEARS","ADTM":"2020-07-02","ADY":60,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-392","SUBJID":"id-392","SITEID":"CHN-11","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.77395,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-04-29","TRTSDTM":"2020-05-03 19:30:17","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04308,"AVALU":"YEARS","ADTM":"2021-01-26","ADY":268,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-54","SUBJID":"id-54","SITEID":"CHN-11","AGE":26,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":4.81516,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-03-22","TRTSDTM":"2020-03-26 16:01:39","TRTEDTM":"2022-03-27 03:40:03","EOSSTT":"COMPLETED","EOSDT":"2022-03-27","EOSDY":731,"DTHDT":"2022-03-27","LSTALVDT":"2022-04-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0051,"AVALU":"YEARS","ADTM":"2020-07-29","ADY":125,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-54","SUBJID":"id-54","SITEID":"CHN-11","AGE":26,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":4.81516,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-03-22","TRTSDTM":"2020-03-26 16:01:39","TRTEDTM":"2022-03-27 03:40:03","EOSSTT":"COMPLETED","EOSDT":"2022-03-27","EOSDY":731,"DTHDT":"2022-03-27","LSTALVDT":"2022-04-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.47694,"AVALU":"YEARS","ADTM":"2021-08-03","ADY":495,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-54","SUBJID":"id-54","SITEID":"CHN-11","AGE":26,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":4.81516,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-03-22","TRTSDTM":"2020-03-26 16:01:39","TRTEDTM":"2022-03-27 03:40:03","EOSSTT":"COMPLETED","EOSDT":"2022-03-27","EOSDY":731,"DTHDT":"2022-03-27","LSTALVDT":"2022-04-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":1.70763,"AVALU":"YEARS","ADTM":"2021-01-18","ADY":298,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-55","SUBJID":"id-55","SITEID":"CHN-11","AGE":43,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":6.30181,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-27","TRTSDTM":"2021-06-30 02:21:02","TRTEDTM":"2021-09-25 11:44:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":88,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.13246,"AVALU":"YEARS","ADTM":"2021-09-14","ADY":76,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-55","SUBJID":"id-55","SITEID":"CHN-11","AGE":43,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":6.30181,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-27","TRTSDTM":"2021-06-30 02:21:02","TRTEDTM":"2021-09-25 11:44:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":88,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.57003,"AVALU":"YEARS","ADTM":"2021-08-23","ADY":54,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-55","SUBJID":"id-55","SITEID":"CHN-11","AGE":43,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":6.30181,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-27","TRTSDTM":"2021-06-30 02:21:02","TRTEDTM":"2021-09-25 11:44:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":88,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02731,"AVALU":"YEARS","ADTM":"2021-08-28","ADY":59,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-60","SUBJID":"id-60","SITEID":"CHN-11","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.21027,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-04-14","TRTSDTM":"2020-04-14 20:15:26","TRTEDTM":"2022-04-15 07:53:50","EOSSTT":"COMPLETED","EOSDT":"2022-04-15","EOSDY":731,"DTHDT":"2022-04-15","LSTALVDT":"2022-05-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14774,"AVALU":"YEARS","ADTM":"2021-05-29","ADY":410,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-60","SUBJID":"id-60","SITEID":"CHN-11","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.21027,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-04-14","TRTSDTM":"2020-04-14 20:15:26","TRTEDTM":"2022-04-15 07:53:50","EOSSTT":"COMPLETED","EOSDT":"2022-04-15","EOSDY":731,"DTHDT":"2022-04-15","LSTALVDT":"2022-05-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01247,"AVALU":"YEARS","ADTM":"2021-04-13","ADY":364,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-60","SUBJID":"id-60","SITEID":"CHN-11","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.21027,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-04-14","TRTSDTM":"2020-04-14 20:15:26","TRTEDTM":"2022-04-15 07:53:50","EOSSTT":"COMPLETED","EOSDT":"2022-04-15","EOSDY":731,"DTHDT":"2022-04-15","LSTALVDT":"2022-05-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.12378,"AVALU":"YEARS","ADTM":"2021-01-18","ADY":279,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-63","SUBJID":"id-63","SITEID":"CHN-11","AGE":30,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":6.80483,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-19","TRTSDTM":"2020-05-22 08:41:26","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.19931,"AVALU":"YEARS","ADTM":"2021-10-11","ADY":507,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-63","SUBJID":"id-63","SITEID":"CHN-11","AGE":30,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":6.80483,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-19","TRTSDTM":"2020-05-22 08:41:26","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.31863,"AVALU":"YEARS","ADTM":"2020-08-31","ADY":101,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-63","SUBJID":"id-63","SITEID":"CHN-11","AGE":30,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":6.80483,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-19","TRTSDTM":"2020-05-22 08:41:26","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.28071,"AVALU":"YEARS","ADTM":"2020-08-09","ADY":79,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-75","SUBJID":"id-75","SITEID":"CHN-11","AGE":29,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":4.61263,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-10","TRTSDTM":"2020-10-13 14:47:04","TRTEDTM":"2022-10-14 02:25:28","EOSSTT":"COMPLETED","EOSDT":"2022-10-14","EOSDY":731,"DTHDT":"2022-10-14","LSTALVDT":"2022-10-29","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.16084,"AVALU":"YEARS","ADTM":"2021-11-22","ADY":405,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-75","SUBJID":"id-75","SITEID":"CHN-11","AGE":29,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":4.61263,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-10","TRTSDTM":"2020-10-13 14:47:04","TRTEDTM":"2022-10-14 02:25:28","EOSSTT":"COMPLETED","EOSDT":"2022-10-14","EOSDY":731,"DTHDT":"2022-10-14","LSTALVDT":"2022-10-29","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.35033,"AVALU":"YEARS","ADTM":"2022-01-18","ADY":462,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-75","SUBJID":"id-75","SITEID":"CHN-11","AGE":29,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":4.61263,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-10","TRTSDTM":"2020-10-13 14:47:04","TRTEDTM":"2022-10-14 02:25:28","EOSSTT":"COMPLETED","EOSDT":"2022-10-14","EOSDY":731,"DTHDT":"2022-10-14","LSTALVDT":"2022-10-29","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.10101,"AVALU":"YEARS","ADTM":"2021-07-24","ADY":284,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-88","SUBJID":"id-88","SITEID":"CHN-11","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":5.36809,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-27","TRTSDTM":"2019-12-27 09:11:54","TRTEDTM":"2021-12-26 20:50:18","EOSSTT":"COMPLETED","EOSDT":"2021-12-26","EOSDY":731,"DTHDT":"2021-12-26","LSTALVDT":"2022-01-05","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01172,"AVALU":"YEARS","ADTM":"2020-09-28","ADY":276,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-88","SUBJID":"id-88","SITEID":"CHN-11","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":5.36809,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-27","TRTSDTM":"2019-12-27 09:11:54","TRTEDTM":"2021-12-26 20:50:18","EOSSTT":"COMPLETED","EOSDT":"2021-12-26","EOSDY":731,"DTHDT":"2021-12-26","LSTALVDT":"2022-01-05","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.90168,"AVALU":"YEARS","ADTM":"2021-08-10","ADY":592,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-88","SUBJID":"id-88","SITEID":"CHN-11","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":5.36809,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-27","TRTSDTM":"2019-12-27 09:11:54","TRTEDTM":"2021-12-26 20:50:18","EOSSTT":"COMPLETED","EOSDT":"2021-12-26","EOSDY":731,"DTHDT":"2021-12-26","LSTALVDT":"2022-01-05","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.62598,"AVALU":"YEARS","ADTM":"2021-02-24","ADY":425,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-90","SUBJID":"id-90","SITEID":"CHN-11","AGE":37,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":10.2096,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-02","TRTSDTM":"2020-08-06 06:55:17","TRTEDTM":"2021-09-23 07:37:59","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":414,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.38665,"AVALU":"YEARS","ADTM":"2021-01-28","ADY":175,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-90","SUBJID":"id-90","SITEID":"CHN-11","AGE":37,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":10.2096,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-02","TRTSDTM":"2020-08-06 06:55:17","TRTEDTM":"2021-09-23 07:37:59","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":414,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.38004,"AVALU":"YEARS","ADTM":"2021-08-28","ADY":387,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-90","SUBJID":"id-90","SITEID":"CHN-11","AGE":37,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":10.2096,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-02","TRTSDTM":"2020-08-06 06:55:17","TRTEDTM":"2021-09-23 07:37:59","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":414,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1102,"AVALU":"YEARS","ADTM":"2020-10-25","ADY":80,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-91","SUBJID":"id-91","SITEID":"CHN-11","AGE":44,"SEX":"UNDIFFERENTIATED","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.001,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-01-01","TRTSDTM":"2021-01-02 23:32:28","TRTEDTM":"2023-01-03 11:10:52","EOSSTT":"COMPLETED","EOSDT":"2023-01-03","EOSDY":731,"DTHDT":"2023-01-03","LSTALVDT":"2023-01-31","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.04537,"AVALU":"YEARS","ADTM":"2022-03-20","ADY":442,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-91","SUBJID":"id-91","SITEID":"CHN-11","AGE":44,"SEX":"UNDIFFERENTIATED","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.001,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-01-01","TRTSDTM":"2021-01-02 23:32:28","TRTEDTM":"2023-01-03 11:10:52","EOSSTT":"COMPLETED","EOSDT":"2023-01-03","EOSDY":731,"DTHDT":"2023-01-03","LSTALVDT":"2023-01-31","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02387,"AVALU":"YEARS","ADTM":"2021-06-05","ADY":154,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-11-id-91","SUBJID":"id-91","SITEID":"CHN-11","AGE":44,"SEX":"UNDIFFERENTIATED","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.001,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-01-01","TRTSDTM":"2021-01-02 23:32:28","TRTEDTM":"2023-01-03 11:10:52","EOSSTT":"COMPLETED","EOSDT":"2023-01-03","EOSDY":731,"DTHDT":"2023-01-03","LSTALVDT":"2023-01-31","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0875,"AVALU":"YEARS","ADTM":"2022-09-23","ADY":629,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-255","SUBJID":"id-255","SITEID":"CHN-12","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":1.49031,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-01-21","TRTSDTM":"2021-01-25 04:50:59","TRTEDTM":"2023-01-25 16:29:23","EOSSTT":"COMPLETED","EOSDT":"2023-01-25","EOSDY":731,"DTHDT":"2023-01-25","LSTALVDT":"2023-02-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.09487,"AVALU":"YEARS","ADTM":"2022-10-23","ADY":636,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-255","SUBJID":"id-255","SITEID":"CHN-12","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":1.49031,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-01-21","TRTSDTM":"2021-01-25 04:50:59","TRTEDTM":"2023-01-25 16:29:23","EOSSTT":"COMPLETED","EOSDT":"2023-01-25","EOSDY":731,"DTHDT":"2023-01-25","LSTALVDT":"2023-02-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01357,"AVALU":"YEARS","ADTM":"2021-08-13","ADY":200,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-255","SUBJID":"id-255","SITEID":"CHN-12","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":1.49031,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-01-21","TRTSDTM":"2021-01-25 04:50:59","TRTEDTM":"2023-01-25 16:29:23","EOSSTT":"COMPLETED","EOSDT":"2023-01-25","EOSDY":731,"DTHDT":"2023-01-25","LSTALVDT":"2023-02-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.5209,"AVALU":"YEARS","ADTM":"2021-10-08","ADY":256,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-258","SUBJID":"id-258","SITEID":"CHN-12","AGE":45,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":1.71573,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-10-05","TRTSDTM":"2020-10-05 16:04:09","TRTEDTM":"2022-10-06 03:42:33","EOSSTT":"COMPLETED","EOSDT":"2022-10-06","EOSDY":731,"DTHDT":"2022-10-06","LSTALVDT":"2022-10-20","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.11359,"AVALU":"YEARS","ADTM":"2022-03-11","ADY":522,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-258","SUBJID":"id-258","SITEID":"CHN-12","AGE":45,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":1.71573,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-10-05","TRTSDTM":"2020-10-05 16:04:09","TRTEDTM":"2022-10-06 03:42:33","EOSSTT":"COMPLETED","EOSDT":"2022-10-06","EOSDY":731,"DTHDT":"2022-10-06","LSTALVDT":"2022-10-20","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.18168,"AVALU":"YEARS","ADTM":"2020-12-27","ADY":83,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-258","SUBJID":"id-258","SITEID":"CHN-12","AGE":45,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":1.71573,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-10-05","TRTSDTM":"2020-10-05 16:04:09","TRTEDTM":"2022-10-06 03:42:33","EOSSTT":"COMPLETED","EOSDT":"2022-10-06","EOSDY":731,"DTHDT":"2022-10-06","LSTALVDT":"2022-10-20","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.26787,"AVALU":"YEARS","ADTM":"2022-03-24","ADY":535,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-266","SUBJID":"id-266","SITEID":"CHN-12","AGE":32,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":11.29142,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-01","TRTSDTM":"2020-06-03 17:43:27","TRTEDTM":"2021-09-24 17:50:32","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":479,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-24","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02892,"AVALU":"YEARS","ADTM":"2020-07-24","ADY":51,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-266","SUBJID":"id-266","SITEID":"CHN-12","AGE":32,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":11.29142,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-01","TRTSDTM":"2020-06-03 17:43:27","TRTEDTM":"2021-09-24 17:50:32","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":479,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-24","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.77847,"AVALU":"YEARS","ADTM":"2021-01-08","ADY":219,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-266","SUBJID":"id-266","SITEID":"CHN-12","AGE":32,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":11.29142,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-01","TRTSDTM":"2020-06-03 17:43:27","TRTEDTM":"2021-09-24 17:50:32","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":479,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-24","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01199,"AVALU":"YEARS","ADTM":"2020-06-14","ADY":11,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-285","SUBJID":"id-285","SITEID":"CHN-12","AGE":39,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":4.79676,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-05-01","TRTSDTM":"2021-05-04 04:37:11","TRTEDTM":"2021-09-20 08:24:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":140,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.18842,"AVALU":"YEARS","ADTM":"2021-08-17","ADY":105,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-285","SUBJID":"id-285","SITEID":"CHN-12","AGE":39,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":4.79676,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-05-01","TRTSDTM":"2021-05-04 04:37:11","TRTEDTM":"2021-09-20 08:24:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":140,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.08155,"AVALU":"YEARS","ADTM":"2021-06-29","ADY":56,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-285","SUBJID":"id-285","SITEID":"CHN-12","AGE":39,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":4.79676,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-05-01","TRTSDTM":"2021-05-04 04:37:11","TRTEDTM":"2021-09-20 08:24:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":140,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04456,"AVALU":"YEARS","ADTM":"2021-07-19","ADY":76,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-294","SUBJID":"id-294","SITEID":"CHN-12","AGE":35,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.67351,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-15","TRTSDTM":"2021-05-16 20:19:36","TRTEDTM":"2023-05-17 07:58:00","EOSSTT":"COMPLETED","EOSDT":"2023-05-17","EOSDY":731,"DTHDT":"2023-05-17","LSTALVDT":"2023-06-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.11211,"AVALU":"YEARS","ADTM":"2022-07-16","ADY":426,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-294","SUBJID":"id-294","SITEID":"CHN-12","AGE":35,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.67351,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-15","TRTSDTM":"2021-05-16 20:19:36","TRTEDTM":"2023-05-17 07:58:00","EOSSTT":"COMPLETED","EOSDT":"2023-05-17","EOSDY":731,"DTHDT":"2023-05-17","LSTALVDT":"2023-06-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.64682,"AVALU":"YEARS","ADTM":"2021-05-17","ADY":1,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-294","SUBJID":"id-294","SITEID":"CHN-12","AGE":35,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.67351,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-15","TRTSDTM":"2021-05-16 20:19:36","TRTEDTM":"2023-05-17 07:58:00","EOSSTT":"COMPLETED","EOSDT":"2023-05-17","EOSDY":731,"DTHDT":"2023-05-17","LSTALVDT":"2023-06-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02313,"AVALU":"YEARS","ADTM":"2023-03-04","ADY":657,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-322","SUBJID":"id-322","SITEID":"CHN-12","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":4.28899,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-02-05","TRTSDTM":"2020-02-08 00:38:33","TRTEDTM":"2021-09-24 00:40:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":595,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.35066,"AVALU":"YEARS","ADTM":"2020-11-22","ADY":288,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-322","SUBJID":"id-322","SITEID":"CHN-12","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":4.28899,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-02-05","TRTSDTM":"2020-02-08 00:38:33","TRTEDTM":"2021-09-24 00:40:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":595,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.09245,"AVALU":"YEARS","ADTM":"2020-04-16","ADY":68,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-322","SUBJID":"id-322","SITEID":"CHN-12","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":4.28899,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-02-05","TRTSDTM":"2020-02-08 00:38:33","TRTEDTM":"2021-09-24 00:40:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":595,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.03428,"AVALU":"YEARS","ADTM":"2021-07-31","ADY":539,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-396","SUBJID":"id-396","SITEID":"CHN-12","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":1.15746,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-24","TRTSDTM":"2020-04-25 20:05:39","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.11236,"AVALU":"YEARS","ADTM":"2021-12-21","ADY":605,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-396","SUBJID":"id-396","SITEID":"CHN-12","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":1.15746,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-24","TRTSDTM":"2020-04-25 20:05:39","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.07565,"AVALU":"YEARS","ADTM":"2021-11-14","ADY":568,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-396","SUBJID":"id-396","SITEID":"CHN-12","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":1.15746,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-24","TRTSDTM":"2020-04-25 20:05:39","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.70957,"AVALU":"YEARS","ADTM":"2020-07-01","ADY":67,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-57","SUBJID":"id-57","SITEID":"CHN-12","AGE":45,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":6.92748,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-05-15","TRTSDTM":"2020-05-18 10:38:45","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.25936,"AVALU":"YEARS","ADTM":"2020-11-06","ADY":172,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-57","SUBJID":"id-57","SITEID":"CHN-12","AGE":45,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":6.92748,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-05-15","TRTSDTM":"2020-05-18 10:38:45","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.22013,"AVALU":"YEARS","ADTM":"2021-02-03","ADY":261,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-12-id-57","SUBJID":"id-57","SITEID":"CHN-12","AGE":45,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":6.92748,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-05-15","TRTSDTM":"2020-05-18 10:38:45","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.38688,"AVALU":"YEARS","ADTM":"2020-07-30","ADY":73,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-102","SUBJID":"id-102","SITEID":"CHN-13","AGE":37,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.04895,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-10-27","TRTSDTM":"2019-10-27 15:41:42","TRTEDTM":"2021-10-27 03:20:06","EOSSTT":"COMPLETED","EOSDT":"2021-10-27","EOSDY":731,"DTHDT":"2021-10-27","LSTALVDT":"2021-11-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.66836,"AVALU":"YEARS","ADTM":"2020-05-22","ADY":208,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-102","SUBJID":"id-102","SITEID":"CHN-13","AGE":37,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.04895,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-10-27","TRTSDTM":"2019-10-27 15:41:42","TRTEDTM":"2021-10-27 03:20:06","EOSSTT":"COMPLETED","EOSDT":"2021-10-27","EOSDY":731,"DTHDT":"2021-10-27","LSTALVDT":"2021-11-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.49463,"AVALU":"YEARS","ADTM":"2020-01-06","ADY":71,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-102","SUBJID":"id-102","SITEID":"CHN-13","AGE":37,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.04895,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-10-27","TRTSDTM":"2019-10-27 15:41:42","TRTEDTM":"2021-10-27 03:20:06","EOSSTT":"COMPLETED","EOSDT":"2021-10-27","EOSDY":731,"DTHDT":"2021-10-27","LSTALVDT":"2021-11-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02373,"AVALU":"YEARS","ADTM":"2019-11-02","ADY":6,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-166","SUBJID":"id-166","SITEID":"CHN-13","AGE":43,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":10.57965,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-02-04","TRTSDTM":"2021-02-04 08:02:02","TRTEDTM":"2023-02-04 19:40:26","EOSSTT":"COMPLETED","EOSDT":"2023-02-04","EOSDY":731,"DTHDT":"2023-02-04","LSTALVDT":"2023-03-01","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.2646,"AVALU":"YEARS","ADTM":"2022-08-08","ADY":550,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-166","SUBJID":"id-166","SITEID":"CHN-13","AGE":43,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":10.57965,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-02-04","TRTSDTM":"2021-02-04 08:02:02","TRTEDTM":"2023-02-04 19:40:26","EOSSTT":"COMPLETED","EOSDT":"2023-02-04","EOSDY":731,"DTHDT":"2023-02-04","LSTALVDT":"2023-03-01","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.12167,"AVALU":"YEARS","ADTM":"2022-05-21","ADY":471,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-166","SUBJID":"id-166","SITEID":"CHN-13","AGE":43,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":10.57965,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-02-04","TRTSDTM":"2021-02-04 08:02:02","TRTEDTM":"2023-02-04 19:40:26","EOSSTT":"COMPLETED","EOSDT":"2023-02-04","EOSDY":731,"DTHDT":"2023-02-04","LSTALVDT":"2023-03-01","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0089,"AVALU":"YEARS","ADTM":"2021-07-24","ADY":170,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-19","SUBJID":"id-19","SITEID":"CHN-13","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.95167,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-15","TRTSDTM":"2020-05-18 15:09:36","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":1.12158,"AVALU":"YEARS","ADTM":"2020-10-15","ADY":150,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-19","SUBJID":"id-19","SITEID":"CHN-13","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.95167,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-15","TRTSDTM":"2020-05-18 15:09:36","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.18058,"AVALU":"YEARS","ADTM":"2021-03-15","ADY":301,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-19","SUBJID":"id-19","SITEID":"CHN-13","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.95167,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-15","TRTSDTM":"2020-05-18 15:09:36","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.20506,"AVALU":"YEARS","ADTM":"2021-06-25","ADY":403,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-239","SUBJID":"id-239","SITEID":"CHN-13","AGE":58,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":5.44252,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-12","TRTSDTM":"2021-06-13 07:55:33","TRTEDTM":"2023-06-13 19:33:57","EOSSTT":"COMPLETED","EOSDT":"2023-06-13","EOSDY":731,"DTHDT":"2023-06-13","LSTALVDT":"2023-07-10","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03834,"AVALU":"YEARS","ADTM":"2022-02-15","ADY":247,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-239","SUBJID":"id-239","SITEID":"CHN-13","AGE":58,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":5.44252,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-12","TRTSDTM":"2021-06-13 07:55:33","TRTEDTM":"2023-06-13 19:33:57","EOSSTT":"COMPLETED","EOSDT":"2023-06-13","EOSDY":731,"DTHDT":"2023-06-13","LSTALVDT":"2023-07-10","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.57975,"AVALU":"YEARS","ADTM":"2022-12-22","ADY":557,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-239","SUBJID":"id-239","SITEID":"CHN-13","AGE":58,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":5.44252,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-12","TRTSDTM":"2021-06-13 07:55:33","TRTEDTM":"2023-06-13 19:33:57","EOSSTT":"COMPLETED","EOSDT":"2023-06-13","EOSDY":731,"DTHDT":"2023-06-13","LSTALVDT":"2023-07-10","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.06877,"AVALU":"YEARS","ADTM":"2021-06-17","ADY":4,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-240","SUBJID":"id-240","SITEID":"CHN-13","AGE":42,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.49929,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-11-10","TRTSDTM":"2019-11-12 22:31:25","TRTEDTM":"2021-11-12 10:09:49","EOSSTT":"COMPLETED","EOSDT":"2021-11-12","EOSDY":731,"DTHDT":"2021-11-12","LSTALVDT":"2021-11-25","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00602,"AVALU":"YEARS","ADTM":"2020-09-28","ADY":321,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-240","SUBJID":"id-240","SITEID":"CHN-13","AGE":42,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.49929,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-11-10","TRTSDTM":"2019-11-12 22:31:25","TRTEDTM":"2021-11-12 10:09:49","EOSSTT":"COMPLETED","EOSDT":"2021-11-12","EOSDY":731,"DTHDT":"2021-11-12","LSTALVDT":"2021-11-25","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.44764,"AVALU":"YEARS","ADTM":"2021-07-18","ADY":614,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-240","SUBJID":"id-240","SITEID":"CHN-13","AGE":42,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.49929,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-11-10","TRTSDTM":"2019-11-12 22:31:25","TRTEDTM":"2021-11-12 10:09:49","EOSSTT":"COMPLETED","EOSDT":"2021-11-12","EOSDY":731,"DTHDT":"2021-11-12","LSTALVDT":"2021-11-25","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08483,"AVALU":"YEARS","ADTM":"2020-06-04","ADY":205,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-249","SUBJID":"id-249","SITEID":"CHN-13","AGE":33,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":2.78004,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-09-29","TRTSDTM":"2020-09-30 14:56:01","TRTEDTM":"2021-09-21 22:38:01","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":357,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-21","LSTALVDT":"2021-10-05","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01585,"AVALU":"YEARS","ADTM":"2021-08-03","ADY":307,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-249","SUBJID":"id-249","SITEID":"CHN-13","AGE":33,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":2.78004,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-09-29","TRTSDTM":"2020-09-30 14:56:01","TRTEDTM":"2021-09-21 22:38:01","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":357,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-21","LSTALVDT":"2021-10-05","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.93411,"AVALU":"YEARS","ADTM":"2021-06-08","ADY":251,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-249","SUBJID":"id-249","SITEID":"CHN-13","AGE":33,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":2.78004,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-09-29","TRTSDTM":"2020-09-30 14:56:01","TRTEDTM":"2021-09-21 22:38:01","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":357,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-21","LSTALVDT":"2021-10-05","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0575,"AVALU":"YEARS","ADTM":"2021-09-20","ADY":355,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-270","SUBJID":"id-270","SITEID":"CHN-13","AGE":39,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":15.11156,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-03-19","TRTSDTM":"2020-03-23 00:40:25","TRTEDTM":"2021-09-22 03:39:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":549,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.48379,"AVALU":"YEARS","ADTM":"2021-02-09","ADY":323,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-270","SUBJID":"id-270","SITEID":"CHN-13","AGE":39,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":15.11156,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-03-19","TRTSDTM":"2020-03-23 00:40:25","TRTEDTM":"2021-09-22 03:39:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":549,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.13445,"AVALU":"YEARS","ADTM":"2020-09-03","ADY":164,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-270","SUBJID":"id-270","SITEID":"CHN-13","AGE":39,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":15.11156,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-03-19","TRTSDTM":"2020-03-23 00:40:25","TRTEDTM":"2021-09-22 03:39:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":549,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07511,"AVALU":"YEARS","ADTM":"2020-08-01","ADY":131,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-304","SUBJID":"id-304","SITEID":"CHN-13","AGE":29,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":8.79003,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-09-26","TRTSDTM":"2020-09-28 20:13:21","TRTEDTM":"2022-09-29 07:51:45","EOSSTT":"COMPLETED","EOSDT":"2022-09-29","EOSDY":731,"DTHDT":"2022-09-29","LSTALVDT":"2022-10-27","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.24386,"AVALU":"YEARS","ADTM":"2021-09-05","ADY":342,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-304","SUBJID":"id-304","SITEID":"CHN-13","AGE":29,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":8.79003,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-09-26","TRTSDTM":"2020-09-28 20:13:21","TRTEDTM":"2022-09-29 07:51:45","EOSSTT":"COMPLETED","EOSDT":"2022-09-29","EOSDY":731,"DTHDT":"2022-09-29","LSTALVDT":"2022-10-27","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.32895,"AVALU":"YEARS","ADTM":"2021-02-19","ADY":144,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-13-id-304","SUBJID":"id-304","SITEID":"CHN-13","AGE":29,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":8.79003,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-09-26","TRTSDTM":"2020-09-28 20:13:21","TRTEDTM":"2022-09-29 07:51:45","EOSSTT":"COMPLETED","EOSDT":"2022-09-29","EOSDY":731,"DTHDT":"2022-09-29","LSTALVDT":"2022-10-27","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.82652,"AVALU":"YEARS","ADTM":"2022-06-21","ADY":631,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-1","SUBJID":"id-1","SITEID":"CHN-14","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":7.72251,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-10","TRTSDTM":"2019-12-11 21:33:29","TRTEDTM":"2021-09-24 09:26:41","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":653,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.34889,"AVALU":"YEARS","ADTM":"2020-08-15","ADY":248,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-1","SUBJID":"id-1","SITEID":"CHN-14","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":7.72251,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-10","TRTSDTM":"2019-12-11 21:33:29","TRTEDTM":"2021-09-24 09:26:41","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":653,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.38915,"AVALU":"YEARS","ADTM":"2020-11-05","ADY":330,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-1","SUBJID":"id-1","SITEID":"CHN-14","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":7.72251,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-10","TRTSDTM":"2019-12-11 21:33:29","TRTEDTM":"2021-09-24 09:26:41","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":653,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04117,"AVALU":"YEARS","ADTM":"2020-12-31","ADY":386,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-103","SUBJID":"id-103","SITEID":"CHN-14","AGE":34,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":5.7478,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-06-04","TRTSDTM":"2020-06-08 09:34:25","TRTEDTM":"2021-09-18 15:23:27","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":468,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-18","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.17427,"AVALU":"YEARS","ADTM":"2021-02-12","ADY":249,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-103","SUBJID":"id-103","SITEID":"CHN-14","AGE":34,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":5.7478,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-06-04","TRTSDTM":"2020-06-08 09:34:25","TRTEDTM":"2021-09-18 15:23:27","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":468,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-18","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.40252,"AVALU":"YEARS","ADTM":"2020-07-29","ADY":51,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-103","SUBJID":"id-103","SITEID":"CHN-14","AGE":34,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":5.7478,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-06-04","TRTSDTM":"2020-06-08 09:34:25","TRTEDTM":"2021-09-18 15:23:27","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":468,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-18","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04508,"AVALU":"YEARS","ADTM":"2021-02-16","ADY":253,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-143","SUBJID":"id-143","SITEID":"CHN-14","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.17717,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-03-12","TRTSDTM":"2021-03-13 20:57:12","TRTEDTM":"2023-03-14 08:35:36","EOSSTT":"COMPLETED","EOSDT":"2023-03-14","EOSDY":731,"DTHDT":"2023-03-14","LSTALVDT":"2023-03-27","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.11943,"AVALU":"YEARS","ADTM":"2021-10-11","ADY":212,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-143","SUBJID":"id-143","SITEID":"CHN-14","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.17717,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-03-12","TRTSDTM":"2021-03-13 20:57:12","TRTEDTM":"2023-03-14 08:35:36","EOSSTT":"COMPLETED","EOSDT":"2023-03-14","EOSDY":731,"DTHDT":"2023-03-14","LSTALVDT":"2023-03-27","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.06389,"AVALU":"YEARS","ADTM":"2022-07-20","ADY":494,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-143","SUBJID":"id-143","SITEID":"CHN-14","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.17717,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-03-12","TRTSDTM":"2021-03-13 20:57:12","TRTEDTM":"2023-03-14 08:35:36","EOSSTT":"COMPLETED","EOSDT":"2023-03-14","EOSDY":731,"DTHDT":"2023-03-14","LSTALVDT":"2023-03-27","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08367,"AVALU":"YEARS","ADTM":"2021-11-09","ADY":241,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-161","SUBJID":"id-161","SITEID":"CHN-14","AGE":33,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":3.56375,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-04-14","TRTSDTM":"2020-04-17 12:09:53","TRTEDTM":"2022-04-17 23:48:17","EOSSTT":"COMPLETED","EOSDT":"2022-04-17","EOSDY":731,"DTHDT":"2022-04-17","LSTALVDT":"2022-05-13","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14653,"AVALU":"YEARS","ADTM":"2021-04-05","ADY":353,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-161","SUBJID":"id-161","SITEID":"CHN-14","AGE":33,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":3.56375,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-04-14","TRTSDTM":"2020-04-17 12:09:53","TRTEDTM":"2022-04-17 23:48:17","EOSSTT":"COMPLETED","EOSDT":"2022-04-17","EOSDY":731,"DTHDT":"2022-04-17","LSTALVDT":"2022-05-13","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.0747,"AVALU":"YEARS","ADTM":"2021-03-19","ADY":336,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-161","SUBJID":"id-161","SITEID":"CHN-14","AGE":33,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":3.56375,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-04-14","TRTSDTM":"2020-04-17 12:09:53","TRTEDTM":"2022-04-17 23:48:17","EOSSTT":"COMPLETED","EOSDT":"2022-04-17","EOSDY":731,"DTHDT":"2022-04-17","LSTALVDT":"2022-05-13","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.46558,"AVALU":"YEARS","ADTM":"2021-11-21","ADY":583,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-168","SUBJID":"id-168","SITEID":"CHN-14","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":2.75487,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-29","TRTSDTM":"2020-01-02 22:52:55","TRTEDTM":"2022-01-02 10:31:19","EOSSTT":"COMPLETED","EOSDT":"2022-01-02","EOSDY":731,"DTHDT":"2022-01-02","LSTALVDT":"2022-01-23","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.35963,"AVALU":"YEARS","ADTM":"2021-02-23","ADY":418,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-168","SUBJID":"id-168","SITEID":"CHN-14","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":2.75487,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-29","TRTSDTM":"2020-01-02 22:52:55","TRTEDTM":"2022-01-02 10:31:19","EOSSTT":"COMPLETED","EOSDT":"2022-01-02","EOSDY":731,"DTHDT":"2022-01-02","LSTALVDT":"2022-01-23","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.08063,"AVALU":"YEARS","ADTM":"2021-02-17","ADY":412,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-168","SUBJID":"id-168","SITEID":"CHN-14","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":2.75487,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-29","TRTSDTM":"2020-01-02 22:52:55","TRTEDTM":"2022-01-02 10:31:19","EOSSTT":"COMPLETED","EOSDT":"2022-01-02","EOSDY":731,"DTHDT":"2022-01-02","LSTALVDT":"2022-01-23","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.14229,"AVALU":"YEARS","ADTM":"2020-12-12","ADY":345,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-228","SUBJID":"id-228","SITEID":"CHN-14","AGE":30,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":6.31115,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-19","TRTSDTM":"2020-05-23 22:12:02","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0822,"AVALU":"YEARS","ADTM":"2022-02-09","ADY":627,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-228","SUBJID":"id-228","SITEID":"CHN-14","AGE":30,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":6.31115,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-19","TRTSDTM":"2020-05-23 22:12:02","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.19132,"AVALU":"YEARS","ADTM":"2020-06-24","ADY":32,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-228","SUBJID":"id-228","SITEID":"CHN-14","AGE":30,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":6.31115,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-19","TRTSDTM":"2020-05-23 22:12:02","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.30173,"AVALU":"YEARS","ADTM":"2020-11-28","ADY":189,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-305","SUBJID":"id-305","SITEID":"CHN-14","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":7.83617,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-27","TRTSDTM":"2021-08-30 07:02:53","TRTEDTM":"2021-09-25 02:38:20","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":26,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-25","LSTALVDT":"2021-10-24","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.67981,"AVALU":"YEARS","ADTM":"2021-09-18","ADY":19,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-305","SUBJID":"id-305","SITEID":"CHN-14","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":7.83617,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-27","TRTSDTM":"2021-08-30 07:02:53","TRTEDTM":"2021-09-25 02:38:20","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":26,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-25","LSTALVDT":"2021-10-24","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.2947,"AVALU":"YEARS","ADTM":"2021-09-09","ADY":10,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-305","SUBJID":"id-305","SITEID":"CHN-14","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":7.83617,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-27","TRTSDTM":"2021-08-30 07:02:53","TRTEDTM":"2021-09-25 02:38:20","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":26,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-25","LSTALVDT":"2021-10-24","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.30652,"AVALU":"YEARS","ADTM":"2021-09-10","ADY":11,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-375","SUBJID":"id-375","SITEID":"CHN-14","AGE":32,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.09912,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-30","TRTSDTM":"2020-10-31 16:11:00","TRTEDTM":"2022-11-01 03:49:24","EOSSTT":"COMPLETED","EOSDT":"2022-11-01","EOSDY":731,"DTHDT":"2022-11-01","LSTALVDT":"2022-11-17","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.17789,"AVALU":"YEARS","ADTM":"2020-11-13","ADY":13,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-375","SUBJID":"id-375","SITEID":"CHN-14","AGE":32,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.09912,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-30","TRTSDTM":"2020-10-31 16:11:00","TRTEDTM":"2022-11-01 03:49:24","EOSSTT":"COMPLETED","EOSDT":"2022-11-01","EOSDY":731,"DTHDT":"2022-11-01","LSTALVDT":"2022-11-17","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.13443,"AVALU":"YEARS","ADTM":"2021-07-17","ADY":259,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-375","SUBJID":"id-375","SITEID":"CHN-14","AGE":32,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.09912,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-30","TRTSDTM":"2020-10-31 16:11:00","TRTEDTM":"2022-11-01 03:49:24","EOSSTT":"COMPLETED","EOSDT":"2022-11-01","EOSDY":731,"DTHDT":"2022-11-01","LSTALVDT":"2022-11-17","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11502,"AVALU":"YEARS","ADTM":"2021-09-08","ADY":312,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-56","SUBJID":"id-56","SITEID":"CHN-14","AGE":25,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":3.51563,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-13","TRTSDTM":"2020-05-16 03:34:04","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01387,"AVALU":"YEARS","ADTM":"2021-11-19","ADY":552,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-56","SUBJID":"id-56","SITEID":"CHN-14","AGE":25,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":3.51563,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-13","TRTSDTM":"2020-05-16 03:34:04","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.11183,"AVALU":"YEARS","ADTM":"2022-04-07","ADY":691,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-14-id-56","SUBJID":"id-56","SITEID":"CHN-14","AGE":25,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":3.51563,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-13","TRTSDTM":"2020-05-16 03:34:04","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1538,"AVALU":"YEARS","ADTM":"2021-05-24","ADY":373,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-14","SUBJID":"id-14","SITEID":"CHN-15","AGE":38,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":3.02692,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-04","TRTSDTM":"2020-05-04 21:04:08","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.04625,"AVALU":"YEARS","ADTM":"2021-12-28","ADY":603,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-14","SUBJID":"id-14","SITEID":"CHN-15","AGE":38,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":3.02692,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-04","TRTSDTM":"2020-05-04 21:04:08","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.04648,"AVALU":"YEARS","ADTM":"2022-02-12","ADY":649,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-14","SUBJID":"id-14","SITEID":"CHN-15","AGE":38,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":3.02692,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-04","TRTSDTM":"2020-05-04 21:04:08","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.05122,"AVALU":"YEARS","ADTM":"2022-04-10","ADY":706,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-201","SUBJID":"id-201","SITEID":"CHN-15","AGE":49,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":6.9068,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-10-10","TRTSDTM":"2019-10-10 01:00:04","TRTEDTM":"2021-09-24 06:00:13","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":716,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-24","LSTALVDT":"2021-10-22","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.16016,"AVALU":"YEARS","ADTM":"2020-06-16","ADY":250,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-201","SUBJID":"id-201","SITEID":"CHN-15","AGE":49,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":6.9068,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-10-10","TRTSDTM":"2019-10-10 01:00:04","TRTEDTM":"2021-09-24 06:00:13","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":716,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-24","LSTALVDT":"2021-10-22","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00191,"AVALU":"YEARS","ADTM":"2020-12-29","ADY":446,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-201","SUBJID":"id-201","SITEID":"CHN-15","AGE":49,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":6.9068,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-10-10","TRTSDTM":"2019-10-10 01:00:04","TRTEDTM":"2021-09-24 06:00:13","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":716,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-24","LSTALVDT":"2021-10-22","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.28375,"AVALU":"YEARS","ADTM":"2021-05-04","ADY":572,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-245","SUBJID":"id-245","SITEID":"CHN-15","AGE":34,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":3.68285,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-10-29","TRTSDTM":"2019-11-02 12:02:15","TRTEDTM":"2021-09-21 15:46:58","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":690,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-21","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.1021,"AVALU":"YEARS","ADTM":"2020-04-19","ADY":169,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-245","SUBJID":"id-245","SITEID":"CHN-15","AGE":34,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":3.68285,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-10-29","TRTSDTM":"2019-11-02 12:02:15","TRTEDTM":"2021-09-21 15:46:58","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":690,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-21","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.51769,"AVALU":"YEARS","ADTM":"2021-05-01","ADY":546,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-245","SUBJID":"id-245","SITEID":"CHN-15","AGE":34,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":3.68285,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-10-29","TRTSDTM":"2019-11-02 12:02:15","TRTEDTM":"2021-09-21 15:46:58","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":690,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-21","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.77087,"AVALU":"YEARS","ADTM":"2021-04-29","ADY":544,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-262","SUBJID":"id-262","SITEID":"CHN-15","AGE":35,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.05546,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-02","TRTSDTM":"2019-10-02 18:41:20","TRTEDTM":"2021-10-02 06:19:44","EOSSTT":"COMPLETED","EOSDT":"2021-10-02","EOSDY":731,"DTHDT":"2021-10-02","LSTALVDT":"2021-10-24","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.38411,"AVALU":"YEARS","ADTM":"2021-07-13","ADY":650,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-262","SUBJID":"id-262","SITEID":"CHN-15","AGE":35,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.05546,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-02","TRTSDTM":"2019-10-02 18:41:20","TRTEDTM":"2021-10-02 06:19:44","EOSSTT":"COMPLETED","EOSDT":"2021-10-02","EOSDY":731,"DTHDT":"2021-10-02","LSTALVDT":"2021-10-24","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.38059,"AVALU":"YEARS","ADTM":"2021-04-02","ADY":548,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-262","SUBJID":"id-262","SITEID":"CHN-15","AGE":35,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.05546,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-02","TRTSDTM":"2019-10-02 18:41:20","TRTEDTM":"2021-10-02 06:19:44","EOSSTT":"COMPLETED","EOSDT":"2021-10-02","EOSDY":731,"DTHDT":"2021-10-02","LSTALVDT":"2021-10-24","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.48428,"AVALU":"YEARS","ADTM":"2020-08-12","ADY":315,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-297","SUBJID":"id-297","SITEID":"CHN-15","AGE":31,"SEX":"U","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":11.93491,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-25","TRTSDTM":"2020-04-25 19:54:38","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.04866,"AVALU":"YEARS","ADTM":"2021-05-18","ADY":388,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-297","SUBJID":"id-297","SITEID":"CHN-15","AGE":31,"SEX":"U","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":11.93491,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-25","TRTSDTM":"2020-04-25 19:54:38","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.1958,"AVALU":"YEARS","ADTM":"2022-02-06","ADY":652,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-297","SUBJID":"id-297","SITEID":"CHN-15","AGE":31,"SEX":"U","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":11.93491,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-25","TRTSDTM":"2020-04-25 19:54:38","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.13892,"AVALU":"YEARS","ADTM":"2020-12-16","ADY":235,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-399","SUBJID":"id-399","SITEID":"CHN-15","AGE":33,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":0.99183,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-18","TRTSDTM":"2020-05-20 18:53:40","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.20718,"AVALU":"YEARS","ADTM":"2021-02-07","ADY":263,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-399","SUBJID":"id-399","SITEID":"CHN-15","AGE":33,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":0.99183,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-18","TRTSDTM":"2020-05-20 18:53:40","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.10474,"AVALU":"YEARS","ADTM":"2022-02-11","ADY":632,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-15-id-399","SUBJID":"id-399","SITEID":"CHN-15","AGE":33,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":0.99183,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-18","TRTSDTM":"2020-05-20 18:53:40","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11961,"AVALU":"YEARS","ADTM":"2022-01-12","ADY":602,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-154","SUBJID":"id-154","SITEID":"CHN-16","AGE":36,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-16","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":7.17155,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-17","TRTSDTM":"2020-07-20 18:57:34","TRTEDTM":"2021-09-21 20:29:07","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":429,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-21","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.28023,"AVALU":"YEARS","ADTM":"2021-06-24","ADY":339,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-154","SUBJID":"id-154","SITEID":"CHN-16","AGE":36,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-16","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":7.17155,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-17","TRTSDTM":"2020-07-20 18:57:34","TRTEDTM":"2021-09-21 20:29:07","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":429,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-21","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.12385,"AVALU":"YEARS","ADTM":"2021-03-08","ADY":231,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-154","SUBJID":"id-154","SITEID":"CHN-16","AGE":36,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-16","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":7.17155,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-17","TRTSDTM":"2020-07-20 18:57:34","TRTEDTM":"2021-09-21 20:29:07","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":429,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-21","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":1.178,"AVALU":"YEARS","ADTM":"2021-01-12","ADY":176,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-241","SUBJID":"id-241","SITEID":"CHN-16","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.53579,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-21","TRTSDTM":"2020-06-24 16:41:12","TRTEDTM":"2021-09-25 12:25:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":458,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.1073,"AVALU":"YEARS","ADTM":"2021-02-17","ADY":238,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-241","SUBJID":"id-241","SITEID":"CHN-16","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.53579,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-21","TRTSDTM":"2020-06-24 16:41:12","TRTEDTM":"2021-09-25 12:25:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":458,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.56901,"AVALU":"YEARS","ADTM":"2020-12-16","ADY":175,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-241","SUBJID":"id-241","SITEID":"CHN-16","AGE":41,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.53579,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-21","TRTSDTM":"2020-06-24 16:41:12","TRTEDTM":"2021-09-25 12:25:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":458,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.10141,"AVALU":"YEARS","ADTM":"2021-08-28","ADY":430,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-302","SUBJID":"id-302","SITEID":"CHN-16","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.79834,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-13","TRTSDTM":"2021-06-16 00:59:25","TRTEDTM":"2023-06-16 12:37:49","EOSSTT":"COMPLETED","EOSDT":"2023-06-16","EOSDY":731,"DTHDT":"2023-06-16","LSTALVDT":"2023-07-11","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.1506,"AVALU":"YEARS","ADTM":"2023-04-03","ADY":656,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-302","SUBJID":"id-302","SITEID":"CHN-16","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.79834,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-13","TRTSDTM":"2021-06-16 00:59:25","TRTEDTM":"2023-06-16 12:37:49","EOSSTT":"COMPLETED","EOSDT":"2023-06-16","EOSDY":731,"DTHDT":"2023-06-16","LSTALVDT":"2023-07-11","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.89715,"AVALU":"YEARS","ADTM":"2023-01-21","ADY":584,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-302","SUBJID":"id-302","SITEID":"CHN-16","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.79834,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-13","TRTSDTM":"2021-06-16 00:59:25","TRTEDTM":"2023-06-16 12:37:49","EOSSTT":"COMPLETED","EOSDT":"2023-06-16","EOSDY":731,"DTHDT":"2023-06-16","LSTALVDT":"2023-07-11","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.42562,"AVALU":"YEARS","ADTM":"2022-03-06","ADY":263,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-323","SUBJID":"id-323","SITEID":"CHN-16","AGE":51,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":13.94449,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-31","TRTSDTM":"2020-07-31 05:37:40","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0457,"AVALU":"YEARS","ADTM":"2021-01-02","ADY":155,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-323","SUBJID":"id-323","SITEID":"CHN-16","AGE":51,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":13.94449,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-31","TRTSDTM":"2020-07-31 05:37:40","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.90564,"AVALU":"YEARS","ADTM":"2021-10-26","ADY":452,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-323","SUBJID":"id-323","SITEID":"CHN-16","AGE":51,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":13.94449,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-31","TRTSDTM":"2020-07-31 05:37:40","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01515,"AVALU":"YEARS","ADTM":"2020-09-13","ADY":44,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-352","SUBJID":"id-352","SITEID":"CHN-16","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":4.21681,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-09-05","TRTSDTM":"2021-09-08 18:41:12","TRTEDTM":"2023-09-09 06:19:36","EOSSTT":"COMPLETED","EOSDT":"2023-09-09","EOSDY":731,"DTHDT":"2023-09-09","LSTALVDT":"2023-10-02","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.20962,"AVALU":"YEARS","ADTM":"2023-01-30","ADY":509,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-352","SUBJID":"id-352","SITEID":"CHN-16","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":4.21681,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-09-05","TRTSDTM":"2021-09-08 18:41:12","TRTEDTM":"2023-09-09 06:19:36","EOSSTT":"COMPLETED","EOSDT":"2023-09-09","EOSDY":731,"DTHDT":"2023-09-09","LSTALVDT":"2023-10-02","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.45912,"AVALU":"YEARS","ADTM":"2023-07-12","ADY":672,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-352","SUBJID":"id-352","SITEID":"CHN-16","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":4.21681,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-09-05","TRTSDTM":"2021-09-08 18:41:12","TRTEDTM":"2023-09-09 06:19:36","EOSSTT":"COMPLETED","EOSDT":"2023-09-09","EOSDY":731,"DTHDT":"2023-09-09","LSTALVDT":"2023-10-02","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.16407,"AVALU":"YEARS","ADTM":"2022-07-21","ADY":316,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-381","SUBJID":"id-381","SITEID":"CHN-16","AGE":45,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":4.62925,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-09-19","TRTSDTM":"2020-09-20 17:02:01","TRTEDTM":"2021-09-20 00:35:48","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":365,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-20","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.37023,"AVALU":"YEARS","ADTM":"2020-12-08","ADY":79,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-381","SUBJID":"id-381","SITEID":"CHN-16","AGE":45,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":4.62925,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-09-19","TRTSDTM":"2020-09-20 17:02:01","TRTEDTM":"2021-09-20 00:35:48","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":365,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-20","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.48299,"AVALU":"YEARS","ADTM":"2021-02-21","ADY":154,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-16-id-381","SUBJID":"id-381","SITEID":"CHN-16","AGE":45,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-16","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":4.62925,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-09-19","TRTSDTM":"2020-09-20 17:02:01","TRTEDTM":"2021-09-20 00:35:48","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":365,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-20","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04507,"AVALU":"YEARS","ADTM":"2021-08-31","ADY":345,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-10","SUBJID":"id-10","SITEID":"CHN-17","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":4.58058,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-07-23","TRTSDTM":"2021-07-23 10:20:26","TRTEDTM":"2023-07-23 21:58:50","EOSSTT":"COMPLETED","EOSDT":"2023-07-23","EOSDY":731,"DTHDT":"2023-07-23","LSTALVDT":"2023-08-02","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.1314,"AVALU":"YEARS","ADTM":"2023-03-11","ADY":596,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-10","SUBJID":"id-10","SITEID":"CHN-17","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":4.58058,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-07-23","TRTSDTM":"2021-07-23 10:20:26","TRTEDTM":"2023-07-23 21:58:50","EOSSTT":"COMPLETED","EOSDT":"2023-07-23","EOSDY":731,"DTHDT":"2023-07-23","LSTALVDT":"2023-08-02","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.32336,"AVALU":"YEARS","ADTM":"2023-04-08","ADY":624,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-10","SUBJID":"id-10","SITEID":"CHN-17","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":4.58058,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-07-23","TRTSDTM":"2021-07-23 10:20:26","TRTEDTM":"2023-07-23 21:58:50","EOSSTT":"COMPLETED","EOSDT":"2023-07-23","EOSDY":731,"DTHDT":"2023-07-23","LSTALVDT":"2023-08-02","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.05371,"AVALU":"YEARS","ADTM":"2022-12-03","ADY":498,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-129","SUBJID":"id-129","SITEID":"CHN-17","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.12912,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-14","TRTSDTM":"2021-06-17 10:37:43","TRTEDTM":"2021-09-25 12:32:54","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":101,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.15539,"AVALU":"YEARS","ADTM":"2021-09-17","ADY":92,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-129","SUBJID":"id-129","SITEID":"CHN-17","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.12912,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-14","TRTSDTM":"2021-06-17 10:37:43","TRTEDTM":"2021-09-25 12:32:54","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":101,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.95684,"AVALU":"YEARS","ADTM":"2021-07-02","ADY":15,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-129","SUBJID":"id-129","SITEID":"CHN-17","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.12912,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-06-14","TRTSDTM":"2021-06-17 10:37:43","TRTEDTM":"2021-09-25 12:32:54","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":101,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01997,"AVALU":"YEARS","ADTM":"2021-09-14","ADY":89,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-182","SUBJID":"id-182","SITEID":"CHN-17","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":5.65524,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-04-22","TRTSDTM":"2020-04-23 17:26:16","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.08809,"AVALU":"YEARS","ADTM":"2020-08-25","ADY":124,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-182","SUBJID":"id-182","SITEID":"CHN-17","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":5.65524,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-04-22","TRTSDTM":"2020-04-23 17:26:16","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.21078,"AVALU":"YEARS","ADTM":"2021-09-20","ADY":515,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-182","SUBJID":"id-182","SITEID":"CHN-17","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":5.65524,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-04-22","TRTSDTM":"2020-04-23 17:26:16","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.19285,"AVALU":"YEARS","ADTM":"2021-09-10","ADY":505,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-209","SUBJID":"id-209","SITEID":"CHN-17","AGE":31,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":1.64011,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-20","TRTSDTM":"2021-07-22 20:30:13","TRTEDTM":"2023-07-23 08:08:37","EOSSTT":"COMPLETED","EOSDT":"2023-07-23","EOSDY":731,"DTHDT":"2023-07-23","LSTALVDT":"2023-08-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01749,"AVALU":"YEARS","ADTM":"2022-09-24","ADY":429,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-209","SUBJID":"id-209","SITEID":"CHN-17","AGE":31,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":1.64011,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-20","TRTSDTM":"2021-07-22 20:30:13","TRTEDTM":"2023-07-23 08:08:37","EOSSTT":"COMPLETED","EOSDT":"2023-07-23","EOSDY":731,"DTHDT":"2023-07-23","LSTALVDT":"2023-08-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.16964,"AVALU":"YEARS","ADTM":"2023-01-24","ADY":551,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-209","SUBJID":"id-209","SITEID":"CHN-17","AGE":31,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":1.64011,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-20","TRTSDTM":"2021-07-22 20:30:13","TRTEDTM":"2023-07-23 08:08:37","EOSSTT":"COMPLETED","EOSDT":"2023-07-23","EOSDY":731,"DTHDT":"2023-07-23","LSTALVDT":"2023-08-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.99055,"AVALU":"YEARS","ADTM":"2022-05-10","ADY":292,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-309","SUBJID":"id-309","SITEID":"CHN-17","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.34396,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-02","TRTSDTM":"2019-12-02 00:32:36","TRTEDTM":"2021-12-01 12:11:00","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-11","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.07552,"AVALU":"YEARS","ADTM":"2019-12-17","ADY":15,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-309","SUBJID":"id-309","SITEID":"CHN-17","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.34396,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-02","TRTSDTM":"2019-12-02 00:32:36","TRTEDTM":"2021-12-01 12:11:00","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-11","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.54649,"AVALU":"YEARS","ADTM":"2020-06-10","ADY":191,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-309","SUBJID":"id-309","SITEID":"CHN-17","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.34396,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-02","TRTSDTM":"2019-12-02 00:32:36","TRTEDTM":"2021-12-01 12:11:00","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-11","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07929,"AVALU":"YEARS","ADTM":"2021-02-03","ADY":429,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-31","SUBJID":"id-31","SITEID":"CHN-17","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":2.47905,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-06-20","TRTSDTM":"2020-06-22 16:26:08","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02832,"AVALU":"YEARS","ADTM":"2021-03-22","ADY":273,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-31","SUBJID":"id-31","SITEID":"CHN-17","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":2.47905,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-06-20","TRTSDTM":"2020-06-22 16:26:08","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.08109,"AVALU":"YEARS","ADTM":"2022-04-15","ADY":662,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-31","SUBJID":"id-31","SITEID":"CHN-17","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":2.47905,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-06-20","TRTSDTM":"2020-06-22 16:26:08","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08903,"AVALU":"YEARS","ADTM":"2022-03-07","ADY":623,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-48","SUBJID":"id-48","SITEID":"CHN-17","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":7.25469,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-03","TRTSDTM":"2019-12-07 15:53:48","TRTEDTM":"2021-12-07 03:32:12","EOSSTT":"COMPLETED","EOSDT":"2021-12-07","EOSDY":731,"DTHDT":"2021-12-07","LSTALVDT":"2021-12-25","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.04138,"AVALU":"YEARS","ADTM":"2020-03-25","ADY":109,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-48","SUBJID":"id-48","SITEID":"CHN-17","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":7.25469,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-03","TRTSDTM":"2019-12-07 15:53:48","TRTEDTM":"2021-12-07 03:32:12","EOSSTT":"COMPLETED","EOSDT":"2021-12-07","EOSDY":731,"DTHDT":"2021-12-07","LSTALVDT":"2021-12-25","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01376,"AVALU":"YEARS","ADTM":"2020-12-03","ADY":362,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-48","SUBJID":"id-48","SITEID":"CHN-17","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":7.25469,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-03","TRTSDTM":"2019-12-07 15:53:48","TRTEDTM":"2021-12-07 03:32:12","EOSSTT":"COMPLETED","EOSDT":"2021-12-07","EOSDY":731,"DTHDT":"2021-12-07","LSTALVDT":"2021-12-25","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08654,"AVALU":"YEARS","ADTM":"2021-02-17","ADY":438,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-5","SUBJID":"id-5","SITEID":"CHN-17","AGE":26,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":1.86288,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-08-10","TRTSDTM":"2021-08-13 13:08:52","TRTEDTM":"2023-08-14 00:47:16","EOSSTT":"COMPLETED","EOSDT":"2023-08-14","EOSDY":731,"DTHDT":"2023-08-14","LSTALVDT":"2023-08-27","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.15809,"AVALU":"YEARS","ADTM":"2022-07-20","ADY":341,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-5","SUBJID":"id-5","SITEID":"CHN-17","AGE":26,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":1.86288,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-08-10","TRTSDTM":"2021-08-13 13:08:52","TRTEDTM":"2023-08-14 00:47:16","EOSSTT":"COMPLETED","EOSDT":"2023-08-14","EOSDY":731,"DTHDT":"2023-08-14","LSTALVDT":"2023-08-27","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.15345,"AVALU":"YEARS","ADTM":"2023-06-25","ADY":681,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-5","SUBJID":"id-5","SITEID":"CHN-17","AGE":26,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":1.86288,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-08-10","TRTSDTM":"2021-08-13 13:08:52","TRTEDTM":"2023-08-14 00:47:16","EOSSTT":"COMPLETED","EOSDT":"2023-08-14","EOSDY":731,"DTHDT":"2023-08-14","LSTALVDT":"2023-08-27","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.35495,"AVALU":"YEARS","ADTM":"2023-03-03","ADY":567,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-66","SUBJID":"id-66","SITEID":"CHN-17","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":6.83802,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-01","TRTSDTM":"2020-02-03 08:59:58","TRTEDTM":"2021-09-25 16:32:22","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":601,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.18475,"AVALU":"YEARS","ADTM":"2020-05-24","ADY":111,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-66","SUBJID":"id-66","SITEID":"CHN-17","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":6.83802,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-01","TRTSDTM":"2020-02-03 08:59:58","TRTEDTM":"2021-09-25 16:32:22","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":601,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.44343,"AVALU":"YEARS","ADTM":"2020-10-15","ADY":255,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-66","SUBJID":"id-66","SITEID":"CHN-17","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":6.83802,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-01","TRTSDTM":"2020-02-03 08:59:58","TRTEDTM":"2021-09-25 16:32:22","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":601,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.18732,"AVALU":"YEARS","ADTM":"2020-06-25","ADY":143,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-84","SUBJID":"id-84","SITEID":"CHN-17","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":6.61367,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-27","TRTSDTM":"2019-10-28 19:56:27","TRTEDTM":"2021-09-21 06:02:04","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":694,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-21","LSTALVDT":"2021-10-02","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.2288,"AVALU":"YEARS","ADTM":"2020-06-17","ADY":233,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-84","SUBJID":"id-84","SITEID":"CHN-17","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":6.61367,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-27","TRTSDTM":"2019-10-28 19:56:27","TRTEDTM":"2021-09-21 06:02:04","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":694,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-21","LSTALVDT":"2021-10-02","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.11716,"AVALU":"YEARS","ADTM":"2021-08-19","ADY":661,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-84","SUBJID":"id-84","SITEID":"CHN-17","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":6.61367,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-27","TRTSDTM":"2019-10-28 19:56:27","TRTEDTM":"2021-09-21 06:02:04","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":694,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-21","LSTALVDT":"2021-10-02","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.46617,"AVALU":"YEARS","ADTM":"2020-06-23","ADY":239,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-92","SUBJID":"id-92","SITEID":"CHN-17","AGE":29,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":4.8508,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-04","TRTSDTM":"2020-10-06 08:31:21","TRTEDTM":"2022-10-06 20:09:45","EOSSTT":"COMPLETED","EOSDT":"2022-10-06","EOSDY":731,"DTHDT":"2022-10-06","LSTALVDT":"2022-10-20","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.06697,"AVALU":"YEARS","ADTM":"2021-10-05","ADY":364,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-92","SUBJID":"id-92","SITEID":"CHN-17","AGE":29,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":4.8508,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-04","TRTSDTM":"2020-10-06 08:31:21","TRTEDTM":"2022-10-06 20:09:45","EOSSTT":"COMPLETED","EOSDT":"2022-10-06","EOSDY":731,"DTHDT":"2022-10-06","LSTALVDT":"2022-10-20","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.16639,"AVALU":"YEARS","ADTM":"2021-09-02","ADY":331,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-17-id-92","SUBJID":"id-92","SITEID":"CHN-17","AGE":29,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":4.8508,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-04","TRTSDTM":"2020-10-06 08:31:21","TRTEDTM":"2022-10-06 20:09:45","EOSSTT":"COMPLETED","EOSDT":"2022-10-06","EOSDY":731,"DTHDT":"2022-10-06","LSTALVDT":"2022-10-20","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.37484,"AVALU":"YEARS","ADTM":"2022-08-26","ADY":689,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-18-id-106","SUBJID":"id-106","SITEID":"CHN-18","AGE":30,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-18","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":4.04956,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-14","TRTSDTM":"2021-07-17 11:23:56","TRTEDTM":"2023-07-17 23:02:20","EOSSTT":"COMPLETED","EOSDT":"2023-07-17","EOSDY":731,"DTHDT":"2023-07-17","LSTALVDT":"2023-07-30","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01923,"AVALU":"YEARS","ADTM":"2022-05-20","ADY":307,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-18-id-106","SUBJID":"id-106","SITEID":"CHN-18","AGE":30,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-18","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":4.04956,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-14","TRTSDTM":"2021-07-17 11:23:56","TRTEDTM":"2023-07-17 23:02:20","EOSSTT":"COMPLETED","EOSDT":"2023-07-17","EOSDY":731,"DTHDT":"2023-07-17","LSTALVDT":"2023-07-30","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00814,"AVALU":"YEARS","ADTM":"2021-08-28","ADY":42,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-18-id-106","SUBJID":"id-106","SITEID":"CHN-18","AGE":30,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-18","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":4.04956,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-14","TRTSDTM":"2021-07-17 11:23:56","TRTEDTM":"2023-07-17 23:02:20","EOSSTT":"COMPLETED","EOSDT":"2023-07-17","EOSDY":731,"DTHDT":"2023-07-17","LSTALVDT":"2023-07-30","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.45915,"AVALU":"YEARS","ADTM":"2022-11-20","ADY":491,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-18-id-170","SUBJID":"id-170","SITEID":"CHN-18","AGE":31,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-18","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":12.94197,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-22","TRTSDTM":"2020-08-25 18:02:11","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.04199,"AVALU":"YEARS","ADTM":"2021-08-26","ADY":366,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-18-id-170","SUBJID":"id-170","SITEID":"CHN-18","AGE":31,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-18","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":12.94197,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-22","TRTSDTM":"2020-08-25 18:02:11","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.08371,"AVALU":"YEARS","ADTM":"2021-05-26","ADY":274,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-18-id-170","SUBJID":"id-170","SITEID":"CHN-18","AGE":31,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-18","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":12.94197,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-22","TRTSDTM":"2020-08-25 18:02:11","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11158,"AVALU":"YEARS","ADTM":"2022-04-29","ADY":612,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-18-id-51","SUBJID":"id-51","SITEID":"CHN-18","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-18","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":6.95289,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-01","TRTSDTM":"2020-05-01 00:58:59","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03899,"AVALU":"YEARS","ADTM":"2021-05-04","ADY":368,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-18-id-51","SUBJID":"id-51","SITEID":"CHN-18","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-18","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":6.95289,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-01","TRTSDTM":"2020-05-01 00:58:59","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.18137,"AVALU":"YEARS","ADTM":"2021-10-01","ADY":518,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-18-id-51","SUBJID":"id-51","SITEID":"CHN-18","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-18","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":6.95289,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-01","TRTSDTM":"2020-05-01 00:58:59","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08133,"AVALU":"YEARS","ADTM":"2021-12-19","ADY":597,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-118","SUBJID":"id-118","SITEID":"CHN-2","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.22229,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-11-11","TRTSDTM":"2020-11-13 21:12:58","TRTEDTM":"2021-09-18 17:14:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":309,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-18","LSTALVDT":"2021-10-05","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.44027,"AVALU":"YEARS","ADTM":"2021-08-18","ADY":278,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-118","SUBJID":"id-118","SITEID":"CHN-2","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.22229,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-11-11","TRTSDTM":"2020-11-13 21:12:58","TRTEDTM":"2021-09-18 17:14:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":309,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-18","LSTALVDT":"2021-10-05","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.47817,"AVALU":"YEARS","ADTM":"2021-04-18","ADY":156,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-118","SUBJID":"id-118","SITEID":"CHN-2","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.22229,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-11-11","TRTSDTM":"2020-11-13 21:12:58","TRTEDTM":"2021-09-18 17:14:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":309,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-18","LSTALVDT":"2021-10-05","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00526,"AVALU":"YEARS","ADTM":"2021-09-15","ADY":306,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-149","SUBJID":"id-149","SITEID":"CHN-2","AGE":32,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":9.64074,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-08","TRTSDTM":"2020-08-12 17:53:32","TRTEDTM":"2021-09-25 21:13:06","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":410,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02344,"AVALU":"YEARS","ADTM":"2021-01-10","ADY":151,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-149","SUBJID":"id-149","SITEID":"CHN-2","AGE":32,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":9.64074,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-08","TRTSDTM":"2020-08-12 17:53:32","TRTEDTM":"2021-09-25 21:13:06","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":410,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.15628,"AVALU":"YEARS","ADTM":"2020-08-22","ADY":10,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-149","SUBJID":"id-149","SITEID":"CHN-2","AGE":32,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":9.64074,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-08","TRTSDTM":"2020-08-12 17:53:32","TRTEDTM":"2021-09-25 21:13:06","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":410,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08146,"AVALU":"YEARS","ADTM":"2021-08-15","ADY":368,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-22","SUBJID":"id-22","SITEID":"CHN-2","AGE":29,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.69016,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-21","TRTSDTM":"2021-08-22 08:53:47","TRTEDTM":"2021-09-21 13:52:42","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":31,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-21","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.20731,"AVALU":"YEARS","ADTM":"2021-09-03","ADY":12,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-22","SUBJID":"id-22","SITEID":"CHN-2","AGE":29,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.69016,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-21","TRTSDTM":"2021-08-22 08:53:47","TRTEDTM":"2021-09-21 13:52:42","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":31,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-21","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.03988,"AVALU":"YEARS","ADTM":"2021-09-14","ADY":23,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-22","SUBJID":"id-22","SITEID":"CHN-2","AGE":29,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.69016,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-21","TRTSDTM":"2021-08-22 08:53:47","TRTEDTM":"2021-09-21 13:52:42","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":31,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-21","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.55523,"AVALU":"YEARS","ADTM":"2021-08-31","ADY":9,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-223","SUBJID":"id-223","SITEID":"CHN-2","AGE":29,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":4.62508,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-21","TRTSDTM":"2021-06-24 19:40:06","TRTEDTM":"2023-06-25 07:18:30","EOSSTT":"COMPLETED","EOSDT":"2023-06-25","EOSDY":731,"DTHDT":"2023-06-25","LSTALVDT":"2023-07-13","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.09537,"AVALU":"YEARS","ADTM":"2022-02-14","ADY":235,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-223","SUBJID":"id-223","SITEID":"CHN-2","AGE":29,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":4.62508,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-21","TRTSDTM":"2021-06-24 19:40:06","TRTEDTM":"2023-06-25 07:18:30","EOSSTT":"COMPLETED","EOSDT":"2023-06-25","EOSDY":731,"DTHDT":"2023-06-25","LSTALVDT":"2023-07-13","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.28113,"AVALU":"YEARS","ADTM":"2023-04-14","ADY":659,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-223","SUBJID":"id-223","SITEID":"CHN-2","AGE":29,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":4.62508,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-21","TRTSDTM":"2021-06-24 19:40:06","TRTEDTM":"2023-06-25 07:18:30","EOSSTT":"COMPLETED","EOSDT":"2023-06-25","EOSDY":731,"DTHDT":"2023-06-25","LSTALVDT":"2023-07-13","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01289,"AVALU":"YEARS","ADTM":"2022-08-10","ADY":412,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-272","SUBJID":"id-272","SITEID":"CHN-2","AGE":41,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.17023,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-13","TRTSDTM":"2020-08-16 13:01:20","TRTEDTM":"2021-09-25 14:43:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":406,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.16472,"AVALU":"YEARS","ADTM":"2021-02-07","ADY":175,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-272","SUBJID":"id-272","SITEID":"CHN-2","AGE":41,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.17023,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-13","TRTSDTM":"2020-08-16 13:01:20","TRTEDTM":"2021-09-25 14:43:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":406,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.64739,"AVALU":"YEARS","ADTM":"2021-06-27","ADY":315,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-272","SUBJID":"id-272","SITEID":"CHN-2","AGE":41,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.17023,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-13","TRTSDTM":"2020-08-16 13:01:20","TRTEDTM":"2021-09-25 14:43:08","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":406,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0934,"AVALU":"YEARS","ADTM":"2020-09-21","ADY":36,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-274","SUBJID":"id-274","SITEID":"CHN-2","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":2.58528,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-16","TRTSDTM":"2020-05-20 02:26:48","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.15936,"AVALU":"YEARS","ADTM":"2021-05-28","ADY":373,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-274","SUBJID":"id-274","SITEID":"CHN-2","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":2.58528,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-16","TRTSDTM":"2020-05-20 02:26:48","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.1878,"AVALU":"YEARS","ADTM":"2021-07-21","ADY":427,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-274","SUBJID":"id-274","SITEID":"CHN-2","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":2.58528,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-16","TRTSDTM":"2020-05-20 02:26:48","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1586,"AVALU":"YEARS","ADTM":"2022-04-26","ADY":706,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-284","SUBJID":"id-284","SITEID":"CHN-2","AGE":36,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":8.02225,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-20","TRTSDTM":"2021-04-20 08:52:37","TRTEDTM":"2023-04-20 20:31:01","EOSSTT":"COMPLETED","EOSDT":"2023-04-20","EOSDY":731,"DTHDT":"2023-04-20","LSTALVDT":"2023-05-18","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.11506,"AVALU":"YEARS","ADTM":"2022-09-03","ADY":501,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-284","SUBJID":"id-284","SITEID":"CHN-2","AGE":36,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":8.02225,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-20","TRTSDTM":"2021-04-20 08:52:37","TRTEDTM":"2023-04-20 20:31:01","EOSSTT":"COMPLETED","EOSDT":"2023-04-20","EOSDY":731,"DTHDT":"2023-04-20","LSTALVDT":"2023-05-18","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.75124,"AVALU":"YEARS","ADTM":"2022-11-10","ADY":569,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-284","SUBJID":"id-284","SITEID":"CHN-2","AGE":36,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":8.02225,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-20","TRTSDTM":"2021-04-20 08:52:37","TRTEDTM":"2023-04-20 20:31:01","EOSSTT":"COMPLETED","EOSDT":"2023-04-20","EOSDY":731,"DTHDT":"2023-04-20","LSTALVDT":"2023-05-18","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11331,"AVALU":"YEARS","ADTM":"2022-02-20","ADY":306,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-286","SUBJID":"id-286","SITEID":"CHN-2","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":2.63472,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-21","TRTSDTM":"2019-12-21 00:57:12","TRTEDTM":"2021-09-24 11:06:14","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":644,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.2027,"AVALU":"YEARS","ADTM":"2020-04-22","ADY":123,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-286","SUBJID":"id-286","SITEID":"CHN-2","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":2.63472,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-21","TRTSDTM":"2019-12-21 00:57:12","TRTEDTM":"2021-09-24 11:06:14","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":644,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.09335,"AVALU":"YEARS","ADTM":"2021-04-15","ADY":481,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-286","SUBJID":"id-286","SITEID":"CHN-2","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":2.63472,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-21","TRTSDTM":"2019-12-21 00:57:12","TRTEDTM":"2021-09-24 11:06:14","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":644,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.37902,"AVALU":"YEARS","ADTM":"2020-11-24","ADY":339,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-292","SUBJID":"id-292","SITEID":"CHN-2","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":7.87128,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-10","TRTSDTM":"2021-02-13 18:05:47","TRTEDTM":"2021-09-20 08:42:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":219,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01313,"AVALU":"YEARS","ADTM":"2021-08-06","ADY":174,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-292","SUBJID":"id-292","SITEID":"CHN-2","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":7.87128,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-10","TRTSDTM":"2021-02-13 18:05:47","TRTEDTM":"2021-09-20 08:42:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":219,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.3667,"AVALU":"YEARS","ADTM":"2021-08-22","ADY":190,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-292","SUBJID":"id-292","SITEID":"CHN-2","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":7.87128,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-10","TRTSDTM":"2021-02-13 18:05:47","TRTEDTM":"2021-09-20 08:42:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":219,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.16982,"AVALU":"YEARS","ADTM":"2021-08-25","ADY":193,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-332","SUBJID":"id-332","SITEID":"CHN-2","AGE":31,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":4.21853,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-13","TRTSDTM":"2020-05-13 17:19:55","TRTEDTM":"2021-09-21 22:54:34","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":497,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-21","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00394,"AVALU":"YEARS","ADTM":"2021-02-05","ADY":268,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-332","SUBJID":"id-332","SITEID":"CHN-2","AGE":31,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":4.21853,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-13","TRTSDTM":"2020-05-13 17:19:55","TRTEDTM":"2021-09-21 22:54:34","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":497,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-21","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.07331,"AVALU":"YEARS","ADTM":"2021-01-24","ADY":256,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-332","SUBJID":"id-332","SITEID":"CHN-2","AGE":31,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":4.21853,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-13","TRTSDTM":"2020-05-13 17:19:55","TRTEDTM":"2021-09-21 22:54:34","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":497,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-21","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08658,"AVALU":"YEARS","ADTM":"2021-08-18","ADY":462,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-34","SUBJID":"id-34","SITEID":"CHN-2","AGE":48,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":9.61602,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-20","TRTSDTM":"2020-02-20 19:28:10","TRTEDTM":"2021-09-23 12:57:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":581,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.29722,"AVALU":"YEARS","ADTM":"2021-03-29","ADY":403,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-34","SUBJID":"id-34","SITEID":"CHN-2","AGE":48,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":9.61602,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-20","TRTSDTM":"2020-02-20 19:28:10","TRTEDTM":"2021-09-23 12:57:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":581,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00842,"AVALU":"YEARS","ADTM":"2020-05-10","ADY":80,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-34","SUBJID":"id-34","SITEID":"CHN-2","AGE":48,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":9.61602,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-20","TRTSDTM":"2020-02-20 19:28:10","TRTEDTM":"2021-09-23 12:57:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":581,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.16,"AVALU":"YEARS","ADTM":"2020-10-08","ADY":231,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-342","SUBJID":"id-342","SITEID":"CHN-2","AGE":32,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":6.05374,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-07","TRTSDTM":"2020-12-09 09:01:52","TRTEDTM":"2022-12-09 20:40:16","EOSSTT":"COMPLETED","EOSDT":"2022-12-09","EOSDY":731,"DTHDT":"2022-12-09","LSTALVDT":"2023-01-03","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.04339,"AVALU":"YEARS","ADTM":"2022-04-09","ADY":486,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-342","SUBJID":"id-342","SITEID":"CHN-2","AGE":32,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":6.05374,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-07","TRTSDTM":"2020-12-09 09:01:52","TRTEDTM":"2022-12-09 20:40:16","EOSSTT":"COMPLETED","EOSDT":"2022-12-09","EOSDY":731,"DTHDT":"2022-12-09","LSTALVDT":"2023-01-03","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.12262,"AVALU":"YEARS","ADTM":"2022-01-03","ADY":390,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-342","SUBJID":"id-342","SITEID":"CHN-2","AGE":32,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":6.05374,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-07","TRTSDTM":"2020-12-09 09:01:52","TRTEDTM":"2022-12-09 20:40:16","EOSSTT":"COMPLETED","EOSDT":"2022-12-09","EOSDY":731,"DTHDT":"2022-12-09","LSTALVDT":"2023-01-03","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.13389,"AVALU":"YEARS","ADTM":"2022-09-04","ADY":634,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-367","SUBJID":"id-367","SITEID":"CHN-2","AGE":40,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":3.81441,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-01-29","TRTSDTM":"2021-02-01 04:04:41","TRTEDTM":"2023-02-01 15:43:05","EOSSTT":"COMPLETED","EOSDT":"2023-02-01","EOSDY":731,"DTHDT":"2023-02-01","LSTALVDT":"2023-02-17","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02037,"AVALU":"YEARS","ADTM":"2021-12-27","ADY":329,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-367","SUBJID":"id-367","SITEID":"CHN-2","AGE":40,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":3.81441,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-01-29","TRTSDTM":"2021-02-01 04:04:41","TRTEDTM":"2023-02-01 15:43:05","EOSSTT":"COMPLETED","EOSDT":"2023-02-01","EOSDY":731,"DTHDT":"2023-02-01","LSTALVDT":"2023-02-17","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.25782,"AVALU":"YEARS","ADTM":"2022-04-15","ADY":438,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-367","SUBJID":"id-367","SITEID":"CHN-2","AGE":40,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":3.81441,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-01-29","TRTSDTM":"2021-02-01 04:04:41","TRTEDTM":"2023-02-01 15:43:05","EOSSTT":"COMPLETED","EOSDT":"2023-02-01","EOSDY":731,"DTHDT":"2023-02-01","LSTALVDT":"2023-02-17","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.2132,"AVALU":"YEARS","ADTM":"2021-09-19","ADY":230,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-395","SUBJID":"id-395","SITEID":"CHN-2","AGE":28,"SEX":"UNDIFFERENTIATED","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":9.4824,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-30","TRTSDTM":"2019-12-02 04:32:45","TRTEDTM":"2021-12-01 16:11:09","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03901,"AVALU":"YEARS","ADTM":"2020-05-03","ADY":153,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-395","SUBJID":"id-395","SITEID":"CHN-2","AGE":28,"SEX":"UNDIFFERENTIATED","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":9.4824,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-30","TRTSDTM":"2019-12-02 04:32:45","TRTEDTM":"2021-12-01 16:11:09","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02293,"AVALU":"YEARS","ADTM":"2020-10-25","ADY":328,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-395","SUBJID":"id-395","SITEID":"CHN-2","AGE":28,"SEX":"UNDIFFERENTIATED","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":9.4824,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-30","TRTSDTM":"2019-12-02 04:32:45","TRTEDTM":"2021-12-01 16:11:09","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.71449,"AVALU":"YEARS","ADTM":"2020-08-01","ADY":243,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-398","SUBJID":"id-398","SITEID":"CHN-2","AGE":46,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.3426,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-22","TRTSDTM":"2020-05-25 07:13:45","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12145,"AVALU":"YEARS","ADTM":"2021-02-18","ADY":269,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-398","SUBJID":"id-398","SITEID":"CHN-2","AGE":46,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.3426,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-22","TRTSDTM":"2020-05-25 07:13:45","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.01378,"AVALU":"YEARS","ADTM":"2020-06-19","ADY":25,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-398","SUBJID":"id-398","SITEID":"CHN-2","AGE":46,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.3426,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-22","TRTSDTM":"2020-05-25 07:13:45","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.50559,"AVALU":"YEARS","ADTM":"2022-03-14","ADY":658,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-98","SUBJID":"id-98","SITEID":"CHN-2","AGE":48,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.0539,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-29","TRTSDTM":"2020-10-31 13:00:54","TRTEDTM":"2022-11-01 00:39:18","EOSSTT":"COMPLETED","EOSDT":"2022-11-01","EOSDY":731,"DTHDT":"2022-11-01","LSTALVDT":"2022-11-17","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.08472,"AVALU":"YEARS","ADTM":"2021-09-05","ADY":309,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-98","SUBJID":"id-98","SITEID":"CHN-2","AGE":48,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.0539,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-29","TRTSDTM":"2020-10-31 13:00:54","TRTEDTM":"2022-11-01 00:39:18","EOSSTT":"COMPLETED","EOSDT":"2022-11-01","EOSDY":731,"DTHDT":"2022-11-01","LSTALVDT":"2022-11-17","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.14826,"AVALU":"YEARS","ADTM":"2021-09-19","ADY":323,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-2-id-98","SUBJID":"id-98","SITEID":"CHN-2","AGE":48,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.0539,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-29","TRTSDTM":"2020-10-31 13:00:54","TRTEDTM":"2022-11-01 00:39:18","EOSSTT":"COMPLETED","EOSDT":"2022-11-01","EOSDY":731,"DTHDT":"2022-11-01","LSTALVDT":"2022-11-17","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.09835,"AVALU":"YEARS","ADTM":"2021-05-11","ADY":192,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-128","SUBJID":"id-128","SITEID":"CHN-3","AGE":32,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":14.42493,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-09-28","TRTSDTM":"2019-09-30 20:45:38","TRTEDTM":"2021-09-30 08:24:02","EOSSTT":"COMPLETED","EOSDT":"2021-09-30","EOSDY":731,"DTHDT":"2021-09-30","LSTALVDT":"2021-10-22","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.37071,"AVALU":"YEARS","ADTM":"2020-10-01","ADY":367,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-128","SUBJID":"id-128","SITEID":"CHN-3","AGE":32,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":14.42493,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-09-28","TRTSDTM":"2019-09-30 20:45:38","TRTEDTM":"2021-09-30 08:24:02","EOSSTT":"COMPLETED","EOSDT":"2021-09-30","EOSDY":731,"DTHDT":"2021-09-30","LSTALVDT":"2021-10-22","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01488,"AVALU":"YEARS","ADTM":"2020-09-23","ADY":359,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-128","SUBJID":"id-128","SITEID":"CHN-3","AGE":32,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":14.42493,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-09-28","TRTSDTM":"2019-09-30 20:45:38","TRTEDTM":"2021-09-30 08:24:02","EOSSTT":"COMPLETED","EOSDT":"2021-09-30","EOSDY":731,"DTHDT":"2021-09-30","LSTALVDT":"2021-10-22","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0024,"AVALU":"YEARS","ADTM":"2020-02-14","ADY":137,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-155","SUBJID":"id-155","SITEID":"CHN-3","AGE":35,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":13.27087,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-21","TRTSDTM":"2020-12-24 22:34:52","TRTEDTM":"2021-09-23 03:47:13","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":273,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-22","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03132,"AVALU":"YEARS","ADTM":"2021-04-13","ADY":110,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-155","SUBJID":"id-155","SITEID":"CHN-3","AGE":35,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":13.27087,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-21","TRTSDTM":"2020-12-24 22:34:52","TRTEDTM":"2021-09-23 03:47:13","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":273,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-22","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.28056,"AVALU":"YEARS","ADTM":"2021-07-31","ADY":219,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-155","SUBJID":"id-155","SITEID":"CHN-3","AGE":35,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":13.27087,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-21","TRTSDTM":"2020-12-24 22:34:52","TRTEDTM":"2021-09-23 03:47:13","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":273,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-22","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01944,"AVALU":"YEARS","ADTM":"2021-09-10","ADY":260,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-193","SUBJID":"id-193","SITEID":"CHN-3","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.46044,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-08-30","TRTSDTM":"2021-09-01 10:25:22","TRTEDTM":"2023-09-01 22:03:46","EOSSTT":"COMPLETED","EOSDT":"2023-09-01","EOSDY":731,"DTHDT":"2023-09-01","LSTALVDT":"2023-09-23","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.17087,"AVALU":"YEARS","ADTM":"2023-03-29","ADY":574,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-193","SUBJID":"id-193","SITEID":"CHN-3","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.46044,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-08-30","TRTSDTM":"2021-09-01 10:25:22","TRTEDTM":"2023-09-01 22:03:46","EOSSTT":"COMPLETED","EOSDT":"2023-09-01","EOSDY":731,"DTHDT":"2023-09-01","LSTALVDT":"2023-09-23","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.08344,"AVALU":"YEARS","ADTM":"2021-10-06","ADY":35,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-193","SUBJID":"id-193","SITEID":"CHN-3","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":5.46044,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-08-30","TRTSDTM":"2021-09-01 10:25:22","TRTEDTM":"2023-09-01 22:03:46","EOSSTT":"COMPLETED","EOSDT":"2023-09-01","EOSDY":731,"DTHDT":"2023-09-01","LSTALVDT":"2023-09-23","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.26512,"AVALU":"YEARS","ADTM":"2022-10-26","ADY":420,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-204","SUBJID":"id-204","SITEID":"CHN-3","AGE":34,"SEX":"U","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":4.68264,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-12","TRTSDTM":"2020-03-14 06:31:43","TRTEDTM":"2022-03-14 18:10:07","EOSSTT":"COMPLETED","EOSDT":"2022-03-14","EOSDY":731,"DTHDT":"2022-03-14","LSTALVDT":"2022-03-27","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.05028,"AVALU":"YEARS","ADTM":"2022-02-11","ADY":699,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-204","SUBJID":"id-204","SITEID":"CHN-3","AGE":34,"SEX":"U","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":4.68264,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-12","TRTSDTM":"2020-03-14 06:31:43","TRTEDTM":"2022-03-14 18:10:07","EOSSTT":"COMPLETED","EOSDT":"2022-03-14","EOSDY":731,"DTHDT":"2022-03-14","LSTALVDT":"2022-03-27","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00339,"AVALU":"YEARS","ADTM":"2021-10-11","ADY":576,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-204","SUBJID":"id-204","SITEID":"CHN-3","AGE":34,"SEX":"U","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":4.68264,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-12","TRTSDTM":"2020-03-14 06:31:43","TRTEDTM":"2022-03-14 18:10:07","EOSSTT":"COMPLETED","EOSDT":"2022-03-14","EOSDY":731,"DTHDT":"2022-03-14","LSTALVDT":"2022-03-27","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.22888,"AVALU":"YEARS","ADTM":"2020-12-14","ADY":275,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-259","SUBJID":"id-259","SITEID":"CHN-3","AGE":27,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":3.3313,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-03-09","TRTSDTM":"2020-03-12 16:50:10","TRTEDTM":"2021-09-25 20:01:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":563,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-25","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.46144,"AVALU":"YEARS","ADTM":"2021-06-23","ADY":468,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-259","SUBJID":"id-259","SITEID":"CHN-3","AGE":27,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":3.3313,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-03-09","TRTSDTM":"2020-03-12 16:50:10","TRTEDTM":"2021-09-25 20:01:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":563,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-25","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.12905,"AVALU":"YEARS","ADTM":"2021-07-25","ADY":500,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-259","SUBJID":"id-259","SITEID":"CHN-3","AGE":27,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":3.3313,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-03-09","TRTSDTM":"2020-03-12 16:50:10","TRTEDTM":"2021-09-25 20:01:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":563,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-25","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.45765,"AVALU":"YEARS","ADTM":"2020-06-15","ADY":95,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-271","SUBJID":"id-271","SITEID":"CHN-3","AGE":24,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":3.80752,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-10","TRTSDTM":"2021-03-12 11:42:46","TRTEDTM":"2021-09-18 08:40:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":190,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-18","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.06411,"AVALU":"YEARS","ADTM":"2021-07-14","ADY":124,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-271","SUBJID":"id-271","SITEID":"CHN-3","AGE":24,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":3.80752,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-10","TRTSDTM":"2021-03-12 11:42:46","TRTEDTM":"2021-09-18 08:40:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":190,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-18","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.37384,"AVALU":"YEARS","ADTM":"2021-05-29","ADY":78,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-271","SUBJID":"id-271","SITEID":"CHN-3","AGE":24,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":3.80752,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-10","TRTSDTM":"2021-03-12 11:42:46","TRTEDTM":"2021-09-18 08:40:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":190,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-18","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.21723,"AVALU":"YEARS","ADTM":"2021-03-29","ADY":17,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-281","SUBJID":"id-281","SITEID":"CHN-3","AGE":41,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":5.37455,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-04-07","TRTSDTM":"2021-04-09 01:29:44","TRTEDTM":"2023-04-09 13:08:08","EOSSTT":"COMPLETED","EOSDT":"2023-04-09","EOSDY":731,"DTHDT":"2023-04-09","LSTALVDT":"2023-04-29","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.08771,"AVALU":"YEARS","ADTM":"2022-06-08","ADY":425,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-281","SUBJID":"id-281","SITEID":"CHN-3","AGE":41,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":5.37455,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-04-07","TRTSDTM":"2021-04-09 01:29:44","TRTEDTM":"2023-04-09 13:08:08","EOSSTT":"COMPLETED","EOSDT":"2023-04-09","EOSDY":731,"DTHDT":"2023-04-09","LSTALVDT":"2023-04-29","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.03605,"AVALU":"YEARS","ADTM":"2021-12-06","ADY":241,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-281","SUBJID":"id-281","SITEID":"CHN-3","AGE":41,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":5.37455,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-04-07","TRTSDTM":"2021-04-09 01:29:44","TRTEDTM":"2023-04-09 13:08:08","EOSSTT":"COMPLETED","EOSDT":"2023-04-09","EOSDY":731,"DTHDT":"2023-04-09","LSTALVDT":"2023-04-29","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.25448,"AVALU":"YEARS","ADTM":"2022-08-22","ADY":500,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-303","SUBJID":"id-303","SITEID":"CHN-3","AGE":44,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":3.81708,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-06","TRTSDTM":"2020-08-10 10:32:35","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14452,"AVALU":"YEARS","ADTM":"2022-04-19","ADY":617,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-303","SUBJID":"id-303","SITEID":"CHN-3","AGE":44,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":3.81708,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-06","TRTSDTM":"2020-08-10 10:32:35","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.2705,"AVALU":"YEARS","ADTM":"2022-04-23","ADY":621,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-303","SUBJID":"id-303","SITEID":"CHN-3","AGE":44,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":3.81708,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-06","TRTSDTM":"2020-08-10 10:32:35","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.06178,"AVALU":"YEARS","ADTM":"2022-01-04","ADY":512,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-333","SUBJID":"id-333","SITEID":"CHN-3","AGE":30,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":2.72886,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-18","TRTSDTM":"2020-08-18 16:28:07","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03518,"AVALU":"YEARS","ADTM":"2020-08-31","ADY":13,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-333","SUBJID":"id-333","SITEID":"CHN-3","AGE":30,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":2.72886,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-18","TRTSDTM":"2020-08-18 16:28:07","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.2468,"AVALU":"YEARS","ADTM":"2021-09-28","ADY":406,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-333","SUBJID":"id-333","SITEID":"CHN-3","AGE":30,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":2.72886,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-18","TRTSDTM":"2020-08-18 16:28:07","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.32292,"AVALU":"YEARS","ADTM":"2021-07-16","ADY":332,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-361","SUBJID":"id-361","SITEID":"CHN-3","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":6.32503,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-16","TRTSDTM":"2019-11-16 04:15:19","TRTEDTM":"2021-09-21 01:10:55","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":675,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-21","LSTALVDT":"2021-10-10","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.22168,"AVALU":"YEARS","ADTM":"2019-11-25","ADY":9,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-361","SUBJID":"id-361","SITEID":"CHN-3","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":6.32503,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-16","TRTSDTM":"2019-11-16 04:15:19","TRTEDTM":"2021-09-21 01:10:55","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":675,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-21","LSTALVDT":"2021-10-10","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.04888,"AVALU":"YEARS","ADTM":"2021-09-07","ADY":661,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-361","SUBJID":"id-361","SITEID":"CHN-3","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":6.32503,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-16","TRTSDTM":"2019-11-16 04:15:19","TRTEDTM":"2021-09-21 01:10:55","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":675,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-21","LSTALVDT":"2021-10-10","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.19383,"AVALU":"YEARS","ADTM":"2020-09-07","ADY":296,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-81","SUBJID":"id-81","SITEID":"CHN-3","AGE":35,"SEX":"U","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":9.81724,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-14","TRTSDTM":"2021-04-16 08:20:34","TRTEDTM":"2023-04-16 19:58:58","EOSSTT":"COMPLETED","EOSDT":"2023-04-16","EOSDY":731,"DTHDT":"2023-04-16","LSTALVDT":"2023-05-13","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.24674,"AVALU":"YEARS","ADTM":"2021-04-26","ADY":10,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-81","SUBJID":"id-81","SITEID":"CHN-3","AGE":35,"SEX":"U","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":9.81724,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-14","TRTSDTM":"2021-04-16 08:20:34","TRTEDTM":"2023-04-16 19:58:58","EOSSTT":"COMPLETED","EOSDT":"2023-04-16","EOSDY":731,"DTHDT":"2023-04-16","LSTALVDT":"2023-05-13","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.20272,"AVALU":"YEARS","ADTM":"2021-08-21","ADY":127,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-3-id-81","SUBJID":"id-81","SITEID":"CHN-3","AGE":35,"SEX":"U","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":9.81724,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-14","TRTSDTM":"2021-04-16 08:20:34","TRTEDTM":"2023-04-16 19:58:58","EOSSTT":"COMPLETED","EOSDT":"2023-04-16","EOSDY":731,"DTHDT":"2023-04-16","LSTALVDT":"2023-05-13","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01554,"AVALU":"YEARS","ADTM":"2021-12-22","ADY":250,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-114","SUBJID":"id-114","SITEID":"CHN-4","AGE":23,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":5.10419,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-22","TRTSDTM":"2020-03-24 08:10:15","TRTEDTM":"2021-09-24 16:53:06","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":550,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-24","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.22945,"AVALU":"YEARS","ADTM":"2021-08-16","ADY":510,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-114","SUBJID":"id-114","SITEID":"CHN-4","AGE":23,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":5.10419,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-22","TRTSDTM":"2020-03-24 08:10:15","TRTEDTM":"2021-09-24 16:53:06","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":550,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-24","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01508,"AVALU":"YEARS","ADTM":"2021-03-09","ADY":350,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-114","SUBJID":"id-114","SITEID":"CHN-4","AGE":23,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":5.10419,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-22","TRTSDTM":"2020-03-24 08:10:15","TRTEDTM":"2021-09-24 16:53:06","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":550,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-24","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.24828,"AVALU":"YEARS","ADTM":"2020-12-31","ADY":282,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-115","SUBJID":"id-115","SITEID":"CHN-4","AGE":38,"SEX":"U","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":9.00519,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-30","TRTSDTM":"2019-11-01 19:08:59","TRTEDTM":"2021-11-01 06:47:23","EOSSTT":"COMPLETED","EOSDT":"2021-11-01","EOSDY":731,"DTHDT":"2021-11-01","LSTALVDT":"2021-11-23","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.41588,"AVALU":"YEARS","ADTM":"2021-05-04","ADY":550,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-115","SUBJID":"id-115","SITEID":"CHN-4","AGE":38,"SEX":"U","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":9.00519,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-30","TRTSDTM":"2019-11-01 19:08:59","TRTEDTM":"2021-11-01 06:47:23","EOSSTT":"COMPLETED","EOSDT":"2021-11-01","EOSDY":731,"DTHDT":"2021-11-01","LSTALVDT":"2021-11-23","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.06838,"AVALU":"YEARS","ADTM":"2020-01-04","ADY":64,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-115","SUBJID":"id-115","SITEID":"CHN-4","AGE":38,"SEX":"U","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":9.00519,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-30","TRTSDTM":"2019-11-01 19:08:59","TRTEDTM":"2021-11-01 06:47:23","EOSSTT":"COMPLETED","EOSDT":"2021-11-01","EOSDY":731,"DTHDT":"2021-11-01","LSTALVDT":"2021-11-23","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1845,"AVALU":"YEARS","ADTM":"2021-09-20","ADY":689,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-122","SUBJID":"id-122","SITEID":"CHN-4","AGE":23,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.85899,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-26","TRTSDTM":"2020-07-26 17:36:12","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01874,"AVALU":"YEARS","ADTM":"2022-05-02","ADY":645,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-122","SUBJID":"id-122","SITEID":"CHN-4","AGE":23,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.85899,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-26","TRTSDTM":"2020-07-26 17:36:12","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02137,"AVALU":"YEARS","ADTM":"2021-07-03","ADY":342,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-122","SUBJID":"id-122","SITEID":"CHN-4","AGE":23,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.85899,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-26","TRTSDTM":"2020-07-26 17:36:12","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.61679,"AVALU":"YEARS","ADTM":"2020-08-09","ADY":14,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-310","SUBJID":"id-310","SITEID":"CHN-4","AGE":36,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.85139,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-02-23","TRTSDTM":"2020-02-23 21:34:15","TRTEDTM":"2022-02-23 09:12:39","EOSSTT":"COMPLETED","EOSDT":"2022-02-23","EOSDY":731,"DTHDT":"2022-02-23","LSTALVDT":"2022-03-17","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.52661,"AVALU":"YEARS","ADTM":"2021-03-08","ADY":379,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-310","SUBJID":"id-310","SITEID":"CHN-4","AGE":36,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.85139,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-02-23","TRTSDTM":"2020-02-23 21:34:15","TRTEDTM":"2022-02-23 09:12:39","EOSSTT":"COMPLETED","EOSDT":"2022-02-23","EOSDY":731,"DTHDT":"2022-02-23","LSTALVDT":"2022-03-17","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.50529,"AVALU":"YEARS","ADTM":"2020-08-17","ADY":176,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-310","SUBJID":"id-310","SITEID":"CHN-4","AGE":36,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.85139,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-02-23","TRTSDTM":"2020-02-23 21:34:15","TRTEDTM":"2022-02-23 09:12:39","EOSSTT":"COMPLETED","EOSDT":"2022-02-23","EOSDY":731,"DTHDT":"2022-02-23","LSTALVDT":"2022-03-17","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.25267,"AVALU":"YEARS","ADTM":"2021-11-30","ADY":646,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-311","SUBJID":"id-311","SITEID":"CHN-4","AGE":29,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.30046,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-12","TRTSDTM":"2021-03-16 14:00:16","TRTEDTM":"2021-09-20 07:24:25","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":188,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-20","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01797,"AVALU":"YEARS","ADTM":"2021-09-14","ADY":182,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-311","SUBJID":"id-311","SITEID":"CHN-4","AGE":29,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.30046,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-12","TRTSDTM":"2021-03-16 14:00:16","TRTEDTM":"2021-09-20 07:24:25","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":188,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-20","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.33508,"AVALU":"YEARS","ADTM":"2021-05-11","ADY":56,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-311","SUBJID":"id-311","SITEID":"CHN-4","AGE":29,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.30046,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-12","TRTSDTM":"2021-03-16 14:00:16","TRTEDTM":"2021-09-20 07:24:25","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":188,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-20","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.49248,"AVALU":"YEARS","ADTM":"2021-07-31","ADY":137,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-335","SUBJID":"id-335","SITEID":"CHN-4","AGE":33,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-4","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":2.57019,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-17","TRTSDTM":"2020-11-21 22:22:38","TRTEDTM":"2022-11-22 10:01:02","EOSSTT":"COMPLETED","EOSDT":"2022-11-22","EOSDY":731,"DTHDT":"2022-11-22","LSTALVDT":"2022-12-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03059,"AVALU":"YEARS","ADTM":"2021-01-07","ADY":47,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-335","SUBJID":"id-335","SITEID":"CHN-4","AGE":33,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-4","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":2.57019,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-17","TRTSDTM":"2020-11-21 22:22:38","TRTEDTM":"2022-11-22 10:01:02","EOSSTT":"COMPLETED","EOSDT":"2022-11-22","EOSDY":731,"DTHDT":"2022-11-22","LSTALVDT":"2022-12-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.12965,"AVALU":"YEARS","ADTM":"2021-08-20","ADY":272,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-335","SUBJID":"id-335","SITEID":"CHN-4","AGE":33,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-4","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":2.57019,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-17","TRTSDTM":"2020-11-21 22:22:38","TRTEDTM":"2022-11-22 10:01:02","EOSSTT":"COMPLETED","EOSDT":"2022-11-22","EOSDY":731,"DTHDT":"2022-11-22","LSTALVDT":"2022-12-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.34999,"AVALU":"YEARS","ADTM":"2021-01-26","ADY":66,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-370","SUBJID":"id-370","SITEID":"CHN-4","AGE":45,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":7.09845,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-11-02","TRTSDTM":"2019-11-03 05:31:06","TRTEDTM":"2021-11-02 17:09:30","EOSSTT":"COMPLETED","EOSDT":"2021-11-02","EOSDY":731,"DTHDT":"2021-11-02","LSTALVDT":"2021-11-30","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.08445,"AVALU":"YEARS","ADTM":"2020-01-16","ADY":74,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-370","SUBJID":"id-370","SITEID":"CHN-4","AGE":45,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":7.09845,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-11-02","TRTSDTM":"2019-11-03 05:31:06","TRTEDTM":"2021-11-02 17:09:30","EOSSTT":"COMPLETED","EOSDT":"2021-11-02","EOSDY":731,"DTHDT":"2021-11-02","LSTALVDT":"2021-11-30","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.24827,"AVALU":"YEARS","ADTM":"2021-04-12","ADY":526,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-370","SUBJID":"id-370","SITEID":"CHN-4","AGE":45,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":7.09845,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-11-02","TRTSDTM":"2019-11-03 05:31:06","TRTEDTM":"2021-11-02 17:09:30","EOSSTT":"COMPLETED","EOSDT":"2021-11-02","EOSDY":731,"DTHDT":"2021-11-02","LSTALVDT":"2021-11-30","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.27911,"AVALU":"YEARS","ADTM":"2021-09-15","ADY":682,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-67","SUBJID":"id-67","SITEID":"CHN-4","AGE":26,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":3.89305,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-09-15","TRTSDTM":"2020-09-16 13:37:25","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.09611,"AVALU":"YEARS","ADTM":"2021-04-06","ADY":202,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-67","SUBJID":"id-67","SITEID":"CHN-4","AGE":26,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":3.89305,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-09-15","TRTSDTM":"2020-09-16 13:37:25","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.10242,"AVALU":"YEARS","ADTM":"2021-05-12","ADY":238,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-67","SUBJID":"id-67","SITEID":"CHN-4","AGE":26,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":3.89305,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-09-15","TRTSDTM":"2020-09-16 13:37:25","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0827,"AVALU":"YEARS","ADTM":"2022-02-17","ADY":519,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-73","SUBJID":"id-73","SITEID":"CHN-4","AGE":24,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":2.86312,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-10-20","TRTSDTM":"2019-10-21 23:53:53","TRTEDTM":"2021-10-21 11:32:17","EOSSTT":"COMPLETED","EOSDT":"2021-10-21","EOSDY":731,"DTHDT":"2021-10-21","LSTALVDT":"2021-11-03","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.11877,"AVALU":"YEARS","ADTM":"2020-07-22","ADY":275,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-73","SUBJID":"id-73","SITEID":"CHN-4","AGE":24,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":2.86312,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-10-20","TRTSDTM":"2019-10-21 23:53:53","TRTEDTM":"2021-10-21 11:32:17","EOSSTT":"COMPLETED","EOSDT":"2021-10-21","EOSDY":731,"DTHDT":"2021-10-21","LSTALVDT":"2021-11-03","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.38865,"AVALU":"YEARS","ADTM":"2020-08-15","ADY":299,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-4-id-73","SUBJID":"id-73","SITEID":"CHN-4","AGE":24,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-4","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":2.86312,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-10-20","TRTSDTM":"2019-10-21 23:53:53","TRTEDTM":"2021-10-21 11:32:17","EOSSTT":"COMPLETED","EOSDT":"2021-10-21","EOSDY":731,"DTHDT":"2021-10-21","LSTALVDT":"2021-11-03","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00552,"AVALU":"YEARS","ADTM":"2021-07-31","ADY":649,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-108","SUBJID":"id-108","SITEID":"CHN-5","AGE":28,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":6.74721,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-12","TRTSDTM":"2020-04-16 15:40:27","TRTEDTM":"2022-04-17 03:18:51","EOSSTT":"COMPLETED","EOSDT":"2022-04-17","EOSDY":731,"DTHDT":"2022-04-17","LSTALVDT":"2022-05-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14122,"AVALU":"YEARS","ADTM":"2021-07-09","ADY":449,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-108","SUBJID":"id-108","SITEID":"CHN-5","AGE":28,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":6.74721,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-12","TRTSDTM":"2020-04-16 15:40:27","TRTEDTM":"2022-04-17 03:18:51","EOSSTT":"COMPLETED","EOSDT":"2022-04-17","EOSDY":731,"DTHDT":"2022-04-17","LSTALVDT":"2022-05-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.05738,"AVALU":"YEARS","ADTM":"2020-07-07","ADY":82,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-108","SUBJID":"id-108","SITEID":"CHN-5","AGE":28,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":6.74721,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-12","TRTSDTM":"2020-04-16 15:40:27","TRTEDTM":"2022-04-17 03:18:51","EOSSTT":"COMPLETED","EOSDT":"2022-04-17","EOSDY":731,"DTHDT":"2022-04-17","LSTALVDT":"2022-05-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07502,"AVALU":"YEARS","ADTM":"2021-06-26","ADY":436,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-159","SUBJID":"id-159","SITEID":"CHN-5","AGE":38,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.54626,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-12-30","TRTSDTM":"2019-12-31 13:51:59","TRTEDTM":"2021-09-22 11:35:25","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":631,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-22","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00172,"AVALU":"YEARS","ADTM":"2020-03-18","ADY":78,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-159","SUBJID":"id-159","SITEID":"CHN-5","AGE":38,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.54626,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-12-30","TRTSDTM":"2019-12-31 13:51:59","TRTEDTM":"2021-09-22 11:35:25","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":631,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-22","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.0754,"AVALU":"YEARS","ADTM":"2021-02-15","ADY":412,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-159","SUBJID":"id-159","SITEID":"CHN-5","AGE":38,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.54626,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2019-12-30","TRTSDTM":"2019-12-31 13:51:59","TRTEDTM":"2021-09-22 11:35:25","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":631,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-22","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08162,"AVALU":"YEARS","ADTM":"2021-03-18","ADY":443,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-160","SUBJID":"id-160","SITEID":"CHN-5","AGE":21,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":0.16545,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-02-19","TRTSDTM":"2020-02-21 07:00:30","TRTEDTM":"2022-02-20 18:38:54","EOSSTT":"COMPLETED","EOSDT":"2022-02-20","EOSDY":731,"DTHDT":"2022-02-20","LSTALVDT":"2022-03-19","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0192,"AVALU":"YEARS","ADTM":"2020-04-16","ADY":55,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-160","SUBJID":"id-160","SITEID":"CHN-5","AGE":21,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":0.16545,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-02-19","TRTSDTM":"2020-02-21 07:00:30","TRTEDTM":"2022-02-20 18:38:54","EOSSTT":"COMPLETED","EOSDT":"2022-02-20","EOSDY":731,"DTHDT":"2022-02-20","LSTALVDT":"2022-03-19","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.08025,"AVALU":"YEARS","ADTM":"2020-05-06","ADY":75,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-160","SUBJID":"id-160","SITEID":"CHN-5","AGE":21,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":0.16545,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-02-19","TRTSDTM":"2020-02-21 07:00:30","TRTEDTM":"2022-02-20 18:38:54","EOSSTT":"COMPLETED","EOSDT":"2022-02-20","EOSDY":731,"DTHDT":"2022-02-20","LSTALVDT":"2022-03-19","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.4017,"AVALU":"YEARS","ADTM":"2021-02-19","ADY":364,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-175","SUBJID":"id-175","SITEID":"CHN-5","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":4.98017,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-05","TRTSDTM":"2021-05-09 16:02:49","TRTEDTM":"2023-05-10 03:41:13","EOSSTT":"COMPLETED","EOSDT":"2023-05-10","EOSDY":731,"DTHDT":"2023-05-10","LSTALVDT":"2023-06-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.73089,"AVALU":"YEARS","ADTM":"2021-08-14","ADY":97,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-175","SUBJID":"id-175","SITEID":"CHN-5","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":4.98017,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-05","TRTSDTM":"2021-05-09 16:02:49","TRTEDTM":"2023-05-10 03:41:13","EOSSTT":"COMPLETED","EOSDT":"2023-05-10","EOSDY":731,"DTHDT":"2023-05-10","LSTALVDT":"2023-06-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.35095,"AVALU":"YEARS","ADTM":"2023-01-07","ADY":608,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-175","SUBJID":"id-175","SITEID":"CHN-5","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":4.98017,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-05","TRTSDTM":"2021-05-09 16:02:49","TRTEDTM":"2023-05-10 03:41:13","EOSSTT":"COMPLETED","EOSDT":"2023-05-10","EOSDY":731,"DTHDT":"2023-05-10","LSTALVDT":"2023-06-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.43629,"AVALU":"YEARS","ADTM":"2021-11-25","ADY":200,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-195","SUBJID":"id-195","SITEID":"CHN-5","AGE":29,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":1.79756,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-03","TRTSDTM":"2020-10-07 15:23:18","TRTEDTM":"2022-10-08 03:01:42","EOSSTT":"COMPLETED","EOSDT":"2022-10-08","EOSDY":731,"DTHDT":"2022-10-08","LSTALVDT":"2022-10-22","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.22679,"AVALU":"YEARS","ADTM":"2021-10-25","ADY":383,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-195","SUBJID":"id-195","SITEID":"CHN-5","AGE":29,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":1.79756,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-03","TRTSDTM":"2020-10-07 15:23:18","TRTEDTM":"2022-10-08 03:01:42","EOSSTT":"COMPLETED","EOSDT":"2022-10-08","EOSDY":731,"DTHDT":"2022-10-08","LSTALVDT":"2022-10-22","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.33544,"AVALU":"YEARS","ADTM":"2021-11-28","ADY":417,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-195","SUBJID":"id-195","SITEID":"CHN-5","AGE":29,"SEX":"F","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":1.79756,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-03","TRTSDTM":"2020-10-07 15:23:18","TRTEDTM":"2022-10-08 03:01:42","EOSSTT":"COMPLETED","EOSDT":"2022-10-08","EOSDY":731,"DTHDT":"2022-10-08","LSTALVDT":"2022-10-22","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.03716,"AVALU":"YEARS","ADTM":"2022-04-05","ADY":545,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-221","SUBJID":"id-221","SITEID":"CHN-5","AGE":40,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":5.47576,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-31","TRTSDTM":"2021-06-04 05:53:35","TRTEDTM":"2023-06-04 17:31:59","EOSSTT":"COMPLETED","EOSDT":"2023-06-04","EOSDY":731,"DTHDT":"2023-06-04","LSTALVDT":"2023-06-24","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.18806,"AVALU":"YEARS","ADTM":"2022-07-22","ADY":413,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-221","SUBJID":"id-221","SITEID":"CHN-5","AGE":40,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":5.47576,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-31","TRTSDTM":"2021-06-04 05:53:35","TRTEDTM":"2023-06-04 17:31:59","EOSSTT":"COMPLETED","EOSDT":"2023-06-04","EOSDY":731,"DTHDT":"2023-06-04","LSTALVDT":"2023-06-24","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.41386,"AVALU":"YEARS","ADTM":"2021-09-02","ADY":90,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-221","SUBJID":"id-221","SITEID":"CHN-5","AGE":40,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":5.47576,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-31","TRTSDTM":"2021-06-04 05:53:35","TRTEDTM":"2023-06-04 17:31:59","EOSSTT":"COMPLETED","EOSDT":"2023-06-04","EOSDY":731,"DTHDT":"2023-06-04","LSTALVDT":"2023-06-24","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08829,"AVALU":"YEARS","ADTM":"2022-12-07","ADY":551,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-231","SUBJID":"id-231","SITEID":"CHN-5","AGE":37,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":8.59692,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-10","TRTSDTM":"2021-07-14 01:30:06","TRTEDTM":"2023-07-14 13:08:30","EOSSTT":"COMPLETED","EOSDT":"2023-07-14","EOSDY":731,"DTHDT":"2023-07-14","LSTALVDT":"2023-07-27","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.54062,"AVALU":"YEARS","ADTM":"2023-01-13","ADY":548,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-231","SUBJID":"id-231","SITEID":"CHN-5","AGE":37,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":8.59692,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-10","TRTSDTM":"2021-07-14 01:30:06","TRTEDTM":"2023-07-14 13:08:30","EOSSTT":"COMPLETED","EOSDT":"2023-07-14","EOSDY":731,"DTHDT":"2023-07-14","LSTALVDT":"2023-07-27","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.30372,"AVALU":"YEARS","ADTM":"2022-09-20","ADY":433,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-231","SUBJID":"id-231","SITEID":"CHN-5","AGE":37,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":8.59692,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-10","TRTSDTM":"2021-07-14 01:30:06","TRTEDTM":"2023-07-14 13:08:30","EOSSTT":"COMPLETED","EOSDT":"2023-07-14","EOSDY":731,"DTHDT":"2023-07-14","LSTALVDT":"2023-07-27","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.26508,"AVALU":"YEARS","ADTM":"2023-03-15","ADY":609,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-273","SUBJID":"id-273","SITEID":"CHN-5","AGE":34,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":10.53634,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-09","TRTSDTM":"2021-08-09 21:03:24","TRTEDTM":"2021-09-26 07:38:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":48,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-26","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.42901,"AVALU":"YEARS","ADTM":"2021-09-26","ADY":48,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-273","SUBJID":"id-273","SITEID":"CHN-5","AGE":34,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":10.53634,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-09","TRTSDTM":"2021-08-09 21:03:24","TRTEDTM":"2021-09-26 07:38:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":48,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-26","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.28941,"AVALU":"YEARS","ADTM":"2021-09-22","ADY":44,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-273","SUBJID":"id-273","SITEID":"CHN-5","AGE":34,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":10.53634,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-09","TRTSDTM":"2021-08-09 21:03:24","TRTEDTM":"2021-09-26 07:38:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":48,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-26","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1813,"AVALU":"YEARS","ADTM":"2021-08-24","ADY":15,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-338","SUBJID":"id-338","SITEID":"CHN-5","AGE":37,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":1.37538,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-14","TRTSDTM":"2020-03-15 08:59:10","TRTEDTM":"2021-09-23 06:07:27","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":557,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.13829,"AVALU":"YEARS","ADTM":"2021-05-29","ADY":440,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-338","SUBJID":"id-338","SITEID":"CHN-5","AGE":37,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":1.37538,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-14","TRTSDTM":"2020-03-15 08:59:10","TRTEDTM":"2021-09-23 06:07:27","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":557,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.43354,"AVALU":"YEARS","ADTM":"2020-11-26","ADY":256,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-338","SUBJID":"id-338","SITEID":"CHN-5","AGE":37,"SEX":"F","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":1.37538,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-14","TRTSDTM":"2020-03-15 08:59:10","TRTEDTM":"2021-09-23 06:07:27","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":557,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11928,"AVALU":"YEARS","ADTM":"2020-07-15","ADY":122,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-348","SUBJID":"id-348","SITEID":"CHN-5","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":4.3549,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-27","TRTSDTM":"2021-04-29 18:00:27","TRTEDTM":"2023-04-30 05:38:51","EOSSTT":"COMPLETED","EOSDT":"2023-04-30","EOSDY":731,"DTHDT":"2023-04-30","LSTALVDT":"2023-05-28","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.15499,"AVALU":"YEARS","ADTM":"2021-07-21","ADY":83,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-348","SUBJID":"id-348","SITEID":"CHN-5","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":4.3549,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-27","TRTSDTM":"2021-04-29 18:00:27","TRTEDTM":"2023-04-30 05:38:51","EOSSTT":"COMPLETED","EOSDT":"2023-04-30","EOSDY":731,"DTHDT":"2023-04-30","LSTALVDT":"2023-05-28","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.33392,"AVALU":"YEARS","ADTM":"2022-09-06","ADY":495,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-348","SUBJID":"id-348","SITEID":"CHN-5","AGE":37,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":4.3549,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-27","TRTSDTM":"2021-04-29 18:00:27","TRTEDTM":"2023-04-30 05:38:51","EOSSTT":"COMPLETED","EOSDT":"2023-04-30","EOSDY":731,"DTHDT":"2023-04-30","LSTALVDT":"2023-05-28","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.47265,"AVALU":"YEARS","ADTM":"2023-04-28","ADY":729,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-83","SUBJID":"id-83","SITEID":"CHN-5","AGE":44,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":4.60956,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-13","TRTSDTM":"2020-05-13 19:32:57","TRTEDTM":"2021-09-24 04:30:38","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":499,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-17","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01512,"AVALU":"YEARS","ADTM":"2021-06-02","ADY":385,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-83","SUBJID":"id-83","SITEID":"CHN-5","AGE":44,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":4.60956,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-13","TRTSDTM":"2020-05-13 19:32:57","TRTEDTM":"2021-09-24 04:30:38","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":499,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-17","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.2289,"AVALU":"YEARS","ADTM":"2021-05-04","ADY":356,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-5-id-83","SUBJID":"id-83","SITEID":"CHN-5","AGE":44,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":4.60956,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-13","TRTSDTM":"2020-05-13 19:32:57","TRTEDTM":"2021-09-24 04:30:38","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":499,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-17","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.2806,"AVALU":"YEARS","ADTM":"2020-06-21","ADY":39,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-6-id-248","SUBJID":"id-248","SITEID":"CHN-6","AGE":34,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":6.11272,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-19","TRTSDTM":"2021-06-23 10:16:52","TRTEDTM":"2023-06-23 21:55:16","EOSSTT":"COMPLETED","EOSDT":"2023-06-23","EOSDY":731,"DTHDT":"2023-06-23","LSTALVDT":"2023-07-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0435,"AVALU":"YEARS","ADTM":"2022-12-08","ADY":533,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-6-id-248","SUBJID":"id-248","SITEID":"CHN-6","AGE":34,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":6.11272,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-19","TRTSDTM":"2021-06-23 10:16:52","TRTEDTM":"2023-06-23 21:55:16","EOSSTT":"COMPLETED","EOSDT":"2023-06-23","EOSDY":731,"DTHDT":"2023-06-23","LSTALVDT":"2023-07-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02232,"AVALU":"YEARS","ADTM":"2022-06-03","ADY":345,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-6-id-248","SUBJID":"id-248","SITEID":"CHN-6","AGE":34,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":6.11272,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-19","TRTSDTM":"2021-06-23 10:16:52","TRTEDTM":"2023-06-23 21:55:16","EOSSTT":"COMPLETED","EOSDT":"2023-06-23","EOSDY":731,"DTHDT":"2023-06-23","LSTALVDT":"2023-07-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.36556,"AVALU":"YEARS","ADTM":"2021-09-15","ADY":84,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-6-id-30","SUBJID":"id-30","SITEID":"CHN-6","AGE":29,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-6","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":12.22076,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-28","TRTSDTM":"2021-03-30 22:14:34","TRTEDTM":"2023-03-31 09:52:58","EOSSTT":"COMPLETED","EOSDT":"2023-03-31","EOSDY":731,"DTHDT":"2023-03-31","LSTALVDT":"2023-04-10","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.48634,"AVALU":"YEARS","ADTM":"2023-02-19","ADY":691,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-6-id-30","SUBJID":"id-30","SITEID":"CHN-6","AGE":29,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-6","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":12.22076,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-28","TRTSDTM":"2021-03-30 22:14:34","TRTEDTM":"2023-03-31 09:52:58","EOSSTT":"COMPLETED","EOSDT":"2023-03-31","EOSDY":731,"DTHDT":"2023-03-31","LSTALVDT":"2023-04-10","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.04367,"AVALU":"YEARS","ADTM":"2023-01-23","ADY":664,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-6-id-30","SUBJID":"id-30","SITEID":"CHN-6","AGE":29,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-6","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":12.22076,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-28","TRTSDTM":"2021-03-30 22:14:34","TRTEDTM":"2023-03-31 09:52:58","EOSSTT":"COMPLETED","EOSDT":"2023-03-31","EOSDY":731,"DTHDT":"2023-03-31","LSTALVDT":"2023-04-10","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.03971,"AVALU":"YEARS","ADTM":"2021-09-16","ADY":170,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-6-id-385","SUBJID":"id-385","SITEID":"CHN-6","AGE":40,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":8.68372,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-24","TRTSDTM":"2020-06-27 03:15:07","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.20415,"AVALU":"YEARS","ADTM":"2022-03-11","ADY":622,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-6-id-385","SUBJID":"id-385","SITEID":"CHN-6","AGE":40,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":8.68372,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-24","TRTSDTM":"2020-06-27 03:15:07","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.79638,"AVALU":"YEARS","ADTM":"2022-03-18","ADY":629,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-6-id-385","SUBJID":"id-385","SITEID":"CHN-6","AGE":40,"SEX":"M","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":8.68372,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-24","TRTSDTM":"2020-06-27 03:15:07","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1175,"AVALU":"YEARS","ADTM":"2022-01-04","ADY":556,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-6-id-89","SUBJID":"id-89","SITEID":"CHN-6","AGE":39,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":10.35335,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-30","TRTSDTM":"2021-08-30 04:10:39","TRTEDTM":"2023-08-30 15:49:03","EOSSTT":"COMPLETED","EOSDT":"2023-08-30","EOSDY":731,"DTHDT":"2023-08-30","LSTALVDT":"2023-09-28","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.6457,"AVALU":"YEARS","ADTM":"2023-07-17","ADY":686,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-6-id-89","SUBJID":"id-89","SITEID":"CHN-6","AGE":39,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":10.35335,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-30","TRTSDTM":"2021-08-30 04:10:39","TRTEDTM":"2023-08-30 15:49:03","EOSSTT":"COMPLETED","EOSDT":"2023-08-30","EOSDY":731,"DTHDT":"2023-08-30","LSTALVDT":"2023-09-28","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.31945,"AVALU":"YEARS","ADTM":"2022-06-29","ADY":303,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-6-id-89","SUBJID":"id-89","SITEID":"CHN-6","AGE":39,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":10.35335,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-30","TRTSDTM":"2021-08-30 04:10:39","TRTEDTM":"2023-08-30 15:49:03","EOSSTT":"COMPLETED","EOSDT":"2023-08-30","EOSDY":731,"DTHDT":"2023-08-30","LSTALVDT":"2023-09-28","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.25558,"AVALU":"YEARS","ADTM":"2022-12-19","ADY":476,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-126","SUBJID":"id-126","SITEID":"CHN-7","AGE":27,"SEX":"U","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.77455,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-06","TRTSDTM":"2019-12-06 23:57:34","TRTEDTM":"2021-12-06 11:35:58","EOSSTT":"COMPLETED","EOSDT":"2021-12-06","EOSDY":731,"DTHDT":"2021-12-06","LSTALVDT":"2021-12-27","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.59328,"AVALU":"YEARS","ADTM":"2021-08-18","ADY":621,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-126","SUBJID":"id-126","SITEID":"CHN-7","AGE":27,"SEX":"U","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.77455,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-06","TRTSDTM":"2019-12-06 23:57:34","TRTEDTM":"2021-12-06 11:35:58","EOSSTT":"COMPLETED","EOSDT":"2021-12-06","EOSDY":731,"DTHDT":"2021-12-06","LSTALVDT":"2021-12-27","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.1528,"AVALU":"YEARS","ADTM":"2020-11-02","ADY":332,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-126","SUBJID":"id-126","SITEID":"CHN-7","AGE":27,"SEX":"U","RACE":"WHITE","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.77455,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-06","TRTSDTM":"2019-12-06 23:57:34","TRTEDTM":"2021-12-06 11:35:58","EOSSTT":"COMPLETED","EOSDT":"2021-12-06","EOSDY":731,"DTHDT":"2021-12-06","LSTALVDT":"2021-12-27","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01121,"AVALU":"YEARS","ADTM":"2021-09-04","ADY":638,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-202","SUBJID":"id-202","SITEID":"CHN-7","AGE":44,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":5.5983,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-06-11","TRTSDTM":"2020-06-12 05:43:56","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.40065,"AVALU":"YEARS","ADTM":"2021-10-16","ADY":491,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-202","SUBJID":"id-202","SITEID":"CHN-7","AGE":44,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":5.5983,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-06-11","TRTSDTM":"2020-06-12 05:43:56","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.63395,"AVALU":"YEARS","ADTM":"2020-06-12","ADY":0,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-202","SUBJID":"id-202","SITEID":"CHN-7","AGE":44,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":5.5983,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-06-11","TRTSDTM":"2020-06-12 05:43:56","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.13564,"AVALU":"YEARS","ADTM":"2021-04-02","ADY":294,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-267","SUBJID":"id-267","SITEID":"CHN-7","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.20676,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-05","TRTSDTM":"2019-10-06 09:45:36","TRTEDTM":"2021-10-05 21:24:00","EOSSTT":"COMPLETED","EOSDT":"2021-10-05","EOSDY":731,"DTHDT":"2021-10-05","LSTALVDT":"2021-11-03","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.50988,"AVALU":"YEARS","ADTM":"2020-02-07","ADY":124,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-267","SUBJID":"id-267","SITEID":"CHN-7","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.20676,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-05","TRTSDTM":"2019-10-06 09:45:36","TRTEDTM":"2021-10-05 21:24:00","EOSSTT":"COMPLETED","EOSDT":"2021-10-05","EOSDY":731,"DTHDT":"2021-10-05","LSTALVDT":"2021-11-03","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.46617,"AVALU":"YEARS","ADTM":"2021-02-06","ADY":489,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-267","SUBJID":"id-267","SITEID":"CHN-7","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":6.20676,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-05","TRTSDTM":"2019-10-06 09:45:36","TRTEDTM":"2021-10-05 21:24:00","EOSSTT":"COMPLETED","EOSDT":"2021-10-05","EOSDY":731,"DTHDT":"2021-10-05","LSTALVDT":"2021-11-03","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02297,"AVALU":"YEARS","ADTM":"2020-06-22","ADY":260,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-28","SUBJID":"id-28","SITEID":"CHN-7","AGE":40,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":11.14445,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-14","TRTSDTM":"2019-10-15 18:47:39","TRTEDTM":"2021-10-15 06:26:03","EOSSTT":"COMPLETED","EOSDT":"2021-10-15","EOSDY":731,"DTHDT":"2021-10-15","LSTALVDT":"2021-11-01","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.15725,"AVALU":"YEARS","ADTM":"2021-03-27","ADY":529,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-28","SUBJID":"id-28","SITEID":"CHN-7","AGE":40,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":11.14445,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-14","TRTSDTM":"2019-10-15 18:47:39","TRTEDTM":"2021-10-15 06:26:03","EOSSTT":"COMPLETED","EOSDT":"2021-10-15","EOSDY":731,"DTHDT":"2021-10-15","LSTALVDT":"2021-11-01","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.24443,"AVALU":"YEARS","ADTM":"2020-06-01","ADY":230,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-28","SUBJID":"id-28","SITEID":"CHN-7","AGE":40,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":11.14445,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-14","TRTSDTM":"2019-10-15 18:47:39","TRTEDTM":"2021-10-15 06:26:03","EOSSTT":"COMPLETED","EOSDT":"2021-10-15","EOSDY":731,"DTHDT":"2021-10-15","LSTALVDT":"2021-11-01","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.44072,"AVALU":"YEARS","ADTM":"2021-07-01","ADY":625,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-290","SUBJID":"id-290","SITEID":"CHN-7","AGE":33,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-7","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.23873,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-08-17","TRTSDTM":"2021-08-21 12:28:36","TRTEDTM":"2023-08-22 00:07:00","EOSSTT":"COMPLETED","EOSDT":"2023-08-22","EOSDY":731,"DTHDT":"2023-08-22","LSTALVDT":"2023-09-01","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01307,"AVALU":"YEARS","ADTM":"2022-03-06","ADY":197,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-290","SUBJID":"id-290","SITEID":"CHN-7","AGE":33,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-7","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.23873,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-08-17","TRTSDTM":"2021-08-21 12:28:36","TRTEDTM":"2023-08-22 00:07:00","EOSSTT":"COMPLETED","EOSDT":"2023-08-22","EOSDY":731,"DTHDT":"2023-08-22","LSTALVDT":"2023-09-01","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.06845,"AVALU":"YEARS","ADTM":"2023-07-24","ADY":702,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-290","SUBJID":"id-290","SITEID":"CHN-7","AGE":33,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-7","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.23873,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-08-17","TRTSDTM":"2021-08-21 12:28:36","TRTEDTM":"2023-08-22 00:07:00","EOSSTT":"COMPLETED","EOSDT":"2023-08-22","EOSDY":731,"DTHDT":"2023-08-22","LSTALVDT":"2023-09-01","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0636,"AVALU":"YEARS","ADTM":"2022-06-13","ADY":296,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-40","SUBJID":"id-40","SITEID":"CHN-7","AGE":33,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":13.16366,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-07-03","TRTSDTM":"2021-07-06 15:06:31","TRTEDTM":"2021-09-25 17:01:13","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":82,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.6035,"AVALU":"YEARS","ADTM":"2021-08-01","ADY":26,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-40","SUBJID":"id-40","SITEID":"CHN-7","AGE":33,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":13.16366,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-07-03","TRTSDTM":"2021-07-06 15:06:31","TRTEDTM":"2021-09-25 17:01:13","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":82,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.1185,"AVALU":"YEARS","ADTM":"2021-09-09","ADY":65,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-7-id-40","SUBJID":"id-40","SITEID":"CHN-7","AGE":33,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-7","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":13.16366,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-07-03","TRTSDTM":"2021-07-06 15:06:31","TRTEDTM":"2021-09-25 17:01:13","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":82,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0072,"AVALU":"YEARS","ADTM":"2021-08-27","ADY":52,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-8-id-205","SUBJID":"id-205","SITEID":"CHN-8","AGE":34,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-8","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":5.15912,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-08-21","TRTSDTM":"2021-08-25 01:39:20","TRTEDTM":"2021-09-24 10:13:19","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":31,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02141,"AVALU":"YEARS","ADTM":"2021-09-09","ADY":15,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-8-id-205","SUBJID":"id-205","SITEID":"CHN-8","AGE":34,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-8","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":5.15912,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-08-21","TRTSDTM":"2021-08-25 01:39:20","TRTEDTM":"2021-09-24 10:13:19","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":31,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00587,"AVALU":"YEARS","ADTM":"2021-09-03","ADY":9,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-8-id-205","SUBJID":"id-205","SITEID":"CHN-8","AGE":34,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-8","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":5.15912,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-08-21","TRTSDTM":"2021-08-25 01:39:20","TRTEDTM":"2021-09-24 10:13:19","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":31,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.20488,"AVALU":"YEARS","ADTM":"2021-09-22","ADY":28,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-8-id-299","SUBJID":"id-299","SITEID":"CHN-8","AGE":42,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-8","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":3.15502,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-14","TRTSDTM":"2020-06-14 12:17:49","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.09238,"AVALU":"YEARS","ADTM":"2022-05-09","ADY":694,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-8-id-299","SUBJID":"id-299","SITEID":"CHN-8","AGE":42,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-8","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":3.15502,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-14","TRTSDTM":"2020-06-14 12:17:49","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02389,"AVALU":"YEARS","ADTM":"2020-11-10","ADY":149,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-8-id-299","SUBJID":"id-299","SITEID":"CHN-8","AGE":42,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-8","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":3.15502,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-14","TRTSDTM":"2020-06-14 12:17:49","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":1.63987,"AVALU":"YEARS","ADTM":"2022-01-02","ADY":567,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-9-id-11","SUBJID":"id-11","SITEID":"CHN-9","AGE":28,"SEX":"F","RACE":"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","COUNTRY":"CHN","INVID":"CHN-9","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.26792,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-09-01","TRTSDTM":"2021-09-02 11:33:27","TRTEDTM":"2023-09-02 23:11:51","EOSSTT":"COMPLETED","EOSDT":"2023-09-02","EOSDY":731,"DTHDT":"2023-09-02","LSTALVDT":"2023-09-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.18411,"AVALU":"YEARS","ADTM":"2021-11-22","ADY":81,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-9-id-11","SUBJID":"id-11","SITEID":"CHN-9","AGE":28,"SEX":"F","RACE":"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","COUNTRY":"CHN","INVID":"CHN-9","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.26792,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-09-01","TRTSDTM":"2021-09-02 11:33:27","TRTEDTM":"2023-09-02 23:11:51","EOSSTT":"COMPLETED","EOSDT":"2023-09-02","EOSDY":731,"DTHDT":"2023-09-02","LSTALVDT":"2023-09-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.40965,"AVALU":"YEARS","ADTM":"2023-02-10","ADY":526,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-9-id-11","SUBJID":"id-11","SITEID":"CHN-9","AGE":28,"SEX":"F","RACE":"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","COUNTRY":"CHN","INVID":"CHN-9","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.26792,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-09-01","TRTSDTM":"2021-09-02 11:33:27","TRTEDTM":"2023-09-02 23:11:51","EOSSTT":"COMPLETED","EOSDT":"2023-09-02","EOSDY":731,"DTHDT":"2023-09-02","LSTALVDT":"2023-09-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.05305,"AVALU":"YEARS","ADTM":"2023-07-27","ADY":693,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-9-id-147","SUBJID":"id-147","SITEID":"CHN-9","AGE":26,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-9","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.54647,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-09-09","TRTSDTM":"2020-09-12 01:29:45","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.04189,"AVALU":"YEARS","ADTM":"2022-06-27","ADY":653,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-9-id-147","SUBJID":"id-147","SITEID":"CHN-9","AGE":26,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-9","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.54647,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-09-09","TRTSDTM":"2020-09-12 01:29:45","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00718,"AVALU":"YEARS","ADTM":"2021-10-01","ADY":384,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-9-id-147","SUBJID":"id-147","SITEID":"CHN-9","AGE":26,"SEX":"M","RACE":"ASIAN","COUNTRY":"CHN","INVID":"CHN-9","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.54647,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-09-09","TRTSDTM":"2020-09-12 01:29:45","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.23289,"AVALU":"YEARS","ADTM":"2022-01-16","ADY":491,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-9-id-374","SUBJID":"id-374","SITEID":"CHN-9","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-9","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":14.75803,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-06-20","TRTSDTM":"2021-06-23 21:25:51","TRTEDTM":"2021-09-26 03:18:33","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":95,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-26","LSTALVDT":"2021-10-17","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.39707,"AVALU":"YEARS","ADTM":"2021-08-24","ADY":62,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-9-id-374","SUBJID":"id-374","SITEID":"CHN-9","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-9","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":14.75803,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-06-20","TRTSDTM":"2021-06-23 21:25:51","TRTEDTM":"2021-09-26 03:18:33","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":95,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-26","LSTALVDT":"2021-10-17","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.18205,"AVALU":"YEARS","ADTM":"2021-08-11","ADY":49,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-CHN-9-id-374","SUBJID":"id-374","SITEID":"CHN-9","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"CHN","INVID":"CHN-9","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":14.75803,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-06-20","TRTSDTM":"2021-06-23 21:25:51","TRTEDTM":"2021-09-26 03:18:33","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":95,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-26","LSTALVDT":"2021-10-17","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.31256,"AVALU":"YEARS","ADTM":"2021-09-22","ADY":91,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-1-id-319","SUBJID":"id-319","SITEID":"GBR-1","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":1.83077,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-08","TRTSDTM":"2021-05-08 21:39:20","TRTEDTM":"2023-05-09 09:17:44","EOSSTT":"COMPLETED","EOSDT":"2023-05-09","EOSDY":731,"DTHDT":"2023-05-09","LSTALVDT":"2023-05-26","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.07322,"AVALU":"YEARS","ADTM":"2023-04-16","ADY":708,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-1-id-319","SUBJID":"id-319","SITEID":"GBR-1","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":1.83077,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-08","TRTSDTM":"2021-05-08 21:39:20","TRTEDTM":"2023-05-09 09:17:44","EOSSTT":"COMPLETED","EOSDT":"2023-05-09","EOSDY":731,"DTHDT":"2023-05-09","LSTALVDT":"2023-05-26","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.56943,"AVALU":"YEARS","ADTM":"2022-06-18","ADY":406,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-1-id-319","SUBJID":"id-319","SITEID":"GBR-1","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":1.83077,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-08","TRTSDTM":"2021-05-08 21:39:20","TRTEDTM":"2023-05-09 09:17:44","EOSSTT":"COMPLETED","EOSDT":"2023-05-09","EOSDY":731,"DTHDT":"2023-05-09","LSTALVDT":"2023-05-26","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.05623,"AVALU":"YEARS","ADTM":"2021-07-18","ADY":71,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-1-id-355","SUBJID":"id-355","SITEID":"GBR-1","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":10.62796,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-06","TRTSDTM":"2020-11-06 22:18:34","TRTEDTM":"2021-09-20 16:09:16","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":318,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.58099,"AVALU":"YEARS","ADTM":"2021-05-16","ADY":191,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-1-id-355","SUBJID":"id-355","SITEID":"GBR-1","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":10.62796,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-06","TRTSDTM":"2020-11-06 22:18:34","TRTEDTM":"2021-09-20 16:09:16","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":318,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.1613,"AVALU":"YEARS","ADTM":"2020-11-09","ADY":3,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-1-id-355","SUBJID":"id-355","SITEID":"GBR-1","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":10.62796,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-06","TRTSDTM":"2020-11-06 22:18:34","TRTEDTM":"2021-09-20 16:09:16","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":318,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.13914,"AVALU":"YEARS","ADTM":"2021-08-02","ADY":269,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-1-id-384","SUBJID":"id-384","SITEID":"GBR-1","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":2.644,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-21","TRTSDTM":"2020-08-24 16:24:17","TRTEDTM":"2021-09-19 09:15:53","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":391,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-19","LSTALVDT":"2021-10-02","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01603,"AVALU":"YEARS","ADTM":"2020-12-10","ADY":108,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-1-id-384","SUBJID":"id-384","SITEID":"GBR-1","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":2.644,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-21","TRTSDTM":"2020-08-24 16:24:17","TRTEDTM":"2021-09-19 09:15:53","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":391,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-19","LSTALVDT":"2021-10-02","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01106,"AVALU":"YEARS","ADTM":"2020-09-06","ADY":13,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-1-id-384","SUBJID":"id-384","SITEID":"GBR-1","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":2.644,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-21","TRTSDTM":"2020-08-24 16:24:17","TRTEDTM":"2021-09-19 09:15:53","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":391,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-19","LSTALVDT":"2021-10-02","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.12362,"AVALU":"YEARS","ADTM":"2021-02-17","ADY":177,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-11-id-340","SUBJID":"id-340","SITEID":"GBR-11","AGE":26,"SEX":"F","RACE":"WHITE","COUNTRY":"GBR","INVID":"GBR-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":4.11634,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-17","TRTSDTM":"2020-12-21 19:51:16","TRTEDTM":"2021-09-20 09:53:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":273,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-20","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.05584,"AVALU":"YEARS","ADTM":"2021-05-16","ADY":146,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-11-id-340","SUBJID":"id-340","SITEID":"GBR-11","AGE":26,"SEX":"F","RACE":"WHITE","COUNTRY":"GBR","INVID":"GBR-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":4.11634,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-17","TRTSDTM":"2020-12-21 19:51:16","TRTEDTM":"2021-09-20 09:53:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":273,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-20","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.70952,"AVALU":"YEARS","ADTM":"2021-01-26","ADY":36,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-11-id-340","SUBJID":"id-340","SITEID":"GBR-11","AGE":26,"SEX":"F","RACE":"WHITE","COUNTRY":"GBR","INVID":"GBR-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":4.11634,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-12-17","TRTSDTM":"2020-12-21 19:51:16","TRTEDTM":"2021-09-20 09:53:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":273,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-20","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.14189,"AVALU":"YEARS","ADTM":"2021-07-19","ADY":210,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-11-id-390","SUBJID":"id-390","SITEID":"GBR-11","AGE":69,"SEX":"M","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":2.05012,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-02","TRTSDTM":"2020-08-06 04:55:14","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.07887,"AVALU":"YEARS","ADTM":"2022-06-06","ADY":669,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-11-id-390","SUBJID":"id-390","SITEID":"GBR-11","AGE":69,"SEX":"M","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":2.05012,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-02","TRTSDTM":"2020-08-06 04:55:14","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.33506,"AVALU":"YEARS","ADTM":"2021-10-09","ADY":429,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-11-id-390","SUBJID":"id-390","SITEID":"GBR-11","AGE":69,"SEX":"M","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":2.05012,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-02","TRTSDTM":"2020-08-06 04:55:14","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01217,"AVALU":"YEARS","ADTM":"2021-03-15","ADY":221,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-13-id-80","SUBJID":"id-80","SITEID":"GBR-13","AGE":28,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"GBR","INVID":"GBR-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.74987,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-28","TRTSDTM":"2021-05-31 05:04:34","TRTEDTM":"2023-05-31 16:42:58","EOSSTT":"COMPLETED","EOSDT":"2023-05-31","EOSDY":731,"DTHDT":"2023-05-31","LSTALVDT":"2023-06-10","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.2789,"AVALU":"YEARS","ADTM":"2022-02-10","ADY":255,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-13-id-80","SUBJID":"id-80","SITEID":"GBR-13","AGE":28,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"GBR","INVID":"GBR-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.74987,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-28","TRTSDTM":"2021-05-31 05:04:34","TRTEDTM":"2023-05-31 16:42:58","EOSSTT":"COMPLETED","EOSDT":"2023-05-31","EOSDY":731,"DTHDT":"2023-05-31","LSTALVDT":"2023-06-10","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.96073,"AVALU":"YEARS","ADTM":"2022-05-30","ADY":364,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-13-id-80","SUBJID":"id-80","SITEID":"GBR-13","AGE":28,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"GBR","INVID":"GBR-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":7.74987,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-28","TRTSDTM":"2021-05-31 05:04:34","TRTEDTM":"2023-05-31 16:42:58","EOSSTT":"COMPLETED","EOSDT":"2023-05-31","EOSDY":731,"DTHDT":"2023-05-31","LSTALVDT":"2023-06-10","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00388,"AVALU":"YEARS","ADTM":"2023-04-14","ADY":683,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-15-id-293","SUBJID":"id-293","SITEID":"GBR-15","AGE":27,"SEX":"M","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.56299,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-12-22","TRTSDTM":"2020-12-25 18:20:37","TRTEDTM":"2021-09-24 19:12:29","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":274,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0655,"AVALU":"YEARS","ADTM":"2021-08-06","ADY":224,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-15-id-293","SUBJID":"id-293","SITEID":"GBR-15","AGE":27,"SEX":"M","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.56299,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-12-22","TRTSDTM":"2020-12-25 18:20:37","TRTEDTM":"2021-09-24 19:12:29","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":274,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.12272,"AVALU":"YEARS","ADTM":"2021-02-26","ADY":63,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-15-id-293","SUBJID":"id-293","SITEID":"GBR-15","AGE":27,"SEX":"M","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.56299,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-12-22","TRTSDTM":"2020-12-25 18:20:37","TRTEDTM":"2021-09-24 19:12:29","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":274,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.38971,"AVALU":"YEARS","ADTM":"2021-09-14","ADY":263,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-17-id-211","SUBJID":"id-211","SITEID":"GBR-17","AGE":62,"SEX":"M","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.72545,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-26","TRTSDTM":"2021-07-29 12:28:50","TRTEDTM":"2021-09-23 01:34:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":56,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.05555,"AVALU":"YEARS","ADTM":"2021-08-28","ADY":30,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-17-id-211","SUBJID":"id-211","SITEID":"GBR-17","AGE":62,"SEX":"M","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.72545,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-26","TRTSDTM":"2021-07-29 12:28:50","TRTEDTM":"2021-09-23 01:34:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":56,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01965,"AVALU":"YEARS","ADTM":"2021-08-19","ADY":21,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-17-id-211","SUBJID":"id-211","SITEID":"GBR-17","AGE":62,"SEX":"M","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.72545,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-26","TRTSDTM":"2021-07-29 12:28:50","TRTEDTM":"2021-09-23 01:34:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":56,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02114,"AVALU":"YEARS","ADTM":"2021-08-24","ADY":26,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-6-id-111","SUBJID":"id-111","SITEID":"GBR-6","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":4.67011,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-02-29","TRTSDTM":"2020-03-03 10:00:58","TRTEDTM":"2022-03-03 21:39:22","EOSSTT":"COMPLETED","EOSDT":"2022-03-03","EOSDY":731,"DTHDT":"2022-03-03","LSTALVDT":"2022-03-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02879,"AVALU":"YEARS","ADTM":"2021-11-25","ADY":632,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-6-id-111","SUBJID":"id-111","SITEID":"GBR-6","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":4.67011,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-02-29","TRTSDTM":"2020-03-03 10:00:58","TRTEDTM":"2022-03-03 21:39:22","EOSSTT":"COMPLETED","EOSDT":"2022-03-03","EOSDY":731,"DTHDT":"2022-03-03","LSTALVDT":"2022-03-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.05974,"AVALU":"YEARS","ADTM":"2021-05-31","ADY":454,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-GBR-6-id-111","SUBJID":"id-111","SITEID":"GBR-6","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"GBR","INVID":"GBR-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":4.67011,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-02-29","TRTSDTM":"2020-03-03 10:00:58","TRTEDTM":"2022-03-03 21:39:22","EOSSTT":"COMPLETED","EOSDT":"2022-03-03","EOSDY":731,"DTHDT":"2022-03-03","LSTALVDT":"2022-03-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.09495,"AVALU":"YEARS","ADTM":"2021-03-20","ADY":382,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-21","SUBJID":"id-21","SITEID":"JPN-1","AGE":29,"SEX":"F","RACE":"WHITE","COUNTRY":"JPN","INVID":"JPN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":13.29869,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-06-22","TRTSDTM":"2021-06-24 08:44:55","TRTEDTM":"2023-06-24 20:23:19","EOSSTT":"COMPLETED","EOSDT":"2023-06-24","EOSDY":731,"DTHDT":"2023-06-24","LSTALVDT":"2023-07-10","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.94161,"AVALU":"YEARS","ADTM":"2021-08-06","ADY":43,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-21","SUBJID":"id-21","SITEID":"JPN-1","AGE":29,"SEX":"F","RACE":"WHITE","COUNTRY":"JPN","INVID":"JPN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":13.29869,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-06-22","TRTSDTM":"2021-06-24 08:44:55","TRTEDTM":"2023-06-24 20:23:19","EOSSTT":"COMPLETED","EOSDT":"2023-06-24","EOSDY":731,"DTHDT":"2023-06-24","LSTALVDT":"2023-07-10","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.15853,"AVALU":"YEARS","ADTM":"2022-11-08","ADY":502,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-21","SUBJID":"id-21","SITEID":"JPN-1","AGE":29,"SEX":"F","RACE":"WHITE","COUNTRY":"JPN","INVID":"JPN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":13.29869,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-06-22","TRTSDTM":"2021-06-24 08:44:55","TRTEDTM":"2023-06-24 20:23:19","EOSSTT":"COMPLETED","EOSDT":"2023-06-24","EOSDY":731,"DTHDT":"2023-06-24","LSTALVDT":"2023-07-10","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.14308,"AVALU":"YEARS","ADTM":"2021-08-23","ADY":60,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-218","SUBJID":"id-218","SITEID":"JPN-1","AGE":35,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"JPN","INVID":"JPN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":5.8133,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-11","TRTSDTM":"2020-05-15 01:54:56","TRTEDTM":"2021-09-23 05:39:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":497,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.48292,"AVALU":"YEARS","ADTM":"2021-02-15","ADY":276,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-218","SUBJID":"id-218","SITEID":"JPN-1","AGE":35,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"JPN","INVID":"JPN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":5.8133,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-11","TRTSDTM":"2020-05-15 01:54:56","TRTEDTM":"2021-09-23 05:39:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":497,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01719,"AVALU":"YEARS","ADTM":"2020-08-24","ADY":101,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-218","SUBJID":"id-218","SITEID":"JPN-1","AGE":35,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"JPN","INVID":"JPN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":5.8133,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-11","TRTSDTM":"2020-05-15 01:54:56","TRTEDTM":"2021-09-23 05:39:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":497,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.13245,"AVALU":"YEARS","ADTM":"2021-09-07","ADY":480,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-225","SUBJID":"id-225","SITEID":"JPN-1","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":1.86373,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-07-09","TRTSDTM":"2020-07-12 13:03:48","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.24376,"AVALU":"YEARS","ADTM":"2021-10-05","ADY":450,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-225","SUBJID":"id-225","SITEID":"JPN-1","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":1.86373,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-07-09","TRTSDTM":"2020-07-12 13:03:48","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.11227,"AVALU":"YEARS","ADTM":"2021-09-05","ADY":420,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-225","SUBJID":"id-225","SITEID":"JPN-1","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":1.86373,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-07-09","TRTSDTM":"2020-07-12 13:03:48","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02063,"AVALU":"YEARS","ADTM":"2020-11-07","ADY":118,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-300","SUBJID":"id-300","SITEID":"JPN-1","AGE":35,"SEX":"U","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":6.97287,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-12-08","TRTSDTM":"2020-12-11 17:11:57","TRTEDTM":"2022-12-12 04:50:21","EOSSTT":"COMPLETED","EOSDT":"2022-12-12","EOSDY":731,"DTHDT":"2022-12-12","LSTALVDT":"2023-01-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12635,"AVALU":"YEARS","ADTM":"2022-01-29","ADY":414,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-300","SUBJID":"id-300","SITEID":"JPN-1","AGE":35,"SEX":"U","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":6.97287,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-12-08","TRTSDTM":"2020-12-11 17:11:57","TRTEDTM":"2022-12-12 04:50:21","EOSSTT":"COMPLETED","EOSDT":"2022-12-12","EOSDY":731,"DTHDT":"2022-12-12","LSTALVDT":"2023-01-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01023,"AVALU":"YEARS","ADTM":"2021-07-28","ADY":229,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-300","SUBJID":"id-300","SITEID":"JPN-1","AGE":35,"SEX":"U","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":6.97287,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-12-08","TRTSDTM":"2020-12-11 17:11:57","TRTEDTM":"2022-12-12 04:50:21","EOSSTT":"COMPLETED","EOSDT":"2022-12-12","EOSDY":731,"DTHDT":"2022-12-12","LSTALVDT":"2023-01-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.35009,"AVALU":"YEARS","ADTM":"2021-08-19","ADY":251,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-7","SUBJID":"id-7","SITEID":"JPN-1","AGE":54,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":4.08724,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-14","TRTSDTM":"2020-05-15 18:18:29","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.18633,"AVALU":"YEARS","ADTM":"2022-02-07","ADY":633,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-7","SUBJID":"id-7","SITEID":"JPN-1","AGE":54,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":4.08724,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-14","TRTSDTM":"2020-05-15 18:18:29","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.28939,"AVALU":"YEARS","ADTM":"2021-10-07","ADY":510,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-1-id-7","SUBJID":"id-7","SITEID":"JPN-1","AGE":54,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":4.08724,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-14","TRTSDTM":"2020-05-15 18:18:29","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.13435,"AVALU":"YEARS","ADTM":"2020-12-09","ADY":208,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-11-id-135","SUBJID":"id-135","SITEID":"JPN-11","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.12703,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-14","TRTSDTM":"2020-05-17 22:58:34","TRTEDTM":"2021-09-26 00:46:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":497,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-26","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00324,"AVALU":"YEARS","ADTM":"2021-06-29","ADY":408,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-11-id-135","SUBJID":"id-135","SITEID":"JPN-11","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.12703,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-14","TRTSDTM":"2020-05-17 22:58:34","TRTEDTM":"2021-09-26 00:46:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":497,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-26","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.06147,"AVALU":"YEARS","ADTM":"2020-12-19","ADY":216,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-11-id-135","SUBJID":"id-135","SITEID":"JPN-11","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":2.12703,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-05-14","TRTSDTM":"2020-05-17 22:58:34","TRTEDTM":"2021-09-26 00:46:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":497,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-26","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.13794,"AVALU":"YEARS","ADTM":"2021-03-18","ADY":305,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-11-id-373","SUBJID":"id-373","SITEID":"JPN-11","AGE":45,"SEX":"M","RACE":"WHITE","COUNTRY":"JPN","INVID":"JPN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":5.03424,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-28","TRTSDTM":"2021-03-31 16:30:46","TRTEDTM":"2021-09-20 16:36:02","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":174,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-20","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.1766,"AVALU":"YEARS","ADTM":"2021-07-22","ADY":113,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-11-id-373","SUBJID":"id-373","SITEID":"JPN-11","AGE":45,"SEX":"M","RACE":"WHITE","COUNTRY":"JPN","INVID":"JPN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":5.03424,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-28","TRTSDTM":"2021-03-31 16:30:46","TRTEDTM":"2021-09-20 16:36:02","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":174,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-20","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.28799,"AVALU":"YEARS","ADTM":"2021-06-23","ADY":84,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-11-id-373","SUBJID":"id-373","SITEID":"JPN-11","AGE":45,"SEX":"M","RACE":"WHITE","COUNTRY":"JPN","INVID":"JPN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":5.03424,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-28","TRTSDTM":"2021-03-31 16:30:46","TRTEDTM":"2021-09-20 16:36:02","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":174,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-20","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01201,"AVALU":"YEARS","ADTM":"2021-06-27","ADY":88,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-11-id-61","SUBJID":"id-61","SITEID":"JPN-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":14.00869,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-24","TRTSDTM":"2021-07-28 09:55:55","TRTEDTM":"2023-07-28 21:34:19","EOSSTT":"COMPLETED","EOSDT":"2023-07-28","EOSDY":731,"DTHDT":"2023-07-28","LSTALVDT":"2023-08-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.40405,"AVALU":"YEARS","ADTM":"2022-09-30","ADY":429,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-11-id-61","SUBJID":"id-61","SITEID":"JPN-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":14.00869,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-24","TRTSDTM":"2021-07-28 09:55:55","TRTEDTM":"2023-07-28 21:34:19","EOSSTT":"COMPLETED","EOSDT":"2023-07-28","EOSDY":731,"DTHDT":"2023-07-28","LSTALVDT":"2023-08-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00022,"AVALU":"YEARS","ADTM":"2023-05-05","ADY":646,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-11-id-61","SUBJID":"id-61","SITEID":"JPN-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":14.00869,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-07-24","TRTSDTM":"2021-07-28 09:55:55","TRTEDTM":"2023-07-28 21:34:19","EOSSTT":"COMPLETED","EOSDT":"2023-07-28","EOSDY":731,"DTHDT":"2023-07-28","LSTALVDT":"2023-08-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.16251,"AVALU":"YEARS","ADTM":"2023-05-30","ADY":671,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-12-id-219","SUBJID":"id-219","SITEID":"JPN-12","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":2.39188,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-12-04","TRTSDTM":"2020-12-07 14:26:17","TRTEDTM":"2022-12-08 02:04:41","EOSSTT":"COMPLETED","EOSDT":"2022-12-08","EOSDY":731,"DTHDT":"2022-12-08","LSTALVDT":"2022-12-30","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.21968,"AVALU":"YEARS","ADTM":"2022-08-03","ADY":604,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-12-id-219","SUBJID":"id-219","SITEID":"JPN-12","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":2.39188,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-12-04","TRTSDTM":"2020-12-07 14:26:17","TRTEDTM":"2022-12-08 02:04:41","EOSSTT":"COMPLETED","EOSDT":"2022-12-08","EOSDY":731,"DTHDT":"2022-12-08","LSTALVDT":"2022-12-30","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.12006,"AVALU":"YEARS","ADTM":"2022-08-13","ADY":614,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-12-id-219","SUBJID":"id-219","SITEID":"JPN-12","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":2.39188,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-12-04","TRTSDTM":"2020-12-07 14:26:17","TRTEDTM":"2022-12-08 02:04:41","EOSSTT":"COMPLETED","EOSDT":"2022-12-08","EOSDY":731,"DTHDT":"2022-12-08","LSTALVDT":"2022-12-30","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0588,"AVALU":"YEARS","ADTM":"2022-07-04","ADY":574,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-14-id-194","SUBJID":"id-194","SITEID":"JPN-14","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-14","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.44686,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-05","TRTSDTM":"2020-06-06 09:43:13","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.18395,"AVALU":"YEARS","ADTM":"2022-01-08","ADY":581,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-14-id-194","SUBJID":"id-194","SITEID":"JPN-14","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-14","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.44686,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-05","TRTSDTM":"2020-06-06 09:43:13","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.50661,"AVALU":"YEARS","ADTM":"2020-08-20","ADY":75,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-14-id-194","SUBJID":"id-194","SITEID":"JPN-14","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-14","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.44686,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-06-05","TRTSDTM":"2020-06-06 09:43:13","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0955,"AVALU":"YEARS","ADTM":"2021-01-01","ADY":209,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-17-id-250","SUBJID":"id-250","SITEID":"JPN-17","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":5.45958,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-09-22","TRTSDTM":"2020-09-22 19:15:00","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03493,"AVALU":"YEARS","ADTM":"2021-03-20","ADY":179,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-17-id-250","SUBJID":"id-250","SITEID":"JPN-17","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":5.45958,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-09-22","TRTSDTM":"2020-09-22 19:15:00","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.04668,"AVALU":"YEARS","ADTM":"2020-10-27","ADY":35,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-17-id-250","SUBJID":"id-250","SITEID":"JPN-17","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":5.45958,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-09-22","TRTSDTM":"2020-09-22 19:15:00","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07751,"AVALU":"YEARS","ADTM":"2021-10-16","ADY":389,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-17-id-393","SUBJID":"id-393","SITEID":"JPN-17","AGE":26,"SEX":"M","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65965,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-01-12","TRTSDTM":"2021-01-13 09:07:04","TRTEDTM":"2021-09-19 01:10:10","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":249,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-19","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.36664,"AVALU":"YEARS","ADTM":"2021-05-13","ADY":120,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-17-id-393","SUBJID":"id-393","SITEID":"JPN-17","AGE":26,"SEX":"M","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65965,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-01-12","TRTSDTM":"2021-01-13 09:07:04","TRTEDTM":"2021-09-19 01:10:10","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":249,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-19","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.05409,"AVALU":"YEARS","ADTM":"2021-02-09","ADY":27,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-17-id-393","SUBJID":"id-393","SITEID":"JPN-17","AGE":26,"SEX":"M","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-17","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65965,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-01-12","TRTSDTM":"2021-01-13 09:07:04","TRTEDTM":"2021-09-19 01:10:10","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":249,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-19","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.18821,"AVALU":"YEARS","ADTM":"2021-03-25","ADY":71,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-18-id-189","SUBJID":"id-189","SITEID":"JPN-18","AGE":48,"SEX":"M","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-18","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":8.84644,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-14","TRTSDTM":"2021-04-16 05:14:26","TRTEDTM":"2023-04-16 16:52:50","EOSSTT":"COMPLETED","EOSDT":"2023-04-16","EOSDY":731,"DTHDT":"2023-04-16","LSTALVDT":"2023-05-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01787,"AVALU":"YEARS","ADTM":"2022-10-15","ADY":547,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-18-id-189","SUBJID":"id-189","SITEID":"JPN-18","AGE":48,"SEX":"M","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-18","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":8.84644,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-14","TRTSDTM":"2021-04-16 05:14:26","TRTEDTM":"2023-04-16 16:52:50","EOSSTT":"COMPLETED","EOSDT":"2023-04-16","EOSDY":731,"DTHDT":"2023-04-16","LSTALVDT":"2023-05-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.78967,"AVALU":"YEARS","ADTM":"2023-02-23","ADY":678,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-18-id-189","SUBJID":"id-189","SITEID":"JPN-18","AGE":48,"SEX":"M","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-18","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":8.84644,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-14","TRTSDTM":"2021-04-16 05:14:26","TRTEDTM":"2023-04-16 16:52:50","EOSSTT":"COMPLETED","EOSDT":"2023-04-16","EOSDY":731,"DTHDT":"2023-04-16","LSTALVDT":"2023-05-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.21542,"AVALU":"YEARS","ADTM":"2021-09-21","ADY":158,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-2-id-214","SUBJID":"id-214","SITEID":"JPN-2","AGE":41,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":8.13205,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-30","TRTSDTM":"2020-11-01 17:56:54","TRTEDTM":"2021-09-24 01:21:39","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":327,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-23","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.18581,"AVALU":"YEARS","ADTM":"2021-09-08","ADY":311,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-2-id-214","SUBJID":"id-214","SITEID":"JPN-2","AGE":41,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":8.13205,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-30","TRTSDTM":"2020-11-01 17:56:54","TRTEDTM":"2021-09-24 01:21:39","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":327,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-23","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.10817,"AVALU":"YEARS","ADTM":"2021-06-25","ADY":236,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-2-id-214","SUBJID":"id-214","SITEID":"JPN-2","AGE":41,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":8.13205,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-10-30","TRTSDTM":"2020-11-01 17:56:54","TRTEDTM":"2021-09-24 01:21:39","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":327,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-23","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02494,"AVALU":"YEARS","ADTM":"2021-08-26","ADY":298,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-3-id-109","SUBJID":"id-109","SITEID":"JPN-3","AGE":29,"SEX":"F","RACE":"WHITE","COUNTRY":"JPN","INVID":"JPN-3","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":9.20387,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-21","TRTSDTM":"2020-05-22 14:59:35","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.07164,"AVALU":"YEARS","ADTM":"2021-06-26","ADY":400,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-3-id-109","SUBJID":"id-109","SITEID":"JPN-3","AGE":29,"SEX":"F","RACE":"WHITE","COUNTRY":"JPN","INVID":"JPN-3","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":9.20387,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-21","TRTSDTM":"2020-05-22 14:59:35","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.15295,"AVALU":"YEARS","ADTM":"2020-12-09","ADY":201,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-3-id-109","SUBJID":"id-109","SITEID":"JPN-3","AGE":29,"SEX":"F","RACE":"WHITE","COUNTRY":"JPN","INVID":"JPN-3","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":9.20387,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-21","TRTSDTM":"2020-05-22 14:59:35","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.94934,"AVALU":"YEARS","ADTM":"2021-10-02","ADY":498,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-5-id-252","SUBJID":"id-252","SITEID":"JPN-5","AGE":31,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.54319,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-22","TRTSDTM":"2021-05-22 14:23:03","TRTEDTM":"2021-09-22 02:28:24","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":123,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-17","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14783,"AVALU":"YEARS","ADTM":"2021-06-06","ADY":15,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-5-id-252","SUBJID":"id-252","SITEID":"JPN-5","AGE":31,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.54319,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-22","TRTSDTM":"2021-05-22 14:23:03","TRTEDTM":"2021-09-22 02:28:24","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":123,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-17","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.10333,"AVALU":"YEARS","ADTM":"2021-08-19","ADY":89,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-5-id-252","SUBJID":"id-252","SITEID":"JPN-5","AGE":31,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.54319,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-22","TRTSDTM":"2021-05-22 14:23:03","TRTEDTM":"2021-09-22 02:28:24","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":123,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-22","LSTALVDT":"2021-10-17","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04264,"AVALU":"YEARS","ADTM":"2021-08-03","ADY":73,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-5-id-326","SUBJID":"id-326","SITEID":"JPN-5","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":8.09449,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-06-08","TRTSDTM":"2020-06-08 22:39:10","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00427,"AVALU":"YEARS","ADTM":"2021-03-04","ADY":269,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-5-id-326","SUBJID":"id-326","SITEID":"JPN-5","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":8.09449,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-06-08","TRTSDTM":"2020-06-08 22:39:10","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.39283,"AVALU":"YEARS","ADTM":"2022-05-23","ADY":714,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-5-id-326","SUBJID":"id-326","SITEID":"JPN-5","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"JPN","INVID":"JPN-5","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":8.09449,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-06-08","TRTSDTM":"2020-06-08 22:39:10","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.36075,"AVALU":"YEARS","ADTM":"2021-06-10","ADY":367,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-6-id-260","SUBJID":"id-260","SITEID":"JPN-6","AGE":29,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"JPN","INVID":"JPN-6","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":2.71335,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-10","TRTSDTM":"2021-08-13 08:36:38","TRTEDTM":"2021-09-21 02:16:49","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":39,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-21","LSTALVDT":"2021-10-01","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.45496,"AVALU":"YEARS","ADTM":"2021-08-28","ADY":15,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-6-id-260","SUBJID":"id-260","SITEID":"JPN-6","AGE":29,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"JPN","INVID":"JPN-6","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":2.71335,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-10","TRTSDTM":"2021-08-13 08:36:38","TRTEDTM":"2021-09-21 02:16:49","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":39,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-21","LSTALVDT":"2021-10-01","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.12385,"AVALU":"YEARS","ADTM":"2021-08-13","ADY":0,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-JPN-6-id-260","SUBJID":"id-260","SITEID":"JPN-6","AGE":29,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"JPN","INVID":"JPN-6","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":2.71335,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-08-10","TRTSDTM":"2021-08-13 08:36:38","TRTEDTM":"2021-09-21 02:16:49","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":39,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-21","LSTALVDT":"2021-10-01","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.12884,"AVALU":"YEARS","ADTM":"2021-08-20","ADY":7,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-172","SUBJID":"id-172","SITEID":"NGA-1","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.61988,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-06","TRTSDTM":"2020-10-10 17:55:02","TRTEDTM":"2022-10-11 05:33:26","EOSSTT":"COMPLETED","EOSDT":"2022-10-11","EOSDY":731,"DTHDT":"2022-10-11","LSTALVDT":"2022-10-23","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.53507,"AVALU":"YEARS","ADTM":"2022-06-04","ADY":602,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-172","SUBJID":"id-172","SITEID":"NGA-1","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.61988,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-06","TRTSDTM":"2020-10-10 17:55:02","TRTEDTM":"2022-10-11 05:33:26","EOSSTT":"COMPLETED","EOSDT":"2022-10-11","EOSDY":731,"DTHDT":"2022-10-11","LSTALVDT":"2022-10-23","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.49399,"AVALU":"YEARS","ADTM":"2021-08-04","ADY":298,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-172","SUBJID":"id-172","SITEID":"NGA-1","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.61988,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-06","TRTSDTM":"2020-10-10 17:55:02","TRTEDTM":"2022-10-11 05:33:26","EOSSTT":"COMPLETED","EOSDT":"2022-10-11","EOSDY":731,"DTHDT":"2022-10-11","LSTALVDT":"2022-10-23","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.03303,"AVALU":"YEARS","ADTM":"2022-01-09","ADY":456,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-198","SUBJID":"id-198","SITEID":"NGA-1","AGE":32,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":8.96,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-31","TRTSDTM":"2020-08-01 03:01:32","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.10207,"AVALU":"YEARS","ADTM":"2021-07-07","ADY":340,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-198","SUBJID":"id-198","SITEID":"NGA-1","AGE":32,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":8.96,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-31","TRTSDTM":"2020-08-01 03:01:32","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.45611,"AVALU":"YEARS","ADTM":"2021-09-06","ADY":401,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-198","SUBJID":"id-198","SITEID":"NGA-1","AGE":32,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":8.96,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-31","TRTSDTM":"2020-08-01 03:01:32","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0651,"AVALU":"YEARS","ADTM":"2022-06-19","ADY":687,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-200","SUBJID":"id-200","SITEID":"NGA-1","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.92477,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-04-04","TRTSDTM":"2020-04-06 10:09:30","TRTEDTM":"2022-04-06 21:47:54","EOSSTT":"COMPLETED","EOSDT":"2022-04-06","EOSDY":731,"DTHDT":"2022-04-06","LSTALVDT":"2022-04-18","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.41965,"AVALU":"YEARS","ADTM":"2022-03-31","ADY":724,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-200","SUBJID":"id-200","SITEID":"NGA-1","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.92477,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-04-04","TRTSDTM":"2020-04-06 10:09:30","TRTEDTM":"2022-04-06 21:47:54","EOSSTT":"COMPLETED","EOSDT":"2022-04-06","EOSDY":731,"DTHDT":"2022-04-06","LSTALVDT":"2022-04-18","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.22817,"AVALU":"YEARS","ADTM":"2022-03-29","ADY":722,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-200","SUBJID":"id-200","SITEID":"NGA-1","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.92477,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-04-04","TRTSDTM":"2020-04-06 10:09:30","TRTEDTM":"2022-04-06 21:47:54","EOSSTT":"COMPLETED","EOSDT":"2022-04-06","EOSDY":731,"DTHDT":"2022-04-06","LSTALVDT":"2022-04-18","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07477,"AVALU":"YEARS","ADTM":"2020-11-02","ADY":210,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-325","SUBJID":"id-325","SITEID":"NGA-1","AGE":28,"SEX":"F","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":7.97282,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-04-12","TRTSDTM":"2020-04-13 22:53:25","TRTEDTM":"2021-09-23 14:22:55","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":528,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.06986,"AVALU":"YEARS","ADTM":"2021-09-18","ADY":523,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-325","SUBJID":"id-325","SITEID":"NGA-1","AGE":28,"SEX":"F","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":7.97282,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-04-12","TRTSDTM":"2020-04-13 22:53:25","TRTEDTM":"2021-09-23 14:22:55","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":528,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.51828,"AVALU":"YEARS","ADTM":"2021-06-18","ADY":431,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-325","SUBJID":"id-325","SITEID":"NGA-1","AGE":28,"SEX":"F","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":7.97282,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-04-12","TRTSDTM":"2020-04-13 22:53:25","TRTEDTM":"2021-09-23 14:22:55","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":528,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-23","LSTALVDT":"2021-10-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08673,"AVALU":"YEARS","ADTM":"2021-03-19","ADY":340,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-327","SUBJID":"id-327","SITEID":"NGA-1","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":6.09908,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-06","TRTSDTM":"2020-08-06 17:50:22","TRTEDTM":"2021-09-18 20:02:35","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":409,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-18","LSTALVDT":"2021-10-01","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01688,"AVALU":"YEARS","ADTM":"2021-08-22","ADY":381,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-327","SUBJID":"id-327","SITEID":"NGA-1","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":6.09908,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-06","TRTSDTM":"2020-08-06 17:50:22","TRTEDTM":"2021-09-18 20:02:35","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":409,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-18","LSTALVDT":"2021-10-01","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.11643,"AVALU":"YEARS","ADTM":"2020-12-15","ADY":131,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-327","SUBJID":"id-327","SITEID":"NGA-1","AGE":36,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":6.09908,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-06","TRTSDTM":"2020-08-06 17:50:22","TRTEDTM":"2021-09-18 20:02:35","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":409,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-18","LSTALVDT":"2021-10-01","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00536,"AVALU":"YEARS","ADTM":"2021-06-26","ADY":324,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-357","SUBJID":"id-357","SITEID":"NGA-1","AGE":41,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.82877,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-22","TRTSDTM":"2020-08-26 12:30:56","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.06106,"AVALU":"YEARS","ADTM":"2022-03-16","ADY":567,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-357","SUBJID":"id-357","SITEID":"NGA-1","AGE":41,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.82877,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-22","TRTSDTM":"2020-08-26 12:30:56","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.06081,"AVALU":"YEARS","ADTM":"2022-04-24","ADY":606,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-357","SUBJID":"id-357","SITEID":"NGA-1","AGE":41,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.82877,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-22","TRTSDTM":"2020-08-26 12:30:56","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01943,"AVALU":"YEARS","ADTM":"2021-04-13","ADY":230,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-388","SUBJID":"id-388","SITEID":"NGA-1","AGE":39,"SEX":"F","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":4.19789,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-22","TRTSDTM":"2019-12-22 00:37:07","TRTEDTM":"2021-12-21 12:15:31","EOSSTT":"COMPLETED","EOSDT":"2021-12-21","EOSDY":731,"DTHDT":"2021-12-21","LSTALVDT":"2022-01-03","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12821,"AVALU":"YEARS","ADTM":"2021-01-17","ADY":392,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-388","SUBJID":"id-388","SITEID":"NGA-1","AGE":39,"SEX":"F","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":4.19789,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-22","TRTSDTM":"2019-12-22 00:37:07","TRTEDTM":"2021-12-21 12:15:31","EOSSTT":"COMPLETED","EOSDT":"2021-12-21","EOSDY":731,"DTHDT":"2021-12-21","LSTALVDT":"2022-01-03","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.82837,"AVALU":"YEARS","ADTM":"2021-02-26","ADY":432,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-388","SUBJID":"id-388","SITEID":"NGA-1","AGE":39,"SEX":"F","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":4.19789,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-22","TRTSDTM":"2019-12-22 00:37:07","TRTEDTM":"2021-12-21 12:15:31","EOSSTT":"COMPLETED","EOSDT":"2021-12-21","EOSDY":731,"DTHDT":"2021-12-21","LSTALVDT":"2022-01-03","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00843,"AVALU":"YEARS","ADTM":"2020-11-02","ADY":316,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-43","SUBJID":"id-43","SITEID":"NGA-1","AGE":37,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":5.08774,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-04-14","TRTSDTM":"2021-04-16 12:40:05","TRTEDTM":"2023-04-17 00:18:29","EOSSTT":"COMPLETED","EOSDT":"2023-04-17","EOSDY":731,"DTHDT":"2023-04-17","LSTALVDT":"2023-05-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.21557,"AVALU":"YEARS","ADTM":"2022-08-18","ADY":489,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-43","SUBJID":"id-43","SITEID":"NGA-1","AGE":37,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":5.08774,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-04-14","TRTSDTM":"2021-04-16 12:40:05","TRTEDTM":"2023-04-17 00:18:29","EOSSTT":"COMPLETED","EOSDT":"2023-04-17","EOSDY":731,"DTHDT":"2023-04-17","LSTALVDT":"2023-05-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.75599,"AVALU":"YEARS","ADTM":"2023-03-29","ADY":712,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-43","SUBJID":"id-43","SITEID":"NGA-1","AGE":37,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":5.08774,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-04-14","TRTSDTM":"2021-04-16 12:40:05","TRTEDTM":"2023-04-17 00:18:29","EOSSTT":"COMPLETED","EOSDT":"2023-04-17","EOSDY":731,"DTHDT":"2023-04-17","LSTALVDT":"2023-05-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.48341,"AVALU":"YEARS","ADTM":"2022-07-29","ADY":469,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-46","SUBJID":"id-46","SITEID":"NGA-1","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.84648,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-03","TRTSDTM":"2020-11-06 05:29:29","TRTEDTM":"2022-11-06 17:07:53","EOSSTT":"COMPLETED","EOSDT":"2022-11-06","EOSDY":731,"DTHDT":"2022-11-06","LSTALVDT":"2022-11-17","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00058,"AVALU":"YEARS","ADTM":"2022-06-21","ADY":592,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-46","SUBJID":"id-46","SITEID":"NGA-1","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.84648,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-03","TRTSDTM":"2020-11-06 05:29:29","TRTEDTM":"2022-11-06 17:07:53","EOSSTT":"COMPLETED","EOSDT":"2022-11-06","EOSDY":731,"DTHDT":"2022-11-06","LSTALVDT":"2022-11-17","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.08015,"AVALU":"YEARS","ADTM":"2021-06-14","ADY":220,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-46","SUBJID":"id-46","SITEID":"NGA-1","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.84648,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-03","TRTSDTM":"2020-11-06 05:29:29","TRTEDTM":"2022-11-06 17:07:53","EOSSTT":"COMPLETED","EOSDT":"2022-11-06","EOSDY":731,"DTHDT":"2022-11-06","LSTALVDT":"2022-11-17","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0097,"AVALU":"YEARS","ADTM":"2021-06-25","ADY":231,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-96","SUBJID":"id-96","SITEID":"NGA-1","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":12.92348,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-02-21","TRTSDTM":"2020-02-25 07:52:50","TRTEDTM":"2022-02-24 19:31:14","EOSSTT":"COMPLETED","EOSDT":"2022-02-24","EOSDY":731,"DTHDT":"2022-02-24","LSTALVDT":"2022-03-23","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01322,"AVALU":"YEARS","ADTM":"2020-08-05","ADY":162,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-96","SUBJID":"id-96","SITEID":"NGA-1","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":12.92348,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-02-21","TRTSDTM":"2020-02-25 07:52:50","TRTEDTM":"2022-02-24 19:31:14","EOSSTT":"COMPLETED","EOSDT":"2022-02-24","EOSDY":731,"DTHDT":"2022-02-24","LSTALVDT":"2022-03-23","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.03696,"AVALU":"YEARS","ADTM":"2022-02-10","ADY":716,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-1-id-96","SUBJID":"id-96","SITEID":"NGA-1","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":12.92348,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-02-21","TRTSDTM":"2020-02-25 07:52:50","TRTEDTM":"2022-02-24 19:31:14","EOSSTT":"COMPLETED","EOSDT":"2022-02-24","EOSDY":731,"DTHDT":"2022-02-24","LSTALVDT":"2022-03-23","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08963,"AVALU":"YEARS","ADTM":"2021-10-29","ADY":612,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-173","SUBJID":"id-173","SITEID":"NGA-11","AGE":24,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":4.99723,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-10-12","TRTSDTM":"2019-10-14 19:11:18","TRTEDTM":"2021-10-14 06:49:42","EOSSTT":"COMPLETED","EOSDT":"2021-10-14","EOSDY":731,"DTHDT":"2021-10-14","LSTALVDT":"2021-10-25","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14684,"AVALU":"YEARS","ADTM":"2020-10-21","ADY":373,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-173","SUBJID":"id-173","SITEID":"NGA-11","AGE":24,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":4.99723,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-10-12","TRTSDTM":"2019-10-14 19:11:18","TRTEDTM":"2021-10-14 06:49:42","EOSSTT":"COMPLETED","EOSDT":"2021-10-14","EOSDY":731,"DTHDT":"2021-10-14","LSTALVDT":"2021-10-25","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.36711,"AVALU":"YEARS","ADTM":"2021-06-06","ADY":601,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-173","SUBJID":"id-173","SITEID":"NGA-11","AGE":24,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":4.99723,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-10-12","TRTSDTM":"2019-10-14 19:11:18","TRTEDTM":"2021-10-14 06:49:42","EOSSTT":"COMPLETED","EOSDT":"2021-10-14","EOSDY":731,"DTHDT":"2021-10-14","LSTALVDT":"2021-10-25","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0878,"AVALU":"YEARS","ADTM":"2021-03-19","ADY":522,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-313","SUBJID":"id-313","SITEID":"NGA-11","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.91108,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-14","TRTSDTM":"2019-12-17 04:18:04","TRTEDTM":"2021-09-22 16:15:46","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":646,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.25757,"AVALU":"YEARS","ADTM":"2020-12-31","ADY":380,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-313","SUBJID":"id-313","SITEID":"NGA-11","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.91108,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-14","TRTSDTM":"2019-12-17 04:18:04","TRTEDTM":"2021-09-22 16:15:46","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":646,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.55358,"AVALU":"YEARS","ADTM":"2021-07-21","ADY":582,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-313","SUBJID":"id-313","SITEID":"NGA-11","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.91108,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-14","TRTSDTM":"2019-12-17 04:18:04","TRTEDTM":"2021-09-22 16:15:46","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":646,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.36797,"AVALU":"YEARS","ADTM":"2021-08-14","ADY":606,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-334","SUBJID":"id-334","SITEID":"NGA-11","AGE":20,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":2.90932,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-22","TRTSDTM":"2021-08-22 18:16:56","TRTEDTM":"2023-08-23 05:55:20","EOSSTT":"COMPLETED","EOSDT":"2023-08-23","EOSDY":731,"DTHDT":"2023-08-23","LSTALVDT":"2023-09-02","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0346,"AVALU":"YEARS","ADTM":"2022-05-20","ADY":271,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-334","SUBJID":"id-334","SITEID":"NGA-11","AGE":20,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":2.90932,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-22","TRTSDTM":"2021-08-22 18:16:56","TRTEDTM":"2023-08-23 05:55:20","EOSSTT":"COMPLETED","EOSDT":"2023-08-23","EOSDY":731,"DTHDT":"2023-08-23","LSTALVDT":"2023-09-02","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.44949,"AVALU":"YEARS","ADTM":"2022-04-07","ADY":228,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-334","SUBJID":"id-334","SITEID":"NGA-11","AGE":20,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":2.90932,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-22","TRTSDTM":"2021-08-22 18:16:56","TRTEDTM":"2023-08-23 05:55:20","EOSSTT":"COMPLETED","EOSDT":"2023-08-23","EOSDY":731,"DTHDT":"2023-08-23","LSTALVDT":"2023-09-02","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00588,"AVALU":"YEARS","ADTM":"2022-07-16","ADY":328,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-35","SUBJID":"id-35","SITEID":"NGA-11","AGE":32,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":9.02841,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-29","TRTSDTM":"2020-03-31 14:41:19","TRTEDTM":"2021-09-23 02:00:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":541,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14066,"AVALU":"YEARS","ADTM":"2021-04-27","ADY":392,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-35","SUBJID":"id-35","SITEID":"NGA-11","AGE":32,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":9.02841,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-29","TRTSDTM":"2020-03-31 14:41:19","TRTEDTM":"2021-09-23 02:00:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":541,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.45931,"AVALU":"YEARS","ADTM":"2021-04-25","ADY":390,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-35","SUBJID":"id-35","SITEID":"NGA-11","AGE":32,"SEX":"M","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":9.02841,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-29","TRTSDTM":"2020-03-31 14:41:19","TRTEDTM":"2021-09-23 02:00:43","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":541,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-23","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.3995,"AVALU":"YEARS","ADTM":"2020-05-08","ADY":38,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-366","SUBJID":"id-366","SITEID":"NGA-11","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.31624,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-11","TRTSDTM":"2021-05-12 06:39:55","TRTEDTM":"2023-05-12 18:18:19","EOSSTT":"COMPLETED","EOSDT":"2023-05-12","EOSDY":731,"DTHDT":"2023-05-12","LSTALVDT":"2023-06-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.34127,"AVALU":"YEARS","ADTM":"2021-07-15","ADY":64,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-366","SUBJID":"id-366","SITEID":"NGA-11","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.31624,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-11","TRTSDTM":"2021-05-12 06:39:55","TRTEDTM":"2023-05-12 18:18:19","EOSSTT":"COMPLETED","EOSDT":"2023-05-12","EOSDY":731,"DTHDT":"2023-05-12","LSTALVDT":"2023-06-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.23445,"AVALU":"YEARS","ADTM":"2023-03-16","ADY":673,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-366","SUBJID":"id-366","SITEID":"NGA-11","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":3.31624,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-05-11","TRTSDTM":"2021-05-12 06:39:55","TRTEDTM":"2023-05-12 18:18:19","EOSSTT":"COMPLETED","EOSDT":"2023-05-12","EOSDY":731,"DTHDT":"2023-05-12","LSTALVDT":"2023-06-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.05714,"AVALU":"YEARS","ADTM":"2021-08-10","ADY":90,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-41","SUBJID":"id-41","SITEID":"NGA-11","AGE":29,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"NGA","INVID":"NGA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":7.20651,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-03","TRTSDTM":"2021-03-07 10:12:56","TRTEDTM":"2023-03-07 21:51:20","EOSSTT":"COMPLETED","EOSDT":"2023-03-07","EOSDY":731,"DTHDT":"2023-03-07","LSTALVDT":"2023-03-19","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.3053,"AVALU":"YEARS","ADTM":"2022-02-03","ADY":333,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-41","SUBJID":"id-41","SITEID":"NGA-11","AGE":29,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"NGA","INVID":"NGA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":7.20651,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-03","TRTSDTM":"2021-03-07 10:12:56","TRTEDTM":"2023-03-07 21:51:20","EOSSTT":"COMPLETED","EOSDT":"2023-03-07","EOSDY":731,"DTHDT":"2023-03-07","LSTALVDT":"2023-03-19","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.42113,"AVALU":"YEARS","ADTM":"2021-12-06","ADY":274,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-11-id-41","SUBJID":"id-41","SITEID":"NGA-11","AGE":29,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"NGA","INVID":"NGA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":7.20651,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-03","TRTSDTM":"2021-03-07 10:12:56","TRTEDTM":"2023-03-07 21:51:20","EOSSTT":"COMPLETED","EOSDT":"2023-03-07","EOSDY":731,"DTHDT":"2023-03-07","LSTALVDT":"2023-03-19","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.20532,"AVALU":"YEARS","ADTM":"2022-02-02","ADY":332,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-12-id-264","SUBJID":"id-264","SITEID":"NGA-12","AGE":24,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"NGA","INVID":"NGA-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.82764,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-11-10","TRTSDTM":"2020-11-13 15:34:41","TRTEDTM":"2022-11-14 03:13:05","EOSSTT":"COMPLETED","EOSDT":"2022-11-14","EOSDY":731,"DTHDT":"2022-11-14","LSTALVDT":"2022-12-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.96713,"AVALU":"YEARS","ADTM":"2021-07-11","ADY":240,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-12-id-264","SUBJID":"id-264","SITEID":"NGA-12","AGE":24,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"NGA","INVID":"NGA-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.82764,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-11-10","TRTSDTM":"2020-11-13 15:34:41","TRTEDTM":"2022-11-14 03:13:05","EOSSTT":"COMPLETED","EOSDT":"2022-11-14","EOSDY":731,"DTHDT":"2022-11-14","LSTALVDT":"2022-12-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.23794,"AVALU":"YEARS","ADTM":"2022-07-08","ADY":602,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-12-id-264","SUBJID":"id-264","SITEID":"NGA-12","AGE":24,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"NGA","INVID":"NGA-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.82764,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-11-10","TRTSDTM":"2020-11-13 15:34:41","TRTEDTM":"2022-11-14 03:13:05","EOSSTT":"COMPLETED","EOSDT":"2022-11-14","EOSDY":731,"DTHDT":"2022-11-14","LSTALVDT":"2022-12-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.03134,"AVALU":"YEARS","ADTM":"2022-01-28","ADY":441,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-12-id-387","SUBJID":"id-387","SITEID":"NGA-12","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.36861,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-11","TRTSDTM":"2020-08-13 02:34:28","TRTEDTM":"2021-09-20 11:21:40","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":404,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-20","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.10881,"AVALU":"YEARS","ADTM":"2021-06-13","ADY":304,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-12-id-387","SUBJID":"id-387","SITEID":"NGA-12","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.36861,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-11","TRTSDTM":"2020-08-13 02:34:28","TRTEDTM":"2021-09-20 11:21:40","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":404,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-20","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.25266,"AVALU":"YEARS","ADTM":"2021-01-09","ADY":149,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-12-id-387","SUBJID":"id-387","SITEID":"NGA-12","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.36861,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-08-11","TRTSDTM":"2020-08-13 02:34:28","TRTEDTM":"2021-09-20 11:21:40","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":404,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-20","LSTALVDT":"2021-10-09","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02318,"AVALU":"YEARS","ADTM":"2021-03-15","ADY":214,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-17-id-230","SUBJID":"id-230","SITEID":"NGA-17","AGE":31,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":17.67234,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-12-10","TRTSDTM":"2020-12-10 01:24:50","TRTEDTM":"2022-12-10 13:03:14","EOSSTT":"COMPLETED","EOSDT":"2022-12-10","EOSDY":731,"DTHDT":"2022-12-10","LSTALVDT":"2022-12-20","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.30662,"AVALU":"YEARS","ADTM":"2020-12-24","ADY":14,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-17-id-230","SUBJID":"id-230","SITEID":"NGA-17","AGE":31,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":17.67234,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-12-10","TRTSDTM":"2020-12-10 01:24:50","TRTEDTM":"2022-12-10 13:03:14","EOSSTT":"COMPLETED","EOSDT":"2022-12-10","EOSDY":731,"DTHDT":"2022-12-10","LSTALVDT":"2022-12-20","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.18876,"AVALU":"YEARS","ADTM":"2020-12-15","ADY":5,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-17-id-230","SUBJID":"id-230","SITEID":"NGA-17","AGE":31,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":17.67234,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-12-10","TRTSDTM":"2020-12-10 01:24:50","TRTEDTM":"2022-12-10 13:03:14","EOSSTT":"COMPLETED","EOSDT":"2022-12-10","EOSDY":731,"DTHDT":"2022-12-10","LSTALVDT":"2022-12-20","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.03631,"AVALU":"YEARS","ADTM":"2021-01-21","ADY":42,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-17-id-72","SUBJID":"id-72","SITEID":"NGA-17","AGE":50,"SEX":"M","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":6.40254,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-14","TRTSDTM":"2020-04-16 23:01:54","TRTEDTM":"2021-09-18 08:49:01","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":520,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-18","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.18614,"AVALU":"YEARS","ADTM":"2021-05-27","ADY":406,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-17-id-72","SUBJID":"id-72","SITEID":"NGA-17","AGE":50,"SEX":"M","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":6.40254,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-14","TRTSDTM":"2020-04-16 23:01:54","TRTEDTM":"2021-09-18 08:49:01","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":520,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-18","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.08535,"AVALU":"YEARS","ADTM":"2021-01-18","ADY":277,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-17-id-72","SUBJID":"id-72","SITEID":"NGA-17","AGE":50,"SEX":"M","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":6.40254,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-14","TRTSDTM":"2020-04-16 23:01:54","TRTEDTM":"2021-09-18 08:49:01","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":520,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-18","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.19122,"AVALU":"YEARS","ADTM":"2021-01-19","ADY":278,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-2-id-308","SUBJID":"id-308","SITEID":"NGA-2","AGE":26,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.824,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-04-27","TRTSDTM":"2020-04-30 20:13:58","TRTEDTM":"2021-09-19 14:37:58","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":507,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-19","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03004,"AVALU":"YEARS","ADTM":"2021-08-26","ADY":483,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-2-id-308","SUBJID":"id-308","SITEID":"NGA-2","AGE":26,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.824,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-04-27","TRTSDTM":"2020-04-30 20:13:58","TRTEDTM":"2021-09-19 14:37:58","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":507,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-19","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.80693,"AVALU":"YEARS","ADTM":"2021-02-03","ADY":279,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-2-id-308","SUBJID":"id-308","SITEID":"NGA-2","AGE":26,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.824,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-04-27","TRTSDTM":"2020-04-30 20:13:58","TRTEDTM":"2021-09-19 14:37:58","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-19","EOSDY":507,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-19","LSTALVDT":"2021-10-18","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.16013,"AVALU":"YEARS","ADTM":"2021-06-19","ADY":415,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-2-id-353","SUBJID":"id-353","SITEID":"NGA-2","AGE":28,"SEX":"U","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.94481,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-04","TRTSDTM":"2020-10-07 06:51:59","TRTEDTM":"2022-10-07 18:30:23","EOSSTT":"COMPLETED","EOSDT":"2022-10-07","EOSDY":731,"DTHDT":"2022-10-07","LSTALVDT":"2022-10-17","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02118,"AVALU":"YEARS","ADTM":"2021-09-23","ADY":351,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-2-id-353","SUBJID":"id-353","SITEID":"NGA-2","AGE":28,"SEX":"U","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.94481,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-04","TRTSDTM":"2020-10-07 06:51:59","TRTEDTM":"2022-10-07 18:30:23","EOSSTT":"COMPLETED","EOSDT":"2022-10-07","EOSDY":731,"DTHDT":"2022-10-07","LSTALVDT":"2022-10-17","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.25143,"AVALU":"YEARS","ADTM":"2021-02-01","ADY":117,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-2-id-353","SUBJID":"id-353","SITEID":"NGA-2","AGE":28,"SEX":"U","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.94481,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-04","TRTSDTM":"2020-10-07 06:51:59","TRTEDTM":"2022-10-07 18:30:23","EOSSTT":"COMPLETED","EOSDT":"2022-10-07","EOSDY":731,"DTHDT":"2022-10-07","LSTALVDT":"2022-10-17","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.03041,"AVALU":"YEARS","ADTM":"2021-08-24","ADY":321,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-4-id-215","SUBJID":"id-215","SITEID":"NGA-4","AGE":40,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"NGA","INVID":"NGA-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":10.49773,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-19","TRTSDTM":"2020-12-23 09:27:08","TRTEDTM":"2022-12-23 21:05:32","EOSSTT":"COMPLETED","EOSDT":"2022-12-23","EOSDY":731,"DTHDT":"2022-12-23","LSTALVDT":"2023-01-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.34934,"AVALU":"YEARS","ADTM":"2022-05-23","ADY":516,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-4-id-215","SUBJID":"id-215","SITEID":"NGA-4","AGE":40,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"NGA","INVID":"NGA-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":10.49773,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-19","TRTSDTM":"2020-12-23 09:27:08","TRTEDTM":"2022-12-23 21:05:32","EOSSTT":"COMPLETED","EOSDT":"2022-12-23","EOSDY":731,"DTHDT":"2022-12-23","LSTALVDT":"2023-01-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.4385,"AVALU":"YEARS","ADTM":"2022-05-26","ADY":519,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-4-id-215","SUBJID":"id-215","SITEID":"NGA-4","AGE":40,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"NGA","INVID":"NGA-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":10.49773,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-12-19","TRTSDTM":"2020-12-23 09:27:08","TRTEDTM":"2022-12-23 21:05:32","EOSSTT":"COMPLETED","EOSDT":"2022-12-23","EOSDY":731,"DTHDT":"2022-12-23","LSTALVDT":"2023-01-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02725,"AVALU":"YEARS","ADTM":"2022-07-17","ADY":571,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-4-id-37","SUBJID":"id-37","SITEID":"NGA-4","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-4","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":4.57225,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-21","TRTSDTM":"2021-03-24 05:30:33","TRTEDTM":"2023-03-24 17:08:57","EOSSTT":"COMPLETED","EOSDT":"2023-03-24","EOSDY":731,"DTHDT":"2023-03-24","LSTALVDT":"2023-04-10","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01121,"AVALU":"YEARS","ADTM":"2021-07-15","ADY":113,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-4-id-37","SUBJID":"id-37","SITEID":"NGA-4","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-4","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":4.57225,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-21","TRTSDTM":"2021-03-24 05:30:33","TRTEDTM":"2023-03-24 17:08:57","EOSSTT":"COMPLETED","EOSDT":"2023-03-24","EOSDY":731,"DTHDT":"2023-03-24","LSTALVDT":"2023-04-10","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.38394,"AVALU":"YEARS","ADTM":"2022-04-20","ADY":392,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-4-id-37","SUBJID":"id-37","SITEID":"NGA-4","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"NGA","INVID":"NGA-4","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":4.57225,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-03-21","TRTSDTM":"2021-03-24 05:30:33","TRTEDTM":"2023-03-24 17:08:57","EOSSTT":"COMPLETED","EOSDT":"2023-03-24","EOSDY":731,"DTHDT":"2023-03-24","LSTALVDT":"2023-04-10","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.05901,"AVALU":"YEARS","ADTM":"2021-11-09","ADY":230,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-5-id-99","SUBJID":"id-99","SITEID":"NGA-5","AGE":31,"SEX":"F","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":5.48616,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-07-06","TRTSDTM":"2021-07-10 12:36:42","TRTEDTM":"2023-07-11 00:15:06","EOSSTT":"COMPLETED","EOSDT":"2023-07-11","EOSDY":731,"DTHDT":"2023-07-11","LSTALVDT":"2023-07-26","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.40412,"AVALU":"YEARS","ADTM":"2022-05-29","ADY":323,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-5-id-99","SUBJID":"id-99","SITEID":"NGA-5","AGE":31,"SEX":"F","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":5.48616,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-07-06","TRTSDTM":"2021-07-10 12:36:42","TRTEDTM":"2023-07-11 00:15:06","EOSSTT":"COMPLETED","EOSDT":"2023-07-11","EOSDY":731,"DTHDT":"2023-07-11","LSTALVDT":"2023-07-26","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00457,"AVALU":"YEARS","ADTM":"2021-09-10","ADY":62,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-5-id-99","SUBJID":"id-99","SITEID":"NGA-5","AGE":31,"SEX":"F","RACE":"WHITE","COUNTRY":"NGA","INVID":"NGA-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":5.48616,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-07-06","TRTSDTM":"2021-07-10 12:36:42","TRTEDTM":"2023-07-11 00:15:06","EOSSTT":"COMPLETED","EOSDT":"2023-07-11","EOSDY":731,"DTHDT":"2023-07-11","LSTALVDT":"2023-07-26","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.18104,"AVALU":"YEARS","ADTM":"2022-03-05","ADY":238,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-6-id-363","SUBJID":"id-363","SITEID":"NGA-6","AGE":50,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-6","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":4.17937,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-11-12","TRTSDTM":"2020-11-13 02:20:06","TRTEDTM":"2021-09-25 10:22:57","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":317,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-25","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0839,"AVALU":"YEARS","ADTM":"2021-03-18","ADY":125,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-6-id-363","SUBJID":"id-363","SITEID":"NGA-6","AGE":50,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-6","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":4.17937,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-11-12","TRTSDTM":"2020-11-13 02:20:06","TRTEDTM":"2021-09-25 10:22:57","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":317,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-25","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.14393,"AVALU":"YEARS","ADTM":"2021-04-10","ADY":148,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-NGA-6-id-363","SUBJID":"id-363","SITEID":"NGA-6","AGE":50,"SEX":"F","RACE":"ASIAN","COUNTRY":"NGA","INVID":"NGA-6","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":4.17937,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-11-12","TRTSDTM":"2020-11-13 02:20:06","TRTEDTM":"2021-09-25 10:22:57","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":317,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-25","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.12097,"AVALU":"YEARS","ADTM":"2020-12-04","ADY":21,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-112","SUBJID":"id-112","SITEID":"PAK-1","AGE":44,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":14.23741,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-07-29","TRTSDTM":"2020-07-31 15:49:37","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.18195,"AVALU":"YEARS","ADTM":"2021-09-18","ADY":414,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-112","SUBJID":"id-112","SITEID":"PAK-1","AGE":44,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":14.23741,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-07-29","TRTSDTM":"2020-07-31 15:49:37","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.49984,"AVALU":"YEARS","ADTM":"2020-10-15","ADY":76,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-112","SUBJID":"id-112","SITEID":"PAK-1","AGE":44,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":14.23741,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-07-29","TRTSDTM":"2020-07-31 15:49:37","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.25334,"AVALU":"YEARS","ADTM":"2021-12-22","ADY":509,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-125","SUBJID":"id-125","SITEID":"PAK-1","AGE":49,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":6.63963,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-15","TRTSDTM":"2021-06-17 19:58:03","TRTEDTM":"2023-06-18 07:36:27","EOSSTT":"COMPLETED","EOSDT":"2023-06-18","EOSDY":731,"DTHDT":"2023-06-18","LSTALVDT":"2023-07-10","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.66868,"AVALU":"YEARS","ADTM":"2022-10-12","ADY":482,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-125","SUBJID":"id-125","SITEID":"PAK-1","AGE":49,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":6.63963,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-15","TRTSDTM":"2021-06-17 19:58:03","TRTEDTM":"2023-06-18 07:36:27","EOSSTT":"COMPLETED","EOSDT":"2023-06-18","EOSDY":731,"DTHDT":"2023-06-18","LSTALVDT":"2023-07-10","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00706,"AVALU":"YEARS","ADTM":"2023-05-02","ADY":684,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-125","SUBJID":"id-125","SITEID":"PAK-1","AGE":49,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":6.63963,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-15","TRTSDTM":"2021-06-17 19:58:03","TRTEDTM":"2023-06-18 07:36:27","EOSSTT":"COMPLETED","EOSDT":"2023-06-18","EOSDY":731,"DTHDT":"2023-06-18","LSTALVDT":"2023-07-10","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11035,"AVALU":"YEARS","ADTM":"2022-11-12","ADY":513,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-148","SUBJID":"id-148","SITEID":"PAK-1","AGE":46,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":5.39563,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-01-20","TRTSDTM":"2020-01-21 23:12:16","TRTEDTM":"2022-01-21 10:50:40","EOSSTT":"COMPLETED","EOSDT":"2022-01-21","EOSDY":731,"DTHDT":"2022-01-21","LSTALVDT":"2022-02-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.1807,"AVALU":"YEARS","ADTM":"2021-04-07","ADY":442,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-148","SUBJID":"id-148","SITEID":"PAK-1","AGE":46,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":5.39563,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-01-20","TRTSDTM":"2020-01-21 23:12:16","TRTEDTM":"2022-01-21 10:50:40","EOSSTT":"COMPLETED","EOSDT":"2022-01-21","EOSDY":731,"DTHDT":"2022-01-21","LSTALVDT":"2022-02-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.06883,"AVALU":"YEARS","ADTM":"2020-11-07","ADY":291,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-148","SUBJID":"id-148","SITEID":"PAK-1","AGE":46,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":5.39563,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-01-20","TRTSDTM":"2020-01-21 23:12:16","TRTEDTM":"2022-01-21 10:50:40","EOSSTT":"COMPLETED","EOSDT":"2022-01-21","EOSDY":731,"DTHDT":"2022-01-21","LSTALVDT":"2022-02-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.36197,"AVALU":"YEARS","ADTM":"2020-04-14","ADY":84,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-169","SUBJID":"id-169","SITEID":"PAK-1","AGE":29,"SEX":"M","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":12.87444,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-17","TRTSDTM":"2020-06-20 23:08:22","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.28279,"AVALU":"YEARS","ADTM":"2021-11-05","ADY":503,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-169","SUBJID":"id-169","SITEID":"PAK-1","AGE":29,"SEX":"M","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":12.87444,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-17","TRTSDTM":"2020-06-20 23:08:22","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.49241,"AVALU":"YEARS","ADTM":"2022-01-11","ADY":570,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-169","SUBJID":"id-169","SITEID":"PAK-1","AGE":29,"SEX":"M","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":12.87444,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-17","TRTSDTM":"2020-06-20 23:08:22","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01934,"AVALU":"YEARS","ADTM":"2021-06-25","ADY":370,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-17","SUBJID":"id-17","SITEID":"PAK-1","AGE":33,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":9.27195,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-02-11","TRTSDTM":"2020-02-15 10:35:33","TRTEDTM":"2022-02-14 22:13:57","EOSSTT":"COMPLETED","EOSDT":"2022-02-14","EOSDY":731,"DTHDT":"2022-02-14","LSTALVDT":"2022-02-26","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.32892,"AVALU":"YEARS","ADTM":"2020-07-26","ADY":162,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-17","SUBJID":"id-17","SITEID":"PAK-1","AGE":33,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":9.27195,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-02-11","TRTSDTM":"2020-02-15 10:35:33","TRTEDTM":"2022-02-14 22:13:57","EOSSTT":"COMPLETED","EOSDT":"2022-02-14","EOSDY":731,"DTHDT":"2022-02-14","LSTALVDT":"2022-02-26","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00168,"AVALU":"YEARS","ADTM":"2021-04-01","ADY":411,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-17","SUBJID":"id-17","SITEID":"PAK-1","AGE":33,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":9.27195,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-02-11","TRTSDTM":"2020-02-15 10:35:33","TRTEDTM":"2022-02-14 22:13:57","EOSSTT":"COMPLETED","EOSDT":"2022-02-14","EOSDY":731,"DTHDT":"2022-02-14","LSTALVDT":"2022-02-26","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.27976,"AVALU":"YEARS","ADTM":"2021-04-16","ADY":426,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-178","SUBJID":"id-178","SITEID":"PAK-1","AGE":46,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":5.32131,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-01-10","TRTSDTM":"2020-01-10 12:20:21","TRTEDTM":"2022-01-09 23:58:45","EOSSTT":"COMPLETED","EOSDT":"2022-01-09","EOSDY":731,"DTHDT":"2022-01-09","LSTALVDT":"2022-01-31","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.1103,"AVALU":"YEARS","ADTM":"2021-11-13","ADY":673,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-178","SUBJID":"id-178","SITEID":"PAK-1","AGE":46,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":5.32131,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-01-10","TRTSDTM":"2020-01-10 12:20:21","TRTEDTM":"2022-01-09 23:58:45","EOSSTT":"COMPLETED","EOSDT":"2022-01-09","EOSDY":731,"DTHDT":"2022-01-09","LSTALVDT":"2022-01-31","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.09938,"AVALU":"YEARS","ADTM":"2020-06-07","ADY":149,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-178","SUBJID":"id-178","SITEID":"PAK-1","AGE":46,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":5.32131,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-01-10","TRTSDTM":"2020-01-10 12:20:21","TRTEDTM":"2022-01-09 23:58:45","EOSSTT":"COMPLETED","EOSDT":"2022-01-09","EOSDY":731,"DTHDT":"2022-01-09","LSTALVDT":"2022-01-31","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.21731,"AVALU":"YEARS","ADTM":"2021-10-02","ADY":631,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-280","SUBJID":"id-280","SITEID":"PAK-1","AGE":30,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":2.96261,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-31","TRTSDTM":"2020-01-02 07:03:35","TRTEDTM":"2022-01-01 18:41:59","EOSSTT":"COMPLETED","EOSDT":"2022-01-01","EOSDY":731,"DTHDT":"2022-01-01","LSTALVDT":"2022-01-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.07077,"AVALU":"YEARS","ADTM":"2020-02-12","ADY":41,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-280","SUBJID":"id-280","SITEID":"PAK-1","AGE":30,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":2.96261,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-31","TRTSDTM":"2020-01-02 07:03:35","TRTEDTM":"2022-01-01 18:41:59","EOSSTT":"COMPLETED","EOSDT":"2022-01-01","EOSDY":731,"DTHDT":"2022-01-01","LSTALVDT":"2022-01-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.20591,"AVALU":"YEARS","ADTM":"2021-11-03","ADY":671,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-280","SUBJID":"id-280","SITEID":"PAK-1","AGE":30,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":2.96261,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2019-12-31","TRTSDTM":"2020-01-02 07:03:35","TRTEDTM":"2022-01-01 18:41:59","EOSSTT":"COMPLETED","EOSDT":"2022-01-01","EOSDY":731,"DTHDT":"2022-01-01","LSTALVDT":"2022-01-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.26165,"AVALU":"YEARS","ADTM":"2021-06-12","ADY":527,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-39","SUBJID":"id-39","SITEID":"PAK-1","AGE":36,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.56183,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-03-07","TRTSDTM":"2021-03-11 16:16:19","TRTEDTM":"2023-03-12 03:54:43","EOSSTT":"COMPLETED","EOSDT":"2023-03-12","EOSDY":731,"DTHDT":"2023-03-12","LSTALVDT":"2023-03-27","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0632,"AVALU":"YEARS","ADTM":"2022-01-19","ADY":314,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-39","SUBJID":"id-39","SITEID":"PAK-1","AGE":36,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.56183,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-03-07","TRTSDTM":"2021-03-11 16:16:19","TRTEDTM":"2023-03-12 03:54:43","EOSSTT":"COMPLETED","EOSDT":"2023-03-12","EOSDY":731,"DTHDT":"2023-03-12","LSTALVDT":"2023-03-27","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.08838,"AVALU":"YEARS","ADTM":"2022-06-05","ADY":451,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-39","SUBJID":"id-39","SITEID":"PAK-1","AGE":36,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":4.56183,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-03-07","TRTSDTM":"2021-03-11 16:16:19","TRTEDTM":"2023-03-12 03:54:43","EOSSTT":"COMPLETED","EOSDT":"2023-03-12","EOSDY":731,"DTHDT":"2023-03-12","LSTALVDT":"2023-03-27","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.21735,"AVALU":"YEARS","ADTM":"2021-10-17","ADY":220,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-79","SUBJID":"id-79","SITEID":"PAK-1","AGE":37,"SEX":"M","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":4.7217,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-23","TRTSDTM":"2020-06-27 12:33:46","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.0377,"AVALU":"YEARS","ADTM":"2020-06-28","ADY":1,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-79","SUBJID":"id-79","SITEID":"PAK-1","AGE":37,"SEX":"M","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":4.7217,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-23","TRTSDTM":"2020-06-27 12:33:46","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.58116,"AVALU":"YEARS","ADTM":"2020-09-09","ADY":74,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-79","SUBJID":"id-79","SITEID":"PAK-1","AGE":37,"SEX":"M","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":4.7217,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-06-23","TRTSDTM":"2020-06-27 12:33:46","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.55435,"AVALU":"YEARS","ADTM":"2021-05-01","ADY":308,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-95","SUBJID":"id-95","SITEID":"PAK-1","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":2.88673,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-05","TRTSDTM":"2019-12-05 11:54:27","TRTEDTM":"2021-09-25 12:31:31","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":661,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.05916,"AVALU":"YEARS","ADTM":"2020-12-19","ADY":380,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-95","SUBJID":"id-95","SITEID":"PAK-1","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":2.88673,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-05","TRTSDTM":"2019-12-05 11:54:27","TRTEDTM":"2021-09-25 12:31:31","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":661,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.17405,"AVALU":"YEARS","ADTM":"2021-09-15","ADY":650,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-1-id-95","SUBJID":"id-95","SITEID":"PAK-1","AGE":28,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":2.88673,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-05","TRTSDTM":"2019-12-05 11:54:27","TRTEDTM":"2021-09-25 12:31:31","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":661,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04013,"AVALU":"YEARS","ADTM":"2021-02-02","ADY":425,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-145","SUBJID":"id-145","SITEID":"PAK-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":8.20279,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-23","TRTSDTM":"2020-08-23 00:41:48","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.07729,"AVALU":"YEARS","ADTM":"2021-04-14","ADY":234,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-145","SUBJID":"id-145","SITEID":"PAK-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":8.20279,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-23","TRTSDTM":"2020-08-23 00:41:48","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.76014,"AVALU":"YEARS","ADTM":"2022-05-04","ADY":619,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-145","SUBJID":"id-145","SITEID":"PAK-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":8.20279,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-23","TRTSDTM":"2020-08-23 00:41:48","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.44694,"AVALU":"YEARS","ADTM":"2021-05-28","ADY":278,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-187","SUBJID":"id-187","SITEID":"PAK-11","AGE":32,"SEX":"F","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":3.3773,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-07-26","TRTSDTM":"2020-07-29 11:42:40","TRTEDTM":"2021-09-18 23:05:47","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":417,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-18","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.49124,"AVALU":"YEARS","ADTM":"2021-07-04","ADY":340,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-187","SUBJID":"id-187","SITEID":"PAK-11","AGE":32,"SEX":"F","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":3.3773,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-07-26","TRTSDTM":"2020-07-29 11:42:40","TRTEDTM":"2021-09-18 23:05:47","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":417,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-18","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.21448,"AVALU":"YEARS","ADTM":"2020-08-15","ADY":17,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-187","SUBJID":"id-187","SITEID":"PAK-11","AGE":32,"SEX":"F","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":3.3773,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-07-26","TRTSDTM":"2020-07-29 11:42:40","TRTEDTM":"2021-09-18 23:05:47","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":417,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-18","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.03406,"AVALU":"YEARS","ADTM":"2020-08-28","ADY":30,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-210","SUBJID":"id-210","SITEID":"PAK-11","AGE":23,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":13.6416,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-01","TRTSDTM":"2020-05-01 01:23:17","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.13765,"AVALU":"YEARS","ADTM":"2020-07-19","ADY":79,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-210","SUBJID":"id-210","SITEID":"PAK-11","AGE":23,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":13.6416,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-01","TRTSDTM":"2020-05-01 01:23:17","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02033,"AVALU":"YEARS","ADTM":"2021-08-18","ADY":474,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-210","SUBJID":"id-210","SITEID":"PAK-11","AGE":23,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":13.6416,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-05-01","TRTSDTM":"2020-05-01 01:23:17","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.3853,"AVALU":"YEARS","ADTM":"2021-03-10","ADY":313,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-268","SUBJID":"id-268","SITEID":"PAK-11","AGE":28,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":2.82014,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-26","TRTSDTM":"2019-10-26 09:29:20","TRTEDTM":"2021-09-25 17:40:51","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":701,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.19574,"AVALU":"YEARS","ADTM":"2020-04-23","ADY":180,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-268","SUBJID":"id-268","SITEID":"PAK-11","AGE":28,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":2.82014,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-26","TRTSDTM":"2019-10-26 09:29:20","TRTEDTM":"2021-09-25 17:40:51","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":701,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.4325,"AVALU":"YEARS","ADTM":"2021-03-02","ADY":493,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-268","SUBJID":"id-268","SITEID":"PAK-11","AGE":28,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":2.82014,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-26","TRTSDTM":"2019-10-26 09:29:20","TRTEDTM":"2021-09-25 17:40:51","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":701,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-11","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.21969,"AVALU":"YEARS","ADTM":"2020-08-01","ADY":280,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-330","SUBJID":"id-330","SITEID":"PAK-11","AGE":32,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":6.69531,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-18","TRTSDTM":"2020-08-20 18:31:27","TRTEDTM":"2021-09-21 05:15:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":397,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-21","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.45389,"AVALU":"YEARS","ADTM":"2020-12-16","ADY":118,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-330","SUBJID":"id-330","SITEID":"PAK-11","AGE":32,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":6.69531,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-18","TRTSDTM":"2020-08-20 18:31:27","TRTEDTM":"2021-09-21 05:15:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":397,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-21","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.08277,"AVALU":"YEARS","ADTM":"2020-09-03","ADY":14,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-330","SUBJID":"id-330","SITEID":"PAK-11","AGE":32,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":6.69531,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-18","TRTSDTM":"2020-08-20 18:31:27","TRTEDTM":"2021-09-21 05:15:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":397,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-21","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.22046,"AVALU":"YEARS","ADTM":"2021-01-08","ADY":141,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-49","SUBJID":"id-49","SITEID":"PAK-11","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.14573,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-07-29","TRTSDTM":"2020-07-30 19:27:32","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02706,"AVALU":"YEARS","ADTM":"2021-07-14","ADY":349,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-49","SUBJID":"id-49","SITEID":"PAK-11","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.14573,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-07-29","TRTSDTM":"2020-07-30 19:27:32","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.38672,"AVALU":"YEARS","ADTM":"2021-07-09","ADY":344,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-49","SUBJID":"id-49","SITEID":"PAK-11","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.14573,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-07-29","TRTSDTM":"2020-07-30 19:27:32","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11158,"AVALU":"YEARS","ADTM":"2021-02-21","ADY":206,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-68","SUBJID":"id-68","SITEID":"PAK-11","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":5.24086,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-07","TRTSDTM":"2020-01-08 02:06:17","TRTEDTM":"2021-09-25 20:09:15","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":627,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.50568,"AVALU":"YEARS","ADTM":"2020-07-13","ADY":187,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-68","SUBJID":"id-68","SITEID":"PAK-11","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":5.24086,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-07","TRTSDTM":"2020-01-08 02:06:17","TRTEDTM":"2021-09-25 20:09:15","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":627,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.07637,"AVALU":"YEARS","ADTM":"2020-09-04","ADY":240,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-68","SUBJID":"id-68","SITEID":"PAK-11","AGE":37,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":5.24086,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-07","TRTSDTM":"2020-01-08 02:06:17","TRTEDTM":"2021-09-25 20:09:15","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":627,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0853,"AVALU":"YEARS","ADTM":"2020-02-12","ADY":35,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-82","SUBJID":"id-82","SITEID":"PAK-11","AGE":32,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":5.98363,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-23","TRTSDTM":"2021-05-25 01:13:39","TRTEDTM":"2023-05-25 12:52:03","EOSSTT":"COMPLETED","EOSDT":"2023-05-25","EOSDY":731,"DTHDT":"2023-05-25","LSTALVDT":"2023-06-19","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.51306,"AVALU":"YEARS","ADTM":"2023-04-06","ADY":681,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-82","SUBJID":"id-82","SITEID":"PAK-11","AGE":32,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":5.98363,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-23","TRTSDTM":"2021-05-25 01:13:39","TRTEDTM":"2023-05-25 12:52:03","EOSSTT":"COMPLETED","EOSDT":"2023-05-25","EOSDY":731,"DTHDT":"2023-05-25","LSTALVDT":"2023-06-19","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.35501,"AVALU":"YEARS","ADTM":"2022-06-01","ADY":372,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-82","SUBJID":"id-82","SITEID":"PAK-11","AGE":32,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":5.98363,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-05-23","TRTSDTM":"2021-05-25 01:13:39","TRTEDTM":"2023-05-25 12:52:03","EOSSTT":"COMPLETED","EOSDT":"2023-05-25","EOSDY":731,"DTHDT":"2023-05-25","LSTALVDT":"2023-06-19","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.19677,"AVALU":"YEARS","ADTM":"2022-05-21","ADY":361,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-87","SUBJID":"id-87","SITEID":"PAK-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":13.47621,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-22","TRTSDTM":"2020-02-24 09:52:09","TRTEDTM":"2022-02-23 21:30:33","EOSSTT":"COMPLETED","EOSDT":"2022-02-23","EOSDY":731,"DTHDT":"2022-02-23","LSTALVDT":"2022-03-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.30096,"AVALU":"YEARS","ADTM":"2020-12-01","ADY":281,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-87","SUBJID":"id-87","SITEID":"PAK-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":13.47621,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-22","TRTSDTM":"2020-02-24 09:52:09","TRTEDTM":"2022-02-23 21:30:33","EOSSTT":"COMPLETED","EOSDT":"2022-02-23","EOSDY":731,"DTHDT":"2022-02-23","LSTALVDT":"2022-03-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.21934,"AVALU":"YEARS","ADTM":"2020-07-08","ADY":135,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-11-id-87","SUBJID":"id-87","SITEID":"PAK-11","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":13.47621,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-22","TRTSDTM":"2020-02-24 09:52:09","TRTEDTM":"2022-02-23 21:30:33","EOSSTT":"COMPLETED","EOSDT":"2022-02-23","EOSDY":731,"DTHDT":"2022-02-23","LSTALVDT":"2022-03-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.06516,"AVALU":"YEARS","ADTM":"2020-10-07","ADY":226,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-12-id-328","SUBJID":"id-328","SITEID":"PAK-12","AGE":21,"SEX":"F","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":9.04077,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-15","TRTSDTM":"2020-04-15 20:19:02","TRTEDTM":"2022-04-16 07:57:26","EOSSTT":"COMPLETED","EOSDT":"2022-04-16","EOSDY":731,"DTHDT":"2022-04-16","LSTALVDT":"2022-04-30","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03532,"AVALU":"YEARS","ADTM":"2021-09-06","ADY":509,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-12-id-328","SUBJID":"id-328","SITEID":"PAK-12","AGE":21,"SEX":"F","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":9.04077,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-15","TRTSDTM":"2020-04-15 20:19:02","TRTEDTM":"2022-04-16 07:57:26","EOSSTT":"COMPLETED","EOSDT":"2022-04-16","EOSDY":731,"DTHDT":"2022-04-16","LSTALVDT":"2022-04-30","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.16851,"AVALU":"YEARS","ADTM":"2021-04-30","ADY":380,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-12-id-328","SUBJID":"id-328","SITEID":"PAK-12","AGE":21,"SEX":"F","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":9.04077,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-04-15","TRTSDTM":"2020-04-15 20:19:02","TRTEDTM":"2022-04-16 07:57:26","EOSSTT":"COMPLETED","EOSDT":"2022-04-16","EOSDY":731,"DTHDT":"2022-04-16","LSTALVDT":"2022-04-30","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.12512,"AVALU":"YEARS","ADTM":"2020-12-10","ADY":239,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-12-id-85","SUBJID":"id-85","SITEID":"PAK-12","AGE":31,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":3.6978,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-12","TRTSDTM":"2021-04-15 13:26:29","TRTEDTM":"2021-09-26 07:53:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":164,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-26","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.41045,"AVALU":"YEARS","ADTM":"2021-05-11","ADY":26,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-12-id-85","SUBJID":"id-85","SITEID":"PAK-12","AGE":31,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":3.6978,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-12","TRTSDTM":"2021-04-15 13:26:29","TRTEDTM":"2021-09-26 07:53:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":164,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-26","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.30271,"AVALU":"YEARS","ADTM":"2021-07-03","ADY":79,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-12-id-85","SUBJID":"id-85","SITEID":"PAK-12","AGE":31,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":3.6978,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-12","TRTSDTM":"2021-04-15 13:26:29","TRTEDTM":"2021-09-26 07:53:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":164,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-26","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07639,"AVALU":"YEARS","ADTM":"2021-08-23","ADY":130,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-13-id-251","SUBJID":"id-251","SITEID":"PAK-13","AGE":32,"SEX":"M","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":5.6604,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-22","TRTSDTM":"2020-10-23 20:17:18","TRTEDTM":"2022-10-24 07:55:42","EOSSTT":"COMPLETED","EOSDT":"2022-10-24","EOSDY":731,"DTHDT":"2022-10-24","LSTALVDT":"2022-11-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00286,"AVALU":"YEARS","ADTM":"2021-11-04","ADY":377,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-13-id-251","SUBJID":"id-251","SITEID":"PAK-13","AGE":32,"SEX":"M","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":5.6604,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-22","TRTSDTM":"2020-10-23 20:17:18","TRTEDTM":"2022-10-24 07:55:42","EOSSTT":"COMPLETED","EOSDT":"2022-10-24","EOSDY":731,"DTHDT":"2022-10-24","LSTALVDT":"2022-11-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.1641,"AVALU":"YEARS","ADTM":"2021-09-27","ADY":339,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-13-id-251","SUBJID":"id-251","SITEID":"PAK-13","AGE":32,"SEX":"M","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":5.6604,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-22","TRTSDTM":"2020-10-23 20:17:18","TRTEDTM":"2022-10-24 07:55:42","EOSSTT":"COMPLETED","EOSDT":"2022-10-24","EOSDY":731,"DTHDT":"2022-10-24","LSTALVDT":"2022-11-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.30621,"AVALU":"YEARS","ADTM":"2022-02-02","ADY":467,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-13-id-350","SUBJID":"id-350","SITEID":"PAK-13","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":5.71377,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-27","TRTSDTM":"2021-06-30 16:23:27","TRTEDTM":"2021-09-25 18:30:36","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":88,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-19","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.22107,"AVALU":"YEARS","ADTM":"2021-08-04","ADY":35,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-13-id-350","SUBJID":"id-350","SITEID":"PAK-13","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":5.71377,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-27","TRTSDTM":"2021-06-30 16:23:27","TRTEDTM":"2021-09-25 18:30:36","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":88,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-19","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.61773,"AVALU":"YEARS","ADTM":"2021-08-17","ADY":48,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-13-id-350","SUBJID":"id-350","SITEID":"PAK-13","AGE":39,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-13","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":5.71377,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-27","TRTSDTM":"2021-06-30 16:23:27","TRTEDTM":"2021-09-25 18:30:36","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":88,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-19","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.13147,"AVALU":"YEARS","ADTM":"2021-07-12","ADY":12,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-14-id-117","SUBJID":"id-117","SITEID":"PAK-14","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":6.26523,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-14","TRTSDTM":"2020-02-18 13:55:52","TRTEDTM":"2022-02-18 01:34:16","EOSSTT":"COMPLETED","EOSDT":"2022-02-18","EOSDY":731,"DTHDT":"2022-02-18","LSTALVDT":"2022-03-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.2232,"AVALU":"YEARS","ADTM":"2021-07-02","ADY":500,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-14-id-117","SUBJID":"id-117","SITEID":"PAK-14","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":6.26523,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-14","TRTSDTM":"2020-02-18 13:55:52","TRTEDTM":"2022-02-18 01:34:16","EOSSTT":"COMPLETED","EOSDT":"2022-02-18","EOSDY":731,"DTHDT":"2022-02-18","LSTALVDT":"2022-03-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.98128,"AVALU":"YEARS","ADTM":"2021-06-23","ADY":491,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-14-id-117","SUBJID":"id-117","SITEID":"PAK-14","AGE":25,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":6.26523,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-02-14","TRTSDTM":"2020-02-18 13:55:52","TRTEDTM":"2022-02-18 01:34:16","EOSSTT":"COMPLETED","EOSDT":"2022-02-18","EOSDY":731,"DTHDT":"2022-02-18","LSTALVDT":"2022-03-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1231,"AVALU":"YEARS","ADTM":"2021-03-11","ADY":387,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-15-id-314","SUBJID":"id-314","SITEID":"PAK-15","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":3.51131,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-04-19","TRTSDTM":"2020-04-23 08:38:24","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.2994,"AVALU":"YEARS","ADTM":"2021-02-17","ADY":300,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-15-id-314","SUBJID":"id-314","SITEID":"PAK-15","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":3.51131,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-04-19","TRTSDTM":"2020-04-23 08:38:24","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02761,"AVALU":"YEARS","ADTM":"2021-09-05","ADY":500,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-15-id-314","SUBJID":"id-314","SITEID":"PAK-15","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-15","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":3.51131,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-04-19","TRTSDTM":"2020-04-23 08:38:24","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.19581,"AVALU":"YEARS","ADTM":"2021-05-25","ADY":397,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-2-id-188","SUBJID":"id-188","SITEID":"PAK-2","AGE":23,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"PAK","INVID":"PAK-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":16.48767,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-15","TRTSDTM":"2020-10-16 20:09:02","TRTEDTM":"2022-10-17 07:47:26","EOSSTT":"COMPLETED","EOSDT":"2022-10-17","EOSDY":731,"DTHDT":"2022-10-17","LSTALVDT":"2022-10-29","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.60219,"AVALU":"YEARS","ADTM":"2022-01-14","ADY":455,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-2-id-188","SUBJID":"id-188","SITEID":"PAK-2","AGE":23,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"PAK","INVID":"PAK-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":16.48767,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-15","TRTSDTM":"2020-10-16 20:09:02","TRTEDTM":"2022-10-17 07:47:26","EOSSTT":"COMPLETED","EOSDT":"2022-10-17","EOSDY":731,"DTHDT":"2022-10-17","LSTALVDT":"2022-10-29","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.17198,"AVALU":"YEARS","ADTM":"2022-05-31","ADY":592,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-2-id-188","SUBJID":"id-188","SITEID":"PAK-2","AGE":23,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"PAK","INVID":"PAK-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":16.48767,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-15","TRTSDTM":"2020-10-16 20:09:02","TRTEDTM":"2022-10-17 07:47:26","EOSSTT":"COMPLETED","EOSDT":"2022-10-17","EOSDY":731,"DTHDT":"2022-10-17","LSTALVDT":"2022-10-29","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.56182,"AVALU":"YEARS","ADTM":"2021-12-07","ADY":417,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-2-id-191","SUBJID":"id-191","SITEID":"PAK-2","AGE":38,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.14369,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-11-08","TRTSDTM":"2019-11-12 02:50:53","TRTEDTM":"2021-09-25 14:39:19","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":684,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02985,"AVALU":"YEARS","ADTM":"2020-12-05","ADY":389,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-2-id-191","SUBJID":"id-191","SITEID":"PAK-2","AGE":38,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.14369,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-11-08","TRTSDTM":"2019-11-12 02:50:53","TRTEDTM":"2021-09-25 14:39:19","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":684,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00382,"AVALU":"YEARS","ADTM":"2021-03-08","ADY":482,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-2-id-191","SUBJID":"id-191","SITEID":"PAK-2","AGE":38,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"PAK","INVID":"PAK-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":3.14369,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-11-08","TRTSDTM":"2019-11-12 02:50:53","TRTEDTM":"2021-09-25 14:39:19","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":684,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01862,"AVALU":"YEARS","ADTM":"2021-01-15","ADY":430,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-2-id-213","SUBJID":"id-213","SITEID":"PAK-2","AGE":38,"SEX":"F","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.81794,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-18","TRTSDTM":"2020-08-21 23:01:38","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.36736,"AVALU":"YEARS","ADTM":"2021-02-18","ADY":181,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-2-id-213","SUBJID":"id-213","SITEID":"PAK-2","AGE":38,"SEX":"F","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.81794,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-18","TRTSDTM":"2020-08-21 23:01:38","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.15864,"AVALU":"YEARS","ADTM":"2022-05-25","ADY":642,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-2-id-213","SUBJID":"id-213","SITEID":"PAK-2","AGE":38,"SEX":"F","RACE":"WHITE","COUNTRY":"PAK","INVID":"PAK-2","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":1.81794,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-18","TRTSDTM":"2020-08-21 23:01:38","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00309,"AVALU":"YEARS","ADTM":"2021-04-10","ADY":232,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-4-id-15","SUBJID":"id-15","SITEID":"PAK-4","AGE":30,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":8.81159,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-30","TRTSDTM":"2020-08-01 15:10:27","TRTEDTM":"2021-09-22 04:22:42","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":417,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-22","LSTALVDT":"2021-10-10","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.31029,"AVALU":"YEARS","ADTM":"2020-08-24","ADY":23,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-4-id-15","SUBJID":"id-15","SITEID":"PAK-4","AGE":30,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":8.81159,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-30","TRTSDTM":"2020-08-01 15:10:27","TRTEDTM":"2021-09-22 04:22:42","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":417,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-22","LSTALVDT":"2021-10-10","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.38368,"AVALU":"YEARS","ADTM":"2020-12-11","ADY":132,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-4-id-15","SUBJID":"id-15","SITEID":"PAK-4","AGE":30,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":8.81159,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-30","TRTSDTM":"2020-08-01 15:10:27","TRTEDTM":"2021-09-22 04:22:42","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":417,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-22","LSTALVDT":"2021-10-10","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01975,"AVALU":"YEARS","ADTM":"2021-03-10","ADY":221,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-4-id-164","SUBJID":"id-164","SITEID":"PAK-4","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":1.8305,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-03","TRTSDTM":"2020-07-06 07:55:19","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.27687,"AVALU":"YEARS","ADTM":"2021-10-18","ADY":469,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-4-id-164","SUBJID":"id-164","SITEID":"PAK-4","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":1.8305,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-03","TRTSDTM":"2020-07-06 07:55:19","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":2.21473,"AVALU":"YEARS","ADTM":"2020-10-17","ADY":103,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-4-id-164","SUBJID":"id-164","SITEID":"PAK-4","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":1.8305,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-07-03","TRTSDTM":"2020-07-06 07:55:19","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1461,"AVALU":"YEARS","ADTM":"2021-06-27","ADY":356,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-5-id-20","SUBJID":"id-20","SITEID":"PAK-5","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":5.84789,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-26","TRTSDTM":"2021-04-27 15:56:40","TRTEDTM":"2021-09-22 09:36:22","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":148,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01823,"AVALU":"YEARS","ADTM":"2021-08-06","ADY":101,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-5-id-20","SUBJID":"id-20","SITEID":"PAK-5","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":5.84789,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-26","TRTSDTM":"2021-04-27 15:56:40","TRTEDTM":"2021-09-22 09:36:22","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":148,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.03459,"AVALU":"YEARS","ADTM":"2021-07-04","ADY":68,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-PAK-5-id-20","SUBJID":"id-20","SITEID":"PAK-5","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"PAK","INVID":"PAK-5","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":5.84789,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-04-26","TRTSDTM":"2021-04-27 15:56:40","TRTEDTM":"2021-09-22 09:36:22","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":148,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.81223,"AVALU":"YEARS","ADTM":"2021-06-23","ADY":57,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-1-id-52","SUBJID":"id-52","SITEID":"RUS-1","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":7.20635,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-21","TRTSDTM":"2019-10-22 19:14:29","TRTEDTM":"2021-10-22 06:52:53","EOSSTT":"COMPLETED","EOSDT":"2021-10-22","EOSDY":731,"DTHDT":"2021-10-22","LSTALVDT":"2021-11-05","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":1.13014,"AVALU":"YEARS","ADTM":"2020-03-24","ADY":154,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-1-id-52","SUBJID":"id-52","SITEID":"RUS-1","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":7.20635,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-21","TRTSDTM":"2019-10-22 19:14:29","TRTEDTM":"2021-10-22 06:52:53","EOSSTT":"COMPLETED","EOSDT":"2021-10-22","EOSDY":731,"DTHDT":"2021-10-22","LSTALVDT":"2021-11-05","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.30733,"AVALU":"YEARS","ADTM":"2020-04-04","ADY":165,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-1-id-52","SUBJID":"id-52","SITEID":"RUS-1","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":7.20635,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-21","TRTSDTM":"2019-10-22 19:14:29","TRTEDTM":"2021-10-22 06:52:53","EOSSTT":"COMPLETED","EOSDT":"2021-10-22","EOSDY":731,"DTHDT":"2021-10-22","LSTALVDT":"2021-11-05","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.35854,"AVALU":"YEARS","ADTM":"2020-05-26","ADY":217,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-11-id-162","SUBJID":"id-162","SITEID":"RUS-11","AGE":37,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":8.34705,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-04","TRTSDTM":"2020-11-04 06:44:16","TRTEDTM":"2021-09-22 04:31:07","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":322,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-02","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.98254,"AVALU":"YEARS","ADTM":"2021-03-29","ADY":145,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-11-id-162","SUBJID":"id-162","SITEID":"RUS-11","AGE":37,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":8.34705,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-04","TRTSDTM":"2020-11-04 06:44:16","TRTEDTM":"2021-09-22 04:31:07","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":322,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-02","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.13111,"AVALU":"YEARS","ADTM":"2021-04-30","ADY":177,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-11-id-162","SUBJID":"id-162","SITEID":"RUS-11","AGE":37,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":8.34705,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-11-04","TRTSDTM":"2020-11-04 06:44:16","TRTEDTM":"2021-09-22 04:31:07","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-22","EOSDY":322,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-22","LSTALVDT":"2021-10-02","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.22151,"AVALU":"YEARS","ADTM":"2021-05-23","ADY":200,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-11-id-283","SUBJID":"id-283","SITEID":"RUS-11","AGE":37,"SEX":"U","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":2.78881,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-02-22","TRTSDTM":"2021-02-26 21:10:13","TRTEDTM":"2021-09-23 03:00:57","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":209,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-23","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14047,"AVALU":"YEARS","ADTM":"2021-07-31","ADY":155,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-11-id-283","SUBJID":"id-283","SITEID":"RUS-11","AGE":37,"SEX":"U","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":2.78881,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-02-22","TRTSDTM":"2021-02-26 21:10:13","TRTEDTM":"2021-09-23 03:00:57","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":209,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-23","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02391,"AVALU":"YEARS","ADTM":"2021-03-08","ADY":10,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-11-id-283","SUBJID":"id-283","SITEID":"RUS-11","AGE":37,"SEX":"U","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":2.78881,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-02-22","TRTSDTM":"2021-02-26 21:10:13","TRTEDTM":"2021-09-23 03:00:57","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-23","EOSDY":209,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-23","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.12432,"AVALU":"YEARS","ADTM":"2021-09-20","ADY":206,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-11-id-76","SUBJID":"id-76","SITEID":"RUS-11","AGE":25,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":3.74484,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-13","TRTSDTM":"2020-03-17 00:10:42","TRTEDTM":"2022-03-17 11:49:06","EOSSTT":"COMPLETED","EOSDT":"2022-03-17","EOSDY":731,"DTHDT":"2022-03-17","LSTALVDT":"2022-04-13","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.65351,"AVALU":"YEARS","ADTM":"2021-02-02","ADY":322,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-11-id-76","SUBJID":"id-76","SITEID":"RUS-11","AGE":25,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":3.74484,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-13","TRTSDTM":"2020-03-17 00:10:42","TRTEDTM":"2022-03-17 11:49:06","EOSSTT":"COMPLETED","EOSDT":"2022-03-17","EOSDY":731,"DTHDT":"2022-03-17","LSTALVDT":"2022-04-13","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.07777,"AVALU":"YEARS","ADTM":"2020-10-28","ADY":225,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-11-id-76","SUBJID":"id-76","SITEID":"RUS-11","AGE":25,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":3.74484,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-13","TRTSDTM":"2020-03-17 00:10:42","TRTEDTM":"2022-03-17 11:49:06","EOSSTT":"COMPLETED","EOSDT":"2022-03-17","EOSDY":731,"DTHDT":"2022-03-17","LSTALVDT":"2022-04-13","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.23943,"AVALU":"YEARS","ADTM":"2020-11-27","ADY":255,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-11-id-94","SUBJID":"id-94","SITEID":"RUS-11","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":9.31688,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-25","TRTSDTM":"2020-03-29 06:48:51","TRTEDTM":"2022-03-29 18:27:15","EOSSTT":"COMPLETED","EOSDT":"2022-03-29","EOSDY":731,"DTHDT":"2022-03-29","LSTALVDT":"2022-04-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.42701,"AVALU":"YEARS","ADTM":"2020-12-21","ADY":267,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-11-id-94","SUBJID":"id-94","SITEID":"RUS-11","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":9.31688,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-25","TRTSDTM":"2020-03-29 06:48:51","TRTEDTM":"2022-03-29 18:27:15","EOSSTT":"COMPLETED","EOSDT":"2022-03-29","EOSDY":731,"DTHDT":"2022-03-29","LSTALVDT":"2022-04-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.75596,"AVALU":"YEARS","ADTM":"2021-09-28","ADY":548,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-11-id-94","SUBJID":"id-94","SITEID":"RUS-11","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":9.31688,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-25","TRTSDTM":"2020-03-29 06:48:51","TRTEDTM":"2022-03-29 18:27:15","EOSSTT":"COMPLETED","EOSDT":"2022-03-29","EOSDY":731,"DTHDT":"2022-03-29","LSTALVDT":"2022-04-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.36198,"AVALU":"YEARS","ADTM":"2020-09-22","ADY":177,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-12-id-185","SUBJID":"id-185","SITEID":"RUS-12","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":7.67625,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-07-09","TRTSDTM":"2020-07-13 20:46:49","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00695,"AVALU":"YEARS","ADTM":"2020-07-13","ADY":0,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-12-id-185","SUBJID":"id-185","SITEID":"RUS-12","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":7.67625,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-07-09","TRTSDTM":"2020-07-13 20:46:49","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":2.63992,"AVALU":"YEARS","ADTM":"2020-12-26","ADY":166,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-12-id-185","SUBJID":"id-185","SITEID":"RUS-12","AGE":31,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":7.67625,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-07-09","TRTSDTM":"2020-07-13 20:46:49","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.21061,"AVALU":"YEARS","ADTM":"2022-04-22","ADY":648,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-13-id-70","SUBJID":"id-70","SITEID":"RUS-13","AGE":39,"SEX":"F","RACE":"WHITE","COUNTRY":"RUS","INVID":"RUS-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":3.48732,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-19","TRTSDTM":"2019-11-19 11:14:17","TRTEDTM":"2021-09-25 12:42:18","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":677,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12763,"AVALU":"YEARS","ADTM":"2020-03-06","ADY":108,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-13-id-70","SUBJID":"id-70","SITEID":"RUS-13","AGE":39,"SEX":"F","RACE":"WHITE","COUNTRY":"RUS","INVID":"RUS-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":3.48732,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-19","TRTSDTM":"2019-11-19 11:14:17","TRTEDTM":"2021-09-25 12:42:18","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":677,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.61319,"AVALU":"YEARS","ADTM":"2020-02-14","ADY":87,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-13-id-70","SUBJID":"id-70","SITEID":"RUS-13","AGE":39,"SEX":"F","RACE":"WHITE","COUNTRY":"RUS","INVID":"RUS-13","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":3.48732,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-19","TRTSDTM":"2019-11-19 11:14:17","TRTEDTM":"2021-09-25 12:42:18","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":677,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.16278,"AVALU":"YEARS","ADTM":"2020-01-01","ADY":43,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-14-id-183","SUBJID":"id-183","SITEID":"RUS-14","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.19605,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-29","TRTSDTM":"2020-04-02 08:35:17","TRTEDTM":"2022-04-02 20:13:41","EOSSTT":"COMPLETED","EOSDT":"2022-04-02","EOSDY":731,"DTHDT":"2022-04-02","LSTALVDT":"2022-04-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12143,"AVALU":"YEARS","ADTM":"2020-04-03","ADY":1,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-14-id-183","SUBJID":"id-183","SITEID":"RUS-14","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.19605,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-29","TRTSDTM":"2020-04-02 08:35:17","TRTEDTM":"2022-04-02 20:13:41","EOSSTT":"COMPLETED","EOSDT":"2022-04-02","EOSDY":731,"DTHDT":"2022-04-02","LSTALVDT":"2022-04-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.13195,"AVALU":"YEARS","ADTM":"2021-07-12","ADY":466,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-14-id-183","SUBJID":"id-183","SITEID":"RUS-14","AGE":28,"SEX":"M","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-14","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":4.19605,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-03-29","TRTSDTM":"2020-04-02 08:35:17","TRTEDTM":"2022-04-02 20:13:41","EOSSTT":"COMPLETED","EOSDT":"2022-04-02","EOSDY":731,"DTHDT":"2022-04-02","LSTALVDT":"2022-04-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.21616,"AVALU":"YEARS","ADTM":"2021-05-02","ADY":395,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-16-id-165","SUBJID":"id-165","SITEID":"RUS-16","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-16","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.49284,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-02-08","TRTSDTM":"2021-02-10 01:13:15","TRTEDTM":"2023-02-10 12:51:39","EOSSTT":"COMPLETED","EOSDT":"2023-02-10","EOSDY":731,"DTHDT":"2023-02-10","LSTALVDT":"2023-02-22","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.18456,"AVALU":"YEARS","ADTM":"2022-08-09","ADY":545,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-16-id-165","SUBJID":"id-165","SITEID":"RUS-16","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-16","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.49284,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-02-08","TRTSDTM":"2021-02-10 01:13:15","TRTEDTM":"2023-02-10 12:51:39","EOSSTT":"COMPLETED","EOSDT":"2023-02-10","EOSDY":731,"DTHDT":"2023-02-10","LSTALVDT":"2023-02-22","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.24515,"AVALU":"YEARS","ADTM":"2021-11-13","ADY":276,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-16-id-165","SUBJID":"id-165","SITEID":"RUS-16","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-16","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S2","BMRKR1":3.49284,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-02-08","TRTSDTM":"2021-02-10 01:13:15","TRTEDTM":"2023-02-10 12:51:39","EOSSTT":"COMPLETED","EOSDT":"2023-02-10","EOSDY":731,"DTHDT":"2023-02-10","LSTALVDT":"2023-02-22","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11361,"AVALU":"YEARS","ADTM":"2022-09-17","ADY":584,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-16-id-4","SUBJID":"id-4","SITEID":"RUS-16","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-16","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":12.7694,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-29","TRTSDTM":"2020-11-01 13:25:42","TRTEDTM":"2021-09-25 22:38:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":329,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.23602,"AVALU":"YEARS","ADTM":"2021-01-16","ADY":76,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-16-id-4","SUBJID":"id-4","SITEID":"RUS-16","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-16","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":12.7694,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-29","TRTSDTM":"2020-11-01 13:25:42","TRTEDTM":"2021-09-25 22:38:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":329,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.11654,"AVALU":"YEARS","ADTM":"2021-09-11","ADY":314,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-16-id-4","SUBJID":"id-4","SITEID":"RUS-16","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-16","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":12.7694,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-29","TRTSDTM":"2020-11-01 13:25:42","TRTEDTM":"2021-09-25 22:38:00","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":329,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-25","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.34309,"AVALU":"YEARS","ADTM":"2021-01-08","ADY":68,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-18-id-359","SUBJID":"id-359","SITEID":"RUS-18","AGE":47,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-18","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":4.42016,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-01-11","TRTSDTM":"2020-01-13 00:37:52","TRTEDTM":"2022-01-12 12:16:16","EOSSTT":"COMPLETED","EOSDT":"2022-01-12","EOSDY":731,"DTHDT":"2022-01-12","LSTALVDT":"2022-02-09","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.14303,"AVALU":"YEARS","ADTM":"2020-05-03","ADY":111,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-18-id-359","SUBJID":"id-359","SITEID":"RUS-18","AGE":47,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-18","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":4.42016,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-01-11","TRTSDTM":"2020-01-13 00:37:52","TRTEDTM":"2022-01-12 12:16:16","EOSSTT":"COMPLETED","EOSDT":"2022-01-12","EOSDY":731,"DTHDT":"2022-01-12","LSTALVDT":"2022-02-09","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00582,"AVALU":"YEARS","ADTM":"2021-11-15","ADY":672,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-18-id-359","SUBJID":"id-359","SITEID":"RUS-18","AGE":47,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-18","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":4.42016,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-01-11","TRTSDTM":"2020-01-13 00:37:52","TRTEDTM":"2022-01-12 12:16:16","EOSSTT":"COMPLETED","EOSDT":"2022-01-12","EOSDY":731,"DTHDT":"2022-01-12","LSTALVDT":"2022-02-09","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04668,"AVALU":"YEARS","ADTM":"2021-10-22","ADY":648,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-2-id-176","SUBJID":"id-176","SITEID":"RUS-2","AGE":42,"SEX":"F","RACE":"WHITE","COUNTRY":"RUS","INVID":"RUS-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65962,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-11-16","TRTSDTM":"2020-11-16 23:12:53","TRTEDTM":"2022-11-17 10:51:17","EOSSTT":"COMPLETED","EOSDT":"2022-11-17","EOSDY":731,"DTHDT":"2022-11-17","LSTALVDT":"2022-12-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.29737,"AVALU":"YEARS","ADTM":"2021-12-05","ADY":384,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-2-id-176","SUBJID":"id-176","SITEID":"RUS-2","AGE":42,"SEX":"F","RACE":"WHITE","COUNTRY":"RUS","INVID":"RUS-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65962,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-11-16","TRTSDTM":"2020-11-16 23:12:53","TRTEDTM":"2022-11-17 10:51:17","EOSSTT":"COMPLETED","EOSDT":"2022-11-17","EOSDY":731,"DTHDT":"2022-11-17","LSTALVDT":"2022-12-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.15676,"AVALU":"YEARS","ADTM":"2021-09-12","ADY":300,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-2-id-176","SUBJID":"id-176","SITEID":"RUS-2","AGE":42,"SEX":"F","RACE":"WHITE","COUNTRY":"RUS","INVID":"RUS-2","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":5.65962,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-11-16","TRTSDTM":"2020-11-16 23:12:53","TRTEDTM":"2022-11-17 10:51:17","EOSSTT":"COMPLETED","EOSDT":"2022-11-17","EOSDY":731,"DTHDT":"2022-11-17","LSTALVDT":"2022-12-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.41322,"AVALU":"YEARS","ADTM":"2022-08-04","ADY":626,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-3-id-378","SUBJID":"id-378","SITEID":"RUS-3","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":2.80324,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-09-30","TRTSDTM":"2019-10-04 12:55:28","TRTEDTM":"2021-10-04 00:33:52","EOSSTT":"COMPLETED","EOSDT":"2021-10-04","EOSDY":731,"DTHDT":"2021-10-04","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01511,"AVALU":"YEARS","ADTM":"2020-10-05","ADY":367,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-3-id-378","SUBJID":"id-378","SITEID":"RUS-3","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":2.80324,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-09-30","TRTSDTM":"2019-10-04 12:55:28","TRTEDTM":"2021-10-04 00:33:52","EOSSTT":"COMPLETED","EOSDT":"2021-10-04","EOSDY":731,"DTHDT":"2021-10-04","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.09286,"AVALU":"YEARS","ADTM":"2021-04-02","ADY":546,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-3-id-378","SUBJID":"id-378","SITEID":"RUS-3","AGE":30,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":2.80324,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-09-30","TRTSDTM":"2019-10-04 12:55:28","TRTEDTM":"2021-10-04 00:33:52","EOSSTT":"COMPLETED","EOSDT":"2021-10-04","EOSDY":731,"DTHDT":"2021-10-04","LSTALVDT":"2021-10-15","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.0474,"AVALU":"YEARS","ADTM":"2020-08-12","ADY":313,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-4-id-150","SUBJID":"id-150","SITEID":"RUS-4","AGE":29,"SEX":"M","RACE":"WHITE","COUNTRY":"RUS","INVID":"RUS-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.31455,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-13","TRTSDTM":"2020-10-13 14:14:57","TRTEDTM":"2022-10-14 01:53:21","EOSSTT":"COMPLETED","EOSDT":"2022-10-14","EOSDY":731,"DTHDT":"2022-10-14","LSTALVDT":"2022-11-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.64535,"AVALU":"YEARS","ADTM":"2021-01-16","ADY":95,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-4-id-150","SUBJID":"id-150","SITEID":"RUS-4","AGE":29,"SEX":"M","RACE":"WHITE","COUNTRY":"RUS","INVID":"RUS-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.31455,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-13","TRTSDTM":"2020-10-13 14:14:57","TRTEDTM":"2022-10-14 01:53:21","EOSSTT":"COMPLETED","EOSDT":"2022-10-14","EOSDY":731,"DTHDT":"2022-10-14","LSTALVDT":"2022-11-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.66696,"AVALU":"YEARS","ADTM":"2021-03-09","ADY":147,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-4-id-150","SUBJID":"id-150","SITEID":"RUS-4","AGE":29,"SEX":"M","RACE":"WHITE","COUNTRY":"RUS","INVID":"RUS-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.31455,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-13","TRTSDTM":"2020-10-13 14:14:57","TRTEDTM":"2022-10-14 01:53:21","EOSSTT":"COMPLETED","EOSDT":"2022-10-14","EOSDY":731,"DTHDT":"2022-10-14","LSTALVDT":"2022-11-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.59033,"AVALU":"YEARS","ADTM":"2021-05-05","ADY":204,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-4-id-180","SUBJID":"id-180","SITEID":"RUS-4","AGE":31,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":1.62272,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-21","TRTSDTM":"2020-01-25 11:41:02","TRTEDTM":"2022-01-24 23:19:26","EOSSTT":"COMPLETED","EOSDT":"2022-01-24","EOSDY":731,"DTHDT":"2022-01-24","LSTALVDT":"2022-02-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.51935,"AVALU":"YEARS","ADTM":"2020-07-09","ADY":166,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-4-id-180","SUBJID":"id-180","SITEID":"RUS-4","AGE":31,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":1.62272,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-21","TRTSDTM":"2020-01-25 11:41:02","TRTEDTM":"2022-01-24 23:19:26","EOSSTT":"COMPLETED","EOSDT":"2022-01-24","EOSDY":731,"DTHDT":"2022-01-24","LSTALVDT":"2022-02-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.02805,"AVALU":"YEARS","ADTM":"2022-01-13","ADY":719,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-4-id-180","SUBJID":"id-180","SITEID":"RUS-4","AGE":31,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":1.62272,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-21","TRTSDTM":"2020-01-25 11:41:02","TRTEDTM":"2022-01-24 23:19:26","EOSSTT":"COMPLETED","EOSDT":"2022-01-24","EOSDY":731,"DTHDT":"2022-01-24","LSTALVDT":"2022-02-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.22726,"AVALU":"YEARS","ADTM":"2020-11-07","ADY":287,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-4-id-6","SUBJID":"id-6","SITEID":"RUS-4","AGE":44,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":4.9442,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-04","TRTSDTM":"2019-11-07 10:36:52","TRTEDTM":"2021-11-06 22:15:16","EOSSTT":"COMPLETED","EOSDT":"2021-11-06","EOSDY":731,"DTHDT":"2021-11-06","LSTALVDT":"2021-12-01","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.10583,"AVALU":"YEARS","ADTM":"2019-12-15","ADY":38,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-4-id-6","SUBJID":"id-6","SITEID":"RUS-4","AGE":44,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":4.9442,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-04","TRTSDTM":"2019-11-07 10:36:52","TRTEDTM":"2021-11-06 22:15:16","EOSSTT":"COMPLETED","EOSDT":"2021-11-06","EOSDY":731,"DTHDT":"2021-11-06","LSTALVDT":"2021-12-01","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00039,"AVALU":"YEARS","ADTM":"2021-06-06","ADY":577,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-4-id-6","SUBJID":"id-6","SITEID":"RUS-4","AGE":44,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":4.9442,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-04","TRTSDTM":"2019-11-07 10:36:52","TRTEDTM":"2021-11-06 22:15:16","EOSSTT":"COMPLETED","EOSDT":"2021-11-06","EOSDY":731,"DTHDT":"2021-11-06","LSTALVDT":"2021-12-01","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.14956,"AVALU":"YEARS","ADTM":"2020-07-07","ADY":243,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-5-id-29","SUBJID":"id-29","SITEID":"RUS-5","AGE":58,"SEX":"M","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.11508,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-07-11","TRTSDTM":"2021-07-14 10:27:26","TRTEDTM":"2021-09-24 16:58:16","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":73,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.51703,"AVALU":"YEARS","ADTM":"2021-09-07","ADY":55,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-5-id-29","SUBJID":"id-29","SITEID":"RUS-5","AGE":58,"SEX":"M","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.11508,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-07-11","TRTSDTM":"2021-07-14 10:27:26","TRTEDTM":"2021-09-24 16:58:16","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":73,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00391,"AVALU":"YEARS","ADTM":"2021-08-08","ADY":25,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-5-id-29","SUBJID":"id-29","SITEID":"RUS-5","AGE":58,"SEX":"M","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":2.11508,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-07-11","TRTSDTM":"2021-07-14 10:27:26","TRTEDTM":"2021-09-24 16:58:16","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":73,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-24","LSTALVDT":"2021-10-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":1.04305,"AVALU":"YEARS","ADTM":"2021-09-18","ADY":66,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-6-id-77","SUBJID":"id-77","SITEID":"RUS-6","AGE":26,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-6","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":5.81259,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-30","TRTSDTM":"2021-07-01 06:28:19","TRTEDTM":"2021-09-25 01:39:55","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":86,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.31807,"AVALU":"YEARS","ADTM":"2021-09-12","ADY":73,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-6-id-77","SUBJID":"id-77","SITEID":"RUS-6","AGE":26,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-6","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":5.81259,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-30","TRTSDTM":"2021-07-01 06:28:19","TRTEDTM":"2021-09-25 01:39:55","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":86,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.03601,"AVALU":"YEARS","ADTM":"2021-07-01","ADY":0,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-6-id-77","SUBJID":"id-77","SITEID":"RUS-6","AGE":26,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"RUS","INVID":"RUS-6","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":5.81259,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-30","TRTSDTM":"2021-07-01 06:28:19","TRTEDTM":"2021-09-25 01:39:55","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":86,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-13","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.7766,"AVALU":"YEARS","ADTM":"2021-08-14","ADY":44,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-7-id-243","SUBJID":"id-243","SITEID":"RUS-7","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-7","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":3.0318,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-08-28","TRTSDTM":"2021-08-29 17:20:23","TRTEDTM":"2021-09-21 19:55:15","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":24,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-21","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01761,"AVALU":"YEARS","ADTM":"2021-09-21","ADY":23,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-7-id-243","SUBJID":"id-243","SITEID":"RUS-7","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-7","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":3.0318,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-08-28","TRTSDTM":"2021-08-29 17:20:23","TRTEDTM":"2021-09-21 19:55:15","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":24,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-21","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.07085,"AVALU":"YEARS","ADTM":"2021-09-10","ADY":12,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-RUS-7-id-243","SUBJID":"id-243","SITEID":"RUS-7","AGE":27,"SEX":"F","RACE":"ASIAN","COUNTRY":"RUS","INVID":"RUS-7","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":3.0318,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-08-28","TRTSDTM":"2021-08-29 17:20:23","TRTEDTM":"2021-09-21 19:55:15","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":24,"DCSREAS":"ADVERSE EVENT","DTHDT":"2021-09-21","LSTALVDT":"2021-10-03","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07742,"AVALU":"YEARS","ADTM":"2021-09-08","ADY":10,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-137","SUBJID":"id-137","SITEID":"USA-1","AGE":29,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":3.40697,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-06","TRTSDTM":"2019-12-08 04:52:54","TRTEDTM":"2021-09-20 11:18:20","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":653,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12435,"AVALU":"YEARS","ADTM":"2020-11-26","ADY":354,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-137","SUBJID":"id-137","SITEID":"USA-1","AGE":29,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":3.40697,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-06","TRTSDTM":"2019-12-08 04:52:54","TRTEDTM":"2021-09-20 11:18:20","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":653,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.12577,"AVALU":"YEARS","ADTM":"2021-05-27","ADY":536,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-137","SUBJID":"id-137","SITEID":"USA-1","AGE":29,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":3.40697,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-06","TRTSDTM":"2019-12-08 04:52:54","TRTEDTM":"2021-09-20 11:18:20","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":653,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-04","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.31413,"AVALU":"YEARS","ADTM":"2021-06-25","ADY":565,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-138","SUBJID":"id-138","SITEID":"USA-1","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.96586,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-20","TRTSDTM":"2021-03-21 12:30:15","TRTEDTM":"2021-09-21 13:05:07","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":185,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-21","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03606,"AVALU":"YEARS","ADTM":"2021-09-14","ADY":177,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-138","SUBJID":"id-138","SITEID":"USA-1","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.96586,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-20","TRTSDTM":"2021-03-21 12:30:15","TRTEDTM":"2021-09-21 13:05:07","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":185,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-21","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.81961,"AVALU":"YEARS","ADTM":"2021-05-03","ADY":43,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-138","SUBJID":"id-138","SITEID":"USA-1","AGE":36,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":2.96586,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-03-20","TRTSDTM":"2021-03-21 12:30:15","TRTEDTM":"2021-09-21 13:05:07","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-21","EOSDY":185,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-21","LSTALVDT":"2021-10-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.23476,"AVALU":"YEARS","ADTM":"2021-04-24","ADY":34,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-207","SUBJID":"id-207","SITEID":"USA-1","AGE":38,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":5.30656,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-20","TRTSDTM":"2021-08-21 06:43:46","TRTEDTM":"2023-08-21 18:22:10","EOSSTT":"COMPLETED","EOSDT":"2023-08-21","EOSDY":731,"DTHDT":"2023-08-21","LSTALVDT":"2023-09-08","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.16963,"AVALU":"YEARS","ADTM":"2022-08-21","ADY":365,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-207","SUBJID":"id-207","SITEID":"USA-1","AGE":38,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":5.30656,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-20","TRTSDTM":"2021-08-21 06:43:46","TRTEDTM":"2023-08-21 18:22:10","EOSSTT":"COMPLETED","EOSDT":"2023-08-21","EOSDY":731,"DTHDT":"2023-08-21","LSTALVDT":"2023-09-08","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.80435,"AVALU":"YEARS","ADTM":"2022-02-19","ADY":182,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-207","SUBJID":"id-207","SITEID":"USA-1","AGE":38,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":5.30656,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-08-20","TRTSDTM":"2021-08-21 06:43:46","TRTEDTM":"2023-08-21 18:22:10","EOSSTT":"COMPLETED","EOSDT":"2023-08-21","EOSDY":731,"DTHDT":"2023-08-21","LSTALVDT":"2023-09-08","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.52392,"AVALU":"YEARS","ADTM":"2021-11-16","ADY":87,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-242","SUBJID":"id-242","SITEID":"USA-1","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":13.87859,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-30","TRTSDTM":"2019-12-02 05:29:54","TRTEDTM":"2021-12-01 17:08:18","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03568,"AVALU":"YEARS","ADTM":"2019-12-17","ADY":15,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-242","SUBJID":"id-242","SITEID":"USA-1","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":13.87859,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-30","TRTSDTM":"2019-12-02 05:29:54","TRTEDTM":"2021-12-01 17:08:18","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.24997,"AVALU":"YEARS","ADTM":"2020-09-21","ADY":294,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-242","SUBJID":"id-242","SITEID":"USA-1","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":13.87859,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-11-30","TRTSDTM":"2019-12-02 05:29:54","TRTEDTM":"2021-12-01 17:08:18","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.31479,"AVALU":"YEARS","ADTM":"2020-09-11","ADY":284,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-254","SUBJID":"id-254","SITEID":"USA-1","AGE":28,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":2.65998,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-20","TRTSDTM":"2021-04-22 00:21:52","TRTEDTM":"2023-04-22 12:00:16","EOSSTT":"COMPLETED","EOSDT":"2023-04-22","EOSDY":731,"DTHDT":"2023-04-22","LSTALVDT":"2023-05-18","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00363,"AVALU":"YEARS","ADTM":"2021-09-04","ADY":135,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-254","SUBJID":"id-254","SITEID":"USA-1","AGE":28,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":2.65998,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-20","TRTSDTM":"2021-04-22 00:21:52","TRTEDTM":"2023-04-22 12:00:16","EOSSTT":"COMPLETED","EOSDT":"2023-04-22","EOSDY":731,"DTHDT":"2023-04-22","LSTALVDT":"2023-05-18","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.21471,"AVALU":"YEARS","ADTM":"2022-06-18","ADY":422,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-254","SUBJID":"id-254","SITEID":"USA-1","AGE":28,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":2.65998,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-20","TRTSDTM":"2021-04-22 00:21:52","TRTEDTM":"2023-04-22 12:00:16","EOSSTT":"COMPLETED","EOSDT":"2023-04-22","EOSDY":731,"DTHDT":"2023-04-22","LSTALVDT":"2023-05-18","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07335,"AVALU":"YEARS","ADTM":"2021-10-23","ADY":184,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-261","SUBJID":"id-261","SITEID":"USA-1","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":2.85516,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-10-07","TRTSDTM":"2019-10-11 02:57:15","TRTEDTM":"2021-10-10 14:35:39","EOSSTT":"COMPLETED","EOSDT":"2021-10-10","EOSDY":731,"DTHDT":"2021-10-10","LSTALVDT":"2021-10-26","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.19881,"AVALU":"YEARS","ADTM":"2020-06-16","ADY":249,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-261","SUBJID":"id-261","SITEID":"USA-1","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":2.85516,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-10-07","TRTSDTM":"2019-10-11 02:57:15","TRTEDTM":"2021-10-10 14:35:39","EOSSTT":"COMPLETED","EOSDT":"2021-10-10","EOSDY":731,"DTHDT":"2021-10-10","LSTALVDT":"2021-10-26","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00877,"AVALU":"YEARS","ADTM":"2020-03-29","ADY":170,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-261","SUBJID":"id-261","SITEID":"USA-1","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":2.85516,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-10-07","TRTSDTM":"2019-10-11 02:57:15","TRTEDTM":"2021-10-10 14:35:39","EOSSTT":"COMPLETED","EOSDT":"2021-10-10","EOSDY":731,"DTHDT":"2021-10-10","LSTALVDT":"2021-10-26","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.61537,"AVALU":"YEARS","ADTM":"2020-11-08","ADY":394,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-269","SUBJID":"id-269","SITEID":"USA-1","AGE":35,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.54767,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-20","TRTSDTM":"2019-12-21 20:48:10","TRTEDTM":"2021-12-21 08:26:34","EOSSTT":"COMPLETED","EOSDT":"2021-12-21","EOSDY":731,"DTHDT":"2021-12-21","LSTALVDT":"2022-01-07","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.08514,"AVALU":"YEARS","ADTM":"2020-04-24","ADY":125,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-269","SUBJID":"id-269","SITEID":"USA-1","AGE":35,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.54767,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-20","TRTSDTM":"2019-12-21 20:48:10","TRTEDTM":"2021-12-21 08:26:34","EOSSTT":"COMPLETED","EOSDT":"2021-12-21","EOSDY":731,"DTHDT":"2021-12-21","LSTALVDT":"2022-01-07","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.2126,"AVALU":"YEARS","ADTM":"2020-07-12","ADY":204,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-269","SUBJID":"id-269","SITEID":"USA-1","AGE":35,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":3.54767,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-20","TRTSDTM":"2019-12-21 20:48:10","TRTEDTM":"2021-12-21 08:26:34","EOSSTT":"COMPLETED","EOSDT":"2021-12-21","EOSDY":731,"DTHDT":"2021-12-21","LSTALVDT":"2022-01-07","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11548,"AVALU":"YEARS","ADTM":"2020-12-25","ADY":370,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-295","SUBJID":"id-295","SITEID":"USA-1","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":1.68619,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-13","TRTSDTM":"2020-03-15 09:20:44","TRTEDTM":"2022-03-15 20:59:08","EOSSTT":"COMPLETED","EOSDT":"2022-03-15","EOSDY":731,"DTHDT":"2022-03-15","LSTALVDT":"2022-04-04","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.19734,"AVALU":"YEARS","ADTM":"2021-05-03","ADY":414,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-295","SUBJID":"id-295","SITEID":"USA-1","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":1.68619,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-13","TRTSDTM":"2020-03-15 09:20:44","TRTEDTM":"2022-03-15 20:59:08","EOSSTT":"COMPLETED","EOSDT":"2022-03-15","EOSDY":731,"DTHDT":"2022-03-15","LSTALVDT":"2022-04-04","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.17377,"AVALU":"YEARS","ADTM":"2020-03-26","ADY":11,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-295","SUBJID":"id-295","SITEID":"USA-1","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-1","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":1.68619,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-03-13","TRTSDTM":"2020-03-15 09:20:44","TRTEDTM":"2022-03-15 20:59:08","EOSSTT":"COMPLETED","EOSDT":"2022-03-15","EOSDY":731,"DTHDT":"2022-03-15","LSTALVDT":"2022-04-04","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.29768,"AVALU":"YEARS","ADTM":"2021-07-22","ADY":494,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-394","SUBJID":"id-394","SITEID":"USA-1","AGE":46,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":6.14556,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-07-20","TRTSDTM":"2020-07-24 04:50:21","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.08759,"AVALU":"YEARS","ADTM":"2021-09-17","ADY":420,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-394","SUBJID":"id-394","SITEID":"USA-1","AGE":46,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":6.14556,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-07-20","TRTSDTM":"2020-07-24 04:50:21","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.18836,"AVALU":"YEARS","ADTM":"2020-12-31","ADY":160,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-394","SUBJID":"id-394","SITEID":"USA-1","AGE":46,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-1","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":6.14556,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-07-20","TRTSDTM":"2020-07-24 04:50:21","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.60519,"AVALU":"YEARS","ADTM":"2020-11-20","ADY":119,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-45","SUBJID":"id-45","SITEID":"USA-1","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":0.46356,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-08","TRTSDTM":"2019-10-10 16:08:24","TRTEDTM":"2021-10-10 03:46:48","EOSSTT":"COMPLETED","EOSDT":"2021-10-10","EOSDY":731,"DTHDT":"2021-10-10","LSTALVDT":"2021-10-24","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.23968,"AVALU":"YEARS","ADTM":"2020-04-02","ADY":175,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-45","SUBJID":"id-45","SITEID":"USA-1","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":0.46356,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-08","TRTSDTM":"2019-10-10 16:08:24","TRTEDTM":"2021-10-10 03:46:48","EOSSTT":"COMPLETED","EOSDT":"2021-10-10","EOSDY":731,"DTHDT":"2021-10-10","LSTALVDT":"2021-10-24","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":1.08037,"AVALU":"YEARS","ADTM":"2021-06-08","ADY":607,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-1-id-45","SUBJID":"id-45","SITEID":"USA-1","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-1","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S1","BMRKR1":0.46356,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-10-08","TRTSDTM":"2019-10-10 16:08:24","TRTEDTM":"2021-10-10 03:46:48","EOSSTT":"COMPLETED","EOSDT":"2021-10-10","EOSDY":731,"DTHDT":"2021-10-10","LSTALVDT":"2021-10-24","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.22788,"AVALU":"YEARS","ADTM":"2021-02-08","ADY":487,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-100","SUBJID":"id-100","SITEID":"USA-11","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":6.64371,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-13","TRTSDTM":"2020-10-15 03:27:54","TRTEDTM":"2022-10-15 15:06:18","EOSSTT":"COMPLETED","EOSDT":"2022-10-15","EOSDY":731,"DTHDT":"2022-10-15","LSTALVDT":"2022-10-29","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.00631,"AVALU":"YEARS","ADTM":"2021-01-21","ADY":98,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-100","SUBJID":"id-100","SITEID":"USA-11","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":6.64371,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-13","TRTSDTM":"2020-10-15 03:27:54","TRTEDTM":"2022-10-15 15:06:18","EOSSTT":"COMPLETED","EOSDT":"2022-10-15","EOSDY":731,"DTHDT":"2022-10-15","LSTALVDT":"2022-10-29","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.08319,"AVALU":"YEARS","ADTM":"2021-07-10","ADY":268,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-100","SUBJID":"id-100","SITEID":"USA-11","AGE":40,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":6.64371,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-13","TRTSDTM":"2020-10-15 03:27:54","TRTEDTM":"2022-10-15 15:06:18","EOSSTT":"COMPLETED","EOSDT":"2022-10-15","EOSDY":731,"DTHDT":"2022-10-15","LSTALVDT":"2022-10-29","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.12046,"AVALU":"YEARS","ADTM":"2021-09-14","ADY":334,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-136","SUBJID":"id-136","SITEID":"USA-11","AGE":38,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.57955,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-03","TRTSDTM":"2020-05-07 14:34:36","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.1721,"AVALU":"YEARS","ADTM":"2020-11-06","ADY":183,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-136","SUBJID":"id-136","SITEID":"USA-11","AGE":38,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.57955,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-03","TRTSDTM":"2020-05-07 14:34:36","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.05066,"AVALU":"YEARS","ADTM":"2022-03-05","ADY":667,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-136","SUBJID":"id-136","SITEID":"USA-11","AGE":38,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.57955,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-05-03","TRTSDTM":"2020-05-07 14:34:36","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.1172,"AVALU":"YEARS","ADTM":"2021-01-20","ADY":258,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-157","SUBJID":"id-157","SITEID":"USA-11","AGE":50,"SEX":"M","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":6.18035,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-01-19","TRTSDTM":"2021-01-19 06:38:52","TRTEDTM":"2021-09-25 08:39:18","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":250,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-25","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.12286,"AVALU":"YEARS","ADTM":"2021-03-24","ADY":64,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-157","SUBJID":"id-157","SITEID":"USA-11","AGE":50,"SEX":"M","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":6.18035,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-01-19","TRTSDTM":"2021-01-19 06:38:52","TRTEDTM":"2021-09-25 08:39:18","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":250,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-25","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.11876,"AVALU":"YEARS","ADTM":"2021-08-08","ADY":201,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-157","SUBJID":"id-157","SITEID":"USA-11","AGE":50,"SEX":"M","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S2","BMRKR1":6.18035,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-01-19","TRTSDTM":"2021-01-19 06:38:52","TRTEDTM":"2021-09-25 08:39:18","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":250,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-25","LSTALVDT":"2021-10-06","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07185,"AVALU":"YEARS","ADTM":"2021-03-14","ADY":54,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-203","SUBJID":"id-203","SITEID":"USA-11","AGE":41,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":5.60082,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-07-31","TRTSDTM":"2020-08-03 19:02:37","TRTEDTM":"2021-09-24 10:16:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":417,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.10434,"AVALU":"YEARS","ADTM":"2020-08-22","ADY":19,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-203","SUBJID":"id-203","SITEID":"USA-11","AGE":41,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":5.60082,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-07-31","TRTSDTM":"2020-08-03 19:02:37","TRTEDTM":"2021-09-24 10:16:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":417,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.07246,"AVALU":"YEARS","ADTM":"2021-08-18","ADY":380,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-203","SUBJID":"id-203","SITEID":"USA-11","AGE":41,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":5.60082,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-07-31","TRTSDTM":"2020-08-03 19:02:37","TRTEDTM":"2021-09-24 10:16:26","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":417,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.46728,"AVALU":"YEARS","ADTM":"2021-09-11","ADY":404,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-224","SUBJID":"id-224","SITEID":"USA-11","AGE":36,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":6.42717,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-20","TRTSDTM":"2021-06-24 06:45:26","TRTEDTM":"2023-06-24 18:23:50","EOSSTT":"COMPLETED","EOSDT":"2023-06-24","EOSDY":731,"DTHDT":"2023-06-24","LSTALVDT":"2023-07-21","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03842,"AVALU":"YEARS","ADTM":"2022-06-01","ADY":342,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-224","SUBJID":"id-224","SITEID":"USA-11","AGE":36,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":6.42717,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-20","TRTSDTM":"2021-06-24 06:45:26","TRTEDTM":"2023-06-24 18:23:50","EOSSTT":"COMPLETED","EOSDT":"2023-06-24","EOSDY":731,"DTHDT":"2023-06-24","LSTALVDT":"2023-07-21","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.19668,"AVALU":"YEARS","ADTM":"2022-05-27","ADY":337,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-224","SUBJID":"id-224","SITEID":"USA-11","AGE":36,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":6.42717,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-06-20","TRTSDTM":"2021-06-24 06:45:26","TRTEDTM":"2023-06-24 18:23:50","EOSSTT":"COMPLETED","EOSDT":"2023-06-24","EOSDY":731,"DTHDT":"2023-06-24","LSTALVDT":"2023-07-21","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.11067,"AVALU":"YEARS","ADTM":"2023-05-24","ADY":699,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-238","SUBJID":"id-238","SITEID":"USA-11","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":8.0392,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-07-21","TRTSDTM":"2020-07-23 01:44:58","TRTEDTM":"2021-09-24 11:23:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":429,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-23","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.27255,"AVALU":"YEARS","ADTM":"2021-06-11","ADY":323,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"End of AE Reporting Period"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-238","SUBJID":"id-238","SITEID":"USA-11","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":8.0392,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-07-21","TRTSDTM":"2020-07-23 01:44:58","TRTEDTM":"2021-09-24 11:23:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":429,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-23","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.36624,"AVALU":"YEARS","ADTM":"2021-08-23","ADY":396,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-238","SUBJID":"id-238","SITEID":"USA-11","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"C","STRATA2":"S2","BMRKR1":8.0392,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-07-21","TRTSDTM":"2020-07-23 01:44:58","TRTEDTM":"2021-09-24 11:23:45","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":429,"DCSREAS":"WITHDRAWAL BY SUBJECT","DTHDT":"2021-09-24","LSTALVDT":"2021-10-23","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.26743,"AVALU":"YEARS","ADTM":"2021-02-22","ADY":214,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-32","SUBJID":"id-32","SITEID":"USA-11","AGE":24,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":8.45456,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-14","TRTSDTM":"2020-10-18 08:02:57","TRTEDTM":"2022-10-18 19:41:21","EOSSTT":"COMPLETED","EOSDT":"2022-10-18","EOSDY":731,"DTHDT":"2022-10-18","LSTALVDT":"2022-11-05","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.16069,"AVALU":"YEARS","ADTM":"2021-02-15","ADY":120,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-32","SUBJID":"id-32","SITEID":"USA-11","AGE":24,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":8.45456,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-14","TRTSDTM":"2020-10-18 08:02:57","TRTEDTM":"2022-10-18 19:41:21","EOSSTT":"COMPLETED","EOSDT":"2022-10-18","EOSDY":731,"DTHDT":"2022-10-18","LSTALVDT":"2022-11-05","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.00681,"AVALU":"YEARS","ADTM":"2022-01-01","ADY":440,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-32","SUBJID":"id-32","SITEID":"USA-11","AGE":24,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":8.45456,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-10-14","TRTSDTM":"2020-10-18 08:02:57","TRTEDTM":"2022-10-18 19:41:21","EOSSTT":"COMPLETED","EOSDT":"2022-10-18","EOSDY":731,"DTHDT":"2022-10-18","LSTALVDT":"2022-11-05","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01366,"AVALU":"YEARS","ADTM":"2021-05-16","ADY":210,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-339","SUBJID":"id-339","SITEID":"USA-11","AGE":39,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":17.21213,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-05-23","TRTSDTM":"2020-05-25 05:14:38","TRTEDTM":"2021-09-20 15:15:46","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":484,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-20","LSTALVDT":"2021-10-02","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.02415,"AVALU":"YEARS","ADTM":"2021-07-26","ADY":427,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-339","SUBJID":"id-339","SITEID":"USA-11","AGE":39,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":17.21213,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-05-23","TRTSDTM":"2020-05-25 05:14:38","TRTEDTM":"2021-09-20 15:15:46","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":484,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-20","LSTALVDT":"2021-10-02","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.03981,"AVALU":"YEARS","ADTM":"2021-05-29","ADY":369,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-339","SUBJID":"id-339","SITEID":"USA-11","AGE":39,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-11","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":17.21213,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-05-23","TRTSDTM":"2020-05-25 05:14:38","TRTEDTM":"2021-09-20 15:15:46","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":484,"DCSREAS":"WITHDRAWAL BY PARENT/GUARDIAN","DTHDT":"2021-09-20","LSTALVDT":"2021-10-02","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.039,"AVALU":"YEARS","ADTM":"2020-09-20","ADY":118,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-365","SUBJID":"id-365","SITEID":"USA-11","AGE":34,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":1.90915,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-14","TRTSDTM":"2020-01-14 03:56:39","TRTEDTM":"2022-01-13 15:35:03","EOSSTT":"COMPLETED","EOSDT":"2022-01-13","EOSDY":731,"DTHDT":"2022-01-13","LSTALVDT":"2022-01-28","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.40682,"AVALU":"YEARS","ADTM":"2021-07-03","ADY":536,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-365","SUBJID":"id-365","SITEID":"USA-11","AGE":34,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":1.90915,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-14","TRTSDTM":"2020-01-14 03:56:39","TRTEDTM":"2022-01-13 15:35:03","EOSSTT":"COMPLETED","EOSDT":"2022-01-13","EOSDY":731,"DTHDT":"2022-01-13","LSTALVDT":"2022-01-28","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.33523,"AVALU":"YEARS","ADTM":"2021-08-01","ADY":565,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-11-id-365","SUBJID":"id-365","SITEID":"USA-11","AGE":34,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-11","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":1.90915,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-01-14","TRTSDTM":"2020-01-14 03:56:39","TRTEDTM":"2022-01-13 15:35:03","EOSSTT":"COMPLETED","EOSDT":"2022-01-13","EOSDY":731,"DTHDT":"2022-01-13","LSTALVDT":"2022-01-28","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.09806,"AVALU":"YEARS","ADTM":"2021-04-02","ADY":444,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-131","SUBJID":"id-131","SITEID":"USA-12","AGE":44,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.72694,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-09-21","TRTSDTM":"2021-09-24 00:18:47","TRTEDTM":"2023-09-24 11:57:11","EOSSTT":"COMPLETED","EOSDT":"2023-09-24","EOSDY":731,"DTHDT":"2023-09-24","LSTALVDT":"2023-10-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.08077,"AVALU":"YEARS","ADTM":"2023-09-07","ADY":713,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-131","SUBJID":"id-131","SITEID":"USA-12","AGE":44,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.72694,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-09-21","TRTSDTM":"2021-09-24 00:18:47","TRTEDTM":"2023-09-24 11:57:11","EOSSTT":"COMPLETED","EOSDT":"2023-09-24","EOSDY":731,"DTHDT":"2023-09-24","LSTALVDT":"2023-10-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.01067,"AVALU":"YEARS","ADTM":"2021-12-30","ADY":97,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-131","SUBJID":"id-131","SITEID":"USA-12","AGE":44,"SEX":"F","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-12","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.72694,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-09-21","TRTSDTM":"2021-09-24 00:18:47","TRTEDTM":"2023-09-24 11:57:11","EOSSTT":"COMPLETED","EOSDT":"2023-09-24","EOSDY":731,"DTHDT":"2023-09-24","LSTALVDT":"2023-10-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04133,"AVALU":"YEARS","ADTM":"2022-12-20","ADY":452,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-140","SUBJID":"id-140","SITEID":"USA-12","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":14.22993,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-07","TRTSDTM":"2021-02-09 06:53:15","TRTEDTM":"2023-02-09 18:31:39","EOSSTT":"COMPLETED","EOSDT":"2023-02-09","EOSDY":731,"DTHDT":"2023-02-09","LSTALVDT":"2023-02-28","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.18707,"AVALU":"YEARS","ADTM":"2022-04-24","ADY":439,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-140","SUBJID":"id-140","SITEID":"USA-12","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":14.22993,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-07","TRTSDTM":"2021-02-09 06:53:15","TRTEDTM":"2023-02-09 18:31:39","EOSSTT":"COMPLETED","EOSDT":"2023-02-09","EOSDY":731,"DTHDT":"2023-02-09","LSTALVDT":"2023-02-28","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.08937,"AVALU":"YEARS","ADTM":"2022-03-08","ADY":392,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-140","SUBJID":"id-140","SITEID":"USA-12","AGE":32,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":14.22993,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-07","TRTSDTM":"2021-02-09 06:53:15","TRTEDTM":"2023-02-09 18:31:39","EOSSTT":"COMPLETED","EOSDT":"2023-02-09","EOSDY":731,"DTHDT":"2023-02-09","LSTALVDT":"2023-02-28","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.06873,"AVALU":"YEARS","ADTM":"2022-11-06","ADY":635,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-152","SUBJID":"id-152","SITEID":"USA-12","AGE":29,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":6.7299,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-03-20","TRTSDTM":"2021-03-23 17:55:58","TRTEDTM":"2023-03-24 05:34:22","EOSSTT":"COMPLETED","EOSDT":"2023-03-24","EOSDY":731,"DTHDT":"2023-03-24","LSTALVDT":"2023-04-13","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.21572,"AVALU":"YEARS","ADTM":"2021-12-27","ADY":279,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-152","SUBJID":"id-152","SITEID":"USA-12","AGE":29,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":6.7299,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-03-20","TRTSDTM":"2021-03-23 17:55:58","TRTEDTM":"2023-03-24 05:34:22","EOSSTT":"COMPLETED","EOSDT":"2023-03-24","EOSDY":731,"DTHDT":"2023-03-24","LSTALVDT":"2023-04-13","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.20098,"AVALU":"YEARS","ADTM":"2022-08-29","ADY":524,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-152","SUBJID":"id-152","SITEID":"USA-12","AGE":29,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":6.7299,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-03-20","TRTSDTM":"2021-03-23 17:55:58","TRTEDTM":"2023-03-24 05:34:22","EOSSTT":"COMPLETED","EOSDT":"2023-03-24","EOSDY":731,"DTHDT":"2023-03-24","LSTALVDT":"2023-04-13","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.03561,"AVALU":"YEARS","ADTM":"2023-02-13","ADY":692,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-226","SUBJID":"id-226","SITEID":"USA-12","AGE":30,"SEX":"M","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":4.21439,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-31","TRTSDTM":"2020-09-04 03:48:14","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":1.78582,"AVALU":"YEARS","ADTM":"2021-02-02","ADY":151,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-226","SUBJID":"id-226","SITEID":"USA-12","AGE":30,"SEX":"M","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":4.21439,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-31","TRTSDTM":"2020-09-04 03:48:14","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.17463,"AVALU":"YEARS","ADTM":"2021-08-04","ADY":334,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-226","SUBJID":"id-226","SITEID":"USA-12","AGE":30,"SEX":"M","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-12","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"A","STRATA2":"S1","BMRKR1":4.21439,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2020-08-31","TRTSDTM":"2020-09-04 03:48:14","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.52717,"AVALU":"YEARS","ADTM":"2021-10-09","ADY":400,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-343","SUBJID":"id-343","SITEID":"USA-12","AGE":38,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":3.75539,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-20","TRTSDTM":"2020-10-23 02:38:09","TRTEDTM":"2021-09-26 06:11:52","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":339,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-26","LSTALVDT":"2021-10-22","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.4633,"AVALU":"YEARS","ADTM":"2021-03-15","ADY":143,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-343","SUBJID":"id-343","SITEID":"USA-12","AGE":38,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":3.75539,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-20","TRTSDTM":"2020-10-23 02:38:09","TRTEDTM":"2021-09-26 06:11:52","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":339,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-26","LSTALVDT":"2021-10-22","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.27194,"AVALU":"YEARS","ADTM":"2021-09-15","ADY":327,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-343","SUBJID":"id-343","SITEID":"USA-12","AGE":38,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S2","BMRKR1":3.75539,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-10-20","TRTSDTM":"2020-10-23 02:38:09","TRTEDTM":"2021-09-26 06:11:52","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-26","EOSDY":339,"DCSREAS":"PROTOCOL VIOLATION","DTHDT":"2021-09-26","LSTALVDT":"2021-10-22","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00994,"AVALU":"YEARS","ADTM":"2021-02-17","ADY":117,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-44","SUBJID":"id-44","SITEID":"USA-12","AGE":34,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":8.53653,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-02","TRTSDTM":"2019-12-02 10:09:28","TRTEDTM":"2021-12-01 21:47:52","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-25","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.4579,"AVALU":"YEARS","ADTM":"2020-01-30","ADY":59,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-44","SUBJID":"id-44","SITEID":"USA-12","AGE":34,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":8.53653,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-02","TRTSDTM":"2019-12-02 10:09:28","TRTEDTM":"2021-12-01 21:47:52","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-25","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.1263,"AVALU":"YEARS","ADTM":"2021-03-30","ADY":484,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-12-id-44","SUBJID":"id-44","SITEID":"USA-12","AGE":34,"SEX":"F","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-12","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S2","BMRKR1":8.53653,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-02","TRTSDTM":"2019-12-02 10:09:28","TRTEDTM":"2021-12-01 21:47:52","EOSSTT":"COMPLETED","EOSDT":"2021-12-01","EOSDY":731,"DTHDT":"2021-12-01","LSTALVDT":"2021-12-25","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01206,"AVALU":"YEARS","ADTM":"2020-06-04","ADY":185,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-14-id-196","SUBJID":"id-196","SITEID":"USA-14","AGE":31,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":3.92637,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-27","TRTSDTM":"2020-08-30 21:07:50","TRTEDTM":"2021-09-18 12:08:39","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":384,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-18","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.23975,"AVALU":"YEARS","ADTM":"2020-11-17","ADY":79,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-14-id-196","SUBJID":"id-196","SITEID":"USA-14","AGE":31,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":3.92637,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-27","TRTSDTM":"2020-08-30 21:07:50","TRTEDTM":"2021-09-18 12:08:39","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":384,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-18","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.48679,"AVALU":"YEARS","ADTM":"2020-10-17","ADY":48,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-14-id-196","SUBJID":"id-196","SITEID":"USA-14","AGE":31,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-14","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":3.92637,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-08-27","TRTSDTM":"2020-08-30 21:07:50","TRTEDTM":"2021-09-18 12:08:39","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-18","EOSDY":384,"DCSREAS":"LACK OF EFFICACY","DTHDT":"2021-09-18","LSTALVDT":"2021-10-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.02016,"AVALU":"YEARS","ADTM":"2021-09-04","ADY":370,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-15-id-127","SUBJID":"id-127","SITEID":"USA-15","AGE":57,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-15","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":3.37225,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-13","TRTSDTM":"2019-12-16 10:06:43","TRTEDTM":"2021-12-15 21:45:07","EOSSTT":"COMPLETED","EOSDT":"2021-12-15","EOSDY":731,"DTHDT":"2021-12-15","LSTALVDT":"2022-01-05","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.30345,"AVALU":"YEARS","ADTM":"2019-12-28","ADY":12,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-15-id-127","SUBJID":"id-127","SITEID":"USA-15","AGE":57,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-15","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":3.37225,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-13","TRTSDTM":"2019-12-16 10:06:43","TRTEDTM":"2021-12-15 21:45:07","EOSSTT":"COMPLETED","EOSDT":"2021-12-15","EOSDY":731,"DTHDT":"2021-12-15","LSTALVDT":"2022-01-05","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.07496,"AVALU":"YEARS","ADTM":"2020-10-09","ADY":298,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-15-id-127","SUBJID":"id-127","SITEID":"USA-15","AGE":57,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-15","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":3.37225,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2019-12-13","TRTSDTM":"2019-12-16 10:06:43","TRTEDTM":"2021-12-15 21:45:07","EOSSTT":"COMPLETED","EOSDT":"2021-12-15","EOSDY":731,"DTHDT":"2021-12-15","LSTALVDT":"2022-01-05","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.33477,"AVALU":"YEARS","ADTM":"2020-05-20","ADY":156,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-15-id-372","SUBJID":"id-372","SITEID":"USA-15","AGE":27,"SEX":"M","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.4481,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-25","TRTSDTM":"2020-08-27 21:51:51","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.20846,"AVALU":"YEARS","ADTM":"2020-09-27","ADY":31,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-15-id-372","SUBJID":"id-372","SITEID":"USA-15","AGE":27,"SEX":"M","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.4481,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-25","TRTSDTM":"2020-08-27 21:51:51","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.52158,"AVALU":"YEARS","ADTM":"2022-03-17","ADY":567,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-15-id-372","SUBJID":"id-372","SITEID":"USA-15","AGE":27,"SEX":"M","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-15","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":3.4481,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-25","TRTSDTM":"2020-08-27 21:51:51","EOSSTT":"ONGOING","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.08301,"AVALU":"YEARS","ADTM":"2021-11-19","ADY":449,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-17-id-142","SUBJID":"id-142","SITEID":"USA-17","AGE":31,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":8.8187,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-17","TRTSDTM":"2019-12-18 22:30:02","TRTEDTM":"2021-12-18 10:08:26","EOSSTT":"COMPLETED","EOSDT":"2021-12-18","EOSDY":731,"DTHDT":"2021-12-18","LSTALVDT":"2022-01-04","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.08467,"AVALU":"YEARS","ADTM":"2020-10-05","ADY":292,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-17-id-142","SUBJID":"id-142","SITEID":"USA-17","AGE":31,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":8.8187,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-17","TRTSDTM":"2019-12-18 22:30:02","TRTEDTM":"2021-12-18 10:08:26","EOSSTT":"COMPLETED","EOSDT":"2021-12-18","EOSDY":731,"DTHDT":"2021-12-18","LSTALVDT":"2022-01-04","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.60099,"AVALU":"YEARS","ADTM":"2021-11-22","ADY":705,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-17-id-142","SUBJID":"id-142","SITEID":"USA-17","AGE":31,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-17","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S2","BMRKR1":8.8187,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2019-12-17","TRTSDTM":"2019-12-18 22:30:02","TRTEDTM":"2021-12-18 10:08:26","EOSSTT":"COMPLETED","EOSDT":"2021-12-18","EOSDY":731,"DTHDT":"2021-12-18","LSTALVDT":"2022-01-04","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.12352,"AVALU":"YEARS","ADTM":"2021-05-24","ADY":523,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-17-id-3","SUBJID":"id-3","SITEID":"USA-17","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":5.39748,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-31","TRTSDTM":"2020-09-01 00:57:16","TRTEDTM":"2021-09-24 21:48:06","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":389,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-05","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01174,"AVALU":"YEARS","ADTM":"2021-02-15","ADY":167,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-17-id-3","SUBJID":"id-3","SITEID":"USA-17","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":5.39748,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-31","TRTSDTM":"2020-09-01 00:57:16","TRTEDTM":"2021-09-24 21:48:06","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":389,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-05","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.26534,"AVALU":"YEARS","ADTM":"2021-05-06","ADY":247,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Completion or Discontinuation"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-17-id-3","SUBJID":"id-3","SITEID":"USA-17","AGE":36,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-17","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S1","BMRKR1":5.39748,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-08-31","TRTSDTM":"2020-09-01 00:57:16","TRTEDTM":"2021-09-24 21:48:06","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-24","EOSDY":389,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-24","LSTALVDT":"2021-10-05","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.09358,"AVALU":"YEARS","ADTM":"2021-03-19","ADY":199,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-19-id-58","SUBJID":"id-58","SITEID":"USA-19","AGE":47,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-19","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":2.54605,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-05","TRTSDTM":"2021-06-07 05:44:35","TRTEDTM":"2023-06-07 17:22:59","EOSSTT":"COMPLETED","EOSDT":"2023-06-07","EOSDY":731,"DTHDT":"2023-06-07","LSTALVDT":"2023-06-30","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01873,"AVALU":"YEARS","ADTM":"2021-12-04","ADY":180,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-19-id-58","SUBJID":"id-58","SITEID":"USA-19","AGE":47,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-19","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":2.54605,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-05","TRTSDTM":"2021-06-07 05:44:35","TRTEDTM":"2023-06-07 17:22:59","EOSSTT":"COMPLETED","EOSDT":"2023-06-07","EOSDY":731,"DTHDT":"2023-06-07","LSTALVDT":"2023-06-30","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.58473,"AVALU":"YEARS","ADTM":"2023-01-01","ADY":573,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-19-id-58","SUBJID":"id-58","SITEID":"USA-19","AGE":47,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-19","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S1","BMRKR1":2.54605,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2021-06-05","TRTSDTM":"2021-06-07 05:44:35","TRTEDTM":"2023-06-07 17:22:59","EOSSTT":"COMPLETED","EOSDT":"2023-06-07","EOSDY":731,"DTHDT":"2023-06-07","LSTALVDT":"2023-06-30","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.07633,"AVALU":"YEARS","ADTM":"2023-05-03","ADY":695,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-2-id-110","SUBJID":"id-110","SITEID":"USA-2","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":9.67482,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-26","TRTSDTM":"2021-02-26 23:47:13","TRTEDTM":"2021-09-20 09:59:31","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":206,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.01633,"AVALU":"YEARS","ADTM":"2021-06-01","ADY":95,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-2-id-110","SUBJID":"id-110","SITEID":"USA-2","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":9.67482,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-26","TRTSDTM":"2021-02-26 23:47:13","TRTEDTM":"2021-09-20 09:59:31","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":206,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.40358,"AVALU":"YEARS","ADTM":"2021-08-01","ADY":156,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-2-id-110","SUBJID":"id-110","SITEID":"USA-2","AGE":35,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-2","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"A","STRATA2":"S2","BMRKR1":9.67482,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-26","TRTSDTM":"2021-02-26 23:47:13","TRTEDTM":"2021-09-20 09:59:31","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-20","EOSDY":206,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-20","LSTALVDT":"2021-10-16","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.10572,"AVALU":"YEARS","ADTM":"2021-08-25","ADY":180,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-3-id-282","SUBJID":"id-282","SITEID":"USA-3","AGE":38,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.35944,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-22","TRTSDTM":"2021-02-23 13:18:35","TRTEDTM":"2023-02-24 00:56:59","EOSSTT":"COMPLETED","EOSDT":"2023-02-24","EOSDY":731,"DTHDT":"2023-02-24","LSTALVDT":"2023-03-09","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.495,"AVALU":"YEARS","ADTM":"2022-10-10","ADY":594,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-3-id-282","SUBJID":"id-282","SITEID":"USA-3","AGE":38,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.35944,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-22","TRTSDTM":"2021-02-23 13:18:35","TRTEDTM":"2023-02-24 00:56:59","EOSSTT":"COMPLETED","EOSDT":"2023-02-24","EOSDY":731,"DTHDT":"2023-02-24","LSTALVDT":"2023-03-09","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.14046,"AVALU":"YEARS","ADTM":"2022-07-02","ADY":494,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-3-id-282","SUBJID":"id-282","SITEID":"USA-3","AGE":38,"SEX":"M","RACE":"AMERICAN INDIAN OR ALASKA NATIVE","COUNTRY":"USA","INVID":"USA-3","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"B","STRATA2":"S1","BMRKR1":3.35944,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"Y","RANDDT":"2021-02-22","TRTSDTM":"2021-02-23 13:18:35","TRTEDTM":"2023-02-24 00:56:59","EOSSTT":"COMPLETED","EOSDT":"2023-02-24","EOSDY":731,"DTHDT":"2023-02-24","LSTALVDT":"2023-03-09","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.69832,"AVALU":"YEARS","ADTM":"2022-03-01","ADY":371,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-3-id-320","SUBJID":"id-320","SITEID":"USA-3","AGE":42,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":4.73445,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-02-29","TRTSDTM":"2020-03-03 21:16:01","TRTEDTM":"2022-03-04 08:54:25","EOSSTT":"COMPLETED","EOSDT":"2022-03-04","EOSDY":731,"DTHDT":"2022-03-04","LSTALVDT":"2022-03-17","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.09309,"AVALU":"YEARS","ADTM":"2020-09-11","ADY":192,"CNSR":0,"EVNTDESC":"Completion or Discontinuation","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-3-id-320","SUBJID":"id-320","SITEID":"USA-3","AGE":42,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":4.73445,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-02-29","TRTSDTM":"2020-03-03 21:16:01","TRTEDTM":"2022-03-04 08:54:25","EOSSTT":"COMPLETED","EOSDT":"2022-03-04","EOSDY":731,"DTHDT":"2022-03-04","LSTALVDT":"2022-03-17","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.06128,"AVALU":"YEARS","ADTM":"2021-05-17","ADY":440,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-3-id-320","SUBJID":"id-320","SITEID":"USA-3","AGE":42,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-3","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":4.73445,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-02-29","TRTSDTM":"2020-03-03 21:16:01","TRTEDTM":"2022-03-04 08:54:25","EOSSTT":"COMPLETED","EOSDT":"2022-03-04","EOSDY":731,"DTHDT":"2022-03-04","LSTALVDT":"2022-03-17","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.00991,"AVALU":"YEARS","ADTM":"2020-07-22","ADY":141,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-4-id-190","SUBJID":"id-190","SITEID":"USA-4","AGE":53,"SEX":"M","RACE":"MULTIPLE","COUNTRY":"USA","INVID":"USA-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":1.14956,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-06-04","TRTSDTM":"2020-06-04 00:23:04","TRTEDTM":"2021-09-25 13:40:40","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":479,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.04523,"AVALU":"YEARS","ADTM":"2021-01-07","ADY":217,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-4-id-190","SUBJID":"id-190","SITEID":"USA-4","AGE":53,"SEX":"M","RACE":"MULTIPLE","COUNTRY":"USA","INVID":"USA-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":1.14956,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-06-04","TRTSDTM":"2020-06-04 00:23:04","TRTEDTM":"2021-09-25 13:40:40","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":479,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":2.35851,"AVALU":"YEARS","ADTM":"2020-11-13","ADY":162,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-4-id-190","SUBJID":"id-190","SITEID":"USA-4","AGE":53,"SEX":"M","RACE":"MULTIPLE","COUNTRY":"USA","INVID":"USA-4","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"B","STRATA2":"S2","BMRKR1":1.14956,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-06-04","TRTSDTM":"2020-06-04 00:23:04","TRTEDTM":"2021-09-25 13:40:40","EOSSTT":"DISCONTINUED","EOSDT":"2021-09-25","EOSDY":479,"DCSREAS":"PHYSICIAN DECISION","DTHDT":"2021-09-25","LSTALVDT":"2021-10-20","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.28875,"AVALU":"YEARS","ADTM":"2020-11-12","ADY":161,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-4-id-382","SUBJID":"id-382","SITEID":"USA-4","AGE":31,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":7.94871,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-04-06","TRTSDTM":"2020-04-08 20:18:25","TRTEDTM":"2022-04-09 07:56:49","EOSSTT":"COMPLETED","EOSDT":"2022-04-09","EOSDY":731,"DTHDT":"2022-04-09","LSTALVDT":"2022-04-27","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.62484,"AVALU":"YEARS","ADTM":"2021-09-11","ADY":521,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-4-id-382","SUBJID":"id-382","SITEID":"USA-4","AGE":31,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":7.94871,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-04-06","TRTSDTM":"2020-04-08 20:18:25","TRTEDTM":"2022-04-09 07:56:49","EOSSTT":"COMPLETED","EOSDT":"2022-04-09","EOSDY":731,"DTHDT":"2022-04-09","LSTALVDT":"2022-04-27","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.27982,"AVALU":"YEARS","ADTM":"2020-09-09","ADY":154,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-4-id-382","SUBJID":"id-382","SITEID":"USA-4","AGE":31,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-4","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"C","STRATA2":"S1","BMRKR1":7.94871,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2020-04-06","TRTSDTM":"2020-04-08 20:18:25","TRTEDTM":"2022-04-09 07:56:49","EOSSTT":"COMPLETED","EOSDT":"2022-04-09","EOSDY":731,"DTHDT":"2022-04-09","LSTALVDT":"2022-04-27","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.12884,"AVALU":"YEARS","ADTM":"2020-08-01","ADY":115,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-5-id-179","SUBJID":"id-179","SITEID":"USA-5","AGE":30,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.67743,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-13","TRTSDTM":"2021-04-14 11:35:38","TRTEDTM":"2023-04-14 23:14:02","EOSSTT":"COMPLETED","EOSDT":"2023-04-14","EOSDY":731,"DTHDT":"2023-04-14","LSTALVDT":"2023-05-09","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.21191,"AVALU":"YEARS","ADTM":"2022-12-18","ADY":613,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-5-id-179","SUBJID":"id-179","SITEID":"USA-5","AGE":30,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.67743,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-13","TRTSDTM":"2021-04-14 11:35:38","TRTEDTM":"2023-04-14 23:14:02","EOSSTT":"COMPLETED","EOSDT":"2023-04-14","EOSDY":731,"DTHDT":"2023-04-14","LSTALVDT":"2023-05-09","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.54319,"AVALU":"YEARS","ADTM":"2022-01-17","ADY":278,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-5-id-179","SUBJID":"id-179","SITEID":"USA-5","AGE":30,"SEX":"M","RACE":"BLACK OR AFRICAN AMERICAN","COUNTRY":"USA","INVID":"USA-5","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S1","BMRKR1":4.67743,"BMRKR2":"LOW","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2021-04-13","TRTSDTM":"2021-04-14 11:35:38","TRTEDTM":"2023-04-14 23:14:02","EOSSTT":"COMPLETED","EOSDT":"2023-04-14","EOSDY":731,"DTHDT":"2023-04-14","LSTALVDT":"2023-05-09","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.10002,"AVALU":"YEARS","ADTM":"2022-03-28","ADY":348,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-6-id-151","SUBJID":"id-151","SITEID":"USA-6","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":2.04531,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-11-12","TRTSDTM":"2020-11-16 06:29:30","TRTEDTM":"2022-11-16 18:07:54","EOSSTT":"COMPLETED","EOSDT":"2022-11-16","EOSDY":731,"DTHDT":"2022-11-16","LSTALVDT":"2022-12-03","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.40428,"AVALU":"YEARS","ADTM":"2021-03-18","ADY":122,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-6-id-151","SUBJID":"id-151","SITEID":"USA-6","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":2.04531,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-11-12","TRTSDTM":"2020-11-16 06:29:30","TRTEDTM":"2022-11-16 18:07:54","EOSSTT":"COMPLETED","EOSDT":"2022-11-16","EOSDY":731,"DTHDT":"2022-11-16","LSTALVDT":"2022-12-03","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.70835,"AVALU":"YEARS","ADTM":"2021-04-07","ADY":142,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-6-id-151","SUBJID":"id-151","SITEID":"USA-6","AGE":30,"SEX":"F","RACE":"WHITE","COUNTRY":"USA","INVID":"USA-6","ARM":"B: Placebo","ARMCD":"ARM B","ACTARM":"B: Placebo","ACTARMCD":"ARM B","STRATA1":"C","STRATA2":"S2","BMRKR1":2.04531,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"N","RANDDT":"2020-11-12","TRTSDTM":"2020-11-16 06:29:30","TRTEDTM":"2022-11-16 18:07:54","EOSSTT":"COMPLETED","EOSDT":"2022-11-16","EOSDY":731,"DTHDT":"2022-11-16","LSTALVDT":"2022-12-03","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.04481,"AVALU":"YEARS","ADTM":"2022-10-12","ADY":695,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-8-id-206","SUBJID":"id-206","SITEID":"USA-8","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-8","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":14.47806,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-02-22","TRTSDTM":"2020-02-25 19:55:21","TRTEDTM":"2022-02-25 07:33:45","EOSSTT":"COMPLETED","EOSDT":"2022-02-25","EOSDY":731,"DTHDT":"2022-02-25","LSTALVDT":"2022-03-12","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.03974,"AVALU":"YEARS","ADTM":"2022-01-21","ADY":696,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-8-id-206","SUBJID":"id-206","SITEID":"USA-8","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-8","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":14.47806,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-02-22","TRTSDTM":"2020-02-25 19:55:21","TRTEDTM":"2022-02-25 07:33:45","EOSSTT":"COMPLETED","EOSDT":"2022-02-25","EOSDY":731,"DTHDT":"2022-02-25","LSTALVDT":"2022-03-12","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.07634,"AVALU":"YEARS","ADTM":"2021-10-17","ADY":600,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Clinical Cut Off"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-8-id-206","SUBJID":"id-206","SITEID":"USA-8","AGE":34,"SEX":"F","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-8","ARM":"C: Combination","ARMCD":"ARM C","ACTARM":"C: Combination","ACTARMCD":"ARM C","STRATA1":"B","STRATA2":"S1","BMRKR1":14.47806,"BMRKR2":"HIGH","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"Y","BEP01FL":"Y","RANDDT":"2020-02-22","TRTSDTM":"2020-02-25 19:55:21","TRTEDTM":"2022-02-25 07:33:45","EOSSTT":"COMPLETED","EOSDT":"2022-02-25","EOSDY":731,"DTHDT":"2022-02-25","LSTALVDT":"2022-03-12","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.17155,"AVALU":"YEARS","ADTM":"2020-08-20","ADY":177,"CNSR":0,"EVNTDESC":"End of AE Reporting Period","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-9-id-130","SUBJID":"id-130","SITEID":"USA-9","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-9","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":1.28053,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-02-21","TRTSDTM":"2021-02-22 05:04:39","TRTEDTM":"2023-02-22 16:43:03","EOSSTT":"COMPLETED","EOSDT":"2023-02-22","EOSDY":731,"DTHDT":"2023-02-22","LSTALVDT":"2023-03-14","study_duration_secs":63113904,"ASEQ":3,"TTESEQ":3,"PARAM":"Time to first occurrence of any adverse event","PARAMCD":"AETTE1","AVAL":0.83421,"AVALU":"YEARS","ADTM":"2022-05-15","ADY":447,"CNSR":1,"EVNTDESC":"","CNSDTDSC":"Preferred Term"}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-9-id-130","SUBJID":"id-130","SITEID":"USA-9","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-9","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":1.28053,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-02-21","TRTSDTM":"2021-02-22 05:04:39","TRTEDTM":"2023-02-22 16:43:03","EOSSTT":"COMPLETED","EOSDT":"2023-02-22","EOSDY":731,"DTHDT":"2023-02-22","LSTALVDT":"2023-03-14","study_duration_secs":63113904,"ASEQ":1,"TTESEQ":1,"PARAM":"Time to first occurrence of any serious adverse event","PARAMCD":"AETTE2","AVAL":0.15465,"AVALU":"YEARS","ADTM":"2021-04-13","ADY":50,"CNSR":0,"EVNTDESC":"Clinical Cut Off","CNSDTDSC":""}
{"STUDYID":"AB12345","USUBJID":"AB12345-USA-9-id-130","SUBJID":"id-130","SITEID":"USA-9","AGE":40,"SEX":"M","RACE":"ASIAN","COUNTRY":"USA","INVID":"USA-9","ARM":"A: Drug X","ARMCD":"ARM A","ACTARM":"A: Drug X","ACTARMCD":"ARM A","STRATA1":"A","STRATA2":"S1","BMRKR1":1.28053,"BMRKR2":"MEDIUM","ITTFL":"Y","SAFFL":"Y","BMEASIFL":"N","BEP01FL":"N","RANDDT":"2021-02-21","TRTSDTM":"2021-02-22 05:04:39","TRTEDTM":"2023-02-22 16:43:03","EOSSTT":"COMPLETED","EOSDT":"2023-02-22","EOSDY":731,"DTHDT":"2023-02-22","LSTALVDT":"2023-03-14","study_duration_secs":63113904,"ASEQ":2,"TTESEQ":2,"PARAM":"Time to first occurrence of a grade 3-5 adverse event","PARAMCD":"AETTE3","AVAL":0.01038,"AVALU":"YEARS","ADTM":"2022-04-25","ADY":427,"CNSR":0,"EVNTDESC":"Preferred Term","CNSDTDSC":""}